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General Introduction 
Coxiella burnetii is the etiological agent of Q fever; a worldwide zoonotic disease that can result in 
large outbreaks in humans. In the recent years, there has been an immense improvement in our 
understanding of both the biology and pathogenicity of C. burnetii. However very little is known 
about the molecular mechanisms involved in its interaction with hosts. In addition, only a few 
virulence factors have been identified and biologically validated. Virulence factors of this pathogen 
most likely include determinants promoting its survival and replication in hostile intracellular 
environments and facilitating manipulation or evasion of host immune responses. Hence, the 
molecular characterization of C. burnetii isolates is essential for virulence factor analysis, 
epidemiological knowledge, outbreak investigations, development of diagnostic tools, therapeutic 
interventions and most importantly for vaccine development. In this chapter, we present an overview 
of the current knowledge on C. burnetii biology as well as the approaches used to investigate this 
pathogen and identify virulence factors, which is crucial for development of an effective and safe 
vaccine for long-term control of Q fever. 
 
Discovery of the Q fever agent 
Q fever stands for “Query fever” as very little was known about the causative agent and the disease 
when it was first discovered in the 1930s. Q fever was ﬁrst described in abattoir workers in Brisbane, 
Queensland, Australia by Edward Holbrook Derrick [1,2]. Simultaneously, the pathogen was isolated 
by Frank Macfarlane Burnet and Mavis Freeman from samples sent by Derrick, who hypothesized Q 
fever was of rickettsial origin [3]. Around the same time Herald Cox and Gordon Davis at the Rocky 
Mountain Laboratory in Hamilton, independently isolated a new infectious agent from ticks collected 
at Nine Mile Creek, Montana with rickettsia-like properties [4]. A laboratory worker who became 
accidently infected by this new agent displayed symptoms remarkably similar to the Q fever agent 
isolated from abattoir workers in Australia, suggesting a common infectious agent. Further cross-
protection studies in mice confirmed these two newly discovered infectious agents to be the same 
pathogen [5]. The pathogen was initially designated as Rickettsia burneti, on account of its rickettsia-
like properties [2]. Based on phenotypic characters, the pathogen was later classified under a new 
genus comprising of only one species, “Coxiella burnetii” in honor of the contribution made by Cox 
and Burnet.  
C. burnetii is highly infectious with estimated ID50 (number of bacilli required to infect 50% 
of individuals) of one. This is the lowest ID50 known so far, making it one of the most infectious 
organisms. Furthermore, the bacteria are highly resistant to heat and desiccation, ubiquitous, dormant 
in environment for long periods and infectious over several kilometers when aerosolized. Due to these 
characteristics, C. burnetii could potentially be used as biological weapon and is therefore classified as 
a category B bioterrorism agent by the Centers for Disease Control (USA) [6,7]. 
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Q fever disease 
C. burnetii infects a broad range of hosts, but infections are wide-spread in domestic ruminants [8,9]. 
Among these, goats, sheep and cattle are the primary reservoirs of the pathogen and represent the most 
frequent source of human infection [10]. Infections in animals are assumed to occur mostly by 
inhalation of the pathogen from the environment and are often asymptomatic [11]. The disease 
symptoms are usually manifested in pregnant animals and widely differ between hosts [8,10,12]. In 
pregnant goats and sheep, the main clinical manifestations are abortions at final gestation stage. 
Infected cattle usually do not show symptoms although abortions, subfertility and metritis are seen in 
some cases [13]. Abortions in infected animals result in excretion of large numbers of C. burnetii 
(109/gram placenta) into the environment. Inhalation of contaminated aerosols from the environment 
are the main risk factor for infection in humans [8,9,13,14]. Following infection, 60% of infected 
humans are usually asymptomatic. In symptomatic patients, the clinical signs of acute infections vary 
greatly but generally manifest as flu-like illness and pneumonia. Following acute Q fever, a persistent 
fatigue condition causing significant disabilities in the daily life of the individual is referred to as Q 
fever fatigue syndrome (QFS). QFS has been described and well documented in many countries 
following an outbreak, but the cause of development of this condition and proper treatment course are 
still unknown [15,16]. Around 1-5% of the clinical cases can result in chronic infections after months 
or years of contracting the disease. This occurs mainly in immune deficient individuals or in 
individuals with pre-existing cardiac valvular disease and often leads to life-threatening endocarditis 
[8,13,17–19].  
 
Q fever outbreaks in the Netherlands and source identification 
Q fever outbreaks are reported frequently worldwide and have a major public health impact. The 
outbreak in the Netherlands during 2007-2010 increased the attention to Q fever as more than 4000 
human cases were registered. It is by far the largest Q fever outbreak reported in the literature 
[17,19,20]. The factors leading to the outbreak are not fully understood but have been connected with 
an increase in density of dairy goat farms in the affected area. Other speculated reasons for the 
outbreak are based on pathogen  related factors, including the hyper-virulence of the circulating strains 
which might have resulted in an increased zoonotic potential [20–25]. 
Epidemiological studies on the outbreak showed that the increase in human cases of Q fever 
coincided with an increase in abortions among goats [20,26,27]. Laboratory confirmations of the 
observed link were conducted by genotyping studies on C. burnetii isolates from a large set of samples 
from dairy goats, sheep, cattle and humans [34]. The “multilocus variable number tandem repeats” 
(MLVA) [28,30,31] and the “multispacer sequence typing” (MST) [29] methods were used for 
genotyping to determine strain diversity. A total of 13 MLVA genotypes (CbNL01 – CbNL13) of C. 
burnetii were identified in clinical samples. Among these, the CbNL01 genotype was predominantly 
present in isolates from goats and human patients. Similar results were obtained by MST genotyping, 
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genotyping to determine strain diversity. A total of 13 MLVA genotypes (CbNL01 – CbNL13) of C. 
burnetii were identified in clinical samples. Among these, the CbNL01 genotype was predominantly 
present in isolates from goats and human patients. Similar results were obtained by MST genotyping, 
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showing MST33 genotypes in goat and human isolates. A less prevalent CbNL12 genotype was 
majorly found to be associated with cattle and to a lesser extent with goat and sheep isolates 
[28,29,32,33]. This genotype was not found among human isolates, implicating the predominant goat 
associated CbNL01 genotype as the primary source of the human Q fever outbreak in the Netherlands 
and confirming the speculations of earlier epidemiological studies (Table 1) [20,23,24,28,34]. 
 
Table 1. Overview of MLVA genotypes of C. burnetii isolates collected from various hosts and 
clinical samples during the Q fever outbreak period in the Netherlands [28] 
Origin Sample type 
MLVA marker and number of repeats 
Genotype 
1 3 20 21 22 24 27 28 30 31 34 36 
Human heart valve 4 7 19 6 6 11 3 3 5 3 7 13 CbNL01 
Goat 
placenta, vaginal swab, fetal 
tissue, bulk tank milk 
4 7 19 6 6 11 3 3 5 3 7 13 CbNL01 
Sheep placenta - 7 - 6 6 11 3 3 5 3 7 13 CbNL01 
Goat placenta 3 6 15 6 6 13 2 7 6 3 9 4 CbNL12 
Sheep placenta - 6 - 6 6 13 2 7 6 3 9 4 CbNL12 
Cattle placenta 3 6 15 6 6 13 2 7 6 3 9 4 CbNL12 
Goat vaginal swab - 7 - 6 6 11 3 3 5 3 7 7 CbNL02 
Goat vaginal swab - 7 - 6 6 11 - 3 5 - 7 9 CbNL03 
Goat vaginal swab - 7 - 6 6 11 3 - 0 - 7 13 CbNL04 
Goat vaginal swab - 7 - 6 - - 3 3 6 3 7 13 CbNL05 
Goat vaginal swab - 7 - 6 6 11 3 - 4 3 7 - CbNL06 
Goat vaginal swab - 7 - 6 - - 0 3 5 3 7 13 CbNL07 
Goat vaginal swab - 7 - 6 6 - 0 0 5 3 7 13 CbNL08 
Goat fetal tissue - 7 - 6 - 11 3 4 5 3 7 2 CbNL09 
Sheep vaginal swab, bulk tank milk - 7 - 6 6 11 2 3 5 3 3 - CbNL10 
Goat fetal tissue - 7 - 6 - 11 2 0 5 3 7 13 CbNL11 
Cattle placenta - 6 - 6 6 13 2 7 6 3 10 4 CbNL13 
Among all, the CbNL01 genotype occurred most predominant followed by CbNL12 genotype 
 
Following the outbreak drastic measures were taken to reduce the spread of the pathogen and 
control the disease. The measures included large-scale culling of Q fever pregnant goats, mandatory 
vaccinations, stringent hygiene protocols, bulk tank milk monitoring etc. This resulted in a 
stabilization of the number of human cases by 2010. However the number of chronic cases due to 
outbreak infections is still significant [20,24,35]. Hence, Q fever is a significant public health threat 
that can only be diminished by development of improved diagnostic tools, better therapeutics and 
effective vaccines. Active research on the Q fever pathogen and the disease is an absolute requirement 
as little knowledge on diagnosis and treatment is presently available. 
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Life inside the host cell 
C burnetii is an obligate intracellular, small gram-negative bacterium (0.2 to 0.4μm wide, 0.4 to 1μm 
long). Upon infection, C. burnetii enters host cells by phagocytosis and is able to survive within an 
acidic parasitophorous vacuole (PV) created by fusion of phagosomes and lysosomes (Fig 3) [8,36]. 
Several intracellular bacteria such as Mycobacteria tuberculosis [37], Chlamydia psittaci [38], 
Legionella pneumophila [39], Shigellae [40] and Listeria monocytogenes [41] subvert host 
mechanisms to prevent phagolysosomal fusion to survive in host cells in order to avoid the low pH, 
oxygen radicals, and degradative proteases of the phagolysosome. Unlike these intracellular 
pathogens, C. burnetii does not employ any mechanisms to avoid the phagolysosome fusion and 
requires such harsh acidic conditions to activate its metabolism and successful replication.  
C. burnetii has a biphasic life cycle, consisting of small-cell variant (SCV) and a large-cell 
variant (LCV) morphotypes. The variants are easily distinguishable by electron microscopy and 
correspond to different developmental stages of C. burnetii [42]. SCVs are metabolically inactive and 
highly resistant to environmental stress such as osmotic pressure, heat and chemicals. Due to these 
features, SCVs can survive in the environment for long periods of time. SCV can infect eukaryotic 
hosts and transform into LCV under acidic conditions of the PV [43]. LCVs are the metabolically 
active and replicating forms of the bacteria, which can differentiate into spore-like SCVs to complete 
the developmental cycle [42].  
 
Culturing of C. burnetii under laboratory conditions  
During the Q fever outbreak period in the Netherlands, several isolates from different host species 
were obtained [28] and primarily cultured using the BGM (buffalo green monkey) cell line [11,44]. 
Cell-based culture is the gold standard method for in vitro growth of C. burnetii. The bacteria can 
grow in a number of cell types such as macrophage-like cell lines [45,46], fibroblast cells [43,47] and 
Vero cell lines [48]. Apart from cell cultures, C. burnetii also propagates within yolk-sac of 
embryonated eggs which is a widely used method for culturing large quantities of the bacterium 
[33,49]. 
The obligate intracellular nature of C. burnetii has led to experimental constraints hindering 
the research towards a better understanding of the pathogen’s disease mechanisms. A recent, 
significant advance in Q fever research has been the development of a cell-free growth media for C. 
burnetii. This complex medium known as acidified citrate cysteine medium-2 (ACCM-2) was based 
on the metabolic requirements of C. brunetti and supports axenic growth of C. burnetii in liquid broth 
and on agar plates under microaerophilic conditions. The cultured bacteria are infective and exhibit the 
characteristic SCV and LCV developmental forms similar to cell-based or in vivo grown organisms 
[50–52]. Based on ACCM-2, a commercially available defined medium ACCM-D was recently 
developed for host-cell free culture of C. burnetii [53]. 
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C. burnetii genome sequences 
The first complete C. burnetii genome sequence of the Nine Mile I RSA493 (NM) isolate was 
published in 2003. The genome appeared to be circular and was composed of a 1,995,275 bp 
chromosome and a 37,393 bp QpH1 plasmid [54]. All C. burnetii isolates sequenced so far carry an 
autonomous replicating plasmid or the plasmid sequences are integrated into their chromosome. 
Currently four plasmid types, designated as QpH1 (37 kb), QpRS (39 kb), QpDG (42 kb) and QpDV 
(33 kb) have been identified. A 16 kb region is conserved in all plasmids including in the plasmid 
sequences integrated in the chromosome, implying critical function of this region in bacterial survival 
[55–57]. Bioinformatics predictions of gene functions in the NM genome showed transportation, 
biosynthesis and metabolic capabilities, along with a high proportion (33.7%) of hypothetical genes 
with unknown function. A unique feature of C. burnetii genome sequences is the presence of large 
number of transposons compared to other obligate intracellular pathogens [58–60]. These transposase 
genes (insertion sequence elements) are associated with chromosomal rearrangements indicating a 
high plasticity of the genome (Figure 1) [54]. C. burnetii genomes also harbor pseudogenes suggesting  
 
 
 
Figure 1. Chromosomal rearrangements due to transposons. Rearrangement of an NM ORF cluster bound by 
transposase genes (grey ORFs) is shown A) CBU1699a and CBU1896b relative to CbuG_Q212 (Q212) B) 
CBU1896b and CBU1959b relative to CbuK_Q154 (Q154). The red ORFs and black dotted lines represent 
ORFs between transposase genes, orange line show ORF cluster boundaries, dotted grey line indicate deletion 
relative to NM. ORFs in CbuG_Q212 (green and yellow) and CbuK_Q154 (orange and blue) are numbered 
using orthologs of NM. ORFs denoted with + are frameshifted relative to NM. 
 
an ongoing genomic reduction [66]. The presence of pseudogenes is predicted to be specific genome 
manifestations of an intracellular lifestyle most probably contributing to bacterial evolution, 
pathogenicity and host/niche specificity [61,62]. Pseudogenes are also reported in other highly 
pathogenic bacteria such as Mycobacterium, Leprosy bacillus, Shigella spp and E. coli [63,58,64–67]. 
Thus, disparate collection of pseudogenes also in C. burnetii isolates suggest that these isolates are at 
different stages of pathoadaptation [62,68,69]. 
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Apart from the NM genome sequence [54], several other complete and draft genomes 
sequences are published and available in Genbank (Table 2). The availability of genome sequences 
from several strains obtained from various hosts and with different clinical phenotypes will enable 
improved phylogenetic analysis and extended comparative genomic analysis. These approaches may 
enrich our understanding on strain evolutions and provide information on similarities and differences 
in genome architecture and gene content between isolates and its effect on virulence and host tropism 
[71,79]. Previous comparative genomics studies on C. burnetii strains allowed the identification of 
novel genes, point mutations, large deletions and genome rearrangements shedding light on strain 
diversity [62,70,71,78]. So far, the genetic differences among C. burnetii Dutch outbreak strains are 
only based on MLVA/MST loci. Information on genetic variations encoded by these strains, which  
 
Table 2. Features of C. burnetii genome sequences available in the NCBI database 
Strains Accession No. Genome GC Plasmid CDS Reference 
NMRSA493c NC_002971.3 1995281 42.7 QpH1 2134 [54,62] 
CbRSA331c NC_010117.1 2016427 42.8 QpH1 1989 - 
Dugwayc NC_009727.1 2158758 42.4 QpDG 2060 [62] 
CbuG_Q212c NC_011527.1 2008870 42.6 integrated 1853 [62] 
CbuK_Q154c NC_011528.1 2063100 42.7 QpRS 2001 [62] 
Z3055c PRJEB1438 1995463 42.6 QpH1 1913 [70] 
Cb175c HG825990.3 1989565 42.6 QpH1 1363 [71] 
Cb109d AKYP00000000 2030000 42.5 QpH1 1846 [72] 
Q321d AAYJ01000000 2004584 42.7 QpDV 1897 [73] 
Goat Q177d NZ_AAUP00000000.2 2090565 42.6 QpRS 1995 - 
Cb_C2d CCAJ01000000 2013749 42.5 QpH1 1949 [30,74] 
Cb_B1d CCAH01000000 2008014 42.5 QpH1 1919 [30,74] 
EV-Cb_BK10d CCAL01000000 1999727 42 unknown 1909 [74] 
Cb_O184d CCAK01000000 2168222 42.4 QpRS 2014 [30,74] 
EV-Cb_C13d CCAM01000000 2023172 42.6 unknown 1939 [74] 
Cb_B18d CCAI01000000 2008445 42.5 unknown 1917 [74] 
Cb171d CDBG00000000.1 2077120 42.5 unknown - - 
Dog Utadd PRJEB4294 2008938 44.5 integrated 1896 [75] 
Cb196 CCXO00000000.1 2006415 42.9 QpRS 1898 [69] 
Namibiad CP007555 2101438 41.1 QpRS 1979 [76] 
Cb185d NZ_CBTH000000000.1 1991515 42.6 unknown 1806 - 
AuQ01d JPVV00000000 2073000 42.5 QpRS 1984 [77] 
NL-Limburgd JZWL00000000 2214254 42.8 QpH1 2097 [78] 
c: complete genomes (Genome in bp) 
d: draft genomes (Genome in bp) 
Integrated: plasmid sequences integrated in chromosomes 
Unknown: plasmid type not known for these C. burnetii strains 
General introduction
C
ha
pt
er
 1
15
14 
 
C. burnetii genome sequences 
The first complete C. burnetii genome sequence of the Nine Mile I RSA493 (NM) isolate was 
published in 2003. The genome appeared to be circular and was composed of a 1,995,275 bp 
chromosome and a 37,393 bp QpH1 plasmid [54]. All C. burnetii isolates sequenced so far carry an 
autonomous replicating plasmid or the plasmid sequences are integrated into their chromosome. 
Currently four plasmid types, designated as QpH1 (37 kb), QpRS (39 kb), QpDG (42 kb) and QpDV 
(33 kb) have been identified. A 16 kb region is conserved in all plasmids including in the plasmid 
sequences integrated in the chromosome, implying critical function of this region in bacterial survival 
[55–57]. Bioinformatics predictions of gene functions in the NM genome showed transportation, 
biosynthesis and metabolic capabilities, along with a high proportion (33.7%) of hypothetical genes 
with unknown function. A unique feature of C. burnetii genome sequences is the presence of large 
number of transposons compared to other obligate intracellular pathogens [58–60]. These transposase 
genes (insertion sequence elements) are associated with chromosomal rearrangements indicating a 
high plasticity of the genome (Figure 1) [54]. C. burnetii genomes also harbor pseudogenes suggesting  
 
 
 
Figure 1. Chromosomal rearrangements due to transposons. Rearrangement of an NM ORF cluster bound by 
transposase genes (grey ORFs) is shown A) CBU1699a and CBU1896b relative to CbuG_Q212 (Q212) B) 
CBU1896b and CBU1959b relative to CbuK_Q154 (Q154). The red ORFs and black dotted lines represent 
ORFs between transposase genes, orange line show ORF cluster boundaries, dotted grey line indicate deletion 
relative to NM. ORFs in CbuG_Q212 (green and yellow) and CbuK_Q154 (orange and blue) are numbered 
using orthologs of NM. ORFs denoted with + are frameshifted relative to NM. 
 
an ongoing genomic reduction [66]. The presence of pseudogenes is predicted to be specific genome 
manifestations of an intracellular lifestyle most probably contributing to bacterial evolution, 
pathogenicity and host/niche specificity [61,62]. Pseudogenes are also reported in other highly 
pathogenic bacteria such as Mycobacterium, Leprosy bacillus, Shigella spp and E. coli [63,58,64–67]. 
Thus, disparate collection of pseudogenes also in C. burnetii isolates suggest that these isolates are at 
different stages of pathoadaptation [62,68,69]. 
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could have resulted in the epidemic, is still missing. In Chapter 4 and 5 of this thesis we have 
sequenced several Dutch strains and performed a comparative genome analysis to provide an overview 
of clonal diversity of these strains in relation to virulence, and deciphered mechanisms adapted by the 
outbreak strains.  
 
Bacterial virulence 
The intracellular lifestyle of C. burnetii has hampered the identification of virulence factors and as a 
result lipopolysaccharide (LPS) is the major genetically confirmed virulence factor known [80]. 
Bioinformatics predictions of gene functions based on available genome sequences, has not resulted in 
the identification of potential C. burnetti (cyto) toxins. Nevertheless, gene functions were identified 
which are involved in subverting oxidative stress, DNA repair and effector proteins with eukaryotic-
like domains which could be involved in modulating host responses. Researchers now consider these 
factors crucial for pathogenicity and intracellular survival [54,62,81]. The C burnetii genome also 
encompasses several genes encoding hypothetical proteins with unknown functions, a proportion of 
which are highly conserved across C. burnetii strains [62,70]. Several of these hypothetical proteins 
are membrane-associated implying their potential involvement in the interaction with the host, 
whereas other hypothetical proteins could be important for the unique lifestyle of C. burnetii. 
Therefore, functional annotation of the genes with unknown functions will increase our knowledge on 
pathogenicity and may result in the identification of novel virulence factors. 
 
Phase variation: Presence or absence of LPS largely correlates with “phase variation” in C. burnetii. 
Phase I bacteria containing an intact LPS are virulent and able to replicate and persist in 
immunocompetent hosts most likely by avoiding host defense mechanisms. In contrast, phase II  
 
 
 
Figure 2. C. burnetii O-antigen part (38 kb) of LPS encoding genes. The cluster of O-antigen genes, CBU0676-
CBU0706 is labelled as 1-31. The genes indicated in grey are hypothesized to be involved in O-antigen synthesis 
and export, whereas the genes indicated in green are hypothesized to be involved in other LPS synthesis steps 
and carbohydrate metabolism. Genes bordered in red are deleted in the NM phase II strain. 
 
bacteria are mostly characterized by a truncated LPS and are avirulent, being effectively cleared by 
host immune responses [82]. Phase 1 LPS is also identified as a key determinant of protective 
immunity [83] as vaccines prepared from phase I bacteria provide better protection against Q fever in 
human and animals compared to phase II-based vaccines [8,84,85]. A shift from phase I to phase II 
17 
 
forms occurs due to repeated passages of bacteria in in vitro cultures and is often associated with 
deletion of clusters of genes involved in production of O-antigen part of LPS (Figure 2) [73,86].  
 
Ability to subvert oxidative stress: Within the environment of the PV, C. burnetii is exposed to varying 
levels of reactive oxygen and nitrogen species (ROS and RNS), which represent the primary defense 
mechanism of the host cells against invading bacteria. To survive and replicate within this harsh 
environment, C. burnetii encodes numerous enzymes such as superoxide dismutase, catalase and 
peroxiredoxins (encoded by sodBC, katE, ahpC1C2D) capable of detoxifying deleterious reactive 
molecules [62,81]. The bacteria also encode for a limited numbers of DNA repair genes involved in 
base excision repair, nucleotide excision repair and recombinational DNA repair (encoded by addAB 
complex) [81,87,88]. Due to presence of limited DNA repair genes, a constitutive expression of these 
genes might be necessary to maintain the integrity of genome during replication of C. burnetii inside 
host PVs (Figure 3) [81,88]. 
 
 
 
Figure 3. Uptake of C. burnetii by host cells and virulence mechanisms against oxidative stress and intracellular 
host signaling. C. burnetii enters the host cell by phagocytosis and multiplies in acidic PV. C. burnetii uses 
oxidative enzymes and DNA repair as defense mechanisms against reactive oxygen species (ROS) and nitrogen 
species generated by host cells. Manipulation of host responses by C. burnetii could be effected by numerous 
effector proteins, delivered to the host cytosol by the T4SS and other secretion systems. (Acp- acid phosphatase 
enzyme; Anks- Ankyrin repeat containing proteins). 
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could have resulted in the epidemic, is still missing. In Chapter 4 and 5 of this thesis we have 
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forms occurs due to repeated passages of bacteria in in vitro cultures and is often associated with 
deletion of clusters of genes involved in production of O-antigen part of LPS (Figure 2) [73,86].  
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Host component modulations: Like other intracellular pathogens, C. burnetii possibly adapts processes 
resulting in manipulation of host signaling pathways during intracellular growth to ensure a viable, 
sustainable niche to successfully replicate [89]. C. burnetii encodes several signal sequence-containing 
enzymes which could actively manipulate intracellular host signaling [90,91]. For example, an acid 
phosphatase is predicted to inhibit phosphorylation of host proteins and prevent oxidative burst after 
phagocytosis, helping the bacteria to cope with oxidative stress [62,92]. Additionally, enzymes such as 
phospholipases and inositol-phosphate phosphatases are speculated to act on host cell lipids and 
manipulate lipid signaling pathways [62,90,93]. Furthermore, C. burnetii encodes multiple eukaryotic 
like proteins which could mimic activity of host cell proteins [94]. Among these are proteins with the 
ankyrin repeat regions that interferes with host cell apoptosis pathway [95]. Other examples include 
two eukaryotic like sterol reductases. These enzymes are predicted to be involved in final stages of 
cholesterol or novel sterol synthesis using intermediates of host cell lipids, which can have structural 
or signaling roles [90,96]. Other proteins that contain eukaryotic like domains (F boxes, 
serine/threonine protein kinases, tetratricopeptide repeats, leucine-rich repeats and coiled core 
domains) are assumed to be interfering with host ubiquitin signaling pathways and in host cell signal 
transduction [62,97–99]. Many of the effector proteins that are intimately involved in virulence and 
pathogenesis of C. burnetii, are anticipated to translocate into the host cytosol by a Type IV secretion 
system (T4SS) [54,100,101]. The T4SS is conserved in C. burnetii strains implying the critical 
function of this protein secretion system in bacterial survival and intracellular replication (Figure 3). 
 
Animal models, host specificity and immune responses to C. burnetii 
Domestic ruminants such as goat and sheep are the most important source of infection in humans, 
while a minority of the human infections are attributed to cattle [8,28,102]. Strikingly, different 
disease phenotypes are seen in different C. burnetii hosts. Severe forms of disease outcomes, such as 
abortions, commonly occur in goats, whereas infected cattle usually do not show any clinical 
symptoms [8,13,28]. Epidemiological studies based on seroprevalence, reveal the presence of high 
percentage of anti-C. burnetii antibodies in cattle herds than in goats and sheep herds in The 
Netherlands and few other European countries. On the contrary, Q fever outbreaks are rarely linked to 
cattle [102,103]. Additionally, we also see that only a specific genotype of C. burnetii strains 
(CbNL12) are associated in with cattle populations in European countries [28,32,102]. Reasons 
underlying these differences in disease phenotypes, host susceptibility and seroprevalence are not well 
understood and can be assessed in appropriate animal models.  
Mice and guinea pigs are highly susceptible to C. burnetii and are commonly used animal 
models to study disease pathogenesis, strain virulence and host immune responses [33,80,104–109]. C. 
burnetii infection in immunocompetent guinea pigs and mice by intraperitoneal routes result in 
systemic infections characterized by hepato-splenomegaly at early infection periods (7-14 days) [110]. 
The degree of splenomegaly and bacterial load in spleens after infection are regarded important 
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parameters pointing towards the virulence potential of C. burnetii strains [33,105,108,109]. At later 
infection period (21-28 days) a decrease in the spleen weight and bacterial load is seen implying a 
clearance of the infection [33,108]. Also in pregnant mice, a systemic infection occurs with an 
abundant presence of C. burnetii in both fetal as well as maternal parts of the placenta, which results in 
high frequency of abortions and still-births [111]. Although mice models are routinely used, 
experiments with natural Q fever host model like goats can provide significant insights in accurate 
diagnosis of infected animals, mechanisms of bacterial pathogenicity, transmission routes and immune 
responses [11,14,44,112]. In contrast to mice model, C. burnetii infections in pregnant goats results in 
localized infection that are restricted to the trophoblasts of the fetal part of the placenta. As a result, 
abortions can be the major clinical symptoms in goats after a C. burnetii infection. After abortion or 
parturition, infected goats are able to gradually clear the infection [11,112].  
So far, studies in mice showed the importance of both humoral and cell mediated immune 
responses for successful host defense against C. burnetii infection [113]. With respect to humoral 
immunity, IgM and IgG antibodies can be detected in infected mice against C. burnetii phase I and II 
antigens [33,114]. The role of cellular mediated immunity in the host defense against C. burnetii 
infections is not well established. In general, macrophages and other mononuclear cells are primary 
target cells of C. burnetii, T cells are implicated to be critical for bacterial clearance, cytokines IFN-γ 
and TNF-α are associated with early control of infection and B cells are important for the prevention 
of tissue damage [108,109]. In pregnant goats, the humoral immunity against C. burnetii is strong and 
can be detected quite early in infection similar to mice. Both IgM and IgG antibodies against C. 
burnetii phase I and II antigens are elicited after infection. On the contrary, cellular immune responses 
are less prominent and only measurable at later infection periods (4 weeks pre-parturition). An 
increase in systemic IFN-γ mRNA levels and production of IFN-γ by stimulation of systemic PBMCs 
are only prominent at later times post-infection. This indicates that the inflammatory cytokines 
probably do not play a role in preventing C. burnetii replication at the beginning of the infection in 
pregnant goats, as seen in mice [44,109]. 
Similar to mice and different from goats, a systemic infection of Q fever occurs in humans. 
During acute infections, a strong cellular host response is provoked which controls the infection by 
granuloma formation. IFN-γ is produced following acute infections which controls the bacterial 
growth by recruiting monocytes, macrophages and fibroblast at sites of infection and stimulating anti-
microbial responses by forming granulomas that effectively enclose sites of C. burnetii infection [17]. 
Thus, cell-mediated immunity in humans is important for control of acute infection and prevention of 
disease. In contrast, immune responses during chronic Q fever are ineffective and are associated with 
reduced granulomas [17]. Elevated levels of interleukin-10 (IL-10) and induced growth of the 
pathogen in monocytes and macrophages have been found in chronic Q fever patients and are 
implicated as the pathogens ability to establish a persistent infection [115,116]. IL-10 is a pleiotropic 
cytokine exhibiting both pro and anti-inflammatory properties. C. burnetii, like other intracellular 
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Host component modulations: Like other intracellular pathogens, C. burnetii possibly adapts processes 
resulting in manipulation of host signaling pathways during intracellular growth to ensure a viable, 
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domains) are assumed to be interfering with host ubiquitin signaling pathways and in host cell signal 
transduction [62,97–99]. Many of the effector proteins that are intimately involved in virulence and 
pathogenesis of C. burnetii, are anticipated to translocate into the host cytosol by a Type IV secretion 
system (T4SS) [54,100,101]. The T4SS is conserved in C. burnetii strains implying the critical 
function of this protein secretion system in bacterial survival and intracellular replication (Figure 3). 
 
Animal models, host specificity and immune responses to C. burnetii 
Domestic ruminants such as goat and sheep are the most important source of infection in humans, 
while a minority of the human infections are attributed to cattle [8,28,102]. Strikingly, different 
disease phenotypes are seen in different C. burnetii hosts. Severe forms of disease outcomes, such as 
abortions, commonly occur in goats, whereas infected cattle usually do not show any clinical 
symptoms [8,13,28]. Epidemiological studies based on seroprevalence, reveal the presence of high 
percentage of anti-C. burnetii antibodies in cattle herds than in goats and sheep herds in The 
Netherlands and few other European countries. On the contrary, Q fever outbreaks are rarely linked to 
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systemic infections characterized by hepato-splenomegaly at early infection periods (7-14 days) [110]. 
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parameters pointing towards the virulence potential of C. burnetii strains [33,105,108,109]. At later 
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clearance of the infection [33,108]. Also in pregnant mice, a systemic infection occurs with an 
abundant presence of C. burnetii in both fetal as well as maternal parts of the placenta, which results in 
high frequency of abortions and still-births [111]. Although mice models are routinely used, 
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diagnosis of infected animals, mechanisms of bacterial pathogenicity, transmission routes and immune 
responses [11,14,44,112]. In contrast to mice model, C. burnetii infections in pregnant goats results in 
localized infection that are restricted to the trophoblasts of the fetal part of the placenta. As a result, 
abortions can be the major clinical symptoms in goats after a C. burnetii infection. After abortion or 
parturition, infected goats are able to gradually clear the infection [11,112].  
So far, studies in mice showed the importance of both humoral and cell mediated immune 
responses for successful host defense against C. burnetii infection [113]. With respect to humoral 
immunity, IgM and IgG antibodies can be detected in infected mice against C. burnetii phase I and II 
antigens [33,114]. The role of cellular mediated immunity in the host defense against C. burnetii 
infections is not well established. In general, macrophages and other mononuclear cells are primary 
target cells of C. burnetii, T cells are implicated to be critical for bacterial clearance, cytokines IFN-γ 
and TNF-α are associated with early control of infection and B cells are important for the prevention 
of tissue damage [108,109]. In pregnant goats, the humoral immunity against C. burnetii is strong and 
can be detected quite early in infection similar to mice. Both IgM and IgG antibodies against C. 
burnetii phase I and II antigens are elicited after infection. On the contrary, cellular immune responses 
are less prominent and only measurable at later infection periods (4 weeks pre-parturition). An 
increase in systemic IFN-γ mRNA levels and production of IFN-γ by stimulation of systemic PBMCs 
are only prominent at later times post-infection. This indicates that the inflammatory cytokines 
probably do not play a role in preventing C. burnetii replication at the beginning of the infection in 
pregnant goats, as seen in mice [44,109]. 
Similar to mice and different from goats, a systemic infection of Q fever occurs in humans. 
During acute infections, a strong cellular host response is provoked which controls the infection by 
granuloma formation. IFN-γ is produced following acute infections which controls the bacterial 
growth by recruiting monocytes, macrophages and fibroblast at sites of infection and stimulating anti-
microbial responses by forming granulomas that effectively enclose sites of C. burnetii infection [17]. 
Thus, cell-mediated immunity in humans is important for control of acute infection and prevention of 
disease. In contrast, immune responses during chronic Q fever are ineffective and are associated with 
reduced granulomas [17]. Elevated levels of interleukin-10 (IL-10) and induced growth of the 
pathogen in monocytes and macrophages have been found in chronic Q fever patients and are 
implicated as the pathogens ability to establish a persistent infection [115,116]. IL-10 is a pleiotropic 
cytokine exhibiting both pro and anti-inflammatory properties. C. burnetii, like other intracellular 
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pathogens, may take advantage of the anti-inflammatory properties of IL-10 as a means of avoiding 
sterilizing immunity and establishing a persistent infection [117–119].  
 
Diagnosis of Q fever 
Although isolation of C. burnetii provides definitive diagnosis, culturing of the pathogen is 
problematic owing to biosafety standards and extreme infectivity potential of the organism [120]. In 
humans, laboratory diagnosis of Q fever is mainly based on serology by enzyme-linked 
immunosorbent assay (ELISA), indirect immunoﬂuorescence antibody test (IFA) or complement 
ﬁxation test (CFT). These tests allow detection of phase I and II specific antibodies which are 
extremely useful in differentiating acute and chronic illness in humans. In acute infections, higher 
levels of IgM and IgG antibodies against phase II antigens are detected by the third week. During 
chronic infections elevated IgG antibodies against phase I antigens are uniformly detected [8,9,121–
123]. In animals, C. burnetii infections are usually diagnosed with PCR tests on a wide range of 
clinical samples (aborted placenta, milk, feces) and serology (CFT and ELISA tests). PCR tests are 
highly sensitive as it is based on targeting and amplifying multiple copies of genomic IS1111 elements 
[124]. During the Q fever outbreak in Netherlands diagnosis in animals were conducted both directly 
and indirectly using PCR tests on IS1111 elements and ELISAs on serum samples [125]. 
 
Treatments and vaccines for Q fever 
Presently, antibiotics are the choice of treatment for Q fever in humans. Acute infected patients are 
usually treated with doxycycline, whereas for chronic infection patients, long term treatment with 
doxycycline and hydrochloroquine is recommended [8,9,19,120]. In animals, the effect of antibiotics 
is poorly studied and antibiotic treatment with oxytetracycline has shown to be ineffective [126]. The 
primary method of preventing Q fever is through vaccination of humans and animals. Phase I LPS is a 
major protective immunogen in human and animal vaccines providing feasible protection against Q 
fever. The whole-cell formalin-inactivated vaccine (Q-Vax) with an efficacy of 98% is considered to 
be quite safe for humans after a pre-screening skin test [84]. Moreover, a phase I vaccine containing 
inactivated C. burnetii (Coxevac) has proven to be effective in goats and cattle [85,127,128]. 
However, vaccination with whole-cell materials was shown to induce severe local and occasional 
systemic reactions [129]. In addition, the requirement of BSL-3 facilities for production of whole cell 
vaccines makes the process expensive and troublesome. Efforts to overcome this problem by 
developing a subunit vaccine would offer great potential in the control of Q fever outbreaks as well as 
limiting the transmission of C. burnetii to humans.  
 
Tools and approaches to study the pathogen 
Q fever is known from a very long time but still poorly understood majorly due to the intracellular 
lifestyle of the bacterium. Development and validation of new and existing tools is required for 
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characterization of the pathogen and its interactions with host which will accelerate our understanding 
of bacterial pathogenesis. Such knowledge will ultimately aid in development of better vaccines, 
preventing future outbreaks. This section discusses the advantages and critical points of the different 
tools and approaches required to study C. burnetii. 
 
Host cell free culture: Development of cell-free culture system overcomes the drawbacks encountered 
when studying the pathogen in cell-based culture or in vivo models. This system allows the molecular 
characterization of C. burnetii by genetic modification techniques like transformation, transposon 
mutagenesis, gene knock-ins and targeted gene inactivation [51,130–134]. Axenic cultures have also 
resulted in purification of bacteria free from host cell contaminants [135,136]. Such pure bacterial 
cultures are optimal for genetic and biochemical analyses as well as for vaccine production [78]. 
Although, cell-free system rescues the bacterium from host, understanding the behavior of C. burnetii 
obtained from this artificial chemical defined media is crucial to extrapolate the results to the in vivo 
situation. Hence validation of cell-free system with respect to in vivo mimicking systems is important 
for full appreciation of this advanced culture system.  
 
Enumeration of C. burnetii: Quantification of live C. burnetii is a critical parameter to accurately 
determine inoculation doses in animal experiments as well as to assess the proliferative capacity of 
bacterial strains in various culture models. To date, procedures to determine bacterial viability by 
direct enumeration methods are obtained by focus forming unit (FFU) and colony forming unit assays 
(CFU). These techniques involve counting of infectious plaques in cells and colonies on agar plates of 
serially diluted samples respectively. The FFU method involves an indirect immunofluorescent assay 
using C. burnetii specific monoclonal antibodies to demonstrate infected cells which can be counted 
microscopically [52,107,137]. The CFU method involves a soft agarose overlay method resulting in 
minute colonies (diameter of 0.05 mm) embedded in the semi-solid medium [51]. These direct 
enumeration methods are tedious, less sensitive and time consuming (6-12 days). Therefore, bacterial 
quantification is usually conducted by qPCR methods on selected single copy gene [105,108,109]. 
However, qPCR methods fail to discriminate between live/ dead bacterial cells [33]. Hence, it is 
important to develop a simple and easy method to quantify live amounts of C. burnetii cells.  
 
C. burnetii Phase identification: As the ability of C. burnetii to transition between phase I and II forms 
affects virulence, the ability to quantify the presence of these different forms is crucial for assessing 
the virulence potential of bacterial cultures. Currently, the most widely used method to identify phase 
variation is by assessing phase I and II LPS profiles on a SDS-PAGE of extracted LPS samples or 
digested whole cell lysates,[73,138–142]. This method is feasible but as the antigenic phase transition 
is accompanied by a chromosomal deletion [86], this approach does not give exact information on 
which genes are deleted and the mechanism of transition. Additionally, this method also does not give 
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pathogens, may take advantage of the anti-inflammatory properties of IL-10 as a means of avoiding 
sterilizing immunity and establishing a persistent infection [117–119].  
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a quantitative measurement of the percentage of cells in a bacterial population undergoing the change. 
Other molecular techniques used are: PCRs on all genes of the LPS encoding regions [143]; genomics-
oriented tools like genome hybridization by DNA microarrays [73]; reverse transcriptase-PCR for 
expression of genes [143]; and sequencing of the O-antigen encoding genomic region [86,143]. These 
methods are elaborate and tedious; therefore, a more robust and easy to use technique to detect 
functional deletion of all genes resulting in phase variation would be a comprehensive approach to 
detect phase variation in C. burnetii bacterial population.  
 
Pathogen Omics approaches: In the last decade advances in deep-sequencing, computational 
technologies and other genomic technologies have revolutionized the study on viral and bacterial 
pathogens. For example; the availability of the first whole genome sequence of C. burnetii, has 
significantly increased our knowledge on the pathogen physiology as well as on putative host-
pathogen interactions [54]. Genomic approaches and phylogeographical analysis can be effectively 
used for source identification in outbreaks and molecular epidemiology, which are usually conducted 
by more generic genotypic studies [22,28,29,33,144–146]. Available genotyping tools such as MLVA 
takes advantage of rapid occurring variation of tandemly repetitive DNA sequences [30,147] whereas, 
MST is based on intergenic region sequencing to differentiate bacterial isolates [148]. As these 
traditional genotyping methods are based on identification of only a few selected loci on the genome, 
it lacks sufficient discriminatory power to fully resolve the epidemiology of large outbreaks or to 
identify chromosomal changes associated with alterations in virulence. Besides, comparative genomic 
approaches enable the identification of conserved and novel genes as well as Single Nucleotide 
Polymorphisms (SNPs) to investigate variations between isolates [62,70]. Furthermore, whole-genome 
transcriptomics approaches can enable functional analysis of pathogens, which will aid in deciphering 
the mechanism of their interactions with hosts. Therefore, pathogen Omics can be used as a powerful 
approach to gain new insights into evolution of C. burnetii, to unravel bacterial adaptations to host/ 
tissue, identification of virulence factors and track mechanisms of pathogenesis contributing to the 
survival strategy of C. burnetii. Knowledge on such virulence signatures may provide a basis for 
development of next-generation Q fever vaccines. 
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Aim and Outline of Thesis 
The research presented in this thesis focuses on the molecular characterization and pathogenesis of C. 
burnetii (causative agent of Q fever) strains that were isolated during outbreak period in the 
Netherlands. These studies were conducted in order to provide knowledge on bacterial virulence, 
evolution, adaptations under various environmental conditions, identification of factors involved in 
successful infection and host immune responses to C. burnetii infection. We specifically aimed to 
identify the virulence factors and mechanisms that contributed to the increased zoonotic potential of 
the strain associated with the largest Q fever outbreak that occurred from 2007-2010 in The 
Netherlands. In addition, the thesis describes new tools developed and validated to study C. burnetii. 
 
The main objectives of this thesis were  
i. To validate cell-free culture system by comparison of virulence characteristics of C. burnetii 
strains propagated from cell-based and cell-free cultures  
ii. To improve our understanding of pathogenesis of C. burnetii to its microenvironment 
iii. To apply comparative genomics approaches in order to:  
a. Confirm goats as the source of outbreak in humans during the large Q fever epidemic in 
The Netherlands as suggested by epidemiological and genotyping studies 
b. To investigate the phylogenetic diversity among various C. burnetii outbreak strains 
c. To identify potential genetic differences in outbreak strains resulting in hyper-virulence 
characteristics 
iv. To study if differential immune responses to C. burnetii strains isolated from various host-
origin could be an explanation of divergent clinical outcomes observed in infected cattle, goats 
and humans hosts and also to explain the low incidence of human Q fever outbreaks caused by 
cattle. 
 
Chapter 1 provides an overview of our current understanding of the Q fever causative agent C. 
burnetii and associated host-pathogen interactions by reviewing relevant scientific literature. This 
chapter provides a historical perspective regarding discovery of the pathogen and further provides 
information on the disease and why research into Q fever is crucial. Special emphasis is given to the 
recent zoonotic impact of this infectious disease in the Netherlands and factors contributing to this 
unprecedented outbreak of Q fever. 
Standard culturing of C. burnetii involves its troublesome propagation inside eukaryotic cells. 
Whereas since 2009, the introduction of a revolutionary host-cell free culture system, [50] which 
allows culturing of C. burnetii in absence of cells, offers huge advantages in Q fever research. 
Chapter 2 validates the axenic media by comparing various virulence related characteristics of the 
cell-free cultured strains with the gold-standard cell-based culture strains in a newly developed mice 
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model. Also, a simple and easy indirect enumeration method for assessing viable C. burnetii based on 
propidium monoazide (PMA) treatment followed by real time PCR was developed and validated with 
the more laborious direct methods (i.e. counting focus forming and colony forming units). Such a 
method is crucial for instance in determining inoculation doses of bacteria obtained from different 
culture systems for animal experiments. Finally, we evaluated the LPS phase of C. burnetii strains 
using a transcriptomics approach. As deletions of LPS encoding genes are involved in variation from 
phase I LPS to phase II LPS, we assessed expression of these genes to identify the bacterial phase in 
cell-based and cell-free cultured strains. The techniques and mice model developed in this study 
became part of the standard operating procedures for Q fever research in our facility and were applied 
in the further studies described in this thesis. 
To obtain a better understanding of the pathogen interactions with its host, Chapter 3 
describes genome-wide transcriptional profiles of outbreak and reference C. burnetii strains assessed 
in in vivo and different in vitro culture models. Here gene expression differences of bacteria isolated 
from spleens of experimentally infected mice (in vivo model) and bacteria propagated in cell-based 
and cell-free cultures (in vitro model) were determined. This aim of this study was to gain a better   
understanding of the metabolic adaptations and virulence mechanisms employed by the bacteria in its 
microenvironment by comparing gene expression patterns of the C. burnetii during growth under 
different natural and more artificial conditions. 
Chapter 4 and 5 describe the genome analysis of the C. burnetii outbreak strains isolated 
during the Q fever outbreak period (2007-2010) in the Netherlands. Using Whole Genome deep-
Sequencing approaches we fully reconstructed the Dutch veterinary outbreak strain genome and a 
large counterpart of the human outbreak strain. Draft genome sequences of additional C. burnetii 
strains from different origin (country, species) were reconstructed and analyzed by comparative 
genomics approaches. Phylogenetic and comparative analyses were performed, to infer relationship 
between C. burnetii strains and to identify major differences, possible pathogenic adaptation as well as 
virulence factors in outbreak strains. In addition, the study validates available genotyping tools (based 
on MLVA and MST methods), which were previously used for C. burnetii outbreak investigations. 
Next to the pathogen perspective, we also investigated the host immune responses generated 
by various C. burnetii strains. In these studies, the goal was to identify if C. burnetii strains originating 
from various hosts or with different MLVA genotypes have an effect on host immune responses. 
Chapter 6 describes experiments performed in an in vivo mice infection model, whereas experiments 
in an in vitro model using healthy human PBMCs are described in Chapter 7. A large collection of C. 
burnetii strains from different host species (goat, sheep, cattle and human) and different MLVA 
genotypes (CbNL01 and CbNL12) were used in these studies. In the mouse infection model, we 
measured innate and adaptive immune responses at different time points (Chapter 6). Cytokine 
profiles generated by healthy human PBMCs upon stimulation with heat-inactivated C. burnetii strains 
were measured in Chapter 7. 
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In Chapter 8 the major findings of this thesis are presented and discussed in the context of 
available literature. The chapter describes genetic diversity of the Dutch outbreak C. burnetii strains 
and its links with increased pathogenicity in hosts that could have contributed to the outbreak. We 
discuss the contributions of pathogen omics experimental approaches in understanding pathogen 
interactions with host and its potential use in epidemiology and outbreak investigations. Moreover, we 
also discuss the possible factors resulting in the various disease phenotypes observed in naturally 
infected animals and the factors that contribute to low risk of cattle and high risk of goats hosts in Q 
fever outbreaks. Additionally, the relevance of culture and infection models of C. burnetii and tools 
developed to study the pathogen are reviewed. Finally, we discuss the potential utility of the thesis 
results for disease control and future studies on identification of targets for putative differential 
diagnostics and Q fever vaccine candidates. 
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Abstract  
Q fever is caused by the obligate intracellular bacterium Coxiella burnetii. In vitro growth of the 
bacterium is usually limited to viable eukaryotic host cells imposing experimental constraints for 
molecular studies, such as the identification and characterization of major virulence factors. Studies of 
pathogenicity may benefit from the recent development of an extracellular growth medium for C. 
burnetii. However, it is crucial to investigate the consistency of the virulence phenotype of strains 
propagated by the two fundamentally different culturing systems. In the present study, we assessed the 
viability of C. burnetii and the lipopolysaccharide (LPS) encoding region of the bacteria in both 
culture systems as indirect but key parameters to the infection potential of C. burnetii. Propidium 
monoazide (PMA) treatment-based real-time PCR was used for enumeration of viable C. burnetii 
which were validated by fluorescent infectious focus forming unit counting assays. Furthermore, RNA 
isolated from C. burnetii propagated in both the culture systems was examined for LPS-related gene 
expression. All thus far known LPS-related genes were found to be expressed in early passages in both 
culturing systems indicating the presence of predominantly the phase I form of C. burnetii. Finally, we 
used immune-competent mice to provide direct evidence, that the relative virulence of different C. 
burnetii strains is essentially the same for both axenic and cell-based methods of propagation. 
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Introduction 
Coxiella burnetii, the etiological agent of Q fever, is an obligate intracellular bacterium that multiplies 
within a modified phagolysosome of eukaryotic cells. Q fever is primarily a zoonotic infection that is 
transmitted via inhalation of contaminated aerosols associated with domestic livestock operations [1]. 
In humans Q fever manifests as acute and chronic infections. Acute infection symptoms commonly 
include fever, pneumonia or hepatitis [2,3] whereas persistent infections lead to chronic disease 
commonly presenting as endocarditis, which is difficult to treat with antibiotics [4]. A large outbreak 
occurred in the Netherlands during the years 2007-2010 where more than 40,000 people were assumed 
to be infected [5–7]. The causes for the outbreak are not fully understood and one of the main reasons 
speculated were the hyper virulent behavior of the circulating strains which might have resulted in the 
increased zoonotic potential [6,8,9]. Unfortunately, more accessible cell-free cultivation [10,11] of C. 
burnetii to be used in, for instance genetic modification or sample multiplication studies were not 
linked to virulence measurements yet. Validation of such tools assists in improved understanding of 
the pathogenesis of C. burnetii, which in turn may contribute to a more efficient control of the disease.  
The obligate intracellular nature of C. burnetii imposes several obstacles and makes it to be 
largely experimentally intractable to use molecular-genetic approaches aiming at a better 
understanding of its pathogenesis and virulence factors. Studying these factors of C. burnetii may 
benefit from the recent development of an extracellular growth medium [10,11]. However, it is crucial 
to know whether the viability of C. burnetii strains, as well as aspects of phase variation and virulence 
characteristics is not affected by the two different culturing systems. So far procedures to determine 
the viability of the bacteria based on direct enumeration methods (for instance colony counting) are 
not easily achievable for C. burnetii, although this is needed to accurately determine inoculation doses 
in animal experiments. Less often the viability of bacteria is measured by counting the infectious 
plaques/colonies in cells infected with serially diluted samples, but this method is tedious, less 
sensitive and limited to cell-based culture systems [12]. Therefore, quantification of bacteria is usually 
done by total DNA qPCR methods on selected single-copy genes [13–15]. Nevertheless, qPCR 
method fails to differentiate between live and dead cells showing the necessity to develop easier 
methods to quantify live amounts of C. burnetii. 
The production of a structurally and antigenetically unique lipopolysaccharide (LPS) molecule 
is an important feature in C. burnetii as LPS is one of the important virulence factors of the organism. 
The presence or absence of LPS also largely correlates with the phase-variation phenomenon in C. 
burnetii [16]. From the two phases, phase I is characterized by the presence of full LPS and is 
typically the virulent variant whereas phase II has a truncated LPS and usually considered avirulent 
[17]. All the LPS coding genes are located in a 38 kb region in the C. burnetii genome and it has been 
observed that chromosomal deletions in this region result in antigenic phase variation from phase I to 
phase II [18,19]. The shift from phase I to phase II occurs usually due to repeated passages of the 
C. burnetii virulence in cell-free culture
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strains in cultures or embryonated eggs [17,20], but the molecular mechanisms influencing the LPS 
modifications still remain unclear. 
Propagation of C. burnetii in cell-based cultures is considered the gold standard for in vitro 
growth. The development of an axenic (cell-free) growth medium for C. burnetii has greatly facilitated 
genetic manipulation and the isolation of single colonies on solid medium, which is not possible with 
cell-based cultivation methods [10,11,21–24]. However, the cell-free system is an enhanced artificial 
environment for C. burnetii cultivation in comparison to cell-based propagation, which closely mimics 
in vivo infection conditions. Although C. burnetii grown in cell-free medium exhibited developmental 
forms characteristic of in vivo grown organisms and are infective [11], it is not known whether they 
have altered virulence characteristics compared to C. burnetii grown in cell-based culture.  
Within the scope of virulence factor characterization, the aim of the present study was to 
investigate, whether propagation in two different in vitro culturing systems affects the viability, phase 
variation and relative virulence of C. burnetii strains. To assess viability of the C. burnetii strains, we 
used propidium monoazide (PMA) dye after comparing it with ethidium monoazide (EMA) dye for 
selective PCR amplification of DNA from viable bacterial cells [25] as well as with fluorescent 
infectious focus forming units counting (FFU) [12,26,27] and counting colony forming units (CFU) 
[10]. To determine the phase of the strains, expression of LPS coding genes was studied by using 
microarrays on RNA isolated from low and high passaged C. burnetii strains. The level of gene 
expression served as an indicator to predict the functional state of the genes present in the LPS coding 
region. The gene expression studies were further validated by using raw next generation sequencing 
reads to assess for any potential deletions of genes involved in LPS synthesis. Ultimately, the relative 
virulent phenotype of C. burnetii strains was determined by experimental infection using an immune-
competent mice model [28–31]. This study provides evidence that cell-free propagation of C. burnetii 
does not affect its viability, phase variation and relative virulence as seen by mouse virulence 
bioassay. 
 
Materials and methods 
Animals 
Two independent animal experiments were conducted using Specific-Pathogen-Free Swiss female 
OF1 mice (Charles River, l’Arbresle, France). For Experiment 1 (E1) and Experiment 2 (E2), 6 and 7 
week old mice were used respectively. The mice were housed under sterile conditions in biosafety 
level 3 facilities and acclimatized for one week before experimental infection. Each group was housed 
separately and consisted of 10 mice.  
 
Ethics statement 
Animal experiments were approved by the animal experiment commission of the Central Veterinary 
Institute of Wageningen UR, and conducted in accordance with the Dutch regulations on animal 
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experimentation (Registration numbers: 2010011.b, 2012126.a). Humane end points were defined 
prior to the experiments and all possible measures were taken to minimize animal suffering. 
 
C. burnetii strains and cultures 
In this study the isolates X09003262-001 (3262); X08014160-001 (601) and X08014160-002 (602) 
were used. These isolates were primarily isolated from the placentas of goats that aborted during the Q 
fever outbreak in the Netherlands (2007-2010) [5]. These 3 isolates were molecular typed as 2 
genetically different strains (602 and 3262 similar molecular MLVA genotype) [5] and were initially 
propagated in Buffalo Green Monkey (BGM) cells (European Collection of Cell Cultures, Salisbury, 
U.K) without antibiotics as described previously [30]. Two additional strains included in the study 
were Nine-Mile RSA 493 (NM) and Scurry Q217 (scurry) provided by D. Frangoulidis (Bundeswehr 
Institute of Microbiology, Munich) and were initially propagated in the same way. The stock cultures 
of all the strains propagated in BGM cells were stored at -80oC.  Prior to experimentally infecting 
mice, the strains were propagated for a few passages (n<4x times) in cell based and cell free culture 
systems in order to adapt the strains to the new (cell free) culture system [10] and to synchronize the 
passage numbers of the strains. 
 
Viability PCR and quantification of C. burnetii 
To determine viability of C. burnetii, PMA and EMA dyes were compared on strains cultured from 
cell-based and cell-free culture system. The protocol is essentially described before [25], where EMA 
was used to a final concentration of 100 μM to assess the viability of C. burnetii. A similar final 
concentration of 100 μM of EMA and PMA (Geniul, Spain) was used in this study. Briefly, the dyes 
were added to the samples in opaque tubes and incubated in dark for 30 min at 4oC and vortexed 
regularly. The samples were transferred to high transparent tubes and were photo-activated for 
30 minutes using PhAST blue system (Genuil, Spain). DNA was isolated from the samples by using 
NucliSENS easyMag machine (BioMérieux, USA) as per manufacture instructions. One tenth of the 
DNA was used as a template for detection and quantification of number of C. burnetii by using a 
TaqMan-based real-time PCR targeting the single copy gene (CBU_0407a, gene bank number 
AY502846) encoding a C. burnetii specific hypothetical protein as previously published [30]. A 
standard curve was generated by using ADIAVET COX Positive control (Adiagene, Marcy l’Étoile, 
France) according to the manufacturer’s instructions. 
 
Fluorescent infectious focus forming unit’s measurements 
Viability PCRs were validated by a direct enumeration method using microscopic counting of 
fluorescent infectious focus forming units (FFU). The viable number of bacterial cells were 
established by inoculating serial dilutions of bacterial cells (10-1 to 10-9) from both culture systems on 
confluent monolayers of BGM cells in 24 well tissue culture plates (Costar, Corning, USA) containing 
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15 mm coverslips (Menzel GmbH, Germany). After 24 hours incubation at 37oC in 5% CO2, infected 
cells were washed twice and incubated for 6 days. Infected cells were demonstrated by indirect 
immunofluorescence assay using C. burnetii specific monoclonal antibody (MAB313-oregon green, 
Squarix). Number of viable bacteria in the inoculum was determined from the last dilution which 
resulted in at least one infected cell [12]. To further confirm the FFU counts, CFU counts were also 
performed with the same bacterial dilutions used for FFU on solid agar plates as mentioned previously 
[10]. 
 
RNA preparation and microarray analysis 
Total RNA was isolated from C. burnetii strains by using Direct-zol RNA Miniprep Kit (Zymo 
Research, Irvine, USA) as per manufacturer’s instructions. Poly-A tails were tagged to bacterial total 
RNA (500 ng) by using Poly-A Polymerase Tailing kit (Epicenter Illumina company, Madison, USA). 
This RNA was used as starting material for Agilent’s protocols for amplification, labelling, 
hybridization, washing and scanning of the C. burnetii microarrays. The C. burnetii custom 
microarray consisted of user-designed probes (https://earray.chem.agilent.com/earray) covering the 
complete LPS-gene repertoire of several C. burnetii strains (NCBI, Accession numbers: AE016828.2, 
CP000733.1, CP001020.1, CP001019.1, CP001021.1) and were synthesized by Agilent Technologies 
(Santa Clara, CA, USA). Data was obtained through Agilent's feature extraction software (Version 
10.7.3.1) and analyzed by using GeneSpring GX software (Agilent Technologies). 
 
Genome coverage analysis 
Total DNA from high passage C. burnetii strains (n>30x times) propagated in cell-free culture was 
isolated by phenol-chloroform method [32] after overnight incubation with ATL lysis buffer and 
proteinase K (QIAGEN, Hilden, Germany). Whole genome sequencing was performed using 250 bp 
paired-end sequencing libraries (Nextera TAG-mentation sequencing kits, Epicentre, Madison, USA) 
on an Illumina MiSeq sequencer. High quality paired end reads were mapped against the reference 
NM RSA493 genome available from the NCBI database (Accession number: AE016828.2) using 
Bowtie2 alignment tool [33]. The average coverage and standard deviation (excluding repetitive 
regions) were obtained for the whole genome using a sliding-window approach and were used to 
calculate the coverage of genes involved in LPS synthesis (CBU0676 to CBU0706). Coverage below 
the minus 2 SD interval was considered as a significantly deleted gene. Apart from genome analysis, 
the protein profiles of low and high passaged 602 strain were also analyzed by SDS-PAGE using the 
whole cell lysates, as described previously [34]. The method was basically the same except for 
staining of proteins with SYPRO Orange dye (Molecular probes) and visualizing the protein profiles 
with a Typhoon Trio imager and ImageQuant 5.2 software (Molecular Dynamics). 
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Infection mice and collection of tissues 
Two independent infection experiments were performed where 10 Swiss OF1 mice per strain were 
inoculated intraperitoneally with 0.2 ml suspension of C. burnetii in phosphate buffer saline (PBS) in 
order that each mouse receives a dose of 105 genome copy equivalents as determined by quantitative 
PCR. PBS was used for the negative controls. The inocula used to infect mice were tested for number 
of viable cells after the infection experiments by using PMA-PCR. The samples were freeze thawed 
once and similar percentages (55-65%) of live bacterial cells were found in the inocula. All the strains 
from both culture systems were found to be in phase I as measured by expression profiles of LPS 
encoding genes using a microarray. One week after inoculation the mice were euthanized, weighed 
and their spleen were aseptically removed, weighed and frozen at -80°C. Weights were used for 
determining relative spleen weights (means of spleen weight/body weight (%)). 
 
Measurements of bacterial loads from spleens of mice 
To quantify the number of C. burnetii in mice spleens, DNA was extracted from the spleen by using 
the DNeasy Blood and Tissue Kit (QIAGEN, Hilden, Germany). Briefly, the spleen was homogenized 
after addition of PBS. About 200 μl suspension was taken and added to tissue lysis buffer (buffer 
ATL) and proteinase K. DNA was extracted from this suspension according to the protocol for gram-
negative bacteria as recommended by the manufacturer. 
The DNA was used as a template for detection and quantification of number of C. burnetii by using a 
TaqMan-based real-time PCR as explained above. The bacterial genome copy number from PCR was 
log transformed and determined as the mean log2 values per gram spleen. 
 
Statistical analysis 
Samples and sample-derived data from each mouse were kept separate for all treatments and analysis. 
Data from viability of PMA treated samples, normalized expression of LPS genes and relative 
virulence from groups of mice are expressed as means ± standard deviation and compared by 
independent two tailed student t-tests. Differences were considered significant at a p value of <0.01.  
 
Results 
Evaluation and comparison of PMA and EMA dyes for the C. burnetii live/dead assay 
Propidium monoazide (PMA) and Ethidium monoazide (EMA) were utilized to selectively allow real-
time PCR amplification of target DNA from viable C. burnetii cells. The basic principle involves 
selective penetration of these dyes only into dead bacterial cells with compromised membrane 
integrity but not into the live cells with intact membranes. Once inside the cells, the dyes cross link 
with DNA upon exposure to bright light and inhibits its amplification by PCR [35]. In the present 
study serially diluted C. burnetii (NM strain) containing approximately 106 cells/ml from cell-based 
and cell-free culture matrix were treated with EMA and PMA. The results show a clear difference  
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Figure 1. Viability PCR of C. burnetii on the single copy gene in cell-based and cell-free matrix. A) Comparison 
of PMA and EMA PCR with limited dilution FFU assays. PMA and EMA measurements were performed on 
normal and heat-inactivated (dead) cells of C. burnetii. FFU assays were performed to validate PMA-PCR 
measurements. B) C. burnetii strains were exposed with PMA and the genomic DNA yield was expressed as a 
percentage of alive cells corresponding to non-PMA-treated sample. The error bars represent standard deviations 
from two independent replicates. NS indicates p-value > 0.01. 
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between the two dyes. In PMA treated samples 50-60% of alive cells were detected, whereas in EMA 
treated samples only few cells (1-2%) were detected to be viable based on the DNA amplification 
compared to untreated samples (Fig. 1A). We concluded that, PMA dye selectively entered dead cells 
that allowed efficient amplification of live C. burnetii, whereas EMA inhibits DNA amplification of 
almost all cells. To validate the efficiency of PMA-PCR, limiting dilution FFU assays were conducted 
to measure the number of viable cells based on the last dilution that resulted in at least one infected 
cell. Similar amounts of viable bacteria from both the culture systems were measured as seen by 
PMA-PCR (Fig. 1A). Furthermore, CFU counts [10] also confirmed the FFU counts, where the last 
dilution resulting in colonies corresponded with the same dilution which resulted in at least one 
infected cell in FFU assay (data not shown). To test the potential in discriminating live and dead cells 
by these dyes, the samples were subjected to heat treatment at 99oC for 30 min. Very high signal 
reduction was seen in samples both treated with EMA and PMA with >99% decrease in DNA 
amplification. To further test the reproducibility of this technique, different strains from cell-based and 
cell-free culture (3262, Scurry and NM) were tested with PMA followed by qPCR. In PMA treated 
samples 30-65% of live cells were detected based on the DNA amplification (Fig. 1B) with respect to 
non-PMA treated samples. No significant differences were seen between culture systems with respect 
to viability of cells (Fig. 1B). 
 
Gene expression in LPS coding genes of C. burnetii 
Within the 38 kb region of C. burnetii strains the junctions of large, nested deletions are located which 
can lead to phase variation [18]. We first tried to find evidence for the presence or absence of these 
deletions using a PCR approach (data not shown) targeting on multiple locations in this region. By this 
approach, we did not find any clear evidence for the presence of deletions as would be seen in a phase 
II variant [18]. To obtain additional evidence for the absence of LPS gene deletions, we subsequently 
used a microarray approach to measure the expression level of genes in this region in cells grown in 
both cell-based and cell-free culture systems (Fig. 2A). The average gene expression was normalized 
with expression of the housekeeping gene rpoB [36] of C. burnetii and was plotted for the 602 strain 
as a representative example. Here, a measurable expression indicates the presence of transcribed RNA 
from genes located in the 38 kb region, while no expression points towards a possible loss of function 
due to regulation or deletion events. The comparison of normalized LPS gene expressions from strain 
602 shows similar expression levels for all genes in the LPS encoding region in both cell-based and 
cell-free cultured strains. This supports the earlier conclusion that for both culturing systems no 
deletion in the LPS region could be detected. A similar trend of LPS expression is seen in other strains 
(data not shown) that were used in the virulence bioassay of mice as described in this study, indicating 
that the majority of cells as cultured by low passage-number in the cell-based and cell-free system are 
in phase I. In contrast, high passaged 602 strain from cell-free culture showed a very low expression of 
LPS genes at the beginning of the LPS encoding region (CBU0676 to CBU0697) and high expression  
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with expression of the housekeeping gene rpoB [36] of C. burnetii and was plotted for the 602 strain 
as a representative example. Here, a measurable expression indicates the presence of transcribed RNA 
from genes located in the 38 kb region, while no expression points towards a possible loss of function 
due to regulation or deletion events. The comparison of normalized LPS gene expressions from strain 
602 shows similar expression levels for all genes in the LPS encoding region in both cell-based and 
cell-free cultured strains. This supports the earlier conclusion that for both culturing systems no 
deletion in the LPS region could be detected. A similar trend of LPS expression is seen in other strains 
(data not shown) that were used in the virulence bioassay of mice as described in this study, indicating 
that the majority of cells as cultured by low passage-number in the cell-based and cell-free system are 
in phase I. In contrast, high passaged 602 strain from cell-free culture showed a very low expression of 
LPS genes at the beginning of the LPS encoding region (CBU0676 to CBU0697) and high expression  
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Figure 2. Normalized LPS gene expression profiles and genome coverage of C. burnetii 602 strain as a 
representative example. A) Here average transcript signal per gene was normalized with the average transcript 
signal of housekeeping gene rpoB of C. burnetii. The normalized gene expressions are plotted for 602 low 
passage strain in cell-based and cell-free culture systems and 602 high passaged cell-free culture strain. The 
dashed lines represent standard deviations from two independent replicates. B) Genomic coverage of genes 
involved in LPS synthesis of a high passaged cell-free culture 602 strain. Coverage below the minus 2 SD 
interval (dashed line) was considered as a significantly deleted gene. The x-axis for both the A and B graphs are 
shown as a scaled mini-map of C. burnetii LPS encoding genes. Each data point represents to its corresponding 
gene (CBU0676 to CBU0706) labelled as 1 to 31 genes in the gene map. The genes indicated in grey are 
hypothesized to be involved O-antigen synthesis and export. Genes indicated in black are hypothesized to be 
involved in other LPS synthesis steps and carbohydrate metabolism.   
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of the genes towards the end (CBU0698 to CBU0706) (Fig. 2A). Comparing the regulation of LPS 
encoding genes of high passaged cell-free culture with low passaged cell-based and cell-free culture 
strains showed a significant (p<0.01) down regulation of CBU0676 to CBU0697 genes with a 
minimum fold change < 4 (data not shown). These significant difference between the higher passaged 
cells (n>30x times) and the lower passaged cells (n<10x times) shows loss of function of the genes 
(CBU0676 to CBU0697) at the beginning of the LPS cluster and a consecutive variation from phase I 
to phase II in a significant proportion of the cell population.  
 
Deletion of genes involved in LPS formation by whole genome sequence analysis 
The low expression of genes involved in LPS synthesis in the high passaged C. burnetii strain were 
further analyzed for any deletions by whole genome sequencing. The coverage of reads for LPS 
encoding genes (CBU0676 to CBU0697) were significantly lower than the genes present at the end 
(CBU0698 to CBU0706) of the LPS encoding region (Fig. 2B) indicating deletions of these genes in a 
significant proportion of the cell population and a phase variation moving into a phase II form. The 
data also demonstrated that the occurrence of (growing) deletions is most likely an on-going event 
during passage since the read-mapping indicates a mixed metagenomic population at this LPS 
encoding region of the genome. 
 
Mouse bioassay 
All mice remained clinically healthy during the course of the experiment. However, at autopsy mice 
inoculated with C. burnetii strains showed significant splenomegaly as compared to control mice. The 
mice bioassay’s showed a statistically significant level of splenomegaly in infected animals compared 
to the respective controls (p<0.01), except for the cell-based grown Scurry strain (E1) group (p=0.10). 
 
Relative virulence of C. burnetii strains in mice 
The relative virulence of C. burnetii strains was expressed as the “relative spleen weight per number of 
C. burnetii bacteria” which considers both the degree of splenomegaly and the number of C. burnetii 
present in the spleen of infected mice. The in vivo growth of bacteria in the mice spleens were 
measured by qPCR assay, where the bacterial DNA was quantified by CBU_0407a single copy gene 
(results not shown). As shown in Fig. 3 and Table 1, the relative virulence of a particular strain is not 
significantly affected by the in vitro system that is used to propagate the bacteria (p>0.01). These 
results indicate that the phenotypic expression of virulence of the used C. burnetii strains in mice is 
independent of the in vitro culture system chosen for propagating the strains. No statistically 
significant differences for the relative virulence (p>0.01) were obtained between cell-based cultured 
strains of 3262 and 601 in these two independent experiments (E1 and E2), clearly highlighting the 
reproducibility for this measure in the mouse virulence bioassay. 
 
C. burnetii virulence in cell-free culture
C
ha
pt
er
 2
47
46 
 
 
 
Figure 2. Normalized LPS gene expression profiles and genome coverage of C. burnetii 602 strain as a 
representative example. A) Here average transcript signal per gene was normalized with the average transcript 
signal of housekeeping gene rpoB of C. burnetii. The normalized gene expressions are plotted for 602 low 
passage strain in cell-based and cell-free culture systems and 602 high passaged cell-free culture strain. The 
dashed lines represent standard deviations from two independent replicates. B) Genomic coverage of genes 
involved in LPS synthesis of a high passaged cell-free culture 602 strain. Coverage below the minus 2 SD 
interval (dashed line) was considered as a significantly deleted gene. The x-axis for both the A and B graphs are 
shown as a scaled mini-map of C. burnetii LPS encoding genes. Each data point represents to its corresponding 
gene (CBU0676 to CBU0706) labelled as 1 to 31 genes in the gene map. The genes indicated in grey are 
hypothesized to be involved O-antigen synthesis and export. Genes indicated in black are hypothesized to be 
involved in other LPS synthesis steps and carbohydrate metabolism.   
47 
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inoculated with C. burnetii strains showed significant splenomegaly as compared to control mice. The 
mice bioassay’s showed a statistically significant level of splenomegaly in infected animals compared 
to the respective controls (p<0.01), except for the cell-based grown Scurry strain (E1) group (p=0.10). 
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The relative virulence of C. burnetii strains was expressed as the “relative spleen weight per number of 
C. burnetii bacteria” which considers both the degree of splenomegaly and the number of C. burnetii 
present in the spleen of infected mice. The in vivo growth of bacteria in the mice spleens were 
measured by qPCR assay, where the bacterial DNA was quantified by CBU_0407a single copy gene 
(results not shown). As shown in Fig. 3 and Table 1, the relative virulence of a particular strain is not 
significantly affected by the in vitro system that is used to propagate the bacteria (p>0.01). These 
results indicate that the phenotypic expression of virulence of the used C. burnetii strains in mice is 
independent of the in vitro culture system chosen for propagating the strains. No statistically 
significant differences for the relative virulence (p>0.01) were obtained between cell-based cultured 
strains of 3262 and 601 in these two independent experiments (E1 and E2), clearly highlighting the 
reproducibility for this measure in the mouse virulence bioassay. 
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Figure 3. Changes in relative virulence. Relative virulence of different strains cultured in cell-based and cell-free 
systems expressed as the relative spleen weight per number of C. burnetii. E1, experiment 1; E2, experiment 2.
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Figure 3. Changes in relative virulence. Relative virulence of different strains cultured in cell-based and cell-free 
systems expressed as the relative spleen weight per number of C. burnetii. E1, experiment 1; E2, experiment 2.
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Discussion 
In the present study we used three different methods to evaluate virulence-associated characteristics of 
different C. burnetii strains cultured in cell-based and cell-free systems. We did not observe any 
difference in the number of viable cells in the two culturing systems as determined by the use of PMA-
PCR. Furthermore, we did not find any evidence for the occurrence of loss of function of genes in the 
LPS encoding region in the low passaged strains from both the culturing systems. Since the loss of 
gene function of the genes in the LPS cluster can be associated with the variation of the virulent phase 
I to the avirulent phase II, we do not expect significant differences in the phase I to phase II ratios in 
the low passages of C. burnetii strains in both the culturing systems. Finally, we provide evidence that 
the relative virulence of C. burnetii strains is not affected by the cell-based or cell-free method of 
propagation as measured in an immune-competent mouse model. Therefore, our results clearly 
demonstrate that the cell-free culture system does not significantly influence the relative virulent 
phenotype of the tested strains. This indicates that the cell-free culturing system is invaluable for the 
identification and characterization of virulence factors of C. burnetii while allowing the investigation 
of molecular mechanisms involved in the pathogenesis of this obligate intracellular bacterium.  
Our study reports the use of PMA-PCR, which worked better in our hands compared with 
EMA-PCR for quantification of viable cells of C. burnetii. The efficient quantification of genomic 
DNA from live cells by PMA or EMA treatment followed by PCR has been reported previously in 
different bacterial species [25,35,37–39]. It is one of the few current methods available for C. burnetii 
[25], which can be used to determine and quantify viable cells. Compared to PMA-PCR, decrease in 
PCR amplification was seen in EMA-PCR resulting in very low numbers of viable cells. In previous 
studies, EMA treatment showed loss of more than 60% genomic DNA due to penetration in live cells, 
whereas PMA was found to selectively penetrate only dead cells [35,37,39,40]. This higher 
impermeability of PMA through the intact cells might be due to the higher charge of PMA as 
suggested previously [35]. In samples treated at high temperatures, a high decrease in PCR 
amplification efficiency was seen compared to untreated cells, consistent with previously observations 
in other bacterial species. Therefore, a complete inhibition of PCR amplification of DNA from dead 
cells could not be expected at the tested concentrations of C. burnetii cells [39,41,42]. One of the 
important parameters to consider in this method is the matrix of the culture system the bacteria were 
propagated in, as non-specific host DNA also contributes in the efficiency of this technique. EMA-
PCR seemed to work well in egg homogenate matrix of C. burnetii which contains very high amounts 
of host DNA as previously described [25], but not on cell-based culture matrix which contain 
relatively less host DNA or no host DNA as in cell-free culture matrix. Hence, PMA-PCR was seen to 
mitigate the drawbacks observed with EMA-PCR in cell-based and cell-free culture systems. Also the 
viability counts obtained by PMA-PCR corresponded closely with direct enumeration FFU assay and 
CFU assay (data not shown) showing it as an efficient method to enumerate viable C. burnetii. 
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Transcriptomics studies of all LPS encoding genes located in a 38 kb region in the C. burnetii 
genome is one of the robust and easy ways to detect loss of function of all these genes, which basically 
results in phase variation. The measured gene expression profiles showed all the low passaged strains 
of C. burnetii to be in phase I. Several other molecular techniques can also be used to determine the C. 
burnetii phase variation including approaches such as determining LPS sugar composition and 
quantification [43–46], PCR’s on all genes of LPS coding regions [19], microarray-based genome 
comparisons [47], reverse transcriptase-PCR for expression of genes [19] and genome sequencing 
[18,19]. These methods are rather elaborative and tedious. Our result of transcriptomic measurements 
of a representative low passaged strain shows similar levels of expression of all genes in the LPS 
encoding region, without any significant differences in both cell-based and cell-free culture system. 
However, the high passaged cell-free cultured strain, showed significant (p<0.01) lower expression of 
several genes (CBU0676 to CBU0697) in major part of this region, compared with the low passaged 
cell-based and cell-free culture systems. Further, significant (p<0.01) down regulation of these genes 
with a fold change of < 4 confirms the possible loss of gene function, which can result in a transition 
from phase I to phase II phenotype of the bacterium. This significant decrease of transcripts could also 
be regulatory and/or a physical deletion event within the LPS genes. Although lower, the expression of 
these genes are still detected suggesting the presence of mixtures of phase I and II variants of the 
strain, where the observed remaining transcripts of these genes are most likely from bacteria still in 
phase I form. High expression of genes was seen in this strain towards the end of the region 
(CBU0698 to CBU0706) suggesting the possible remains of these regions in the phase II variants.  
Whole genome sequencing was performed to investigate whether any deletion events result in 
the observed low expression/regulation of genes involved in LPS synthesis. Here we used the depth of 
coverage in whole genome sequence data. A significant decrease in coverage was observed in the 
genes which showed low expression (CBU0676 to CBU0697) indicative for a deletion. Some of the 
deleted genes are involved in O-antigen biosynthesis or other LPS biosynthetic steps (Fig. 2) and its 
deletion may result in severe impairment of LPS synthesis correlating with phase variation [18,48]. 
Such large deletions were also seen previously in other phase II strains such as 9Mi/Baca (deletion 
from CBU0678 to CBU0694), 9Mi/II/C1 and 9Mi/II/C4 (deletion from CBU0678 to CBU0698) 
[18,19]. The coverage of the genes (CBU0698 to CBU0706) present at the end of the LPS encoding 
region were higher, corresponding to the observed normal expression of these genes. Hence, the lower 
and higher read depths of genes obtained from sequencing (Fig. 2B) corresponded to lower and higher 
expression of the same genes obtained from expression studies (Fig. 2A). Similar results were also 
seen from SDS-PAGE analysis, where whole cell lysates of low and high passaged 602 strain had a 
similar profile of protein fragments which reflected those of the phase 1 type (bands between 21-14 
kDa). In addition, the high passaged strain comparatively had a more prominent band at 10.7 kDa 
which is characteristic of phase II type. Hence, both phase I and phase II characteristic profiles were 
observed in high passaged cell-free cultured strains (Fig. 4) [34]. We conclude that low passaged 
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strains from both the culture systems were in a predominant phase I form, and high passaged cell-free 
cultured strain shows possible deletions resulting in loss of gene function in the beginning of this LPS 
encoding region which is progressing throughout the region resulting in a phase II variant of the strain. 
Hence, cell surface LPS of C. burnetii is not significantly changed in the cell-free culture system 
similar to cell-based culture system in its early passages. Eventually phase variation occurs due to 
multiple passages in cell-free culture system, due to loss of LPS side chain as suggested previously 
[49].  
 
 
 
Figure 4. SDS-PAGE of C. burnetii whole cell lysates of low passaged cell-based and cell-free cultures and high 
passaged cell-free cultured 602 strain. Three serial dilutions (1:5) marked as 1, 2 and 3 for all samples were used. 
The red box indicates the phase II specific bands seen in high passaged cell-free cultured strain. 
 
In this present study we used immune-competent Swiss OF1 mice to evaluate the virulence 
properties of different C. burnetii strains. This model is currently used by several groups for 
evaluating pathogenicity of C. burnetii with consistent outcomes [28]. We assessed the virulence of C. 
burnetii strains using “splenomegaly” (increase in weight of spleen in relation to the body weight) and 
“RT-PCR quantification of bacteria in the spleen” as the most important read-out parameters 
[13,15,50]. Splenomegaly in response to infection was observed in these mice without any adverse 
clinical signs or mortality at 7 days post infection. Even at 21 days after infection no mortality of mice 
was observed and the splenomegaly reduced as well as the number of bacteria in the spleens, most 
likely indicating a level of clearance of the infection (data not shown). Also the degree of 
splenomegaly correlated with the bacterial load in the spleen as explained before [51]. All strains were 
capable of inducing pathological changes in the Swiss OF1 mice, showing its sensitivity to Q fever 
agent. 
53 
 
The strains propagated in cell-based and cell-free culture systems did not show any significant 
differences in their relative virulence, showing relative virulence is independent of the culture system 
in which the strains are propagated in. We combined both, splenomegaly and bacterial load, which are 
most likely related, as virulence parameters to determine relative virulence of C. burnetii. The extent 
of splenomegaly and presence of C. burnetii in the spleen was strain dependent indicating that the 
strains most likely differentially affect the influx of (T) cells into the spleen and thereby facilitate 
bacterial clearance [15]. The colonization of spleen was a good indicator of infectivity, highlighting 
the relevance of these measurements for comparing strain virulence. Hence, the relative virulence 
showed strain-specific (p<0.01) but similar virulence values (p>0.01) for the same strain, irrespective 
the method of in vitro propagation for the tested low passage strains (Table 1). It is also expected that 
strains propagated from both the culture systems would equally loose virulence with respect to higher 
passages due to loss of LPS structure as seen previously [49]. Finally, the two individual experiments 
conducted showed reproducible relative virulence in 3262 and 601 cell-based cultured strains, 
underlining the precision of virulence associated measurements in the present mouse virulence 
bioassay. 
In conclusion, our results provide evidence that the axenic culture system does not 
significantly influence the viability, phase variation and relative virulence of C. burnetii strains 
compared with cell-based culture. Thereby the cell-free propagation is an invaluable tool when 
studying molecular mechanisms underlying differences in virulence by using molecular genetic 
studies, which are not feasible using cell-based cultivation. Ultimately this system could be useful for 
development of effective subunit vaccines or production of recombinant antigens, which would offer 
great potential in the control of Q fever outbreaks as well as limiting its transmission to humans. 
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Abstract 
Background 
Coxiella burnetii is the causative agent of the zoonotic disease Q fever. As it is an intracellular 
pathogen, infection by C. burnetii requires adaptation to its eukaryotic host and intracellular 
environment. The recently developed cell-free medium also allows the bacteria to propagate without 
host cells, maintaining its infection potential. The adaptation to different hosts or extracellular 
environments has been assumed to involve genome-wide modulation of C. burnetii gene expression. 
However, little is currently known about these adaptation events which are critical for understanding 
the intracellular survival of C. burnetii.  
 
Results 
We studied C. burnetii genome–wide transcriptional patterns in vivo (mice spleen) and in cell and cell-
free in vitro culture models to examine its metabolic pathways and virulence associated gene 
expression patterns that are required to colonize and persist in different environments. Within each 
model, the gene expression profiles of the Dutch C. burnetii outbreak strain (602) and NM reference 
strains were largely similar. In contrast, modulation of gene-expression was strongly influenced by the 
cultivation method, indicating adaptation of the bacterium to available components. Genome–wide 
expression profiles of C. burnetii from in vitro cell culture were more similar to those seen for in vivo 
conditions, while gene expression profiles of cell-free culture were more distant to in vivo. Under in 
vivo conditions, significant alterations of genes involved in metabolism and virulence were identified. 
We observed that C. burnetii under in vivo conditions predominantly uses glucose as a carbon source 
(mostly for biosynthetic processes) and fatty acids for energy generation. C. burnetii experienced 
nutrient limitation and anaerobiosis as major stressors, while phosphate limitation was identified as an 
important signal for intracellular growth inside eukaryotic host cells. Finally, the in vivo environment 
significantly induced expression of several virulence genes, including those implicated in LPS 
synthesis, colonization, host component modulation and DNA repair mechanisms. 
 
Conclusion 
Our study shows that C. burnetii, with its relative small genome, requires only a subset of core gene 
functions to survive under in vitro conditions, but requires the induction of full repertoire of genes for 
successful pathogenesis and thriving in harsh environments in vivo.  
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Background 
Q fever, a worldwide zoonotic infectious disease, is caused by Coxiella burnetii, an intracellular Gram 
negative bacterium. Domestic ruminants (e.g., goat, sheep and cattle) are considered the main 
reservoir for Q fever infections in humans; the bacterium can cause a range of diseases depending on 
the host [1–3]. The main clinical manifestation of Q fever in goats and sheep are abortions, which 
result in the shedding of large numbers of bacteria into the environment. Inhalation of such 
contaminated aerosols is the main route of transmission in humans and can lead to acute or chronic Q 
fever [1, 4]. Acute infections range from asymptomatic to abrupt flu-like illness or pneumonia [5]; 
chronic infection is typically manifested as endocarditis [6]. An unprecedented outbreak of Q fever 
occurred in the Netherlands during the years 2007-2010, with more than 4,000 human cases registered; 
infected dairy goats and sheep were identified as the primary source of the disease [7–11] .  
Attempts to understand the biology and pathogenesis of this bacterium through molecular 
techniques have been hampered by its intracellular lifestyle. However, a better understanding of the 
interactions of the pathogen with the host could be gained using global transcription profiles. This 
might aid in determining adaptations of the bacterium within the infected host and provide a fuller 
appreciation of its pathogenicity.  
As an obligate intracellular pathogen, C. burnetii resides and proliferates within the acidic 
parasitophorous vacuole (PV) of the host cells [12]. The bacteria can infect a wide range of hosts and 
can also propagate to high quantities in different in vitro culture models [1, 13–15]. Within a 
laboratory setup, immune-competent mice are usually used as the in vivo animal model to assess the 
infection potential of C. burnetii [16]. The virulence of the strains is often measured based on 
splenomegaly and load of the bacteria in the spleen of mice [17–19]. C. burnetii are routinely cultured 
in BGM cells [15, 20], Vero cells [21] or macrophage like cell lines [12, 22]. The bacterium can 
establish persistent infections in cell culture, where it multiplies and survives in the cell PV. The latest 
advancement in Q fever research is the development of a host cell-free medium, designed based on the 
metabolic requirements of the bacterium. This complex nutrient medium supports substantial growth 
of most C. burnetii isolates and overcomes the drawbacks encountered when studying the pathogen in 
cell based culture or in vivo models [14, 15, 23]. 
Availability of complete genome sequences of C. burnetii contributed significantly towards 
understanding of the physiology and the pathogenic abilities of the bacterium [24]. However, 
information regarding environmental adaptations and expression of potential virulence factors 
important for bacterial colonization, replication and persistence under in vivo and in vitro systems is 
not entirely clear. Such information will provide insights into processes occurring during intracellular 
and extracellular growth of C. burnetii and allow direct evaluation of the relationship between gene 
expression patterns during growth inside living hosts and under in vitro conditions.  
In this study, we endeavor to understand how the pathogen adapts to the host 
microenvironment, by monitoring the expression changes across the whole transcriptome of C. 
C. burnetii expression patterns in different environments
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burnetii obtained within different propagation models. Main reservoirs of Q fever, such as pregnant 
goat and sheep, harbor the pathogen primarily in placentas, making this an ideal in vivo sample [20]. 
The bacterium has also been detected in oviducts and genital tissues of naturally infected non-pregnant 
goats [25]. However, use of these models to assess in vivo C. burnetii global transcriptional profiles is 
hampered by technical difficulties regarding the required fresh aborted sample collection (placentas), 
low RNA concentrations and quality. To avoid these limitations we used the spleens of experimentally 
infected mice as an in vivo model. We report here the global transcriptional pattern of C. burnetii from 
this in vivo model (mice spleen) compared with C. burnetii grown under laboratory conditions using 
cell-based and cell-free culture methods. In addition, we allowed strains to adapt from cell to cell-free 
culture propagation and considered the first two passages to determine the adaptation capabilities of 
the bacterium as it moves from one environment (propagation inside host cells) to another (cell-free 
cultivation). Our study provides a comprehensive view of C. burnetii metabolic adaptations and other 
important process required for its survival in response to diverse environments. 
 
Results and discussion 
Preparation of C. burnetii cells from different propagation models and measurement of its gene 
expression patterns 
A whole-genome microarray was constructed based on all the available annotated genome sequences 
of C. burnetii in the databases. The mRNA levels of the expressed genes were assessed under in vivo 
and various in vitro conditions. For the in vivo transcriptome analysis, C. burnetii obtained from 
infected mice spleens were chosen, as spleens are highly responsive to infections and bacterial 
colonization in spleen is a good indicator of infectivity and persistence over time [17–19, 26]. During 
the time of sampling, all infected mice showed splenomegaly and an almost 10 fold increase in 
number of bacteria in the spleen. This spleen mice model offers several benefits, although it also has 
limitations, such as the usage of intraperitoneal (IP) infection route rather than intranasal route which 
is the best natural exposure model. However, because no significant changes in splenomegaly or 
bacterial numbers in spleens were observed between different inoculation routes, the IP route seems an 
easy and efficient inoculation route for C. burnetii infections in mice [27]. We determined the global 
transcriptional patterns of C. burnetii at 20 days p.i., because host immune responses towards bacterial 
infection were high around this period (data not shown) allowing us to examine bacterial metabolic 
adaptations, role of virulence factors and mechanisms to evade host defenses. C. burnetii infection in 
mice usually results in higher bacterial numbers in spleen at early infection stages (7-14 days) 
followed by significant decrease in bacteria around 20 days. This most likely indicates an influx of 
immune (T) cells into the spleen around 7 days p.i., resulting in increased splenomegaly and 
facilitating bacterial clearance thereafter [17]. To obtain sufficient bacterial RNA from spleens at day 
20, a higher dose of bacteria (107 genome equivalents) were inoculated in our mice. This high dosage 
was checked in our previous study, which showed that for mice given this dosage, splenomegaly and 
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bacterial replication rate patterns at different time periods (Fig S1) were similar to a lower dosage (104 
genome equivalents) [26]. Transcriptional profiles of C. burnetii from later stage of infection (20 
days), where the bacterial numbers are significantly lower than at early infection stages, were 
compared with stationary phases of in vitro grown bacterium (cell and cell-free cultures) to examine 
environmentally-linked gene expression differences of the bacterium. To further study the various 
adaptations of the bacterium, C. burnetii propagated from first two serial passages in cell-free culture 
(p1 and p2) from cell-cultured strains and (fully) adapted cell-free cultured strains from stationary 
phase were considered. Gene expression of all cell-free cultured strains (p1, p2 and adapted) was 
compared with gene expression from cell culture as reference.  
 
Impact of cultivation conditions on C. burnetii transcriptome 
Good quality RNA was isolated from C. burnetii originating from different culture systems by 
depletion of the host RNA (except in cell-free culture system). The RNA was successfully labelled and 
used for microarray analysis (in triplicate). Principal component analysis (PCA) plots were 
constructed, which clearly showed that most sample triplicate clustered tightly, indicative of good 
experimental reproducibility of samples for each strain in different culture systems (Fig 1).  
 
 
 
Figure 1. Principal component analysis on genome-wide expression profiles of C. burnetii strains 602 and NM 
obtained from various culture systems. Triplicate findings for each sample from different culture systems are 
clustered together indicative for experimental reproducibility. The plots of independent samples demonstrate also 
that based on their transcriptome profile, samples from different culture models can be differentiated.  
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burnetii obtained within different propagation models. Main reservoirs of Q fever, such as pregnant 
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Niche specific gene expression patterns of C. burnetii 
To get an overview of the gene expression of 602 and NM strains induced by different culture models, 
hierarchical clustering was performed based on average normalized signal intensity of probes. 
Clustering showed that the expression profiles of strains are largely determined by the method in 
which they were cultured or isolated (Fig. 2). The expression profiles of C. burnetii isolated from in 
vivo and in vitro models clustered separately. Within the in vitro culture models, expression profiles of 
strains from cell culture were closer to the in vivo model, followed by expression profiles of strains 
obtained from the cell-free culture model. These results suggest that gene expression of C. burnetii 
depends on the available components present in the growth medium, tissue or cell. Hence, the possible 
differences in the metabolic capabilities of the strains are clearly seen in culture models considered in 
the study. 
 
 
 
Figure 2. Hierarchical clustering analysis on normalized signal intensities of probes of 602 and NM strains in 
different culture models. Data shows clustering of in vivo and in vitro models separately based on patterns of 
gene expression. Normalized signal intensity (log2) of probes (average of triplicates) for each condition are 
represented as a color scale from red for high expressions to blue for lower expressions. In vivo (M = mice 
spleen), cell culture (cc), cell-free adapting phase passage 1 (p1) and passage 2 (p2), cell-free culture model (cf).  
 
The global transcription profile in different culture models 
Because the different strains have transcriptional profile clustering based on the culture model in 
which it was propagated, thorough studies of gene expression were conducted. We determined which 
genes showed major differential expression in the spleens of mice compared to in vitro models. 
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Moreover, we looked into differences in gene expression that existed between in vitro culture models. 
These detailed studies were conducted using the data from the Dutch outbreak strain 602, which was 
shown to be highly virulent by our previous mouse virulence bioassays [15]. GeneSpring GX 
microarray software analysis showed 906 of the 2061 genes were, compared to in vitro cell culture, 
differentially regulated (p<0.05, fold change of 2) in 602 strains from mice spleen, with a majority of 
genes (67%) up-regulated. Comparing expression profiles of the 602 strain under in vitro conditions 
(cell-free vs. cell culture model) showed that 438 genes were differentially regulated, but the majority  
 
 
 
Figure 3. Functional COG-categories of differentially regulated C. burnetii genes under in vivo and in vitro 
culture models. Functional categories of regulated genes of the 602 strain under in vivo and cell-free culture 
compared with cell culture model. The up-regulated and down-regulated genes are shown on the right and left 
side of the y-axis respectively. Largest group of regulated genes in all culture models belonged to the unknown 
function category (S). Large number of up-regulated genes under in vivo conditions belonged to the metabolism 
group such as coenzyme, carbohydrate, amino acid and lipid transport and metabolism (HGEI). Whereas, the 
largest number of up-regulated genes in cell-free culture compared to cell culture belonged to the protein 
synthesis group (O). 
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Of genes (71%) were down-regulated. A complete microarray dataset from the different comparisons 
are presented as supplementary material (Table S1). 
 
Table 1. Significantly regulated (KEGG) Pathways in different culture models of C. burnetii 
Pathway ID Pathway m vs. cc p1 vs cc p2 vs. cc cf vs cc 
 Metabolic pathways     
cbu00230 Purine metabolism  5.20E-18* 2.00E-01 5.40E-06* 1.10E-12* 
cbu00010 Glycolysis/ Gluconeogenesis  1.00E-13* 3.80E-03* 1.50E-07* 1.50E-07* 
cbu00190 Oxidative phosphorylation  3.10E-10* 2.40E-01 1.90E-02* 1.30E-01 
cbu00240 Pyrimidine metabolism  5.20E-06* 9.80E-03* 1.80E-08* 5.60E-05* 
cbu00564 Glycerophospholipid metabolism 1.80E-05* 6.30E-02 6.00E-02 6.80E-02 
cbu00020 Citrate cycle (TCA cycle)  9.20E-04* - 3.40E-02* 5.30E-02 
cbu00071 Fatty acid metabolism  3.10E-03* - - - 
cbu00061 Fatty acid biosynthesis  3.20E-03* 1.40E-02* 7.40E-02 7.90E-02 
      
 Biosynthesis of secondary metabolites     
cbu00900 Terpenoid backbone biosynthesis  2.80E-05* - - - 
cbu00780 Biotin metabolism  1.00E-04* 1.00E-03* 2.30E-03* 2.40E-06* 
cbu00730 Thiamine metabolism  6.10E-04* 7.90E-03* 9.80E-03* 1.30E-05* 
      
 Biosynthesis of amino acids      
cbu00400 Aromatic amino acids biosynthesis 8.40E-08* - - - 
cbu00250 Alanine, aspartate and glutamate metabolism 3.40E-05* - 2.30E-02* 1.20E-03* 
cbu00260 Glycine, serine and threonine metabolism  2.20E-04* 1.60E-04* 2.30E-06* 1.10E-04* 
      
 Virulence     
cbu00540 Lipopolysaccharide biosynthesis  5.40E-10* 2.80E-04* 3.70E-05* 1.90E-04* 
cbu03070 Bacterial secretion system 7.40E-08* 6.90E-02 - 1.30E-03* 
      
 Repair mechanisms     
cbu03430 Mismatch repair  7.90E-13* - 3.60E-06* 1.50E-17* 
cbu03410 Base excision repair  1.00E-07* - 3.40E-02* 2.50E-05* 
cbu03420 Nucleotide excision repair  8.00E-07* - - 4.50E-02* 
      
 Others     
cbu00550 Peptidoglycan biosynthesis 4.00E-13* - - 3.30E-03* 
cbu02010 ABC transporters  1.00E-04* - 4.00E-02* 1.10E-03* 
cbu02020 Two-component system 3.50E-03* - - - 
The P value (adjusted by Benjamini-Hochberg method) of regulated pathway is shown for each comparison of 
602 strain. Significant pathways (p<0.05) are depicted with *. In vivo (m = Mice spleen), cell culture (cc), cell-
free adapting phase passage 1 (p1), cell-free adapting phase passage 2 (p2), cell-free culture model (cf) 
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Next, in various growth models, we determined the functional categories [28] and performed 
pathway enrichment analysis of the differentially regulated genes (Fig 3 and Table 1). In the in vivo 
model, when compared with genes expressed in cell culture, with the exception of the group of 
unknown, hypothetical and conserved hypothetical proteins (44% of in vivo induced genes), the largest 
group of functional category genes (HEGCIFPQ) and pathways showing increased expression 
belonged to the metabolism group (Fig 3, Table 1). In contrast, fewer genes and pathways involved in 
metabolism were up-regulated in the cell-free culture model than in the cell culture model. Apart from 
the metabolic genes, other genes seen to be highly up-regulated in vivo when compared to cell culture 
belonged to defense mechanisms (V), cell wall biogenesis (M) and recombination and repair (L) 
categories probably due to bacterial resistance to the harsh environments of PV. In cell-free culture 
16% of induced genes belonged to translation (J) and post translational modifications/protein-turnover 
(O) categories indicating more protein synthesis leading to faster growth rates compared to other 
conditions.  
 
 
 
Figure 4. Venn diagram of differentially expressed genes of 602 strain in different culture models. Comparison 
of differentially regulated genes under in vivo, cell-free adapting serial passages (p1 and p2) and fully adapted 
culture with respect to in vitro growth in cell culture. 
 
To gain insight into the distribution and uniqueness of regulated genes in the different culture 
models, Venn-diagrams were constructed (Fig 4). Comparison of differentially regulated genes under 
in vivo conditions and cell-free culture (including p1, p2 and cell-free adapted) with respect to cell 
culture showed 176 genes which were similarly regulated between different models and a large 
C. burnetii expression patterns in different environments
C
ha
pt
er
 3
67
66 
 
Of genes (71%) were down-regulated. A complete microarray dataset from the different comparisons 
are presented as supplementary material (Table S1). 
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number of genes (366 genes) which were specifically regulated in vivo (Fig 4). These data suggest that 
gene expression of C. burnetii under in vivo conditions is quite different from its in vitro culture 
models. 
Among the in vitro models, comparison between p1 and p2 cultures resulted in differential 
regulation of 0.6% of genes only, suggesting that these cultures were highly similar. Comparison of p1 
and p2 cultures with cell-free adapted and cell culture showed differential regulation of 15% and 30% 
of genes respectively. This indicates that based on the transcriptomic profiles, p1 and p2 cultures are 
closer to cell-free adapted culture than those from cell culture. The 15% of genes that were 
differentially regulated in p1 and p2 compared to cell-free culture were further categorized into 
functional groups. About 40% of these differentially regulated genes in p1 and 30% in p2 were 
involved in metabolism categories (CEFGHIPQ), showing almost a 10% decrease in metabolism 
related genes in p2 within 1 passage, itself in a cell-free environment. This shows that p1 and p2 
cultures regulate the genes in a way similar to adapted cell-free culture, most likely due to available 
resources in the culture media. Thus, the rapid adaptation capabilities of C. burnetii were seen when 
moved from one environment to another. 
 
C. burnetii requires metabolic adaptations for different culture models 
Striking differences were found between in vivo and in vitro culture models in metabolic pathway 
regulation. These differences could be attributed to the type of nutrient the bacteria were able to use 
for metabolism. Under in vivo conditions, genes implicated in glucose transportation (CBU0265), 
phosphorylation and glycolytic intermediates generation were up-regulated compared to in vitro 
models [29]. Further, the terminal enzymes of the glycolytic pathway were repressed and genes 
implicated in phospholipid synthesis were induced, indicating the use of glycolytic intermediates for 
phospholipid synthesis (Fig 5A). Among the different phospholipids [30], gene encoding cardiolipins 
(cls), an anionic phospholipid were highly induced in vivo compared to in vitro conditions, indicating 
an increased synthesis of cardiolipins allowing the bacterium to survive in the highly acidic 
environment of spleen cell PV [31]. A low level expression of cls in cell and cell-free cultures might 
be sufficient for the bacterium to sustain under in vitro environments, while up-regulation in vivo is 
possibly required to cope with specific in vivo conditions associated with the acidic environment. In a 
previous study, cardiolipids were not identified by biochemical analysis of phospholipids in C. 
burnetii grown from in vitro embryonated eggs [32], implying its greater importance under in vivo 
conditions. These data confirm previous research indicating that the phospholipid content of 
microorganisms can differ based on the bacterial environment in order to cope with new 
environmental conditions [33]. 
Genes implicated in the synthesis of lipids were enhanced in vivo more than under in vitro 
conditions. Enhanced expression of a putative long-chain fatty acids translocation gene (CBU1242) 
across the outer membrane of the bacterium was seen, indicating its abundant presence in the PV of 
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host spleen cells. Interestingly, genes coding de novo synthesis of fatty acid were also induced, 
probably to synthesize more fatty acids to meet the overall requirements of the bacterium. The data 
shows C. burnetii can acquire lipids through both de novo bacterial synthesis as well as by subversion 
of host cell pools as indicated previously [30]. Further, the mevalonate pathway, which encodes an 
isoprenoid backbone (Fig 5B), [24, 34] and other genes (uppS, ispB) that use isoprenoids as substrates 
were up-regulated in vivo and might help C. burnetii in cell wall synthesis and normal growth in host 
cells [35, 36]. Apart from synthesis of its own lipids, it has been speculated that C. burnetii can use 
host cell cholesterol precursors and convert these into cholesterol. The genome of C. burnetii encodes 
putative Δ24 sterol reductase (CBU1206) the biological role of which is not known, but in general is 
involved in final stages of cholesterol synthesis in eukaryotic cells. Maintaining such a unique gene in 
its genome and its up-regulation suggests a critical function for this gene in the bacterium in vivo [37–
39]. The role of cholesterol in bacterial pathogenesis is unclear [40, 41], and cell culture of C. burnetii 
lacking cholesterol showed either no effects or negative effects on replication and PV morphology [38, 
39]. Sterol reductase could be involved in cholesterol synthesis in limiting sterol conditions. However, 
since mammalian cells have high sterol content, the bacteria would not need to synthesize more 
cholesterol. It is more likely that up-regulation of sterol reductase is involved in generating novel 
sterol species that have signaling, structural roles or associated with oxidative stress responses [30, 
40–43]. Within in vitro models, induction of these genes was seen in cell culture at lower levels than 
observed in the in vivo system, indicating that the synthesis of these lipids is only intracellular.  
The size of the genome of C. burnetii is highly reduced (around 2Mb) comparable to size in other 
obligate intracellular pathogens. This renders C. burnetii auxotrophic for several amino acids or causes 
it to lack key enzymes in several biosynthetic pathways [24]. Yet under in vivo conditions, several 
amino acid and oligopeptide transporters, pathways implicated in synthesis of aromatic amino acids 
(Fig 5C) [24, 44, 45] and degradation of amino acids (L-serine, L-aspartate, L-glutamine, L-cysteine, 
L-methionine, L-proline) were highly induced. Taken together, these observations suggest that C. 
burnetii can acquire several amino acids from hosts and synthesizes a few that may be in limited 
supply due to severe nutritional stress in host cells. A lower level of nutritional stress can be inferred 
in in vitro conditions, since compared to in vivo only a few transporters are up-regulated in cell culture 
(CBU1798, CBU0539) and cell-free culture (CBU1130, artM). 
A large number of genes coding several co-factors (biotin, thiamine, folic acid and Coenzyme 
A) was also up-regulated in vivo relative to in vitro culture models (Fig 5D,5E). The high level 
expression of these genes implicated in co-factor synthesis, might indicate lack of readily available co-
factors in the spleens of mice. Contrary, it could be possible that the C. burnetii genome might not 
encode co-factor transporters and therefore synthesizes them since they are required for growth under 
in vivo conditions. The cell and cell-free culture media are rich in co-factors and down-regulation of 
pathways involved in co-factor synthesis; imply transportation of co-factors by the bacterium. As of 
now, specific co-factor transporters for these organic co-factors are not reported, but C. burnetii  
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conditions. These data confirm previous research indicating that the phospholipid content of 
microorganisms can differ based on the bacterial environment in order to cope with new 
environmental conditions [33]. 
Genes implicated in the synthesis of lipids were enhanced in vivo more than under in vitro 
conditions. Enhanced expression of a putative long-chain fatty acids translocation gene (CBU1242) 
across the outer membrane of the bacterium was seen, indicating its abundant presence in the PV of 
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host spleen cells. Interestingly, genes coding de novo synthesis of fatty acid were also induced, 
probably to synthesize more fatty acids to meet the overall requirements of the bacterium. The data 
shows C. burnetii can acquire lipids through both de novo bacterial synthesis as well as by subversion 
of host cell pools as indicated previously [30]. Further, the mevalonate pathway, which encodes an 
isoprenoid backbone (Fig 5B), [24, 34] and other genes (uppS, ispB) that use isoprenoids as substrates 
were up-regulated in vivo and might help C. burnetii in cell wall synthesis and normal growth in host 
cells [35, 36]. Apart from synthesis of its own lipids, it has been speculated that C. burnetii can use 
host cell cholesterol precursors and convert these into cholesterol. The genome of C. burnetii encodes 
putative Δ24 sterol reductase (CBU1206) the biological role of which is not known, but in general is 
involved in final stages of cholesterol synthesis in eukaryotic cells. Maintaining such a unique gene in 
its genome and its up-regulation suggests a critical function for this gene in the bacterium in vivo [37–
39]. The role of cholesterol in bacterial pathogenesis is unclear [40, 41], and cell culture of C. burnetii 
lacking cholesterol showed either no effects or negative effects on replication and PV morphology [38, 
39]. Sterol reductase could be involved in cholesterol synthesis in limiting sterol conditions. However, 
since mammalian cells have high sterol content, the bacteria would not need to synthesize more 
cholesterol. It is more likely that up-regulation of sterol reductase is involved in generating novel 
sterol species that have signaling, structural roles or associated with oxidative stress responses [30, 
40–43]. Within in vitro models, induction of these genes was seen in cell culture at lower levels than 
observed in the in vivo system, indicating that the synthesis of these lipids is only intracellular.  
The size of the genome of C. burnetii is highly reduced (around 2Mb) comparable to size in other 
obligate intracellular pathogens. This renders C. burnetii auxotrophic for several amino acids or causes 
it to lack key enzymes in several biosynthetic pathways [24]. Yet under in vivo conditions, several 
amino acid and oligopeptide transporters, pathways implicated in synthesis of aromatic amino acids 
(Fig 5C) [24, 44, 45] and degradation of amino acids (L-serine, L-aspartate, L-glutamine, L-cysteine, 
L-methionine, L-proline) were highly induced. Taken together, these observations suggest that C. 
burnetii can acquire several amino acids from hosts and synthesizes a few that may be in limited 
supply due to severe nutritional stress in host cells. A lower level of nutritional stress can be inferred 
in in vitro conditions, since compared to in vivo only a few transporters are up-regulated in cell culture 
(CBU1798, CBU0539) and cell-free culture (CBU1130, artM). 
A large number of genes coding several co-factors (biotin, thiamine, folic acid and Coenzyme 
A) was also up-regulated in vivo relative to in vitro culture models (Fig 5D,5E). The high level 
expression of these genes implicated in co-factor synthesis, might indicate lack of readily available co-
factors in the spleens of mice. Contrary, it could be possible that the C. burnetii genome might not 
encode co-factor transporters and therefore synthesizes them since they are required for growth under 
in vivo conditions. The cell and cell-free culture media are rich in co-factors and down-regulation of 
pathways involved in co-factor synthesis; imply transportation of co-factors by the bacterium. As of 
now, specific co-factor transporters for these organic co-factors are not reported, but C. burnetii  
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Figure 5. Some metabolic pathways and pathways implicated in virulence and repair mechanisms induced in 
vivo compared to in vitro cultivation. The pathways were drawn according to KEGG database. Circles next to 
each gene display its regulation for each condition. A-I represent significantly up-regulated KEGG pathways 
under in vivo conditions: A) Cardiolipin synthesis, B) Mevalonate pathway, C) Tryptophan synthesis, D) Biotin 
synthesis, E) Thiamine synthesis, F) Fatty acid degradation, G) Base excision repair, H) Nucleotide excision 
repair, and I) LPS synthesis. Reactivity of in vivo vs cell and cell-free cultures are always the same (except 
cbu0608, due to induction of mevalonate pathway in cell culture similar to in vivo, relative to cell-free culture 
system). 
71 
 
encodes several generic transporters in its genome which could potentially transport these co-factors 
that are crucial for several enzyme reactions involved in amino acid, glucose, lipid metabolism or the 
regulation of genes. 
As the fatty acid degradation pathway was up-regulated in vivo, catabolism of fatty acids 
appeared to play an important role in energy metabolism. Among the genes implicated in this 
pathway, the yfcX gene was most strongly induced (Fig 5F). This results in anaerobic degradation of 
long/ medium chain fatty acids and produces NADH as a major cofactor for energy generation [46]. 
Genes involved in carbohydrate metabolism (dehydrogenases such as pdhA, pdhC, lpdA, sucB, sdhA, 
sdhC) were repressed under in vivo conditions, indicating an abundance of fatty acids (and fewer 
carbohydrates) in host cells. In cell and cell-free cultures these carbohydrate metabolism genes were 
enhanced, suggesting oxidation of glycolytic and TCA intermediates for energy production. The 
Cytochrome bd oxidase gene (cydA) was highly induced under in vivo conditions but at lower levels in 
cell culture, indicating an increased affinity for oxygen under intracellular conditions [47]. These 
differences suggest that the kind of nutrients found in the environment affects pathogen manipulation.  
In conclusion, under in vivo conditions, the transportation of organic nutrients was up-
regulated, showing increased dependence of the bacterium on host-derived products. In vivo, the 
bacteria also shows enhanced biosynthetic capacities, which are directed to fulfill metabolic 
requirements that are unavailable directly from the host. In contrast, in vivo the bacterium represses a 
majority of genes coding for nucleotide synthesis and ribonucleotide reductases, which could be 
connected to the slow replication rate observed compared to in vitro culture conditions. Within in vitro 
cultures, gene regulation in cell culture were similar to in vivo but at much lower mRNA levels, 
indicating similar intracellular metabolic adaptations. Hence anaerobiosis, nutrient limitations, 
inaccessibility of co-factors were prominent environmental conditions encountered by C. burnetii 
during growth in vivo in the mice spleens. 
 
Enhanced regulation of transporter systems in hosts 
Bacterial transporters import essential nutrients, but are also used to import physiological substrates 
and export toxic molecules, both critical for cell viability, pathogenicity and virulence [48]. Under in 
vivo conditions, many transporters encoded by C. burnetii due to its intracellular life style were 
probably induced to maintain homeostasis [24]. Among these transporters are, sodium ion/proton 
exchangers (shaE, shaA, nhap.1), which might play a vital role in bacterial cytoplasmic pH 
homeostasis within the acidic PV. Several predicted drug-efflux systems (CBU0804, CBU0048, 
CBU0833, CBU1808, CBU1809) were enhanced, providing resistance and removal of toxins and host 
defensins. Among the metal transporters, gene implicated in inorganic phosphate transport were 
strongly up-regulated (CBU0014) under in vivo conditions along with up-regulation of phosphate 
starvation-responsive loci phoBR, which is one of the few two-component regulatory system present in 
C. burnetii expression patterns in different environments
C
ha
pt
er
 3
71
70 
 
 
 
Figure 5. Some metabolic pathways and pathways implicated in virulence and repair mechanisms induced in 
vivo compared to in vitro cultivation. The pathways were drawn according to KEGG database. Circles next to 
each gene display its regulation for each condition. A-I represent significantly up-regulated KEGG pathways 
under in vivo conditions: A) Cardiolipin synthesis, B) Mevalonate pathway, C) Tryptophan synthesis, D) Biotin 
synthesis, E) Thiamine synthesis, F) Fatty acid degradation, G) Base excision repair, H) Nucleotide excision 
repair, and I) LPS synthesis. Reactivity of in vivo vs cell and cell-free cultures are always the same (except 
cbu0608, due to induction of mevalonate pathway in cell culture similar to in vivo, relative to cell-free culture 
system). 
71 
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appeared to play an important role in energy metabolism. Among the genes implicated in this 
pathway, the yfcX gene was most strongly induced (Fig 5F). This results in anaerobic degradation of 
long/ medium chain fatty acids and produces NADH as a major cofactor for energy generation [46]. 
Genes involved in carbohydrate metabolism (dehydrogenases such as pdhA, pdhC, lpdA, sucB, sdhA, 
sdhC) were repressed under in vivo conditions, indicating an abundance of fatty acids (and fewer 
carbohydrates) in host cells. In cell and cell-free cultures these carbohydrate metabolism genes were 
enhanced, suggesting oxidation of glycolytic and TCA intermediates for energy production. The 
Cytochrome bd oxidase gene (cydA) was highly induced under in vivo conditions but at lower levels in 
cell culture, indicating an increased affinity for oxygen under intracellular conditions [47]. These 
differences suggest that the kind of nutrients found in the environment affects pathogen manipulation.  
In conclusion, under in vivo conditions, the transportation of organic nutrients was up-
regulated, showing increased dependence of the bacterium on host-derived products. In vivo, the 
bacteria also shows enhanced biosynthetic capacities, which are directed to fulfill metabolic 
requirements that are unavailable directly from the host. In contrast, in vivo the bacterium represses a 
majority of genes coding for nucleotide synthesis and ribonucleotide reductases, which could be 
connected to the slow replication rate observed compared to in vitro culture conditions. Within in vitro 
cultures, gene regulation in cell culture were similar to in vivo but at much lower mRNA levels, 
indicating similar intracellular metabolic adaptations. Hence anaerobiosis, nutrient limitations, 
inaccessibility of co-factors were prominent environmental conditions encountered by C. burnetii 
during growth in vivo in the mice spleens. 
 
Enhanced regulation of transporter systems in hosts 
Bacterial transporters import essential nutrients, but are also used to import physiological substrates 
and export toxic molecules, both critical for cell viability, pathogenicity and virulence [48]. Under in 
vivo conditions, many transporters encoded by C. burnetii due to its intracellular life style were 
probably induced to maintain homeostasis [24]. Among these transporters are, sodium ion/proton 
exchangers (shaE, shaA, nhap.1), which might play a vital role in bacterial cytoplasmic pH 
homeostasis within the acidic PV. Several predicted drug-efflux systems (CBU0804, CBU0048, 
CBU0833, CBU1808, CBU1809) were enhanced, providing resistance and removal of toxins and host 
defensins. Among the metal transporters, gene implicated in inorganic phosphate transport were 
strongly up-regulated (CBU0014) under in vivo conditions along with up-regulation of phosphate 
starvation-responsive loci phoBR, which is one of the few two-component regulatory system present in 
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C. burnetii. Under phosphate starvation, enhanced expression of ATP producing genes was observed, 
possibly due to increased ATP demand caused by a limited amount of available phosphate [49]. 
 
High degree of oxidative stress in host cells 
The generation of oxidative stress agents, which damage key bacterial components, is an innate 
defense response of host phagocytic cells. Strategies used by C. burnetii to avoid reactive substances 
mainly involve the enzymatic destruction of radicals and DNA repair mechanisms. Among ROS 
scavenging systems, peroxiredoxin (ahpD) and its response regulator (oxyR) genes were enhanced 
under in vivo conditions. Other ROS scavenging enzymes such as functional catalase (KatE) are 
present in only few C. burnetii strains. Presence or absence of a functional catalase gene in 602 was 
assessed by mapping its genome sequences against a strain containing a functional catalase gene 
(Cbuk_Q154, Accession number: NC_011528.1) as shown previously [15]. The genome sequences of 
602 showed the presence of a highly truncated catalase gene as in NM [50]. The absence of a 
functional catalase gene in 602 and NM might be compensated by peroxiredoxins, which were 
enhanced under in vivo hosts. Under in vitro conditions, other ROS scavenging enzymes were 
enhanced in cell culture (ahpC1, ahpC2) and cell-free culture (sodC), thus indicating an increased 
peroxidase presence in intracellular hosts and superoxide radicals in the extracellular cell-free system. 
An induced protein synthesis was observed in the cell-free system, possibly leading to enhanced 
expression of the glutathione pathway, which restores protein function by reducing oxidized residues. 
Genes implicated in DNA repair (base excision repair, methyl mismatch repair and nucleotide excision 
repair) were strongly enhanced under in vivo conditions and collectively repair various DNA damages 
caused by oxidative stress (Fig 5G, 5H) [51–55]. Also the upregulation of addAB genes was seen; this 
is a novel adaptation of C. burnetii in its intracellular niche, which mediates DNA repair via 
homologous recombination [56]. Thus enhanced expression of DNA repair was seen in vivo and at 
relatively lower rate in cell culture, indicating bacterial response to increased oxidative stress in 
intracellular environments.   
 
Induction of virulence genes in vivo 
Among the known virulence factors, lipopolysaccharides (LPS) are considered to be the major 
determinant of the virulent phenotypic expression and infection of C. burnetii. Most likely the LPS 
shields the bacterial cell surface from innate immune recognition [57, 58] and/or the LPS phase-II 
works as an immunological decoy. Genes encoding structural features of LPS such as lipid A, the core 
region and the cluster of genes involved in O-antigen synthesis were enhanced under in vivo 
conditions compared to in vitro systems (Fig 5I) [59]. ABC transporters implicated in lipid A (MsbA) 
and O-antigen (CBU0703) transport were strongly induced, indicating the export of LPS components 
to the outer membrane, where it plays an important role in bacterial virulence [59, 60]. Within the in 
vitro models, the p1 and p2 cell-free cultures showed similar level of regulation of O-antigen genes as 
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in cell-culture, whereas the adapted cell-free culture (passage n>10) showed a significant down-
regulation of these genes, due to their deletion resulting in an on-going transformation into phase II 
forms [15]. Occurrence of phase II forms through the functional deletion of O-antigen coding genes 
might be an advantageous feature in the bacteria, allowing it to conserve the metabolic energy required 
to synthesize complex polysaccharides [61] and instead use energy for other important processes, such 
as growth or protein synthesis. This would be consistent with the enhanced expression of LPS genes 
seen in C. burnetii under in vivo conditions, and may be important during infection and increase in 
adaptation capabilities of the bacterium in hosts. Moreover, modifications in transcriptome of C. 
burnetii were seen only in the O-antigen region of high passaged cells, which might possibly result in 
reduced virulence potential. 
Among the other virulence factors “Type IV secretion systems” (T4SS) have been identified 
as one of the important transfer systems in C. burnetii that delivers bacterial effector proteins into the 
host cytosol and are intimately involved in the pathogenesis of the bacterium. Genome sequencing has 
revealed the presence of an intact T4SS homologous to L. pneumophila Dot/Icm system. To date, only 
this system has been shown as a virulent determinant essential for the creation of vacuole, establishing 
a niche for intracellular survival and replication of the bacterium in eukaryotic host cells [24, 62–66]. 
Previous transcriptional studies on Dot/Icm system in C. burnetii has shown high expression of these 
genes during early stage infections [67, 68]. Under in vivo conditions, the expression of Dot/Icm genes 
along with their transcription regulator (pmrA) were repressed with respect to in vitro models, 
probably due to later stages of growth of the bacterium in vivo where the infection has already taken 
place and the function of these genes had already been exerted, resulting in the establishment of 
replicative vacuole and a productive infection. Although, the transcription of these genes is repressed 
in later infection stages, decreased protein levels are maintained constantly [68]. Hence secretion of 
effector proteins of the T4SS required for maintaining an intracellular niche is still possible in the host 
cells. Under in vivo conditions, T4SS effector proteins such as ankyrin repeat domain containing 
proteins (ankC, ankG) were up-regulated, and have been shown to interfere with the host cell 
apoptosis pathway [69]. Other effector proteins encoded by plasmid genes (CBU0014, CBU0015, 
CBU0006) were also up-regulated. These proteins are delivered by T4SS into host cytosol and might 
play a role in subversion of host cell functions [70]. Under in vitro conditions, the T4SS was up-
regulated. In cell culture, this system must be enhanced as the bacteria emerging from PV can re-infect 
new cells in the culture. Interestingly, this system was also seen to be enhanced in cell-free culture, 
although the bacterium does not require it as the medium is devoid of cells. Hence, the cell-free in 
vitro environment might induce the full repertoire of transcriptional responses required for successful 
pathogenesis of the bacterium for future challenges and transmission.  
Others predicted virulence factors implicated in the manipulation of host-cell components and 
processes were also relatively enhanced under in vivo conditions. Among these were putative genes 
encoding phospholipase A (CBU0489) which can act on host phospholipids and generate lipid 
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C. burnetii. Under phosphate starvation, enhanced expression of ATP producing genes was observed, 
possibly due to increased ATP demand caused by a limited amount of available phosphate [49]. 
 
High degree of oxidative stress in host cells 
The generation of oxidative stress agents, which damage key bacterial components, is an innate 
defense response of host phagocytic cells. Strategies used by C. burnetii to avoid reactive substances 
mainly involve the enzymatic destruction of radicals and DNA repair mechanisms. Among ROS 
scavenging systems, peroxiredoxin (ahpD) and its response regulator (oxyR) genes were enhanced 
under in vivo conditions. Other ROS scavenging enzymes such as functional catalase (KatE) are 
present in only few C. burnetii strains. Presence or absence of a functional catalase gene in 602 was 
assessed by mapping its genome sequences against a strain containing a functional catalase gene 
(Cbuk_Q154, Accession number: NC_011528.1) as shown previously [15]. The genome sequences of 
602 showed the presence of a highly truncated catalase gene as in NM [50]. The absence of a 
functional catalase gene in 602 and NM might be compensated by peroxiredoxins, which were 
enhanced under in vivo hosts. Under in vitro conditions, other ROS scavenging enzymes were 
enhanced in cell culture (ahpC1, ahpC2) and cell-free culture (sodC), thus indicating an increased 
peroxidase presence in intracellular hosts and superoxide radicals in the extracellular cell-free system. 
An induced protein synthesis was observed in the cell-free system, possibly leading to enhanced 
expression of the glutathione pathway, which restores protein function by reducing oxidized residues. 
Genes implicated in DNA repair (base excision repair, methyl mismatch repair and nucleotide excision 
repair) were strongly enhanced under in vivo conditions and collectively repair various DNA damages 
caused by oxidative stress (Fig 5G, 5H) [51–55]. Also the upregulation of addAB genes was seen; this 
is a novel adaptation of C. burnetii in its intracellular niche, which mediates DNA repair via 
homologous recombination [56]. Thus enhanced expression of DNA repair was seen in vivo and at 
relatively lower rate in cell culture, indicating bacterial response to increased oxidative stress in 
intracellular environments.   
 
Induction of virulence genes in vivo 
Among the known virulence factors, lipopolysaccharides (LPS) are considered to be the major 
determinant of the virulent phenotypic expression and infection of C. burnetii. Most likely the LPS 
shields the bacterial cell surface from innate immune recognition [57, 58] and/or the LPS phase-II 
works as an immunological decoy. Genes encoding structural features of LPS such as lipid A, the core 
region and the cluster of genes involved in O-antigen synthesis were enhanced under in vivo 
conditions compared to in vitro systems (Fig 5I) [59]. ABC transporters implicated in lipid A (MsbA) 
and O-antigen (CBU0703) transport were strongly induced, indicating the export of LPS components 
to the outer membrane, where it plays an important role in bacterial virulence [59, 60]. Within the in 
vitro models, the p1 and p2 cell-free cultures showed similar level of regulation of O-antigen genes as 
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in cell-culture, whereas the adapted cell-free culture (passage n>10) showed a significant down-
regulation of these genes, due to their deletion resulting in an on-going transformation into phase II 
forms [15]. Occurrence of phase II forms through the functional deletion of O-antigen coding genes 
might be an advantageous feature in the bacteria, allowing it to conserve the metabolic energy required 
to synthesize complex polysaccharides [61] and instead use energy for other important processes, such 
as growth or protein synthesis. This would be consistent with the enhanced expression of LPS genes 
seen in C. burnetii under in vivo conditions, and may be important during infection and increase in 
adaptation capabilities of the bacterium in hosts. Moreover, modifications in transcriptome of C. 
burnetii were seen only in the O-antigen region of high passaged cells, which might possibly result in 
reduced virulence potential. 
Among the other virulence factors “Type IV secretion systems” (T4SS) have been identified 
as one of the important transfer systems in C. burnetii that delivers bacterial effector proteins into the 
host cytosol and are intimately involved in the pathogenesis of the bacterium. Genome sequencing has 
revealed the presence of an intact T4SS homologous to L. pneumophila Dot/Icm system. To date, only 
this system has been shown as a virulent determinant essential for the creation of vacuole, establishing 
a niche for intracellular survival and replication of the bacterium in eukaryotic host cells [24, 62–66]. 
Previous transcriptional studies on Dot/Icm system in C. burnetii has shown high expression of these 
genes during early stage infections [67, 68]. Under in vivo conditions, the expression of Dot/Icm genes 
along with their transcription regulator (pmrA) were repressed with respect to in vitro models, 
probably due to later stages of growth of the bacterium in vivo where the infection has already taken 
place and the function of these genes had already been exerted, resulting in the establishment of 
replicative vacuole and a productive infection. Although, the transcription of these genes is repressed 
in later infection stages, decreased protein levels are maintained constantly [68]. Hence secretion of 
effector proteins of the T4SS required for maintaining an intracellular niche is still possible in the host 
cells. Under in vivo conditions, T4SS effector proteins such as ankyrin repeat domain containing 
proteins (ankC, ankG) were up-regulated, and have been shown to interfere with the host cell 
apoptosis pathway [69]. Other effector proteins encoded by plasmid genes (CBU0014, CBU0015, 
CBU0006) were also up-regulated. These proteins are delivered by T4SS into host cytosol and might 
play a role in subversion of host cell functions [70]. Under in vitro conditions, the T4SS was up-
regulated. In cell culture, this system must be enhanced as the bacteria emerging from PV can re-infect 
new cells in the culture. Interestingly, this system was also seen to be enhanced in cell-free culture, 
although the bacterium does not require it as the medium is devoid of cells. Hence, the cell-free in 
vitro environment might induce the full repertoire of transcriptional responses required for successful 
pathogenesis of the bacterium for future challenges and transmission.  
Others predicted virulence factors implicated in the manipulation of host-cell components and 
processes were also relatively enhanced under in vivo conditions. Among these were putative genes 
encoding phospholipase A (CBU0489) which can act on host phospholipids and generate lipid 
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signaling [50, 71], acid phosphatase (CBU0335) which can phosphorylate host proteins and decreases 
oxidative burst after phagocytosis of the bacterium [67], proteins with eukaryotic like domains 
(CBUA0014, CBU2078) which can modulate host ubiquitination pathways and disrupting host cell 
processes during infection [72, 73] and other eukaryotic like protein kinases similar to STPKs 
(CBU0175, CBU1379) which can directly interfere in host cell signal transduction [50, 74]. Hence, 
strong regulation of genes involved in manipulating and functionally mimicking the activity of host 
cell proteins was seen as a virulence property of the bacterium in hosts. 
 
Stringent responses of C. burnetii in hosts 
Under environmental stress (such as the intracellular in vivo conditions), bacterial species show 
stringent responses to escape unfavorable conditions. Under in vivo conditions, genes implicated in 
alarmone degradation were regulated (down-regulation of spoT and up-regulation of relA) which 
results in accumulation of unusual guanosine nucleotides (p)ppGpp, a hallmark of stringent response 
in several bacterial species [75]. In several bacterial species stringent responses were shown to play a 
role in sporulation, virulence and long-term persistence, usually in response to environmental stress 
[75, 76]. For example, in L. pneumophila, a close relative of C. burnetii, the stringent pathways are 
important factors in modulating the virulent attributes that help its survival in the host [77]. The role of 
these regulatory networks in C .burnetii is not known yet and differential regulation of these genes 
under in vivo conditions at later infection stages (Day 20) may result in a greater benefit to the survival 
of the bacteria, which would be an interesting area of study in need of further investigation. 
 
Additional microarray experiments performed in parallel with NM reference strain revealed similar 
gene expression patterns in vivo compared to in vitro models (data not shown) indicating that the 
trends described by the Dutch 602 outbreak field strain are likely to prove relevant to other C. burnetii 
strains more generally. Therefore, the microarray data increases our knowledge regarding pathogen 
adaptation to host micro environments, selective pressures in these environments and bacterial factors 
responsible for evading host responses. Finally, the microarray data can be used as a guide to screen 
and select genes encoding putative membrane proteins and other proteins that have antigenic 
properties among the differentially regulated genes during varying conditions. This might provide a 
framework for new possibilities to investigate and identify virulent factors important in the design of 
vaccines. 
 
Conclusions 
This is the first report on C. burnetii genome-wide transcriptome profiles isolated from in vivo and in 
vitro culture models. The data provide insight into pathways associated with bacterial adaptation to 
varying environmental conditions and identify potential virulent factors based on the mRNA levels of 
genes measured by microarray approach. Transcriptome differences in C. burnetii were profound 
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between in vivo and in vitro culture models. Within the in vitro culture systems, the expression profile 
of C. burnetii from cell culture was closely related to expression profiles from the in vivo model (Fig 
2). This might be due to its intracellular nature and low nutrient availability in cell culture compared to 
free availability of nutrients in the more artificial cell-free culture model. The cell-free culture 
adapting passages (p1 and p2) expression profiles migrated towards cell-free adapted strains indicating 
the ability of the bacterium to adapt promptly to available resources in the environment. 
Between the different models, major differential gene regulations were primarily observed in 
metabolic processes of the bacteria. Under in vivo conditions, the exciting observations in our study 
were; enhanced expression of anionic phospholipid coding gene (cls) for maintenance of acidic pH at 
outer membrane surface; organic molecule transportation indicating non-starvation of the bacteria; 
phosphate limitation as an important intracellular signal, and enhanced DNA repair mechanisms to 
combat against oxidative stress in host cells. We have also been able to provide evidence that based on 
the observed gene regulation; lipids play a very important role in several biosynthetic processes of C. 
burnetii in vivo and are the primary sources for anaerobic energy metabolism, possibly due to their 
abundant presence in mice spleens. However, carbohydrate metabolism was observed under in vitro 
culture systems indicating type and availability of nutrients were important determinants for resulting 
expression patterns of C. burnetii in different models. Relative to in vitro conditions, the in vivo 
environment significantly enhanced expression of virulence genes such as LPS-linked genes and 
factors implicated in host-cell modulations (inhibition of apoptosis, evading defense mechanisms etc.). 
This capability to modulate host response to infection seems to be a key factor for C. burnetii survival 
in vivo. 
 
Materials and methods 
Bacterial strains and culture models 
C. burnetii strain 602 was isolated from aborted placenta of goats during a Q fever outbreak and 
initially propagated on Buffalo Green Monkey (BGM) cells (European Collection of Cell Cultures, 
Salisbury) as described previously [15, 20]. The strain was genotyped by MLVA as CbNL01, a 
predominant genotype during the outbreak. The 602 and Nine Mile RSA493 (NM) reference strain 
were propagated in different models explained below.  
 
Mice spleen model 
The spleens from mice infected with C. burnetii 602 and NM strains were used as in vivo model to 
study bacterial gene expressions. Animal experiments were conducted using 7 week old Specific-
Pathogen-Free Swiss female OF1 mice (Charles River, l’Arbresle). The mice were housed under 
sterile conditions in biosecurity level 3 facilities. After a week of acclimatization, infections were 
performed with 3 Swiss OF1 mice per strain. The mice were inoculated intraperitoneally with 0.2 ml 
PBS suspension of C. burnetii (grown in BGM cell culture) with each mouse receiving a dose of 107 
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varying environmental conditions and identify potential virulent factors based on the mRNA levels of 
genes measured by microarray approach. Transcriptome differences in C. burnetii were profound 
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between in vivo and in vitro culture models. Within the in vitro culture systems, the expression profile 
of C. burnetii from cell culture was closely related to expression profiles from the in vivo model (Fig 
2). This might be due to its intracellular nature and low nutrient availability in cell culture compared to 
free availability of nutrients in the more artificial cell-free culture model. The cell-free culture 
adapting passages (p1 and p2) expression profiles migrated towards cell-free adapted strains indicating 
the ability of the bacterium to adapt promptly to available resources in the environment. 
Between the different models, major differential gene regulations were primarily observed in 
metabolic processes of the bacteria. Under in vivo conditions, the exciting observations in our study 
were; enhanced expression of anionic phospholipid coding gene (cls) for maintenance of acidic pH at 
outer membrane surface; organic molecule transportation indicating non-starvation of the bacteria; 
phosphate limitation as an important intracellular signal, and enhanced DNA repair mechanisms to 
combat against oxidative stress in host cells. We have also been able to provide evidence that based on 
the observed gene regulation; lipids play a very important role in several biosynthetic processes of C. 
burnetii in vivo and are the primary sources for anaerobic energy metabolism, possibly due to their 
abundant presence in mice spleens. However, carbohydrate metabolism was observed under in vitro 
culture systems indicating type and availability of nutrients were important determinants for resulting 
expression patterns of C. burnetii in different models. Relative to in vitro conditions, the in vivo 
environment significantly enhanced expression of virulence genes such as LPS-linked genes and 
factors implicated in host-cell modulations (inhibition of apoptosis, evading defense mechanisms etc.). 
This capability to modulate host response to infection seems to be a key factor for C. burnetii survival 
in vivo. 
 
Materials and methods 
Bacterial strains and culture models 
C. burnetii strain 602 was isolated from aborted placenta of goats during a Q fever outbreak and 
initially propagated on Buffalo Green Monkey (BGM) cells (European Collection of Cell Cultures, 
Salisbury) as described previously [15, 20]. The strain was genotyped by MLVA as CbNL01, a 
predominant genotype during the outbreak. The 602 and Nine Mile RSA493 (NM) reference strain 
were propagated in different models explained below.  
 
Mice spleen model 
The spleens from mice infected with C. burnetii 602 and NM strains were used as in vivo model to 
study bacterial gene expressions. Animal experiments were conducted using 7 week old Specific-
Pathogen-Free Swiss female OF1 mice (Charles River, l’Arbresle). The mice were housed under 
sterile conditions in biosecurity level 3 facilities. After a week of acclimatization, infections were 
performed with 3 Swiss OF1 mice per strain. The mice were inoculated intraperitoneally with 0.2 ml 
PBS suspension of C. burnetii (grown in BGM cell culture) with each mouse receiving a dose of 107 
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genome copy equivalents as determined by quantitative PCR [20]. Twenty days after inoculation the 
mice were euthanized, spleens were harvested aseptically and immediately frozen in liquid nitrogen 
and then at -80°C for RNA isolation. Animal experiments were approved by the animal experiment 
commission of the Central Veterinary Institute of Wageningen UR, and conducted in accordance with 
the Dutch regulations on animal experimentation. 
 
In vitro culture Models 
The C. burnetii strains used in the study were propagated in cell and cell-free cultures in triplicate 
from the low passage stock cultures stored at -80oC. 
 
Cell culture model 
For the cell culture model, BGM cells with EMEM culture media without antibiotics (10% bovine 
serum albumin, 1% NEAA, 1% glutamax) were used to propagate C. burnetii from stock cultures 
(passage n=10-12 in BGM cell culture) until stationary growth phase [20].  
 
Cell-free culture model 
For the cell-free culture, the protocol previously described [23] was used to propagate C. burnetii 
(passage n=10-12 in cell-free culture) until stationary growth phase. Two serial passages (p1 and p2) 
of the strains from cell to cell-free culture model were also performed in addition and were included in 
the study. 
 
C. burnetii specific RNA isolation 
The frozen spleens were thawed on ice and a piece of the tissue was homogenized (PowerGen 125, 
Fischer Scientific, Pittsburgh) in trizol reagent (Ambion, Austin) with a disposable plastic micro pestle 
(OMNI-Tip plastic homogenizing probes, OMNI international, Kennesaw) and used for RNA 
isolation. The in vitro cell culture supernatants were centrifuged at 1200 rpm, 4oC for 10 min to 
remove cell debris. These processed supernatants of cell and the cell-free cultures were centrifuged at 
16000 rpm, 4oC for 30 min to pellet the bacterial cells and subsequently treated with trizol for RNA 
isolation. Total RNA was isolated by using Direct-zol RNA MiniPrep Kit (Zymo Research, Irvine) as 
per manufacturer’s instructions. All samples were DNase treated prior to RNA isolation. The host 
RNA from total spleen RNA was selectively removed by MICROBEnrich kit (Ambion, Austin) 
followed by RNA clean and Concentrator-5 kit (Zymo Research, Irvine) for RNA clean-up and 
concentration. 
 
C. burnetii specific microarray 
Custom gene expression microarrays, 8x15 K, designed by Agilent (Agilent Technologies, Santa 
Clara), consisted of eight arrays per slide with duplicates of 7500 probes. All the probes were user-
77 
 
designed by eArray web-based probe design tool (https://earray.chem.agilent.com/earray) based on the 
complete gene repertoire of C. burnetii (NCBI, Accession numbers: AE016828.2, CP000733.1, 
CP001020.1, CP001019.1, CP001021.1 and draft genomes of Dutch C. burnetii strains). 1 to 4 probes 
of 120 bp in length were designed per gene such that the probes evenly distributed across the gene.  
 
RNA amplification, labelling and hybridization 
Poly A tails were tagged to purified bacterial total RNA (500 ng) from all the culture models with a 
Poly A Polymerase Tailing kit (Epicenter Illumina company, Madison) as per manufacture 
instructions. Poly A tailed RNA (250 ng) were prepared for ampliﬁcation and labelling using the Low 
Input Quick Amp Labeling Kit from Agilent following the detailed kit protocol. Cyanine 3–labelled 
cRNA was puriﬁed using RNeasy mini kit (Qiagen, Hilden). Labelled cRNA was examined with the 
Nanodrop ND-1000 (Thermo Fisher Scientific, Wilmington) to assess its concentration and quality. 
Hybridization and post-hybridization washes were conducted according to Agilent’s one-color 
microarray-based gene expression analysis protocol (Version G4140_90042).  
 
Data and statistical analysis 
Microarray slides were scanned using a SureScan High Resolution DNA microarray scanner (Agilent 
Technologies, Santa Clara). Data was obtained through Agilent’s feature extraction software (Version 
10.7.3.1) and loaded in GeneSpring GX (Version 12.6.1) where signal intensity was log2-transformed 
and median normalized for all triplicate samples before analysis. PCA plots (based on correlation 
coefficients obtained from pair-wise comparisons of samples) and clustering of microarray data (based 
on Euclidian distance and Ward's linkage parameters) were analyzed using Genespring GX to display 
relative differences across samples. Differentially regulated genes between different culture models 
were determined by 2-way ANOVA (p<0.05, adjusted by the Benjamini and Hochberg false discovery 
rate algorithm) and a cut-off of 2 for the fold change was identified as significantly differential 
expression. These differentially regulated genes from different comparisons were plotted by means of 
a Venn diagram using Vennerable package (Version 2.0). David (http://david.abcc.ncifcrf.gov/) and 
KeggArray software (http://www.genome.jp/kegg/) was used for pathway analysis and to obtain P 
values of significantly regulated pathways for each comparison of 602 and NM strains against 
Coxiella burnetii RSA 493 (organism code: cbu) KEGG pathway database. 
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Figure S1. Changes in splenomegaly and bacterial genome equivalents present in the spleens of mice infected 
with 602 and NM C. burnetii strains at 7 and 20 days p.i. A) Bacterial genome equivalents of total spleens are 
evaluated by qPCR quantification and expressed as log2 transformed values, B) Degree of splenomegaly are 
expressed as the percentage of spleen weight compared with the body weight. The results are indicated as means 
± standard deviation, * indicates p-values smaller than 0.05. 
 
Table S1. List of genes differentially regulated in vivo and cell-free culture with respect to cell culture in vitro 
model of 602 strain, after passing statistical significance filter and showing more than two fold change in 
expression. All the genes are arranged based on COG functions. A positive value indicates that the gene is up-
regulated, a negative value indicates that the gene is down-regulated and – indicates no difference compared to 
cell culture in gene regulation under the respective condition. 
http://bmcgenomics.biomedcentral.com/articles/10.1186/s12864-015-2143-7 
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Abstract 
The largest global Q-fever outbreak occurred in the Netherlands during 2007-2010. Goats were 
identified as the major source of disease. Here we report the first complete genome sequence of C. 
burnetii goat outbreak strain NL3262 and that of an epidemiologically-linked chronic human strain, 
both having the outbreak-related CbNL01 MLVA genotype.   
87 
 
Q fever is a zoonotic disease caused by Coxiella burnetii. Starting in 2007, Netherlands has been 
confronted with the largest global Q fever outbreak ever, involving 4026 human cases. Based on 
epidemiological and genotyping studies dairy goats and sheep were identified as the main source of 
the human Q fever outbreak. Special attention was given to the Dutch outbreak-specific strain of 
CbNL01 MLVA-genotype which was identified in abortive dairy goats as well as in humans (1–6). 
Current project was performed with C. burnetii strains of this predominant genotype isolated from an 
aborted goat placenta (1, 7) and from a heart valve of chronic Q fever patient during the outbreak 
period. Genome determination of the veterinary NL3262 strain is crucial for understanding the large 
outbreak and biology of this high virulent strain. The genomes of virulent veterinary (NL3262) and 
related human (NLhu3345937) outbreak strains were sequenced and their reconstructed genomes were 
compared to examine similarities and differences in their genome structures.  
Strains NL3262 and NLhu3345937 were cultivated axenically in ACCM-2 media and BGM-
cells respectively (7, 8). Genomic DNA was isolated by phenol-chloroform method (9). A prior DNase 
treatment was performed to the bacterial pellet of NLhu3345937 to eliminate most host-derived DNA. 
The genome of NL3262 was de novo reconstructed from mixed assemblies using a combination of 
PacBio RS, Roche 454XL and Illumina PE250 MiSeq reads. Reconstructed genomes were improved 
with different Illumina read sets with a total average coverage of 600X using Pilon-1.8 (10). 
NLhu3345937 genome was de novo reconstructed using Illumina PE250 MiSeq reads using SPAdes-
3.6.2 (11) with a total average coverage of 285X.   
The complete NL3262 and draft genome sequence of NLhu3345937 contains 2,093,477 and 
2,088,566 bp with G+C content of 42.9 and 42.6% respectively. Genome comparisons of NL3262, 
NLhu3345937 and the draft NL-Limburg outbreak strains (12) using Nucmer (13), MUMi-BioNJ tree 
(14) and visualised using Artemis Comparison Tool (ACT; (15)) show that these strains are closely 
related with differences mainly based on single base pair mutations. Our veterinary and human strains 
both contain around the 37 kb pQpH1 plasmid similar to reference NM-RSA493 strain. Genome 
annotation of NL3262 by NCBI Prokaryotic Genome Annotation Pipeline 
(http://www.ncbi.nlm.nih.gov/genome/annotation_prok) showed 2,101 coding sequences (CDS), 180 
pseudogenes, 42 tRNA’s, 3 rRNAs and 1 ncRNA. Compared to NM (accession no-NC_002971.3) the 
majority of genes (84%) are orthologs found in both strains with only 16% of specific genes in 
NL3262 comprising mainly hypothetical products. Genome reconstruction was cumbersome between 
different passages of each strain due to high genome complexity as described before for other isolates 
(many transposons, repetitive IS1111 elements and rearrangements) (16). Observed high similarity 
between veterinary (NL3262) and human (NLhu3345937 and NL-Limburg) strains confirms the 
previous epidemiological and genotypic studies linking the goat and human infections during the 
Netherlands Q fever outbreak. A detailed comparative genome analysis of several sequenced C. 
burnetii isolates from different origins is ongoing. 
 
Genomes of the Dutch Q fever outbreak strains 
C
ha
pt
er
 4
87
86 
 
Abstract 
The largest global Q-fever outbreak occurred in the Netherlands during 2007-2010. Goats were 
identified as the major source of disease. Here we report the first complete genome sequence of C. 
burnetii goat outbreak strain NL3262 and that of an epidemiologically-linked chronic human strain, 
both having the outbreak-related CbNL01 MLVA genotype.   
87 
 
Q fever is a zoonotic disease caused by Coxiella burnetii. Starting in 2007, Netherlands has been 
confronted with the largest global Q fever outbreak ever, involving 4026 human cases. Based on 
epidemiological and genotyping studies dairy goats and sheep were identified as the main source of 
the human Q fever outbreak. Special attention was given to the Dutch outbreak-specific strain of 
CbNL01 MLVA-genotype which was identified in abortive dairy goats as well as in humans (1–6). 
Current project was performed with C. burnetii strains of this predominant genotype isolated from an 
aborted goat placenta (1, 7) and from a heart valve of chronic Q fever patient during the outbreak 
period. Genome determination of the veterinary NL3262 strain is crucial for understanding the large 
outbreak and biology of this high virulent strain. The genomes of virulent veterinary (NL3262) and 
related human (NLhu3345937) outbreak strains were sequenced and their reconstructed genomes were 
compared to examine similarities and differences in their genome structures.  
Strains NL3262 and NLhu3345937 were cultivated axenically in ACCM-2 media and BGM-
cells respectively (7, 8). Genomic DNA was isolated by phenol-chloroform method (9). A prior DNase 
treatment was performed to the bacterial pellet of NLhu3345937 to eliminate most host-derived DNA. 
The genome of NL3262 was de novo reconstructed from mixed assemblies using a combination of 
PacBio RS, Roche 454XL and Illumina PE250 MiSeq reads. Reconstructed genomes were improved 
with different Illumina read sets with a total average coverage of 600X using Pilon-1.8 (10). 
NLhu3345937 genome was de novo reconstructed using Illumina PE250 MiSeq reads using SPAdes-
3.6.2 (11) with a total average coverage of 285X.   
The complete NL3262 and draft genome sequence of NLhu3345937 contains 2,093,477 and 
2,088,566 bp with G+C content of 42.9 and 42.6% respectively. Genome comparisons of NL3262, 
NLhu3345937 and the draft NL-Limburg outbreak strains (12) using Nucmer (13), MUMi-BioNJ tree 
(14) and visualised using Artemis Comparison Tool (ACT; (15)) show that these strains are closely 
related with differences mainly based on single base pair mutations. Our veterinary and human strains 
both contain around the 37 kb pQpH1 plasmid similar to reference NM-RSA493 strain. Genome 
annotation of NL3262 by NCBI Prokaryotic Genome Annotation Pipeline 
(http://www.ncbi.nlm.nih.gov/genome/annotation_prok) showed 2,101 coding sequences (CDS), 180 
pseudogenes, 42 tRNA’s, 3 rRNAs and 1 ncRNA. Compared to NM (accession no-NC_002971.3) the 
majority of genes (84%) are orthologs found in both strains with only 16% of specific genes in 
NL3262 comprising mainly hypothetical products. Genome reconstruction was cumbersome between 
different passages of each strain due to high genome complexity as described before for other isolates 
(many transposons, repetitive IS1111 elements and rearrangements) (16). Observed high similarity 
between veterinary (NL3262) and human (NLhu3345937 and NL-Limburg) strains confirms the 
previous epidemiological and genotypic studies linking the goat and human infections during the 
Netherlands Q fever outbreak. A detailed comparative genome analysis of several sequenced C. 
burnetii isolates from different origins is ongoing. 
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GenBank under accession No. CP013667, CP0136678, CP014354 and CP014355 respectively. 
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Abstract 
Coxiella burnetii is an obligate intracellular bacterium and the etiological agent of Q fever. During 
2007-2010 the largest Q fever outbreak ever reported occurred in The Netherlands. It is anticipated 
that strains from this outbreak demonstrated an increased zoonotic potential as more than 40,000 
individuals were assumed to be infected. The acquisition of novel genetic factors by these C. burnetii 
outbreak strains, such as virulence-related genes, has frequently been proposed and discussed, but is 
not proved yet. In the present study, the whole genome sequence of several Dutch strains (CbNL01 
and CbNL12 genotypes), a few additionally selected strains from different geographical locations and 
publicly available genome sequences were used for a comparative bioinformatics approach. The study 
focusses on the identification of specific genetic differences in the outbreak related CbNL01 strains 
compared to other C. burnetii strains. In this approach we investigated the phylogenetic relationship 
and genomic aspects of virulence and host specificity. Phylogenetic clustering of whole genome 
sequences showed a genotype-specific clustering that correlated well with the clustering observed 
using Multiple Locus Variable number Tandem Repeat Analysis (MLVA). Ortholog analysis on 
predicted genes and single nucleotide polymorphism (SNP) analysis of complete genome sequences 
demonstrated the presence of genotype-specific gene contents and SNP variations in the various C. 
burnetii strains. It also demonstrated that the currently used MLVA genotyping methods are highly 
discriminatory for the investigated outbreak strains. In the fully reconstructed genome sequence of the 
Dutch outbreak NL3262 strain of the CbNL01 genotype, a relatively large number of transposon-
linked genes were identified as compared to the other published complete genome sequences of C. 
burnetii. Additionally, large numbers of SNPs in its membrane proteins and predicted virulence-
associated genes were identified in all Dutch outbreak strains compared to the NM reference strain and 
other strains of the CbNL12 genotype. The presence of large numbers of transposable elements and 
mutated genes, thereof most likely resulted in a high level of genome rearrangements and a genotype-
specific pathogenicity of outbreak strains. Thus, the epidemic potential of Dutch outbreak strains 
could be linked to increased genome plasticity and mutations in critical genes involved in virulence 
and the evasion of the host immune system. 
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Introduction 
Coxiella burnetii is the pathogenic agent of Q fever which is a zoonotic infectious disease [1]. It is an 
obligate intracellular gram-negative bacterium, which thrives within the acidic parasitophorous 
vacuole (PV) of eukaryotic cells [2]. Domestic ruminants such as goats, sheep and cattle are usually 
the primary reservoir for the C. burnetii strains causing Q fever in humans [3]. The main clinical 
symptoms of Q fever widely differ between hosts [1,3,4]. Abortions are usually manifested in goats 
[5,6], whereas clinical symptoms are rarely observed in cattle [7,8]. During abortions in goats and 
parturition of infected does, a large number of bacteria are excreted by infected animals into the 
environment [9,10]. Inhalation of pathogen-contaminated aerosols is the main route of infection in 
humans [9]. Most of the infected human individuals (~60%) remain asymptomatic after exposure to 
the pathogen. In symptomatic patients acute infections are usually presented as flu-like illness and 
pneumonia. Around 1-5% of these cases can develop into chronic infections often leading to life-
threatening endocarditis [1,8,11,12]. 
Q fever is prevalent throughout the world, but during 2007-2010 an unprecedented Q fever 
outbreak occurred in The Netherlands and is referred to as the largest outbreak ever reported [11,13–
15]. During this epidemic, several isolates from different host species were isolated and cultured. 
Genotyping by Multiple Locus Variable-number Tandem Repeat Analysis (MLVA) revealed the 
predominant presence of the so-called CbNL01 genotype and, to a lesser extent, the CbNL12 genotype 
among the strains isolated from The Netherlands [6]. The CbNL01 genotype was identified mostly in 
strains isolated from goats and specifically from human patients, indicating that goats harboring the 
CbNL01 genotype strain were most likely the source of the large human Q fever outbreak in The 
Netherlands. These genotyping studies confirmed the earlier observed epidemiological link between 
an increase in human Q fever cases and a high abortion rate in goats [6,13,15–18]. Additionally, the 
genotyping studies also showed that the CbNL12 genotype was majorly associated with strains 
originating from cattle and rarely with strains from goat, sheep and humans [6,13,19,20].  
As an intracellular pathogen, the most important factor for natural selection of C. burnetii 
could be the interactions with its specific host niches. Genome reduction and the presence of mobile 
genetic elements and virulence related pseudo-genes throughout the genome are predicted to be 
specific genome manifestations of the obligate intracellular lifestyle of this pathogen [21]. Hence, a 
comparison of C. burnetii genome sequences with specific emphasize on genes involved in pathogen-
host (cell) interactions or modulation thereof, may shed light on adaptation mechanisms of C. burnetii 
to various host species. Currently lipopolysaccharide (LPS) is the only biologically validated virulence 
factor of C. burnetii and relatively little is known regarding other potential virulence factors, or factors 
involved in pathogen-host interactions and host specificity [21–23]. Previous studies showed the up-
regulation of several genes in a Dutch outbreak strain (602) under in vivo conditions as compared to in 
vitro cell-based and cell-free growth conditions. These studies suggested a role of these up-regulated 
genes during intracellular survival and replication of C. burnetii in hosts. Unfortunately, a large 
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number of the identified in vivo up-regulated genes were of unknown function limiting the information 
derived from this study with regard to adaptation processes of the bacterium in hosts [23]. 
C. burnetii strains with a different genotypic profile can infect a variable range of host species 
with a different efficiency. For example; the CbNL01 genotype strains are predominantly found in 
goats and in humans, whereas the CbNL12 genotype strains are commonly found in cattle and hardly 
in goats and humans [6,19,20,24]. This suggests a higher susceptibility of humans and goats to C. 
burnetii of the CbNL01 genotype than to the CbNL12 genotype strains. Identification of the genomic 
variations between different genotypic strains by comparative analysis using bioinformatics 
approaches may help in the identification of the genetic factors of C. burnetii involved in its host and 
cell tropism. Till now this has not been assessed yet with the Dutch outbreak strains. Therefore, in the 
present study, we sequenced and compared whole genome sequences of several strains with different 
genotypic profiles and originating from various hosts to assess host-specific and/or genotype-specific 
genetic signatures of C. burnetii. Main focus during this study was on strains of the CbNL01 genotype 
which were predominantly found in The Netherlands during the large outbreak, in order to identify 
genomic signatures associated with their hyper-virulence behavior. From the performed research, we 
conclude that an increased genome plasticity and an increased number of single nucleotide 
polymorphisms in genes, potentially involved in virulence and the evasion of bacterial recognition by 
the host immune system, is linked to the increased epidemic potential of the Dutch outbreak strains.  
 
Materials and methods 
Bacterial strains and isolation of genomic DNA 
A summary of the features of all the C. burnetii strains used in this study is indicated in Table 1. The 
strains from the Netherlands were primarily isolated from aborted placentas of goats, sheep and from 
heart valves of human chronic infected patients during the Q fever outbreak period (2007–2010) [6]. 
This study also involves strains isolated from aborted placentas of goats and cattle from France. 
Additionally, a few strains were isolated from Q fever infected humans from elsewhere in the world. 
All the strains were genotyped based on Multiple Locus Variable-number Tandem Repeat Analysis 
(MLVA) [6]. The majority of the strains used for sequencing were cultured with a minimal number of 
sub-passages in BGM cells [10]. A few strains were cultured axenically in acidiﬁed citrate cysteine 
medium (ACCM-2) also maintaining a minimum number of sub-passages to prevent phase variation 
(Table 1) [25]. Genomic DNA was isolated using the phenol-chloroform method [26] after overnight 
incubation with ATL lysis buffer and proteinase K (QIAGEN, Hilden, Germany). A prior DNase 
treatment was performed to the bacterial pellet of cell-culture cultivated strains to eliminate most of 
the host derived DNA.  
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number of the identified in vivo up-regulated genes were of unknown function limiting the information 
derived from this study with regard to adaptation processes of the bacterium in hosts [23]. 
C. burnetii strains with a different genotypic profile can infect a variable range of host species 
with a different efficiency. For example; the CbNL01 genotype strains are predominantly found in 
goats and in humans, whereas the CbNL12 genotype strains are commonly found in cattle and hardly 
in goats and humans [6,19,20,24]. This suggests a higher susceptibility of humans and goats to C. 
burnetii of the CbNL01 genotype than to the CbNL12 genotype strains. Identification of the genomic 
variations between different genotypic strains by comparative analysis using bioinformatics 
approaches may help in the identification of the genetic factors of C. burnetii involved in its host and 
cell tropism. Till now this has not been assessed yet with the Dutch outbreak strains. Therefore, in the 
present study, we sequenced and compared whole genome sequences of several strains with different 
genotypic profiles and originating from various hosts to assess host-specific and/or genotype-specific 
genetic signatures of C. burnetii. Main focus during this study was on strains of the CbNL01 genotype 
which were predominantly found in The Netherlands during the large outbreak, in order to identify 
genomic signatures associated with their hyper-virulence behavior. From the performed research, we 
conclude that an increased genome plasticity and an increased number of single nucleotide 
polymorphisms in genes, potentially involved in virulence and the evasion of bacterial recognition by 
the host immune system, is linked to the increased epidemic potential of the Dutch outbreak strains.  
 
Materials and methods 
Bacterial strains and isolation of genomic DNA 
A summary of the features of all the C. burnetii strains used in this study is indicated in Table 1. The 
strains from the Netherlands were primarily isolated from aborted placentas of goats, sheep and from 
heart valves of human chronic infected patients during the Q fever outbreak period (2007–2010) [6]. 
This study also involves strains isolated from aborted placentas of goats and cattle from France. 
Additionally, a few strains were isolated from Q fever infected humans from elsewhere in the world. 
All the strains were genotyped based on Multiple Locus Variable-number Tandem Repeat Analysis 
(MLVA) [6]. The majority of the strains used for sequencing were cultured with a minimal number of 
sub-passages in BGM cells [10]. A few strains were cultured axenically in acidiﬁed citrate cysteine 
medium (ACCM-2) also maintaining a minimum number of sub-passages to prevent phase variation 
(Table 1) [25]. Genomic DNA was isolated using the phenol-chloroform method [26] after overnight 
incubation with ATL lysis buffer and proteinase K (QIAGEN, Hilden, Germany). A prior DNase 
treatment was performed to the bacterial pellet of cell-culture cultivated strains to eliminate most of 
the host derived DNA.  
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Genome sequences of C. burnetii 
Draft genome sequences of all C. burnetii strains (except 602) were de novo reconstructed from 
Illumina MiSeq paired-end 250 bp reads using SPAdes-3.6.2 [29]. The draft genome sequence of the 
602 strain was obtained by using Roche 454XL sequencing technology and was de novo assembled by 
Newbler 2.6. The Dutch outbreak representative strain NL3262 was fully reconstructed using a 
combination of sequencing technologies (Illumina MiSeq paired-end 250 bp , PacBio RS and Roche 
454XL) as described previously [15]. The contigs of the draft genome sequences were scaffolded and 
joined into an artificial chromosome based on homology with the closest C. burnetii strain from the 
database using BLAT synteny tool (Table 1) [30]. Mapping the reads back on the draft genome 
sequences using Bowtie2 aligner [31] confirmed its correct synteny and occasionally helped to close 
minor gaps. All C. burnetii (complete and draft) genome sequences were annotated by the NCBI 
Prokaryotic Genome Annotation Pipeline (http://www.ncbi.nlm.nih.gov/genome/annotation_prok).  
 
Table 2. Genome sequences of C. burnetii strains obtained from NCBI database for phylogenetic 
analysis and their in silico MLVA genotype 
Strain Accession No. Source MLVA Genome  Plasmid Reference 
NMRSA493c NC_002971.3 Tick NM 1995281 QpH1 [21] 
Cb175c HG825990.3 Human NM 1989565 QpH1 [32] 
Cb185d NZ_CBTH000000000.1 - NM 1991515 unknown - 
Z3055c PRJEB1438 Sheep * 1995463 QpH1 [33] 
Cb109d AKYP00000000 Human CbNL01 2030000 QpH1 [34] 
EV-Cb_C13d CCAM01000000 Ruminant CbNL01 2023172 unknown [35] 
NL-Limburgd JZWL00000000 Human CbNL01 2214254 QpH1 [14] 
Cb_B1d CCAH01000000 Ruminant CbNL12 2008014 QpH1 [35] 
EV-Cb_BK10d CCAL01000000 Ruminant CbNL12 1999727 unknown [35] 
Cb_B18d CCAI01000000 Ruminant CbNL12 2008445 unknown [35] 
CbRSA331c NC_010117.1 Human CbRSA331 2016427 QpH1 - 
Dugwayc NC_009727.1 Rodents Dugway 2158758 QpDG [21] 
CbuG_Q212c NC_011527.1 Human CbuG_Q212 2008870 integrated [21] 
CbuK_Q154c NC_011528.1 Human CbuK_Q154 2063100 QpRS [21] 
Q321d AAYJ01000000 Cattle Q321 2004584 QpDV [36] 
Goat Q177d NZ_AAUP00000000.2 Goat Goat Q177 2090565 QpRS - 
Cb_O184d CCAK01000000 Ruminant Cb_O184 2168222 QpRS [35] 
Namibiad CP007555 Goat Namibia 2101438 QpRS [37] 
AuQ01d JPVV00000000 Human AuQ01 2073000 QpRS [38] 
c: complete genome sequence (Genome in bp) 
d: draft genome sequence (Genome in bp) 
*: in silico MLVA genotype more similar to NM genotype 
Integrated: plasmid sequences integrated in chromosome 
Unknown: plasmid type not known for these C. burnetii strains 
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The (draft) genome sequences and plasmids of all sequenced C. burnetii strains have been deposited at 
GenBank under accession numbers indicated in Table 1. Published genomic sequences of several other 
C. burnetii strains used for phylogenetic studies were obtained from GenBank (Table 2). 
 
Genotyping of C. burnetii strains 
All the sequenced strains were genotyped by MLVA using a selection of 10-12 loci described 
previously [6,39]. As an additional verification step, genotypes of the reconstructed genome sequences 
as well as published genome sequences of strains from NCBI database were checked by in silico 
MLVA genotype analysis using isPCR (BLAT), MLVA primers and genotype references. In silico 
genotypes of all C. burnetii sequenced strains corresponded with known/measured MLVA genotypes. 
The in silico analysis of the database strains gave us information on their MLVA genotype (Table 2). 
Based on the number of repeats per genome loci a minimum spanning tree method was used to cluster 
the MLVA genotypes using Bionumerics (version 6.6) with default settings.  
 
Sequence clustering and phylogenetics 
Reconstructed  as well as database obtained C. burnetii sequences were hierarchical clustered based on 
their MUMi distance [40] and displayed as a phenogram using the BioNJ algorithm [41]. The 
underlying MUMi distance matrix was calculated from the pair-wise non-overlapping maximal unique 
matches (MUMs; using Nucmer version 3.22) [42]. Relative pair-wise distances (MUMi) were 
obtained by dividing the sum of pair-wise MUMs by the average genome size of the two compared 
genomes. This MUMi distance varies between 0 to 1 where 0 indicates very similar genomes and 1 is 
for very distant genomes. MUMi trees were visualized in SplitsTree4 [43]. 
For SNP detection in the sequenced draft genomes and in the complete genome of strain 
NL3262, reads with low quality (bases with a quality score of ≤ Q20) were removed before SNP 
calling. High quality reads were used to map against reference NM genome (GenBank: NC_002971.3) 
using Bowtie2 short-read aligner [31]. SNP calling was performed using bcftools [44] using default 
parameters. SNP sequence alignments were made for only those positions in NM reference strain 
where each of the sequenced strain had sequence coverage. Phylogenetic trees based on SNPs were 
created by Clustal Omega (https://www.ebi.ac.uk/Tools/msa/clustalo/) using standard settings [45] and 
visualized in SplitsTree4 [43]. SNPs and insertions/deletions in CbNL01 and CbNL12 strains 
compared to NM were verified at single nucleotide level of the mapped reads.  
 
Comparison of C. burnetii genome contents 
Alignment of the complete genome sequence of strain NL3262 with the sequences of the reference 
NM, and strains which were related to the outbreak CbNL01 genotype (Z3055, NL-Limburg) [14,33] 
was performed by using Mauve 2.4.0 aligner software with default parameters [46]. Protein orthologs 
analysis of C. burnetii amino acid sequences obtained from GenBank files from NCBI were performed 
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MLVA genotype analysis using isPCR (BLAT), MLVA primers and genotype references. In silico 
genotypes of all C. burnetii sequenced strains corresponded with known/measured MLVA genotypes. 
The in silico analysis of the database strains gave us information on their MLVA genotype (Table 2). 
Based on the number of repeats per genome loci a minimum spanning tree method was used to cluster 
the MLVA genotypes using Bionumerics (version 6.6) with default settings.  
 
Sequence clustering and phylogenetics 
Reconstructed  as well as database obtained C. burnetii sequences were hierarchical clustered based on 
their MUMi distance [40] and displayed as a phenogram using the BioNJ algorithm [41]. The 
underlying MUMi distance matrix was calculated from the pair-wise non-overlapping maximal unique 
matches (MUMs; using Nucmer version 3.22) [42]. Relative pair-wise distances (MUMi) were 
obtained by dividing the sum of pair-wise MUMs by the average genome size of the two compared 
genomes. This MUMi distance varies between 0 to 1 where 0 indicates very similar genomes and 1 is 
for very distant genomes. MUMi trees were visualized in SplitsTree4 [43]. 
For SNP detection in the sequenced draft genomes and in the complete genome of strain 
NL3262, reads with low quality (bases with a quality score of ≤ Q20) were removed before SNP 
calling. High quality reads were used to map against reference NM genome (GenBank: NC_002971.3) 
using Bowtie2 short-read aligner [31]. SNP calling was performed using bcftools [44] using default 
parameters. SNP sequence alignments were made for only those positions in NM reference strain 
where each of the sequenced strain had sequence coverage. Phylogenetic trees based on SNPs were 
created by Clustal Omega (https://www.ebi.ac.uk/Tools/msa/clustalo/) using standard settings [45] and 
visualized in SplitsTree4 [43]. SNPs and insertions/deletions in CbNL01 and CbNL12 strains 
compared to NM were verified at single nucleotide level of the mapped reads.  
 
Comparison of C. burnetii genome contents 
Alignment of the complete genome sequence of strain NL3262 with the sequences of the reference 
NM, and strains which were related to the outbreak CbNL01 genotype (Z3055, NL-Limburg) [14,33] 
was performed by using Mauve 2.4.0 aligner software with default parameters [46]. Protein orthologs 
analysis of C. burnetii amino acid sequences obtained from GenBank files from NCBI were performed 
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using Proteinortho software (Version 5) with default settings [47]. Orthologs and unique proteins in 
sequenced strains were identified from the orthologous list generated by Proteinortho. Additionally, 
ortholog analysis of sequenced strains was conducted using the proteome of NM strain as a reference. 
Pseudo-genes were excluded from the ortholog analysis. Orthologs from different strains were plotted 
by means of Edwards-Venn diagrams using Venerable package (Version 2.0). For a more detailed 
genomic sequence comparison, Artemis Comparison Tool (ACT) [48] was used to visualize whole 
genome MUMmer alignments. Detailed analyses were performed on virulence related genes such as 
variants (mutations/ deletions) in LPS encoding region, which were performed by comparing C. 
burnetii genome sequences to LPS encoding region of NM-I (GenBank: AF387640). Also, variants 
found in the CbNL01 and CbNL12 strains were subsequently pairwise checked against the reference 
NM strain using ACT and ClustalW [49]. We also performed a COG (Cluster of Orthologous Groups) 
enrichment-analysis on all non-synonymous genes in CbNL01 and CbNL12 strains and analyzed the 
proportions of different proteins for each COG category. 
 
Results 
Genome sequences of C. burnetii strains 
In the present study we report the new genome sequences of 11 C. burnetii strains. The reconstruction 
of the genome sequences of the NL3262 and NLhu3345937 strains was described before [15]. Table 1 
is a summary of the main features of the sequenced genomes. Except for strain NL3262, all the other 
strains are reported as draft genome sequences. The assembled contigs of these sequenced strains are 
joined into artificial chromosomes based on scaffolding against the closest genome sequence present 
in the database. In C. burnetii genome sequences, the insertion sequence (IS) elements are dispersed 
all over the chromosome and are not found on the plasmid [50]. These elements are repetitive in nature 
and as a consequence, the majority of contig-breaks in the draft genome assemblies mapped to the 
positions of an IS sequence, when analyzed against the NM reference genome sequence (GenBank: 
NC_002971.3). As expected, all C. burnetii sequenced genomes possess a single circular chromosome 
of around 2 Mb and a QpH1 plasmid of 37 kb size (except the Schperling and Scurry strains). The 
bacterial genomes of all sequenced strains are predicted to contain between 1800-2062 coding 
sequences (CDSs). Around 35-39% of these CDSs were annotated as encoding hypothetical products 
based on the NCBI Prokaryotic Genome Annotation Pipeline. In silico MLVA typing of the genome 
sequences corresponded with similar profiles of strains as measured by lab-based MLVA 
measurements (Table 2).  
 
Genotype-specific structural similarities between C. burnetii genome sequences 
Whole (complete and draft) genome-based phylogenetic analysis was used to infer the relationships 
between sequenced C. burnetii strains of different genotypes. The strains were initially isolated from 
different hosts such as goats, sheep, cattle and human patients (both acute and chronically infected) 
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(Table 1). The analysis also included whole genome sequences of C. burnetii strains that have become 
available in the NCBI database (Table 2). Genome sequences of some of the strains from the database, 
present as draft sequences (several contigs), were scaffolded similarly to our reconstructed genomes 
and joined into artificial chromosomes based on the reference NM strain. The phylogenetic analysis of 
these genome sequences were based on MUMi distance. This approach takes into account the number 
of maximum unique and exact matches (MUMs) of a given minimal length shared by the two genome 
sequences being compared [40,42]. The phylogenetic analysis was conducted for genomes excluding 
the plasmids, as presence or absence of plasmids did not result in any difference in hierarchical 
clustering of C. burnetii strains. 
Based on the clustering analysis, the strains could be divided into 4 main clades (indicated as 
1a, 1b, 2 and 3 in Fig.1). The majority of the C. burnetii sequenced strains segregated into two clusters 
(cluster 1 (a and b) and cluster 2, Fig. 1). These two clusters correspond to the two major genotypes 
(CbNL01 and CbNL12) of strains isolated from The Netherlands, respectively. Strain NL3262 and the 
database strain NL-Limburg clustered closely together (Cluster 1a, Fig 1). The genome of strain 
NL3262 is a complete reconstructed genome derived and curated using different sequencing 
technologies [15]. The NL-Limburg genome is a draft genome generated with a single sequencing 
technology (PacBio) and its assembly constitutes 4 contigs representing the chromosome [14]. The 
contigs of NL-Limburg cover the complete genome of NL3262 without any gaps (as visualized by 
ACT; data not shown). The ends of the contigs in NL-Limburg contain overlapping sequences of 
around 50,000 bp. Due to these additional sequences (which are probably the result of assembly error) 
the genome of strain NL-Limburg (represented as ** in Fig 1) is clustered at some distance away from 
strain NL3262 (MUMi distance 0.025). Upon removal of these repetitive sequences the MUMi 
distance between strains NL-Limburg (indicated in cluster 1a without **) and NL3262 decreases to 
0.01, indicating nearly identical genomes with differences based on 8 SNPs. Draft genome sequences 
of the database strains (Cb109 and EV-Cb_C13) belonging to the CbNL01 genotype (Fig 2 and Table 
2) clustered with the CbNL01 strains (602, CbCVIC1, 3345937, 42785537) originating from The 
Netherlands in cluster 1b (Fig 1). Strains NL3262 and NL-Limburg belong to the CbNL01 genotype 
strains as well (Fig 2 and Table 2)  [14,15]. The major differences between the complete and draft 
genome sequences of the strains belonging to the clusters 1a and 1b are the genomic locations of 
highly repetitive transposon sequences. The genome sequence of strains NL3262 and NL-Limburg 
contain 109 and 115 IS elements respectively scattered around the chromosome. These IS elements are 
missing in draft genome sequences, most probably due to their presence at contig-break regions, as 
indicated above. Thus, due to these structural differences, the draft genome sequences cluster very 
closely to each other (Cluster 1b) relative to the complete genome sequences (Cluster 1a). The 
complete sequence of NL3262 and the nearly complete genome sequence of NL-Limburg (belonging 
to genotype CbNL01) differ with a MUMi distance of around 0.05-0.06 from the draft genome 
sequences in cluster 1b which also belong to CbNL01 genotype.  
Comparative genomics of C. burnetii 
C
ha
pt
er
 5
101
100 
 
using Proteinortho software (Version 5) with default settings [47]. Orthologs and unique proteins in 
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genome MUMmer alignments. Detailed analyses were performed on virulence related genes such as 
variants (mutations/ deletions) in LPS encoding region, which were performed by comparing C. 
burnetii genome sequences to LPS encoding region of NM-I (GenBank: AF387640). Also, variants 
found in the CbNL01 and CbNL12 strains were subsequently pairwise checked against the reference 
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enrichment-analysis on all non-synonymous genes in CbNL01 and CbNL12 strains and analyzed the 
proportions of different proteins for each COG category. 
 
Results 
Genome sequences of C. burnetii strains 
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Genotype-specific structural similarities between C. burnetii genome sequences 
Whole (complete and draft) genome-based phylogenetic analysis was used to infer the relationships 
between sequenced C. burnetii strains of different genotypes. The strains were initially isolated from 
different hosts such as goats, sheep, cattle and human patients (both acute and chronically infected) 
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(Table 1). The analysis also included whole genome sequences of C. burnetii strains that have become 
available in the NCBI database (Table 2). Genome sequences of some of the strains from the database, 
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highly repetitive transposon sequences. The genome sequence of strains NL3262 and NL-Limburg 
contain 109 and 115 IS elements respectively scattered around the chromosome. These IS elements are 
missing in draft genome sequences, most probably due to their presence at contig-break regions, as 
indicated above. Thus, due to these structural differences, the draft genome sequences cluster very 
closely to each other (Cluster 1b) relative to the complete genome sequences (Cluster 1a). The 
complete sequence of NL3262 and the nearly complete genome sequence of NL-Limburg (belonging 
to genotype CbNL01) differ with a MUMi distance of around 0.05-0.06 from the draft genome 
sequences in cluster 1b which also belong to CbNL01 genotype.  
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Cluster 2 includes the draft genome sequences of strains Henzerling, Heizberg and the 
sequences of the CbNL12 genotype group of strains 601, 701CbB1, 2574 and 18430 (Fig 1). Apart 
from these, cluster 2 contains the database strains belonging to the CbNL12 genotype (draft genome 
sequences: CbB1, Cb_B18, EV-Cb_BK10) as well as the reference NM like genotype strains (NM, 
CbRSA331, Cb175, Cb185) (Fig 2 and Table 2). The complete genome sequence of strain Z3055 was 
placed at an equidistance (MUMi distance 0.02) from clusters 1 (CbNL01) and 2 (CbNL12) (Fig 1). 
An in silico PCR analysis of strain Z3055 showed few MLVA markers similar to CbNL01 genotype 
but the majority indicative for the NM genotype. This resulted in the presence of Z3055 in-between 
the nodes of the NM and CbNL01 genotype strains in an MST analysis (Fig 2). Based on the MST and   
 
 
 
Figure 1. Phylogenetic relationships among C. burnetii genome sequences. C. burnetii whole (complete and 
draft) genomes from newly sequenced strains and strains obtained from NCBI database were hierarchical 
clustered and are displayed as a phenogram using the BioNJ algorithm. Strains in bold font are newly sequenced 
strains and other strains are genome sequences obtained from NCBI database. Scale bar indicates 1% of genome 
variability. Clades representing strains from the same MLVA genotype are indicated by colored clouds. Clades 
contain strains with distance ranging from 0.010 to 0.021. Clade 1a and 1b: CbNL01, Clade 2: CbNL12 and NM 
like genotype, Clade 3: Scurry genotype (Plasmid-less strains), non-clustered strains are each of different 
genotypes (except for the sequenced Schperling strain and NCBI obtained Q321 strain, which are of same 
genotype).  
* represents the genome of strain Z3055 which is equidistant from cluster 1 and 2, ** represent the genome of 
strain NL-Limburg with duplicated regions. 
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phylogenome analysis, we assessed the genome sequences of strains Z3055 and NM to be very closely 
related. Cluster 3 included strain Scurry and the database strain CbuG_Q212, both belonging to the 
same genotype (Figs. 1 and 2). These strains clustered separately as they contain plasmid-homologous 
regions integrated in their genomes unlike other strains (Fig 1, Table 1) [51]. From the phylogenetic 
analysis, the Schperling strain was found to be the most distant strain as compared to the other de novo 
sequenced strains used in this study (MUMi distance 0.05) (Fig.1). The genome sequences of strains 
Q321, CbuK_Q154 and Goat Q177 were most similar to the strain Schperling with a MUMi distance 
of around 0.025-0.03. However, except for strain Q321, these strains belonged to different genotypes 
(Fig 2). Hence, a phylogenetic clustering of the strains based on an MLVA classification rather than 
on the host-origin background indicated a high-level of genome sequence similarity of genotype-
specific C. burnetii strains. 
 
 
 
Figure 2. Minimum spanning tree (MST) analysis of the in silico MLVA genotypes from C. burnetii strains used 
in this study and sequences obtained from NCBI database. A total of 12 to 17 micro satellite loci (depending on 
coverage in each particular genome sequence) were used to construct a dendogram using Bionumerics (version 
6.6). Each circle represents a strain and the size of the circle corresponds to the number of strains with the same 
genotype. Colors indicate the genotype of the strain. The connecting lines refer to the distance, while the 
intensity of lines shows closeness between the strains. Strains in bold font are newly sequenced strains and other 
strains are sequences obtained from NCBI database.  
* represents the in silico MLVA genotype of strain Z3055 (the majority of the MLVA markers are of the NM 
genotype and a few of the CbNL01 genotype). 
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A phylogenetic tree was also reconstructed using the identified SNPs among the sequenced 
strains with respect to the reference strain NM using bcftools (Fig 3) [44]. The SNP tree was 
constructed using Clustal Omega [45]. At SNP level, strains belonging to similar genotypes clustered 
together with clade 1 containing the CbNL01 genotype strains; clade 2 containing the strains 
Henzerling and Heizberg and clade 3 containing the CbNL12 genotype strains. This indicates that the 
presence of similar SNPs in the genomes of the same genotype strains relative to the reference strain 
NM. Strains Schperling and Scurry clustered separately, indicating that these strains contain SNPs 
distinct from the SNPs present in other sequenced strains compared to the reference strain NM. The 
data corresponds to the presence of distinct genotypes of Schperling and Scurry compared to other 
sequenced strains (Fig 2). This SNP based clustering of genotype-specific strains further confirms the 
highly similar genome sequences of strains belonging to the same genotype. 
 
 
 
Figure 3. Phylogenetic relationships among sequenced C. burnetii genomes based on SNP analysis. The 
phylogenetic tree is based on SNPs among genomes of the sequenced strains with respect to the genome of 
reference strain NM using bcf tools. The SNP tree was constructed using Clustal Omega and the clustering is 
displayed as a phenogram using the BioNJ algorithm. The scale bar indicates the number of substitutions per 
site. Clades representing strains from the same genotype are indicated by colored clouds. Clade 1:CbNL01, 
Clade 2: Henzerling and Heizberg (similar genotype), Clade 3: CbNL12. The Schperling and Scurry strains are 
present separately due to the presence of distinct SNPs relative to other sequenced strain genomes. NM indicates 
the polymorphic regions in sequenced strain genomes relative to the NM reference genome. 
 
Conserved and unique gene content in C. burnetii sequenced genomes 
A comparison of the genome sequences of C. burnetii shows that all sequenced strains are highly 
conserved in terms of size, number of coding sequences and in nucleotide composition (Table 1). The 
degree of conservation is illustrated by the comparison of the coding capacity of these genomes: 1447 
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predicted proteins are orthologs in all sequenced 13 C. burnetii strains in this study (with a total CDS 
count ranging from 1800-2062) among which 1409 of the predicted proteins are orthologs with 
reference NM. Remaining 38 proteins not shared with NM are majorly hypothetical protein products 
mostly occurring due to modifications (such as point mutations, small deletions/ insertions of <50 bp) 
in existing NM pseudo-genes (Supplementary Table 1). The 1409 orthologs among all strains 
constitute the coding core genome. All sequenced C. burnetii strains contain the QpH1 plasmids, 
except for strain Schperling containing QpRS plasmid and the plasmidless strain Scurry. The QpH1 
plasmids from sequenced strains were all very similar to the reference NM QpH1 plasmid (Accession 
No. NC_002118.1) with differences on an average of 58 point mutations. The draft plasmid sequence 
of Schperling was similar to the published sequence of plasmid QpRS (Accession No. Y15898.1) with 
differences in 63 SNP and a gap of 1810 bp (data not shown). 
Ortholog analysis of the proteome of the sequenced C. burnetii strains showed the presence of 
a few unique proteins annotated as hypothetical protein in CbNL01 and CbNL12 strains (data not 
shown). Further analysis of genes encoding these unique proteins showed that these genes were 
present at the beginning or end of contigs in assembled draft genome sequences. As contig ends of 
draft genome sequences are highly repetitive, genes annotated in these regions were not considered as 
unique genes, because these genes were truncated transposase genes. Taking this factor into account 
and other manual annotation corrections, we found no unique complete genes encoded in CbNL01, 
CbNL12, Henzerling and Heizberg strains. Instead of unique genes for each strain we did find 
orthologs that were genotype-specific. These orthologs were shared between strains of the same 
genotype only and were annotated as hypothetical proteins. When we compared these genotype-
specific genes at the nucleotide level to the genome of the reference strain NM, mutations or partial 
ORF deletion in existing NM pseudo-genes were observed for which altered functionality or 
regulation cannot be directly inferred (Supplementary Table 2). 
By comparing the proteome of the 13 sequenced strains (Table 1) 50 and 98 unique protein 
encoding genes were identified in strains Scurry and Schperling, respectively. Out of these, 3 and 17 
genes are exclusively found in Scurry and Schperling, whereas the other genes were orthologs with the 
closely related strains CbuG_Q212 and CbuK_Q154, respectively (Fig 1). These unique genes in 
Scurry and Schperling strains were annotated as hypothetical proteins and result from point mutations 
in existing pseudo-genes of CbuG_Q212 and CbuG_Q154 (data not shown). 
 
Highly similar C. burnetii gene content within the same genotype-groups 
A comparison of the coding capacity of the genomes of strains belonging to the same genotype 
showed 98%, 99.4% and 100% orthologs in predicted proteins of CbNL01, CbNL12 and the human 
strains (same genotype Henzerling and Heizberg strains), respectively (Fig 4). Fifty-one unique genes 
(non-orthologs) of NL3262 encode for transposase associated proteins (Fig 4a). These genes are not 
properly annotated in 602, CbCVIC1, NLhu3345937 and 42785537, because they fall within contig-
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break regions of the draft genome sequences. The high level of similarities of the proteomes between 
these strains indicates that the gene content is highly conserved within strains of the same genotype.  
 
 
 
Figure 4. Edwards-Venn diagrams showing the number of orthologs and unique predicted coding proteins 
among strains of the same MLVA genotype. Number of ortholog genes shared between a) CbNL01 genotype 
strains b) CbNL12 genotype strains and c) human strains Henzerling and Heizberg is represented by Edwards-
Venn diagrams. Transposase coding proteins were included in the analysis and pseudogenes were scored as 
absent. 
 
As all the 13 C. burnetii strains included in this study were initially isolated from different 
hosts, a comparison was made to assess the percentage of proteins shared by strains derived from each 
host-species. These comparisons resulted in the presence of 94.6%, 100%, 87.9% and 87% orthologs 
in predicted proteins of goat, cattle, human-acute and human–chronic isolated strains respectively 
(Supplementary Fig 1). The lower percentage of orthologs shared by strains obtained from various 
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host species is due to the presence of different genotypes within each host-species, except for the 
cattle-derived strains, as both cattle strains were of same CbNL12 genotype. For example; the strains 
isolated from goat include both CbNL01 (NL3262, 602, CbCVIC1) and CbNL12 (601) genotypes 
(Supplementary Fig 1b). Further, the strains isolated from acute and chronic human Q fever patients 
contain more divergent strains (Schperling and Scurry respectively). Because of this, the protein 
orthologs of acute and chronic human strains are comparatively less (~87%, Supplementary Fig 1c and 
1d). Taken together, the percentage of orthologs in strains obtained from similar host-species is less 
conserved than the strains obtained from similar genotype. This clearly indicates the presence of 
genotype-specific functional characteristics of C. burnetii strains. 
 
Architecture of the NL3262 complete genome sequence 
To assess the genome architecture of strain NL3262 and to study its putative genome rearrangements, 
the complete genome sequence of strain NL3262 was aligned with the genome sequence of strains 
NM, Z3055 and NL-Limburg using the Mauve genome aligner (Fig 5). Among the different C. 
burnetii strains, the CbNL01 genotype strains NL3262 and NL-Limburg encode the highest number of 
transposase genes (106-112 IS110 family transposase, 3 ISAs1 family transposase and 12-13 remnant 
transposase genes, respectively). Other completely sequenced C. burnetii genomes generally contain 
only 30-60 transposase genes [21,33]. Compared to the genome sequence of NL3262, chromosomal 
rearrangements in strains NL-Limburg, NM and Z3055 strains have resulted in 2, 19 and 21 Locally 
Collinear Blocks (LCBs) of the same gene content and gene order respectively (Fig 5). Strains NM 
and Z3055 share almost all LCBs indicating a similar genome structure (Supplementary Table 3). 
Relative to the genome sequences of strains NM and Z3055, at least 18 and 20 genome 
rearrangements occurred in strain NL3262, respectively. Taken together, the LCBs of strains NM and 
Z3055 represent 40 genomic breakpoints relative to the genome of strain NL3262 (Fig 5b and 5c). In 
the genome sequence of strain NL3262, 38 (95%) of the breakpoints occurred at intact or a remnant 
transposase sequences of the IS110 family (Supplementary Table 3). The presence of transposase 
genes at almost all genome breakpoints suggests an important role of homologous recombination in 
order to establish the observed genome rearrangements of the Dutch outbreak strains. Unlike strains 
NM and Z3055, the gene order in strains NL3262 and NL-Limburg are nearly identical, yielding only 
2 LCBs. The absence of rearrangements between NL3262 and NL-Limburg, indicates a similar 
genome structure of these CbNL01 genotype Dutch outbreak strains isolated from goat and human 
patient (Fig 5a).  
 
Increased number of transposons in Dutch outbreak CbNL01 MLVA genotype strains 
Genome sequencing of a number of Dutch outbreak strains belonging to the CbNL01 MLVA genotype 
resulted in 132, 135 and 123 contigs for strains NLhu3345937, 42785537 and CbCVIC1, respectively. 
In contrast, sequencing of the CbNL12 strains 601, 2574, 18430 and 701CbB1 resulted in 43, 40, 66  
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break regions of the draft genome sequences. The high level of similarities of the proteomes between 
these strains indicates that the gene content is highly conserved within strains of the same genotype.  
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transposase genes (106-112 IS110 family transposase, 3 ISAs1 family transposase and 12-13 remnant 
transposase genes, respectively). Other completely sequenced C. burnetii genomes generally contain 
only 30-60 transposase genes [21,33]. Compared to the genome sequence of NL3262, chromosomal 
rearrangements in strains NL-Limburg, NM and Z3055 strains have resulted in 2, 19 and 21 Locally 
Collinear Blocks (LCBs) of the same gene content and gene order respectively (Fig 5). Strains NM 
and Z3055 share almost all LCBs indicating a similar genome structure (Supplementary Table 3). 
Relative to the genome sequences of strains NM and Z3055, at least 18 and 20 genome 
rearrangements occurred in strain NL3262, respectively. Taken together, the LCBs of strains NM and 
Z3055 represent 40 genomic breakpoints relative to the genome of strain NL3262 (Fig 5b and 5c). In 
the genome sequence of strain NL3262, 38 (95%) of the breakpoints occurred at intact or a remnant 
transposase sequences of the IS110 family (Supplementary Table 3). The presence of transposase 
genes at almost all genome breakpoints suggests an important role of homologous recombination in 
order to establish the observed genome rearrangements of the Dutch outbreak strains. Unlike strains 
NM and Z3055, the gene order in strains NL3262 and NL-Limburg are nearly identical, yielding only 
2 LCBs. The absence of rearrangements between NL3262 and NL-Limburg, indicates a similar 
genome structure of these CbNL01 genotype Dutch outbreak strains isolated from goat and human 
patient (Fig 5a).  
 
Increased number of transposons in Dutch outbreak CbNL01 MLVA genotype strains 
Genome sequencing of a number of Dutch outbreak strains belonging to the CbNL01 MLVA genotype 
resulted in 132, 135 and 123 contigs for strains NLhu3345937, 42785537 and CbCVIC1, respectively. 
In contrast, sequencing of the CbNL12 strains 601, 2574, 18430 and 701CbB1 resulted in 43, 40, 66  
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Figure 5. Alignment of the genome sequences of strains NL-Limburg, NM and Z3055 relative to NL3262. 
Comparisons were performed using the Mauve genome alignment tool. The genome rearrangements of strains 
NL-Limburg (a), NM (b) and Z3055 (c) are depicted with respect to strain NL3262. Vertical red lines for each 
genome indicate contig boundaries. Color-coded LCBs (Locally Collinear Blocks, regions within genome 
sequence that are conserved and predicted to be free of any internal rearrangements) indicate conserved 
segments. Upper and lower LCBs of the genomes correspond to forward and reverse orientation with respect to 
NL3262. Plots of sequence conservation are shown within each LCB. Regions with no color indicate no 
detectable homology between the two genomes. Connector lines indicate orthologous LCBs. 
 
and 42 contigs, respectively. As described above, the majority of the contig-break points contained 
repeat sequences and corresponded mostly to transposase genes when mapped against the NM 
reference genome. Based on this observation, we anticipate that the observed number of contigs 
roughly corresponds to the number of transposase genes encoded by the strain. Based on this 
assumption, the CbNL01 and CbNL12 strains contain around 130 and 47 contigs, respectively. The 
assumed high numbers of transposons in the draft genome sequences of CbNL01 strains also matches 
with the number of annotated transposase genes in strains NL3262 (121 intact and remnant 
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transposons) and NL-Limburg strains (128 intact and remnant transposons) belonging to the same 
genotype group. Taken together, the largest number of transposons are encoded by the CbNL01 Dutch 
outbreak strains as these strains contain two to three fold more transposase genes compared to other 
strains of C. burnetii sequenced so far [33,52]. 
 
Differences in Dutch strains at SNP level 
To further asses the differences in the genome sequences of the Dutch strains from different genotypic 
groups, we performed a detailed NM reference-centric variant analysis. For this analysis we used the 
complete genome sequences of the NL3262 strain [15] and the draft genome sequence of the CbNL01 
and CbNL12 strains. We found an average of 2514 SNPs between the CbNL01 strains and NM. 
Among these, 417 SNPs were present in intergenic regions, 1041 were synonymous SNPs in coding 
regions and 1056 were non-synonymous SNP which corresponded to 702 mutated genes. Between the 
CbNL12 strains and NM an average of 2078 SNPs were found, with 340 SNPs in intergenic regions, 
889 SNPs in coding regions (synonymous SNP) and 849 non-synonymous SNPs which corresponded 
to 581 mutated genes. With respect to NM, these mutated genes in CbNL01 and CbNL12 genotype 
strains majorly encoded hypothetical proteins, membrane proteins, transporter proteins, DNA repair 
proteins, translation-related proteins and a few virulence-associated proteins (explained in detail 
below). Compared to the genome of NM, the genomes of the CbNL01 strains showed a deletion of 
3600 bp (containing ankyrin-repeat containing protein; CBU_0072), a deletion of 2300 bp (containing 
several hypothetical proteins; CBU_0877-CBU_0880) and a larger deletion of 9700 bp (containing the 
peptidoglycan catabolism proteins; CBU_1101-CBU_1112). A deletion of around 2250 bp (containing 
several hypothetical proteins; CBU_0016-CBU_0019) was observed in the CbNL01 and CbNL12 
genome sequences, relative to the NM genome sequence (Supplementary Fig 2).  
With respect to mutations in membrane protein encoding genes, a total of 64 and 48 genes 
were mutated in the CbNL01 and CbNL12 strains out of the 104 membrane protein encoding genes in 
the NM strain. Thirty eight of these genes contained the same mutation in both genotype strains. 
Additional mutations in 26 hypothetical membrane proteins were specific for all the CbNL01 strains. 
Although, the exact functions of these hypothetical protein products are not known, changes in these 
cell surface proteins could potentially contribute to an altered antigenic profile of the CbNL01 strains. 
Large numbers of mutations were also seen in transporter genes, where a total of 41 and 25 genes were 
mutated in the CbNL01 and CbNL12 strains (from a total of 75 transporters in NM). Among these, 20 
genes contained identical mutations in both genotype strains, whereas 21 genes contained mutations 
specific for the CbNL01 strains. These transporter genes belonged mostly to the ABC and MFS family 
transporters. Further COG analysis of the mutated transporter genes showed that these genes could be 
primarily involved in transportation of amino acid, carbohydrate and ions (COG categories E, G, P 
respectively). Moreover, we also identified mutations in several translation-related proteins in the 
outbreak CbNL01 strains. Around 29 of these mutated genes were also found in the CbNL12 strains, 
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to 581 mutated genes. With respect to NM, these mutated genes in CbNL01 and CbNL12 genotype 
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below). Compared to the genome of NM, the genomes of the CbNL01 strains showed a deletion of 
3600 bp (containing ankyrin-repeat containing protein; CBU_0072), a deletion of 2300 bp (containing 
several hypothetical proteins; CBU_0877-CBU_0880) and a larger deletion of 9700 bp (containing the 
peptidoglycan catabolism proteins; CBU_1101-CBU_1112). A deletion of around 2250 bp (containing 
several hypothetical proteins; CBU_0016-CBU_0019) was observed in the CbNL01 and CbNL12 
genome sequences, relative to the NM genome sequence (Supplementary Fig 2).  
With respect to mutations in membrane protein encoding genes, a total of 64 and 48 genes 
were mutated in the CbNL01 and CbNL12 strains out of the 104 membrane protein encoding genes in 
the NM strain. Thirty eight of these genes contained the same mutation in both genotype strains. 
Additional mutations in 26 hypothetical membrane proteins were specific for all the CbNL01 strains. 
Although, the exact functions of these hypothetical protein products are not known, changes in these 
cell surface proteins could potentially contribute to an altered antigenic profile of the CbNL01 strains. 
Large numbers of mutations were also seen in transporter genes, where a total of 41 and 25 genes were 
mutated in the CbNL01 and CbNL12 strains (from a total of 75 transporters in NM). Among these, 20 
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specific for the CbNL01 strains. These transporter genes belonged mostly to the ABC and MFS family 
transporters. Further COG analysis of the mutated transporter genes showed that these genes could be 
primarily involved in transportation of amino acid, carbohydrate and ions (COG categories E, G, P 
respectively). Moreover, we also identified mutations in several translation-related proteins in the 
outbreak CbNL01 strains. Around 29 of these mutated genes were also found in the CbNL12 strains, 
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whereas 15 mutated genes were specifically found in the CbNL01 strains (from a total of 121 
translation genes in NM) (Supplementary Fig 2). 
Recognized virulence factors of C. burnetii are genes involved in primary defense 
mechanisms against oxidative stress. These include several DNA repair genes involved in base 
excision repair, nucleotide excision repair, mismatch repair, addAB mediated recombinational repair 
systems and oxidative stress enzymes [53]. Our variant analysis showed high number of mutations in 
the DNA repair genes; wherein 13 mutated genes were shared in both genotype strains and mutations 
in 7 genes were specific to the CbNL01 strains (from a total of 26 DNA repair genes in NM). On the 
contrary, we did not find any mutations in genes encoding for oxidative stress enzymes among the 
various strains indicating that these genes are highly conserved. The secondary defense mechanisms of 
C. burnetii includes the manipulation of host cell processes [53]. A Dot/Icm type IV secretion system 
(T4SS) is predicted to be encoded by the genome of C. burnetii homologous to the L. pneumophila 
Dot/Icm system. This is an important transfer system associated with the delivery of effector proteins 
from the bacterial cell to the host cytosol mediating PV formation and other cellular events required 
for bacterial maintenance and survival [23,50,54]. Among the T4SS genes, 4 genes were mutated in 
both genotype strains and an additional 4 genes were mutated specifically in the CbNL01 strains. 
Furthermore, 12 effector proteins characterized by the presence of eukaryotic like protein domains 
were also mutated in the CbNL01 and CbNL12 strains relative to NM. These genes are predicted to be 
virulence-related as the encoded proteins contain eukaryotic-like domains which may mimic host 
proteins and module host responses required for successful bacterial infection (Supplementary Fig 2). 
Taken together, compared to the reference strain NM, genotype-specific mutations of genes were 
present in the Dutch strains. Furthermore, a relatively larger number of non-synonymous mutations 
were present in critical genes of the CbNL01 strains compared to the CbNL12 strains.  
 
Changes in LPS encoding genes and its effect on phase variation 
Repeated in vitro passages of C. burnetii strains have been shown to induce antigenic variation and 
loss of virulence characteristics due to the transition into a truncated LPS structure. This truncation of 
LPS is associated with chromosomal deletions of O-antigen coding genes, located in a 38 kb region in 
the genome resulting in antigenic phase variation from phase I to phase II [27,55,56]. The genome 
sequences established in this study, were compared with the LPS encoding region (CBU0676 to 
CBU0706) of NM-phase I (GenBank: AF387640) to visualize deletions in this LPS encoding region. 
The human strains Henzerling, Heizberg, Schperling and Scurry contained no deletions in this region 
(Fig 6a). However, a deletion of 201 bp (NM-phase I LPS encoding region: 14604-14805) was 
consistently observed in this region in all sequenced (601, 2574, 701CbB1, 18430) and database 
strains (CbB1, CbB18, EV-Cb_BK10) of the CbNL12 genotype (Fig 6b). This deletion corresponded 
to a portion of CBU_0686 gene (old gene name: JB153-5), a paralog predicted to encode a 2-Oxoacid 
dehydrogenase [56]. As a paralogous gene, deletion of a portion of this gene might not affect the LPS 
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synthesis as the function might be compensated by the other gene in the genome. Similarly, a deletion 
of 355 bp (NM-phase I LPS encoding region: 20476-20830) was consistently observed in this region 
in all sequenced (NL3262, 602, CbCVIC1, NLhu3345937, 42785537) and database strains (NL-
Limburg, Cb109, EV-Cb_C13) of the CbNL01 genotype. This deletion corresponded to a portion of 
CBU_0691 gene (old gene name: JB153-10, Fig 6c and 6d) and is predicted to be involved in virenose 
synthesis which is one of the unusual sugars only present in the C. burnetii LPS-phase I structure [57].  
 
 
 
Figure 6. Artemis Comparison Tool representation of the LPS encoding region of 4 C. burnetii strains compared 
to NM-phase I. Pairwise comparison of sequenced strains with LPS encoding region of NM-phase I. a: 
comparison of Henzerling and NM-phase I showing no deletions (similarly in other strains: Heizberg, Scurry and 
Schperling), b: comparison of the CbNL12 strain 601 and NM-phase I showing a deletion (similarly in other 
CbNL12 strains), c: comparison of  the CbNL01 strain 602 and NM-phase I showing a deletion (similarly in 
other CbNL01 strains) and d: comparison of the CbNL01 strain NLhu3345937 and NM-phase I showing 
deletions. Red bars indicate same DNA sequence identity, blue bars indicate inverted reads. Deletions of a 
portion of genes or complete genes in b, c and d are seen as white gaps. Genes involved in a deletion are colored 
in cyan. 
 
Due to the deletion, CBU_0691 gene is frame-shifted and might consequently not encode for enzymes 
involved in virenose synthesis. We hypothesize that this deletion of 355 bp may induce the start of 
phase shifting in CbNL01 strains. Since the genome sequences of 602 (CbNL01 genotype) was 
obtained from in vitro grown cell cultures, we looked back into our previous functional analysis data 
of the 602 strain cultured in cells maintaining a low passage number. Our transcriptome measurements 
showed that the CBU_0691 gene was actively transcribed in cells [27]. Although the deletion of a 
portion of this gene results in frame shifting of CBU_0691, it is still possible that gene CBU_0691 is 
transcribed but that no protein product is formed. In addition, a complete gene deletion (corresponding 
to CBU_0677 to CBU_0682) and a deletion of part of the genes (corresponding to CBU_0676 and 
CBU_0683) were observed in the NLhu3345937 strain of the CbNL01 genotype. The NLhu3345937 
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whereas 15 mutated genes were specifically found in the CbNL01 strains (from a total of 121 
translation genes in NM) (Supplementary Fig 2). 
Recognized virulence factors of C. burnetii are genes involved in primary defense 
mechanisms against oxidative stress. These include several DNA repair genes involved in base 
excision repair, nucleotide excision repair, mismatch repair, addAB mediated recombinational repair 
systems and oxidative stress enzymes [53]. Our variant analysis showed high number of mutations in 
the DNA repair genes; wherein 13 mutated genes were shared in both genotype strains and mutations 
in 7 genes were specific to the CbNL01 strains (from a total of 26 DNA repair genes in NM). On the 
contrary, we did not find any mutations in genes encoding for oxidative stress enzymes among the 
various strains indicating that these genes are highly conserved. The secondary defense mechanisms of 
C. burnetii includes the manipulation of host cell processes [53]. A Dot/Icm type IV secretion system 
(T4SS) is predicted to be encoded by the genome of C. burnetii homologous to the L. pneumophila 
Dot/Icm system. This is an important transfer system associated with the delivery of effector proteins 
from the bacterial cell to the host cytosol mediating PV formation and other cellular events required 
for bacterial maintenance and survival [23,50,54]. Among the T4SS genes, 4 genes were mutated in 
both genotype strains and an additional 4 genes were mutated specifically in the CbNL01 strains. 
Furthermore, 12 effector proteins characterized by the presence of eukaryotic like protein domains 
were also mutated in the CbNL01 and CbNL12 strains relative to NM. These genes are predicted to be 
virulence-related as the encoded proteins contain eukaryotic-like domains which may mimic host 
proteins and module host responses required for successful bacterial infection (Supplementary Fig 2). 
Taken together, compared to the reference strain NM, genotype-specific mutations of genes were 
present in the Dutch strains. Furthermore, a relatively larger number of non-synonymous mutations 
were present in critical genes of the CbNL01 strains compared to the CbNL12 strains.  
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Repeated in vitro passages of C. burnetii strains have been shown to induce antigenic variation and 
loss of virulence characteristics due to the transition into a truncated LPS structure. This truncation of 
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sequences established in this study, were compared with the LPS encoding region (CBU0676 to 
CBU0706) of NM-phase I (GenBank: AF387640) to visualize deletions in this LPS encoding region. 
The human strains Henzerling, Heizberg, Schperling and Scurry contained no deletions in this region 
(Fig 6a). However, a deletion of 201 bp (NM-phase I LPS encoding region: 14604-14805) was 
consistently observed in this region in all sequenced (601, 2574, 701CbB1, 18430) and database 
strains (CbB1, CbB18, EV-Cb_BK10) of the CbNL12 genotype (Fig 6b). This deletion corresponded 
to a portion of CBU_0686 gene (old gene name: JB153-5), a paralog predicted to encode a 2-Oxoacid 
dehydrogenase [56]. As a paralogous gene, deletion of a portion of this gene might not affect the LPS 
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Due to the deletion, CBU_0691 gene is frame-shifted and might consequently not encode for enzymes 
involved in virenose synthesis. We hypothesize that this deletion of 355 bp may induce the start of 
phase shifting in CbNL01 strains. Since the genome sequences of 602 (CbNL01 genotype) was 
obtained from in vitro grown cell cultures, we looked back into our previous functional analysis data 
of the 602 strain cultured in cells maintaining a low passage number. Our transcriptome measurements 
showed that the CBU_0691 gene was actively transcribed in cells [27]. Although the deletion of a 
portion of this gene results in frame shifting of CBU_0691, it is still possible that gene CBU_0691 is 
transcribed but that no protein product is formed. In addition, a complete gene deletion (corresponding 
to CBU_0677 to CBU_0682) and a deletion of part of the genes (corresponding to CBU_0676 and 
CBU_0683) were observed in the NLhu3345937 strain of the CbNL01 genotype. The NLhu3345937 
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strain was passaged in cells for only 11 times and already showed deletion of several O-antigen genes, 
indicating a high rate of phase shifting in this strain under in vitro culture conditions (Fig 8d). Apart 
from these deletions, non-synonymous mutations in CBU_0688 and CBU_0698 were present in all 
CbNL01 strains relative to NM. Additionally, mutations in 12 O-antigen genes were observed in all 
CbNL01 and CbNL12 strains, compared to NM (Supplementary Fig 2). Taken together, we observed 
genotype-specific deletions and mutations in the LPS encoding region at a higher rate in CbNL01 
strains than in CbNL12 strains. 
 
Discussion 
In this study we used genome comparisons to detail the extent of genomic diversity of several C. 
burnetii strains. Focus was given to goat and human strains of the Dutch predominant CbNL01 
genotype to identify genomic aspects resulting in its anticipated increased virulence characteristics. In 
all the strains, we firstly performed phylogenome analysis to infer the relationships between the 
sequenced strains. Further, we analyzed orthologs and mutations among all sequenced strains with 
respect to the NM reference strain to assess differences between strains at the gene and nucleotide 
level. 
Regardless of whether the sequence data was derived from complete or draft genome 
sequences, the phylogenetic clustering of the strains was based on the MLVA genotype rather than on 
host origin. Clustering of the genome sequences was similar to the clustering based on in silico MLVA 
genotyping. Moreover, a similar genotype-specific clustering of strains was observed based on SNP 
analysis. The inferred topology of C. burnetii strains is consistent with different analysis methods and 
also with previous phylogenetic studies based on MLVA and MST genotypic data [6,20,24]. Based 
on these findings, a close relationship of genotype-specific C. burnetii strains was clearly observed. 
The phylogenetic analysis, as described here, is an improved genotyping tool, besides the MLVA and 
MST methods, as it uses whole genome sequences for comparisons of strains rather than a few 
genomic loci. Nevertheless, similar results were obtained with the three techniques. Thus the results of 
our study validate the traditional genotyping methodologies as sensitive and less-time consuming tools 
used for outbreak investigations and molecular epidemiology of pathogens. 
Among the different Dutch outbreak strains, the NL3262 strain has now a complete genome 
sequence. The NL-Limburg database strain has a draft genome sequence, although with contigs 
covering the complete genome of NL3262. Both strains are clonal as the difference between these 
strains is limited to 8 point mutations. Compared to each other, both strains NL3262 and NL-Limburg 
have only one DNA rearrangement in their genomes (Fig 5) and contain around 121-130 transposase 
encoding genes. This is the highest number of transposase genes encoded by any other C. burnetii 
strain [21]. Upon phylogenetic genome analysis, strains NL3262 and NL-Limburg cluster together in 
cluster 1a. These strains differ from other CbNL01 strains in cluster 1b by point mutations (an average 
of 12 SNPs) and annotation of transposons, which are the major contig break regions in these draft 
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genome sequences (Fig 1). Thus, based on phylogenetic and SNP analysis, the outbreak goat 
(NL3262, 602, CbCVIC1) and human strains (NLhu3345937, 42785537, NL-Limburg) of the 
CbNL01 genotype cluster together and possess almost identical genomes. Furthermore, these data 
confirm that goat are the source of the Dutch human Q fever outbreak as suggested previously by 
genotyping (Fig 1 and 2) [6].  
Both CbNL01 and CbNL12 strains were isolated in The Netherlands during the outbreak 
period from 2007- 2010. The CbNL12 genotype strains were the second most prevalent strains after 
the CbNL01 strains and were only isolated from cattle, goat and sheep, but not from humans. The 
CbNL12 genome sequence was shown to be similar to the genome sequence of the reference strain 
NM (Fig 1 and 2). Compared to CbNL01 strains, the CbNL12 strains clustered separately based on 
phylogenomics (cluster 1 and 2, Fig 1) but the distance between these clusters was very small (MUMi 
distance 0.022-0.03) indicating closely related genomes. Although the CbNL12 and CbNL01 strains 
belong to distinct MLVA genotypes, the major differences were based on point mutations (average of 
2400 SNPs) and the number of transposase encoding genes. The cattle strains 2574 and 701CbB1 used 
in this study are of the CbNL12 genotype and from different geographical locations. The 701CbB1 
strain is an archival sample isolated in France and a similar genotype strain (2574) was recently 
isolated during the Dutch Q fever outbreak period. The cattle strains were clustered together 
phylogenetically, indicating a close relationship between these strains. In addition, the published 
genome sequences of 3 strains (Cb_B1, Cb_B18, EV-Cb_BK10) of the CbNL12 genotype, which 
were isolated from ruminants in France, were also present in the same cluster (Cluster 2, Fig 1). The 
presence of similar genome strains obtained from various geographical locations may imply a clonal 
spread of CbNL12 strains over different European countries. This idea is strengthened by the fact that 
strains of the CbNL12 genotype were identified in consumer cow milk products obtained from various 
European countries [58]. As the CbNL12 strains are not detected in human samples but are spread 
over many European countries, it could be hypothesized that humans are less susceptible to CbNL12 
genotype strains, decreasing its risk for causing an outbreak in humans. 
The core genome of sequenced C. burnetii strains constitutes up to 75% of the complete gene 
repertoire of the sequenced C. burnetii strains, indicating a conservative nature of evolution. Gene 
ortholog analysis showed a 98% overlap between strains of the same genotype which is higher than 
the overlap between strains of the same host-origin. This indicates that strains of the same genotype 
are of clonal origin with highly conserved gene content (Fig 4). Unique genes were not identified in 
the Dutch outbreak strains and other closely related strains (CbNL12, Henzerling, Heizberg), although 
genotype specific genes were identified (Supplementary Table 2). A search of host-specific genes and 
signatures (based on point mutation) didn’t yield any results, indicating that host-specific genes and 
mutation were absent. Thus, genotype-specific changes were clearly observed in strains, whereas host-
specific changes in the strains could not be observed. Based on these findings, the observed 
phenotypic differences in clinical manifestations of Q fever in natural hosts,  goats (abortion), cattle 
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strain was passaged in cells for only 11 times and already showed deletion of several O-antigen genes, 
indicating a high rate of phase shifting in this strain under in vitro culture conditions (Fig 8d). Apart 
from these deletions, non-synonymous mutations in CBU_0688 and CBU_0698 were present in all 
CbNL01 strains relative to NM. Additionally, mutations in 12 O-antigen genes were observed in all 
CbNL01 and CbNL12 strains, compared to NM (Supplementary Fig 2). Taken together, we observed 
genotype-specific deletions and mutations in the LPS encoding region at a higher rate in CbNL01 
strains than in CbNL12 strains. 
 
Discussion 
In this study we used genome comparisons to detail the extent of genomic diversity of several C. 
burnetii strains. Focus was given to goat and human strains of the Dutch predominant CbNL01 
genotype to identify genomic aspects resulting in its anticipated increased virulence characteristics. In 
all the strains, we firstly performed phylogenome analysis to infer the relationships between the 
sequenced strains. Further, we analyzed orthologs and mutations among all sequenced strains with 
respect to the NM reference strain to assess differences between strains at the gene and nucleotide 
level. 
Regardless of whether the sequence data was derived from complete or draft genome 
sequences, the phylogenetic clustering of the strains was based on the MLVA genotype rather than on 
host origin. Clustering of the genome sequences was similar to the clustering based on in silico MLVA 
genotyping. Moreover, a similar genotype-specific clustering of strains was observed based on SNP 
analysis. The inferred topology of C. burnetii strains is consistent with different analysis methods and 
also with previous phylogenetic studies based on MLVA and MST genotypic data [6,20,24]. Based 
on these findings, a close relationship of genotype-specific C. burnetii strains was clearly observed. 
The phylogenetic analysis, as described here, is an improved genotyping tool, besides the MLVA and 
MST methods, as it uses whole genome sequences for comparisons of strains rather than a few 
genomic loci. Nevertheless, similar results were obtained with the three techniques. Thus the results of 
our study validate the traditional genotyping methodologies as sensitive and less-time consuming tools 
used for outbreak investigations and molecular epidemiology of pathogens. 
Among the different Dutch outbreak strains, the NL3262 strain has now a complete genome 
sequence. The NL-Limburg database strain has a draft genome sequence, although with contigs 
covering the complete genome of NL3262. Both strains are clonal as the difference between these 
strains is limited to 8 point mutations. Compared to each other, both strains NL3262 and NL-Limburg 
have only one DNA rearrangement in their genomes (Fig 5) and contain around 121-130 transposase 
encoding genes. This is the highest number of transposase genes encoded by any other C. burnetii 
strain [21]. Upon phylogenetic genome analysis, strains NL3262 and NL-Limburg cluster together in 
cluster 1a. These strains differ from other CbNL01 strains in cluster 1b by point mutations (an average 
of 12 SNPs) and annotation of transposons, which are the major contig break regions in these draft 
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genome sequences (Fig 1). Thus, based on phylogenetic and SNP analysis, the outbreak goat 
(NL3262, 602, CbCVIC1) and human strains (NLhu3345937, 42785537, NL-Limburg) of the 
CbNL01 genotype cluster together and possess almost identical genomes. Furthermore, these data 
confirm that goat are the source of the Dutch human Q fever outbreak as suggested previously by 
genotyping (Fig 1 and 2) [6].  
Both CbNL01 and CbNL12 strains were isolated in The Netherlands during the outbreak 
period from 2007- 2010. The CbNL12 genotype strains were the second most prevalent strains after 
the CbNL01 strains and were only isolated from cattle, goat and sheep, but not from humans. The 
CbNL12 genome sequence was shown to be similar to the genome sequence of the reference strain 
NM (Fig 1 and 2). Compared to CbNL01 strains, the CbNL12 strains clustered separately based on 
phylogenomics (cluster 1 and 2, Fig 1) but the distance between these clusters was very small (MUMi 
distance 0.022-0.03) indicating closely related genomes. Although the CbNL12 and CbNL01 strains 
belong to distinct MLVA genotypes, the major differences were based on point mutations (average of 
2400 SNPs) and the number of transposase encoding genes. The cattle strains 2574 and 701CbB1 used 
in this study are of the CbNL12 genotype and from different geographical locations. The 701CbB1 
strain is an archival sample isolated in France and a similar genotype strain (2574) was recently 
isolated during the Dutch Q fever outbreak period. The cattle strains were clustered together 
phylogenetically, indicating a close relationship between these strains. In addition, the published 
genome sequences of 3 strains (Cb_B1, Cb_B18, EV-Cb_BK10) of the CbNL12 genotype, which 
were isolated from ruminants in France, were also present in the same cluster (Cluster 2, Fig 1). The 
presence of similar genome strains obtained from various geographical locations may imply a clonal 
spread of CbNL12 strains over different European countries. This idea is strengthened by the fact that 
strains of the CbNL12 genotype were identified in consumer cow milk products obtained from various 
European countries [58]. As the CbNL12 strains are not detected in human samples but are spread 
over many European countries, it could be hypothesized that humans are less susceptible to CbNL12 
genotype strains, decreasing its risk for causing an outbreak in humans. 
The core genome of sequenced C. burnetii strains constitutes up to 75% of the complete gene 
repertoire of the sequenced C. burnetii strains, indicating a conservative nature of evolution. Gene 
ortholog analysis showed a 98% overlap between strains of the same genotype which is higher than 
the overlap between strains of the same host-origin. This indicates that strains of the same genotype 
are of clonal origin with highly conserved gene content (Fig 4). Unique genes were not identified in 
the Dutch outbreak strains and other closely related strains (CbNL12, Henzerling, Heizberg), although 
genotype specific genes were identified (Supplementary Table 2). A search of host-specific genes and 
signatures (based on point mutation) didn’t yield any results, indicating that host-specific genes and 
mutation were absent. Thus, genotype-specific changes were clearly observed in strains, whereas host-
specific changes in the strains could not be observed. Based on these findings, the observed 
phenotypic differences in clinical manifestations of Q fever in natural hosts,  goats (abortion), cattle 
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(rarely clinical symptoms), human acute infections (asymptomatic) and human chronic infections 
(endocarditis), is most probably due to host-specific (immune) responses to an infection with C. 
burnetii or other pathogen-related factors (such as host-tropism) which are not known yet. 
The difference between the genome sequences of the Dutch outbreak strains and the reference 
strain NM were based on point mutations, small deletions in parts of genes and a few deletions of 
complete genes in the CbNL01 strains (Supplementary Fig 2 and 7). Novel genes, potentially 
associated with increased bacterial virulence, were absent in the CbNL01 strains. This suggests that 
modifications of existing genes have given rise to the high-virulent features of the outbreak strains 
rather than the acquisition of novel genetic factors by C. burnetii. The present findings support 
previous observations that genomes of C. burnetii lack broad genetic variance, due to absence of DNA 
exchange machinery and the intracellular lifestyle, which limits opportunities for genetic exchange 
[33,36,50]. Upon assessing the variants in the Dutch strains, relative to NM, genotype-specific 
mutations in the CbNL01 strains were predominantly found in hypothetical membrane proteins, 
transporter proteins, translation proteins, DNA repair protein encoding genes and T4SS genes 
(Supplementary Fig 2). Our study showed a large number of mutations in membrane protein encoding 
genes of CbNL01 strains, relative to the CbNL12 strains. Amino acid changes in these membrane 
proteins may lead to a distinct antigenic profile of the CbNL01 strains, which may result in a change 
in immune evasion efficiencies. Based on these findings, we speculate that a shift in the bacterial 
antigenic repertoire has resulted in the increased zoonotic potential of the outbreak strains. 
Furthermore, mutations in transporter genes involved majorly in metabolite transportation, could be 
crucial for efficiently assessing host-derived nutrients to adapt in the host hostile environments. 
Additionally, a large number of mutations in the protein synthesis machinery could be a novel 
mechanism for adaptation of CbNL01 strains to the host environment. These mutations may result in 
altered levels of protein synthesis, thereby influencing the growth rate of the bacterium in the host 
niche [33]. Increased numbers of mutations in DNA-repair genes of the CbNL01 strains could be 
related to an altered/increased capability of these strains to fight against oxidative stress. This feature 
might aid in efficient maintenance of the bacterial cell integrity in harsh environments of host cell PV. 
Finally, the mutations in genes encoding virulence related effector proteins and the T4SS proteins 
delivering system could contribute to an increased/altered virulence potential of CbNL01 strains by an 
enhanced/altered protein export. This could be beneficial for C. burnetii in effective manipulation of 
host components or host intracellular processes to enhance  successful replication and persistent 
infections in hosts [52]. 
Our study shows that non-synonymous SNPs in a number of membrane protein encoding 
genes, transporter genes, genes encoding virulence-related effector proteins and O-antigen genes of 
CbNL01 strains resulted in gene frame-shifts (Supplementary Fig 2). These frameshifts result in the 
gain of pseudo-genes, which could be a mechanism of “genome reduction”. It could be speculated that 
lost gene functions might be compensated by other genes. Alternatively, the bacteria might not require 
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this function anymore due to its intimate relationship with host cells [59]. The presence of frame-shift 
mutations might increase the likelihood of the removal of whole genes by DNA deletion processes 
[60], as evidenced by the observed deletion of an ankyrin repeat protein ortholog to CBU_0072 in all 
CbNL01 strains (Supplementary Fig 2). It could be speculated that loss of genes can be a crucial 
mechanism for specialization of the bacteria to survive in a specific niche as seen previously for other 
bacterial species [61,62]. On the whole, our findings favor the reductive evolution of genomes in the 
CbNL01 strains, where increased gene loss could have led to bacterial specialization in a host niche 
[62].  
In this study we focused on the O-antigen encoding region, the most prominently known 
virulence-related genomic region of C. burnetii, which is prone to deletions resulting in phenotypic 
phase shifting [56]. The sequenced strains were cultivated both in cell-based and in cell-free systems 
and the passage numbers were kept at the minimum to avoid phenotypic phase shifting. Although we 
maintained low passage numbers (passages between 4 to 14), the CbNL01 and CbNL12 genotype 
strains showed partial gene deletions in this region. Such deletions were not observed in the remaining 
human strains used in this study (Schperling, Scurry, Henzerling and Heizberg) (Fig 6a). Deletion of 
portion of the CBU_0691 and CBU_0686 genes in CbNL01 and CbNL12 strains, respectively were 
identified. We anticipate that these deletions could have a significant effect on the structure and 
function of LPS as these genes are primarily involved in LPS biosynthesis. Although, these genes are 
polymorphic and frameshifted, the Dutch strains (CbNL01: NL3262, 602 and CbNL12: 601) were 
shown to be virulent in a mice virulence bioassay [27]. Hence, based on these observations the effect 
of genotype-specific deletions in the LPS encoding region and its effect on virulence of the Dutch 
strains are not clearly known and should be the further investigated.  
Transposable elements are present in C. burnetii genomes and contribute to genome plasticity 
[52]. The Dutch outbreak strains (NL3262, NL-Limburg) encode more than 100 transposase genes 
which is the highest number of transposase genes found in C. burnetii (30 in NM, Z3055, Dugway; 59 
in Cbuk_Q154 and 40 in CbuG_Q212). Although we cannot infer the exact number of transposons in 
draft genome sequences, we anticipate that the higher number of contigs in the sequenced CbNL01 
strains (average of 130) corresponds to the higher number of transposons, as contig ends often map to 
transposase genes relative to NM genome. Transposases are basically mobile genetic units that exhibit 
broad diversity in their structure and transposition mechanisms. Movement and accumulation of these 
elements appear to be a major force shaping C. burnetii genetic diversity [21,36]. The CbNL01 and 
NM genomes are similar in the majority of their gene content, but differ significantly in genome 
structure due to a large number of genome rearrangements. These rearrangements are generated by 
homologous recombination between IS110 family transposon genes as evidenced by the presence of 
transposase genes at almost all genome breakpoints (95%) of NL3262 relative to the NM and Z3055 
genomes (Fig 5, Supplementary Table 3). Due to higher number of transposons, the genomes of 
CbNL01 seem to be highly plastic compared to other strains. Such plasticity of the outbreak strain 
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in immune evasion efficiencies. Based on these findings, we speculate that a shift in the bacterial 
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Furthermore, mutations in transporter genes involved majorly in metabolite transportation, could be 
crucial for efficiently assessing host-derived nutrients to adapt in the host hostile environments. 
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mechanism for adaptation of CbNL01 strains to the host environment. These mutations may result in 
altered levels of protein synthesis, thereby influencing the growth rate of the bacterium in the host 
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might aid in efficient maintenance of the bacterial cell integrity in harsh environments of host cell PV. 
Finally, the mutations in genes encoding virulence related effector proteins and the T4SS proteins 
delivering system could contribute to an increased/altered virulence potential of CbNL01 strains by an 
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host components or host intracellular processes to enhance  successful replication and persistent 
infections in hosts [52]. 
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CbNL01 strains resulted in gene frame-shifts (Supplementary Fig 2). These frameshifts result in the 
gain of pseudo-genes, which could be a mechanism of “genome reduction”. It could be speculated that 
lost gene functions might be compensated by other genes. Alternatively, the bacteria might not require 
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this function anymore due to its intimate relationship with host cells [59]. The presence of frame-shift 
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CbNL01 strains (Supplementary Fig 2). It could be speculated that loss of genes can be a crucial 
mechanism for specialization of the bacteria to survive in a specific niche as seen previously for other 
bacterial species [61,62]. On the whole, our findings favor the reductive evolution of genomes in the 
CbNL01 strains, where increased gene loss could have led to bacterial specialization in a host niche 
[62].  
In this study we focused on the O-antigen encoding region, the most prominently known 
virulence-related genomic region of C. burnetii, which is prone to deletions resulting in phenotypic 
phase shifting [56]. The sequenced strains were cultivated both in cell-based and in cell-free systems 
and the passage numbers were kept at the minimum to avoid phenotypic phase shifting. Although we 
maintained low passage numbers (passages between 4 to 14), the CbNL01 and CbNL12 genotype 
strains showed partial gene deletions in this region. Such deletions were not observed in the remaining 
human strains used in this study (Schperling, Scurry, Henzerling and Heizberg) (Fig 6a). Deletion of 
portion of the CBU_0691 and CBU_0686 genes in CbNL01 and CbNL12 strains, respectively were 
identified. We anticipate that these deletions could have a significant effect on the structure and 
function of LPS as these genes are primarily involved in LPS biosynthesis. Although, these genes are 
polymorphic and frameshifted, the Dutch strains (CbNL01: NL3262, 602 and CbNL12: 601) were 
shown to be virulent in a mice virulence bioassay [27]. Hence, based on these observations the effect 
of genotype-specific deletions in the LPS encoding region and its effect on virulence of the Dutch 
strains are not clearly known and should be the further investigated.  
Transposable elements are present in C. burnetii genomes and contribute to genome plasticity 
[52]. The Dutch outbreak strains (NL3262, NL-Limburg) encode more than 100 transposase genes 
which is the highest number of transposase genes found in C. burnetii (30 in NM, Z3055, Dugway; 59 
in Cbuk_Q154 and 40 in CbuG_Q212). Although we cannot infer the exact number of transposons in 
draft genome sequences, we anticipate that the higher number of contigs in the sequenced CbNL01 
strains (average of 130) corresponds to the higher number of transposons, as contig ends often map to 
transposase genes relative to NM genome. Transposases are basically mobile genetic units that exhibit 
broad diversity in their structure and transposition mechanisms. Movement and accumulation of these 
elements appear to be a major force shaping C. burnetii genetic diversity [21,36]. The CbNL01 and 
NM genomes are similar in the majority of their gene content, but differ significantly in genome 
structure due to a large number of genome rearrangements. These rearrangements are generated by 
homologous recombination between IS110 family transposon genes as evidenced by the presence of 
transposase genes at almost all genome breakpoints (95%) of NL3262 relative to the NM and Z3055 
genomes (Fig 5, Supplementary Table 3). Due to higher number of transposons, the genomes of 
CbNL01 seem to be highly plastic compared to other strains. Such plasticity of the outbreak strain 
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genomes induced by movement of mobile elements could be a potential mechanism for the generation 
of new adaptive mechanisms to efficiently acclimatize in its intracellular niche [64,65].  
In conclusion, the present study provides the first complete study on phylogenetic analysis of 
Dutch outbreak strains, a few additionally selected strains, and all publicly available C. burnetii 
genome sequences. Hierarchical clustering based on genome content, the in silico MLVA genotypes 
and SNP analysis, showed a genotype-specific clustering of strains, showing highly similar genomes 
of C. burnetii within each genotype. The differences between the Dutch outbreak strains relative to the 
reference NM and CbNL12 strains were mainly based on single nucleotide polymorphisms. We 
hypothesize that high numbers of transposons, genotype specific polymorphisms in membrane protein 
encoding genes and virulence related genes could have resulted in a highly flexible genome, an altered 
antigenic profile and specialized virulence mechanisms. The observed subtle genetic differences form 
the basis for the increased epidemic potential and the Q fever outbreak in The Netherlands. Finally, the 
comparative analysis of several C. burnetii strains from this study has the potential to provide 
information on cross-protective vaccine candidates. Additionally, the consistent genotype-specific 
genetic differences; such as SNPs and deletions could be used as additional markers for better 
characterization of C. burnetii isolate. 
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Figure S1. Edwards-Venn diagrams showing the number of orthologs and unique predicted coding proteins 
among strains originated from same host species. 
Number of ortholog genes shared between a) cattle-derived strains b) goat-derived strains c) human (acute 
infected patients)-derived strains and d) human (chronic infected patients)-derived strains is represented by 
Edwards-Venn diagrams. Transposase coding proteins were included in the analysis and pseudogenes were 
scored as absent. 
 
Figure S2. Heat map showing Genes affected (deleted and mutated) in CbNL01 and CbNL12 strains with 
respect to the reference strain NM. 
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* * * * *         1370 - hypothetical outer membrane protein 
                  1372 - inner membrane protein oxaA 
                  1376 M integral membrane protein 
                  1395 - membrane endopeptidase, M50 family 
                  1413 - OmpA-like transmembrane domain protein 
* * * * * * * * * 1530 - outer membrane lipoprotein 
                  1561 - outer membrane lipoprotein LolB 
                  1701 - outer membrane protein 
* * * * *         1733 - outer membrane protein 
                  1814 - outer membrane protein assembly complex 
          * * * * 1818 - outer membrane protein, OMP85 family protein 
                  1829 M putative cytochrome c oxidase, membrane subunit 
                  1851 - TolC family type I secretion outer membrane protein 
                  1863 - type 4 pili biogenesis protein 
                  1950 S type I secretion outer membrane protein 
                  910 R hypothetical membrane associated protein 
                  1333 R hypothetical membrane spanning protein 
                  1334 S hypothetical membrane spanning protein 
                  1556 - hypothetical membrane spanning protein 
                  1884 S hypothetical exported membrane spanning protein 
                  278 U MarC membrane protein 
                  936 - OmpA-like transmembrane domain protein 
                  307 - OmpA-like transmembrane domain protein 
                  311 - outer membrane porin P1 
                  1190 M outer-membrane lipoproteins carrier protein 
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                  728 Q ABC transporter ATP-binding protein 
                  776 V ABC transporter ATP-binding protein 
                  1952 R ABC transporter ATP-binding protein 
                  729 Q ABC transporter  
                  933 GM ABC transporter permease protein 
                  482 ET arginine ABC transporter  
                  1967 G Bcr/CflA subfamily drug resistance transporter 
                  107 P D-methionine ABC transporter, ATP-binding protein 
                  109 P D-methionine ABC transporter 
                  1208 G major facilitator transporter 
* * * * *         1859 EP oligopeptide ABC transporter, permease protein 
                  364 P phosphate transporter 
                  2058 G proline/betaine transporter 
                  1066 P transporter, divalent anion:sodium symporter 
                  272 G transporter, MFS superfamily 
                  432 G transporter, MFS superfamily 
                  566 G transporter, MFS superfamily 
                  906 G transporter, MFS superfamily 
                  1484 G transporter, MFS superfamily 
                  1858 E peptide ABC transporter, permease protein 
                  2055 P zinc uptake transporter 
* * * * * * * * * 371 G multidrug resistance transporter, Bcr family 
* * * * * * * * * 1244 P EmrB/QacA family drug resistance transporter 
          * * * * 14 P low-affinity inorganic phosphate transporter 
                  459 P transporter, monovalent cation:proton antiporter-2 
                  504 E di-/tripeptide transporter 
                  753 V AcrB/AcrD/AcrF family transporter 
                  754 M RND family efflux transporter MFP subunit 
                  777 R ABC transporter permease 
                  797 G EmrB/QacA family drug resistance transporter 
                  803 M RND family efflux transporter MFP subunit 
* * * * *         804 V AcrB/AcrD/AcrF family transporter 
                  833 V ABC transporter permease/ATP-binding protein 
                  856 V lipid ABC transporter permease/ATP-binding protein 
                  922 G transporter, MFS superfamily 
                  1075 M transporter 
                  1130 S OPT family oligopeptide transporter 
                  1362 P cation diffusion facilitator family transporter 
                  1808 V export ABC transporter permease protein 
                  1810 M ABC transporter  
                  1896 G transporter, major facilitator family 
                  2068 G transporter, MFS superfamily 
                  354 E amino acid permease  
                  484 E amino acid ABC transporter, permease protein 
                  953 E amino acid permease 
                  1347 E amino acid antiporter 
                  1539 E tryptophan/tyrosine permease family protein 
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                  1796 E amino acid permease family protein 
                  1798 E amino acid permease family protein 
                  1093 V AcrB/AcrD/AcrF family transporter 
                  481 E arginine ABC transporter ATP-binding protein 
                  1179 G Bcr/CflA subfamily drug resistance transporter 
                  265 G glucose/galactose transporter 
                  649 R riboflavin transporter 
                  484 E amino acid ABC transporter, permease protein 
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                  305 LK RecG-like helicase 
                  1083 L DNA mismatch repair enzyme (predicted ATPase) 
                  1229 S hypothetical protein 
                  1243 L Exonuclease VII, large subunit 
                  1422 O Predicted ATP-dependent serine protease 
                  1148 LK Transcription-repair coupling factor 
                  557 L DNA polymerase III, delta subunit 
                  271 L Single-stranded DNA-binding protein 
                  274 L Excinuclease ATPase subunit 
                  506 L Single-stranded DNA-specific exonuclease 
                  542 L NAD-dependent DNA ligase 
                  1056 L Mismatch repair ATPase (MutS family) 
                  1297 L ATPase involved in DNA repair 
                  2054 L Superfamily I DNA and RNA helicases 
                  297 L Exonuclease III 
                  1795 L DNA polymerase I  
                  518 L Helicase subunit of the DNA excision repair complex 
                  1185 L Nuclease subunit of the excinuclease complex 
                  500 L ATPase involved in DNA replication 
                  1337 L DNA polymerase III, alpha subunit 
                  1476 K Transcriptional regulator 
                  1697 L Predicted EndoIII-related endonuclease 
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                  1651 - hypothetical membrane associated protein 
                  1650 - IcmW 
                  1645 NU Dot/Icm secretion system ATPase DotB 
                  1642 - IcmS 
                  1631 M ompA family protein 
                  1628 S IcmK 
                  1627 S IcmE 
                  1648 S DotA protein 
                  1643 S DotD 
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* * * * * * * * * A0016 - CbhE protein 
* * * * * * * * * A0006 - hypothetical protein 
                  1206 - delta(24(24(1)))-sterol reductase 
          * * * * 599 P 3'(2'),5'-bisphosphate nucleotidase 
                  701 P 3'(2'),5'-bisphosphate nucleotidase 
                  1292 R ankyrin repeat-containing protein 
* * * * * * * * * 1253b - ankyrin repeat-containing protein 
                  175 T serine/threonine kinase protein 
                  1136 R enhanced entry protein enhC 
                  1457 R tetratricopeptide repeat family protein 
                  295 - hypothetical protein 
                  1217 DZ hypothetical membrane spanning protein 
                  A0013 - hypothetical protein 
          * * * * 1158 - sterol delta-7-reductase 
                  547 R TPR domain-containing protein 
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                  698 - hypothetical protein 
                  688 MG GDP-L-fucose synthase 
                  701 P 3'(2'),5'-bisphosphate nucleotidase 
                  700 P bifunctional sulfate adenylyltransferase subunit 1 
                  695 - hypothetical protein 
                  694 - glycosyltransferase 
                  693 C putative pyruvate dehydrogenase 
                  689 M GDP-mannose 4,6 dehydratase 
                  685 - hypothetical protein 
                  706 - hypothetical protein 
* * * * *         687 - hypothetical exported membrane spanning protein 
* * * * *         691 - methyltransferase 
                  701 P 3'(2'),5'-bisphosphate nucleotidase 
         678 M ADP-heptose synthase, putative 
         676 MG NAD dependent epimerase/dehydratase  
         683 - Pseudo gene 
         682 - hypothetical protein 
         681 MG hypothetical protein  
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* * * * *         1370 - hypothetical outer membrane protein 
                  1372 - inner membrane protein oxaA 
                  1376 M integral membrane protein 
                  1395 - membrane endopeptidase, M50 family 
                  1413 - OmpA-like transmembrane domain protein 
* * * * * * * * * 1530 - outer membrane lipoprotein 
                  1561 - outer membrane lipoprotein LolB 
                  1701 - outer membrane protein 
* * * * *         1733 - outer membrane protein 
                  1814 - outer membrane protein assembly complex 
          * * * * 1818 - outer membrane protein, OMP85 family protein 
                  1829 M putative cytochrome c oxidase, membrane subunit 
                  1851 - TolC family type I secretion outer membrane protein 
                  1863 - type 4 pili biogenesis protein 
                  1950 S type I secretion outer membrane protein 
                  910 R hypothetical membrane associated protein 
                  1333 R hypothetical membrane spanning protein 
                  1334 S hypothetical membrane spanning protein 
                  1556 - hypothetical membrane spanning protein 
                  1884 S hypothetical exported membrane spanning protein 
                  278 U MarC membrane protein 
                  936 - OmpA-like transmembrane domain protein 
                  307 - OmpA-like transmembrane domain protein 
                  311 - outer membrane porin P1 
                  1190 M outer-membrane lipoproteins carrier protein 
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                  728 Q ABC transporter ATP-binding protein 
                  776 V ABC transporter ATP-binding protein 
                  1952 R ABC transporter ATP-binding protein 
                  729 Q ABC transporter  
                  933 GM ABC transporter permease protein 
                  482 ET arginine ABC transporter  
                  1967 G Bcr/CflA subfamily drug resistance transporter 
                  107 P D-methionine ABC transporter, ATP-binding protein 
                  109 P D-methionine ABC transporter 
                  1208 G major facilitator transporter 
* * * * *         1859 EP oligopeptide ABC transporter, permease protein 
                  364 P phosphate transporter 
                  2058 G proline/betaine transporter 
                  1066 P transporter, divalent anion:sodium symporter 
                  272 G transporter, MFS superfamily 
                  432 G transporter, MFS superfamily 
                  566 G transporter, MFS superfamily 
                  906 G transporter, MFS superfamily 
                  1484 G transporter, MFS superfamily 
                  1858 E peptide ABC transporter, permease protein 
                  2055 P zinc uptake transporter 
* * * * * * * * * 371 G multidrug resistance transporter, Bcr family 
* * * * * * * * * 1244 P EmrB/QacA family drug resistance transporter 
          * * * * 14 P low-affinity inorganic phosphate transporter 
                  459 P transporter, monovalent cation:proton antiporter-2 
                  504 E di-/tripeptide transporter 
                  753 V AcrB/AcrD/AcrF family transporter 
                  754 M RND family efflux transporter MFP subunit 
                  777 R ABC transporter permease 
                  797 G EmrB/QacA family drug resistance transporter 
                  803 M RND family efflux transporter MFP subunit 
* * * * *         804 V AcrB/AcrD/AcrF family transporter 
                  833 V ABC transporter permease/ATP-binding protein 
                  856 V lipid ABC transporter permease/ATP-binding protein 
                  922 G transporter, MFS superfamily 
                  1075 M transporter 
                  1130 S OPT family oligopeptide transporter 
                  1362 P cation diffusion facilitator family transporter 
                  1808 V export ABC transporter permease protein 
                  1810 M ABC transporter  
                  1896 G transporter, major facilitator family 
                  2068 G transporter, MFS superfamily 
                  354 E amino acid permease  
                  484 E amino acid ABC transporter, permease protein 
                  953 E amino acid permease 
                  1347 E amino acid antiporter 
                  1539 E tryptophan/tyrosine permease family protein 
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                  1796 E amino acid permease family protein 
                  1798 E amino acid permease family protein 
                  1093 V AcrB/AcrD/AcrF family transporter 
                  481 E arginine ABC transporter ATP-binding protein 
                  1179 G Bcr/CflA subfamily drug resistance transporter 
                  265 G glucose/galactose transporter 
                  649 R riboflavin transporter 
                  484 E amino acid ABC transporter, permease protein 
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                  305 LK RecG-like helicase 
                  1083 L DNA mismatch repair enzyme (predicted ATPase) 
                  1229 S hypothetical protein 
                  1243 L Exonuclease VII, large subunit 
                  1422 O Predicted ATP-dependent serine protease 
                  1148 LK Transcription-repair coupling factor 
                  557 L DNA polymerase III, delta subunit 
                  271 L Single-stranded DNA-binding protein 
                  274 L Excinuclease ATPase subunit 
                  506 L Single-stranded DNA-specific exonuclease 
                  542 L NAD-dependent DNA ligase 
                  1056 L Mismatch repair ATPase (MutS family) 
                  1297 L ATPase involved in DNA repair 
                  2054 L Superfamily I DNA and RNA helicases 
                  297 L Exonuclease III 
                  1795 L DNA polymerase I  
                  518 L Helicase subunit of the DNA excision repair complex 
                  1185 L Nuclease subunit of the excinuclease complex 
                  500 L ATPase involved in DNA replication 
                  1337 L DNA polymerase III, alpha subunit 
                  1476 K Transcriptional regulator 
                  1697 L Predicted EndoIII-related endonuclease 
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                  1651 - hypothetical membrane associated protein 
                  1650 - IcmW 
                  1645 NU Dot/Icm secretion system ATPase DotB 
                  1642 - IcmS 
                  1631 M ompA family protein 
                  1628 S IcmK 
                  1627 S IcmE 
                  1648 S DotA protein 
                  1643 S DotD 
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* * * * * * * * * A0016 - CbhE protein 
* * * * * * * * * A0006 - hypothetical protein 
                  1206 - delta(24(24(1)))-sterol reductase 
          * * * * 599 P 3'(2'),5'-bisphosphate nucleotidase 
                  701 P 3'(2'),5'-bisphosphate nucleotidase 
                  1292 R ankyrin repeat-containing protein 
* * * * * * * * * 1253b - ankyrin repeat-containing protein 
                  175 T serine/threonine kinase protein 
                  1136 R enhanced entry protein enhC 
                  1457 R tetratricopeptide repeat family protein 
                  295 - hypothetical protein 
                  1217 DZ hypothetical membrane spanning protein 
                  A0013 - hypothetical protein 
          * * * * 1158 - sterol delta-7-reductase 
                  547 R TPR domain-containing protein 
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                  698 - hypothetical protein 
                  688 MG GDP-L-fucose synthase 
                  701 P 3'(2'),5'-bisphosphate nucleotidase 
                  700 P bifunctional sulfate adenylyltransferase subunit 1 
                  695 - hypothetical protein 
                  694 - glycosyltransferase 
                  693 C putative pyruvate dehydrogenase 
                  689 M GDP-mannose 4,6 dehydratase 
                  685 - hypothetical protein 
                  706 - hypothetical protein 
* * * * *         687 - hypothetical exported membrane spanning protein 
* * * * *         691 - methyltransferase 
                  701 P 3'(2'),5'-bisphosphate nucleotidase 
         678 M ADP-heptose synthase, putative 
         676 MG NAD dependent epimerase/dehydratase  
         683 - Pseudo gene 
         682 - hypothetical protein 
         681 MG hypothetical protein  
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         680 M UDP-glucose/GDP-mannose dehydrogenase 
         679 R oxidoreductase, Gfo/Idh/MocA family 
         677 M NAD dependent epimerase/dehydratase family  
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         241 J 50S ribosomal protein L2 
         253 J 50S ribosomal protein L6 
         286 J poly(A) polymerase 
         487 J ribosomal large subunit pseudouridine synthase C 
         757 J ribosomal large subunit pseudouridine synthase D 
         808 J valyl-tRNA synthetase 
         811 J peptide chain release factor 3 
         1052 J alanyl-tRNA synthetase 
                  1201 J S-adenosylmethionine 
                  1321 J phenylalanyl-tRNA synthetase subunit beta 
                  1353 J 23S rRNA Um2552 2'-O-methyltransferase 
                  1430 J tRNA pseudouridine synthase B 
                  1841 J peptidyl-tRNA hydrolase 
* * * * *         1907 J acetyltransferase 
                  1982 J dimethyladenosine transferase 
                  1432 J translation initiation factor IF-2 
                  234 J 30S ribosomal protein S7 
                  240 J LSU ribosomal protein L23P 
                  244 J SSU ribosomal protein S3P 
                  245 J 50S ribosomal protein L16 
                  247 J SSU ribosomal protein S17P 
                  250 J 50S ribosomal protein L5 
                  257 J LSU ribosomal protein L15P 
                  260 J 30S ribosomal protein S13 
                  304 J putative endoribonuclease L-PSP 
                  396 J isoleucyl-tRNA synthetase 
                  443 J tRNA (Guanine-N(1)-)-methyltransferase 
                  444 J 16S rRNA-processing protein RimM 
                  486 J ribonuclease 
                  904 J tRNA-dihydrouridine synthase A 
                  986 J RNA methyltransferase 
                  1059 J RNA pseudouridine synthase family protein 
                  1065 J 2'-5' RNA ligase 
                  1082 J tRNA delta(2)-isopentenylpyrophosphate transferase 
                  1131 J RNA methyltransferase 
                  1147 J tRNA-specific 2-thiouridylase MnmA 
                  1432 J translation initiation factor IF-2 
                  1475 J aspartyl/glutamyl-tRNA amidotransferase subunit B 
                  1879 J peptide deformylase 
                  1914 J glycyl-tRNA synthetase subunit beta 
          * * * * 1915 J ribosomal RNA small subunit methyltransferase B 
                  2003 J sua5/YciO/YrdC/YwlC family protein 
                  2008 J arginyl-tRNA synthetase 
                  1875 J glutathione synthetase 
                  233 J 30S ribosomal protein S12 
                  852 J polynucleotide phosphorylase/polyadenylase 
                  81 J prolyl-tRNA synthetase 
                  1072 J queuine tRNA-ribosyltransferase 
                  1326 J threonyl-tRNA synthetase 
                  569 J tRNA-i(6)A37 thiotransferase enzyme MiaB 
                  2049 J tryptophanyl-tRNA synthetase 
                  622 J zinc-binding domain-containing protein 
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Table S1. List of orthologs in sequenced C. burnetii along with proteins that are ortholog with 
reference NM as assessed by proteinortho software.  
The non-orthologs with reference NM are represented as “-”. These genes include point mutations and 
small insertion/ deletion of <50 bp in existing pseudo genes of NM (pseudo genes are not included in 
the otholog analysis). Annotation of pseudo genes of NM and COG categories of orthologs are 
mentioned in the table. 
Table S1 available on request from alex.bossers@wur.nl 
 
Table S2. List of genotype-specific orthologs in sequenced C. burnetii strains as assessed by 
proteinortho software. 
Non-orthologs between strains of different genotype as well as non orthologs with reference NM strain 
are represented as “-”. These genotype-specific genes include point mutations and small insertion/ 
deletion of <50 bp in existing pseudo genes of NM (pseudo genes are not included in the otholog 
analysis) or contain partial ORF relative to complete ORF in NM. Pseudo genes and complete ORF of 
NM are mentioned in the table. 
Table S2 available on request from alex.bossers@wur.nl 
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         680 M UDP-glucose/GDP-mannose dehydrogenase 
         679 R oxidoreductase, Gfo/Idh/MocA family 
         677 M NAD dependent epimerase/dehydratase family  
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         241 J 50S ribosomal protein L2 
         253 J 50S ribosomal protein L6 
         286 J poly(A) polymerase 
         487 J ribosomal large subunit pseudouridine synthase C 
         757 J ribosomal large subunit pseudouridine synthase D 
         808 J valyl-tRNA synthetase 
         811 J peptide chain release factor 3 
         1052 J alanyl-tRNA synthetase 
                  1201 J S-adenosylmethionine 
                  1321 J phenylalanyl-tRNA synthetase subunit beta 
                  1353 J 23S rRNA Um2552 2'-O-methyltransferase 
                  1430 J tRNA pseudouridine synthase B 
                  1841 J peptidyl-tRNA hydrolase 
* * * * *         1907 J acetyltransferase 
                  1982 J dimethyladenosine transferase 
                  1432 J translation initiation factor IF-2 
                  234 J 30S ribosomal protein S7 
                  240 J LSU ribosomal protein L23P 
                  244 J SSU ribosomal protein S3P 
                  245 J 50S ribosomal protein L16 
                  247 J SSU ribosomal protein S17P 
                  250 J 50S ribosomal protein L5 
                  257 J LSU ribosomal protein L15P 
                  260 J 30S ribosomal protein S13 
                  304 J putative endoribonuclease L-PSP 
                  396 J isoleucyl-tRNA synthetase 
                  443 J tRNA (Guanine-N(1)-)-methyltransferase 
                  444 J 16S rRNA-processing protein RimM 
                  486 J ribonuclease 
                  904 J tRNA-dihydrouridine synthase A 
                  986 J RNA methyltransferase 
                  1059 J RNA pseudouridine synthase family protein 
                  1065 J 2'-5' RNA ligase 
                  1082 J tRNA delta(2)-isopentenylpyrophosphate transferase 
                  1131 J RNA methyltransferase 
                  1147 J tRNA-specific 2-thiouridylase MnmA 
                  1432 J translation initiation factor IF-2 
                  1475 J aspartyl/glutamyl-tRNA amidotransferase subunit B 
                  1879 J peptide deformylase 
                  1914 J glycyl-tRNA synthetase subunit beta 
          * * * * 1915 J ribosomal RNA small subunit methyltransferase B 
                  2003 J sua5/YciO/YrdC/YwlC family protein 
                  2008 J arginyl-tRNA synthetase 
                  1875 J glutathione synthetase 
                  233 J 30S ribosomal protein S12 
                  852 J polynucleotide phosphorylase/polyadenylase 
                  81 J prolyl-tRNA synthetase 
                  1072 J queuine tRNA-ribosyltransferase 
                  1326 J threonyl-tRNA synthetase 
                  569 J tRNA-i(6)A37 thiotransferase enzyme MiaB 
                  2049 J tryptophanyl-tRNA synthetase 
                  622 J zinc-binding domain-containing protein 
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Table S1. List of orthologs in sequenced C. burnetii along with proteins that are ortholog with 
reference NM as assessed by proteinortho software.  
The non-orthologs with reference NM are represented as “-”. These genes include point mutations and 
small insertion/ deletion of <50 bp in existing pseudo genes of NM (pseudo genes are not included in 
the otholog analysis). Annotation of pseudo genes of NM and COG categories of orthologs are 
mentioned in the table. 
Table S1 available on request from alex.bossers@wur.nl 
 
Table S2. List of genotype-specific orthologs in sequenced C. burnetii strains as assessed by 
proteinortho software. 
Non-orthologs between strains of different genotype as well as non orthologs with reference NM strain 
are represented as “-”. These genotype-specific genes include point mutations and small insertion/ 
deletion of <50 bp in existing pseudo genes of NM (pseudo genes are not included in the otholog 
analysis) or contain partial ORF relative to complete ORF in NM. Pseudo genes and complete ORF of 
NM are mentioned in the table. 
Table S2 available on request from alex.bossers@wur.nl 
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Table S3. NM and Z3055 genome syntenic blocks relative to NL3262 and flanking transposases in 
NL3262 strain 
Strain 
Syntenic 
block 
No. 
Syntenic block other strain 
gene aliasesd 
Syntenic block 
NL3262 gene 
aliasesd 
NL3262                
5' transposase 
ORF alias 
NL3262               
3' transposase 
ORF alias 
NM 1 CBU_0282a to CBU_0041 AUR58_00225 to AUR58_01480 AUR58_11620
b AUR58_01490 
  2 CBU_1960 to CBU_2095 AUR58_01495 to AUR58_02180 AUR58_01490 AUR58_02185 
  3 CBU_2095a to  CBU_0039 AUR58_02195 to AUR58_02400 AUR58_02185 AUR58_02405
c 
  4 CBU_1960 to  CBU_1657 AUR58_02415 to AUR58_04055 AUR58_02405
c AUR58_04065 
  5 CBU_1641 to  CBU_1655 AUR58_04075 to AUR58_04160 AUR58_04065 AUR58_04165 
  6 CBU_1639 to  CBU_1430 AUR58_04175 to AUR58_05380 AUR58_04165 AUR58_05390 
  7 CBU_0343 to  CBU_0446 AUR58_05410 to AUR58_05920 AUR58_05405 AUR58_05930 
  8 CBU_1369 to  CBU_1186b AUR58_05960 to AUR58_06965 AUR58_05950 AUR58_06975 
  9 CBU_0620 to  CBU_0714 AUR58_06980 to AUR58_07480 AUR58_06975 AUR58_07485
b 
  10 CBU_0722 to  CBU_0716 AUR58_07490 to AUR58_07535 AUR58_07485
b AUR58_07540b 
  11 CBU_1085 to  CBU_1063 AUR58_07545 to AUR58_07675 AUR58_07540
b AUR58_07685 
  12 CBU_0758a to  CBU_1061 AUR58_07695 to AUR58_09285 AUR58_07685 AUR58_09295 
  13 CBU_0758 to  CBU_0724a AUR58_09300 to AUR58_09475 AUR58_09295 AUR58_09480
b 
  14 CBU_1087 to  CBU_1185 AUR58_07485 to AUR58_09975 AUR58_09480
b AUR58_09985 
  15 CBU_0619 to  CBU_0600 AUR58_09995 to AUR58_10110 AUR58_09985 AUR58_10125
c 
  16 CBU_0580 to  CBU_0599 AUR58_10130 to AUR58_10225 AUR58_10125
c AUR58_10230b 
  17 CBU_0579 to  CBU_0447 AUR58_10240 to AUR58_10935 AUR58_10230
b AUR58_10945 
  18 CBU_1372 to  CBU_1427 AUR58_10950 to AUR58_11235 AUR58_10945 AUR58_11240 
  19 CBU_0341 to  CBU_0274 AUR58_11265 to AUR58_11615 AUR58_11255 AUR58_11620
b 
        
Z3055 1 TY29_RS01425 to TY29_RS00720 
AUR58_00225 to 
AUR58_00970 AUR58_11620
b Nonea 
  2 TY29_RS00715 to TY29_RS00225 
AUR58_00985 to 
AUR58_01480 None
a AUR58_01490 
  3 TY29_RS09935 to TY29_RS10590 
AUR58_01495 to 
AUR58_02180 AUR58_01490 AUR58_02185 
  4 TY29_RS00005 to TY29_RS00210 
AUR58_02195 to 
AUR58_02400 AUR58_02185 AUR58_02405
c 
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  5 TY29_RS09920 to TY29_RS08410 
AUR58_02415 to 
AUR58_04055 AUR58_02405
c AUR58_04065 
  6 TY29_RS08335 to TY29_RS08405 
AUR58_04075 to 
AUR58_04160 AUR58_04065 AUR58_04165 
  7 TY29_RS08315 to TY29_RS07895 
AUR58_04175 to 
AUR58_04650 AUR58_04165 None
a 
  8 TY29_RS07885 to TY29_RS07280 
AUR58_04660 to 
AUR58_05380 None
a AUR58_05390 
  9 TY29_RS01745 to TY29_RS02250 
AUR58_05410 to 
AUR58_05920 AUR58_05405 AUR58_05930 
  10 TY29_RS06980 to TY29_RS06040 
AUR58_05960 to 
AUR58_06965 AUR58_05950 AUR58_06975 
  11 TY29_RS03130 to TY29_RS03620 
AUR58_06980 to 
AUR58_07480 AUR58_06975 AUR58_07485
b 
  12 TY29_RS03665 to TY29_RS03635 
AUR58_07490 to 
AUR58_07535 AUR58_07485
b AUR58_07540b 
  13 TY29_RS05525 to TY29_RS05405 
AUR58_07545 to 
AUR58_07675 AUR58_07540
b AUR58_07685 
  14 TY29_RS03850 to TY29_RS05385 
AUR58_07695 to 
AUR58_09285 AUR58_07685 AUR58_09295 
  15 TY29_RS03845 to TY29_RS03675 
AUR58_09300 to 
AUR58_09475 AUR58_09295 AUR58_09480
b 
  16 TY29_RS05540 to TY29_RS06020 
AUR58_07485 to 
AUR58_09975 AUR58_09480
b AUR58_09985 
  17 TY29_RS03125 to TY29_RS03035 
AUR58_09995 to 
AUR58_10110 AUR58_09985 AUR58_10125
c 
  18 TY29_RS02935 to TY29_RS03030 
AUR58_10130 to 
AUR58_10225 AUR58_10125
c AUR58_10230b 
  19 TY29_RS02930 to TY29_RS02255 
AUR58_10240 to 
AUR58_10935 AUR58_10230
b AUR58_10945 
  20 TY29_RS06995 to TY29_RS07270 
AUR58_10950 to 
AUR58_11235 AUR58_10945 AUR58_11240 
  21 TY29_RS01740 to TY29_RS01390 
AUR58_11265 to 
AUR58_11615 AUR58_11255 AUR58_11620
b 
a syntenic block rearrangement not associated with a transposase 
b frameshifted transposase 
c shorter transposase ORF 
Bolded syntenic blocks are shared by NM and Z3055 
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Table S3. NM and Z3055 genome syntenic blocks relative to NL3262 and flanking transposases in 
NL3262 strain 
Strain 
Syntenic 
block 
No. 
Syntenic block other strain 
gene aliasesd 
Syntenic block 
NL3262 gene 
aliasesd 
NL3262                
5' transposase 
ORF alias 
NL3262               
3' transposase 
ORF alias 
NM 1 CBU_0282a to CBU_0041 AUR58_00225 to AUR58_01480 AUR58_11620
b AUR58_01490 
  2 CBU_1960 to CBU_2095 AUR58_01495 to AUR58_02180 AUR58_01490 AUR58_02185 
  3 CBU_2095a to  CBU_0039 AUR58_02195 to AUR58_02400 AUR58_02185 AUR58_02405
c 
  4 CBU_1960 to  CBU_1657 AUR58_02415 to AUR58_04055 AUR58_02405
c AUR58_04065 
  5 CBU_1641 to  CBU_1655 AUR58_04075 to AUR58_04160 AUR58_04065 AUR58_04165 
  6 CBU_1639 to  CBU_1430 AUR58_04175 to AUR58_05380 AUR58_04165 AUR58_05390 
  7 CBU_0343 to  CBU_0446 AUR58_05410 to AUR58_05920 AUR58_05405 AUR58_05930 
  8 CBU_1369 to  CBU_1186b AUR58_05960 to AUR58_06965 AUR58_05950 AUR58_06975 
  9 CBU_0620 to  CBU_0714 AUR58_06980 to AUR58_07480 AUR58_06975 AUR58_07485
b 
  10 CBU_0722 to  CBU_0716 AUR58_07490 to AUR58_07535 AUR58_07485
b AUR58_07540b 
  11 CBU_1085 to  CBU_1063 AUR58_07545 to AUR58_07675 AUR58_07540
b AUR58_07685 
  12 CBU_0758a to  CBU_1061 AUR58_07695 to AUR58_09285 AUR58_07685 AUR58_09295 
  13 CBU_0758 to  CBU_0724a AUR58_09300 to AUR58_09475 AUR58_09295 AUR58_09480
b 
  14 CBU_1087 to  CBU_1185 AUR58_07485 to AUR58_09975 AUR58_09480
b AUR58_09985 
  15 CBU_0619 to  CBU_0600 AUR58_09995 to AUR58_10110 AUR58_09985 AUR58_10125
c 
  16 CBU_0580 to  CBU_0599 AUR58_10130 to AUR58_10225 AUR58_10125
c AUR58_10230b 
  17 CBU_0579 to  CBU_0447 AUR58_10240 to AUR58_10935 AUR58_10230
b AUR58_10945 
  18 CBU_1372 to  CBU_1427 AUR58_10950 to AUR58_11235 AUR58_10945 AUR58_11240 
  19 CBU_0341 to  CBU_0274 AUR58_11265 to AUR58_11615 AUR58_11255 AUR58_11620
b 
        
Z3055 1 TY29_RS01425 to TY29_RS00720 
AUR58_00225 to 
AUR58_00970 AUR58_11620
b Nonea 
  2 TY29_RS00715 to TY29_RS00225 
AUR58_00985 to 
AUR58_01480 None
a AUR58_01490 
  3 TY29_RS09935 to TY29_RS10590 
AUR58_01495 to 
AUR58_02180 AUR58_01490 AUR58_02185 
  4 TY29_RS00005 to TY29_RS00210 
AUR58_02195 to 
AUR58_02400 AUR58_02185 AUR58_02405
c 
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  5 TY29_RS09920 to TY29_RS08410 
AUR58_02415 to 
AUR58_04055 AUR58_02405
c AUR58_04065 
  6 TY29_RS08335 to TY29_RS08405 
AUR58_04075 to 
AUR58_04160 AUR58_04065 AUR58_04165 
  7 TY29_RS08315 to TY29_RS07895 
AUR58_04175 to 
AUR58_04650 AUR58_04165 None
a 
  8 TY29_RS07885 to TY29_RS07280 
AUR58_04660 to 
AUR58_05380 None
a AUR58_05390 
  9 TY29_RS01745 to TY29_RS02250 
AUR58_05410 to 
AUR58_05920 AUR58_05405 AUR58_05930 
  10 TY29_RS06980 to TY29_RS06040 
AUR58_05960 to 
AUR58_06965 AUR58_05950 AUR58_06975 
  11 TY29_RS03130 to TY29_RS03620 
AUR58_06980 to 
AUR58_07480 AUR58_06975 AUR58_07485
b 
  12 TY29_RS03665 to TY29_RS03635 
AUR58_07490 to 
AUR58_07535 AUR58_07485
b AUR58_07540b 
  13 TY29_RS05525 to TY29_RS05405 
AUR58_07545 to 
AUR58_07675 AUR58_07540
b AUR58_07685 
  14 TY29_RS03850 to TY29_RS05385 
AUR58_07695 to 
AUR58_09285 AUR58_07685 AUR58_09295 
  15 TY29_RS03845 to TY29_RS03675 
AUR58_09300 to 
AUR58_09475 AUR58_09295 AUR58_09480
b 
  16 TY29_RS05540 to TY29_RS06020 
AUR58_07485 to 
AUR58_09975 AUR58_09480
b AUR58_09985 
  17 TY29_RS03125 to TY29_RS03035 
AUR58_09995 to 
AUR58_10110 AUR58_09985 AUR58_10125
c 
  18 TY29_RS02935 to TY29_RS03030 
AUR58_10130 to 
AUR58_10225 AUR58_10125
c AUR58_10230b 
  19 TY29_RS02930 to TY29_RS02255 
AUR58_10240 to 
AUR58_10935 AUR58_10230
b AUR58_10945 
  20 TY29_RS06995 to TY29_RS07270 
AUR58_10950 to 
AUR58_11235 AUR58_10945 AUR58_11240 
  21 TY29_RS01740 to TY29_RS01390 
AUR58_11265 to 
AUR58_11615 AUR58_11255 AUR58_11620
b 
a syntenic block rearrangement not associated with a transposase 
b frameshifted transposase 
c shorter transposase ORF 
Bolded syntenic blocks are shared by NM and Z3055 
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Abstract 
Q fever is a zoonotic disease caused by the intracellular replicating bacterium Coxiella burnetii. 
Domestic ruminants such as goats, sheep and cattle are the main hosts of C. burnetii causing infections 
in humans. Clinical symptoms of Q fever like abortion are commonly seen in goats and rarely in 
cattle. Human Q fever outbreaks are frequently associated with goats or sheep and only a few cases are 
attributed to cattle as the source of infection. The major Q fever outbreak in The Netherlands during 
2007-2010 underlined this association, since the C. burnetii genotype (CbNL01) that is mainly 
associated with small-ruminants, was linked to human cases, in contrast to the genotype (CbNL12) 
that is predominant in cattle. In the present study, we investigated innate and adaptive immune 
responses against C. burnetii infection in an in vivo mice model to assess whether differences in 
immune responses to strains from different host-origin could be an explanation of the divergent 
clinical outcomes in cattle, goats and humans. At several time points after infection of mice with C. 
burnetii strains, we measured specific phase I and II antibody levels, mRNA levels of several 
cytokines-chemokines in splenocytes, and the number of IFN-γ producing cells upon stimulation of 
peritoneal cells. Differences in immune responses were dependent on the host-origin of the C. burnetii 
strains and not on the MLVA genotype of the strains. Among the different strains, the cattle-derived 
strains generated a significantly higher IgG antibody level against phase I antigen, a higher number of 
IFN-γ producing cells, as well as significantly higher levels of pro-inflammatory cytokines and 
chemokines mRNA. Compared to goat and human-derived strains, the cattle strains induced a more 
profound inflammatory and protective immune response. Such a strong immune response against 
cattle-derived strains may explain the low incidence of C. burnetii induced abortions in cattle and the 
absence of clear clinical signs of C. burnetii infections in cattle. On the other hand, the inadequate 
induction of immune response of mice against goat-derived strains may be indicative for the increased 
risks of the transmission of Q fever from goats to humans. Additionally, similar immune responses 
generated by goat and human strains might indicate similar virulence mechanisms adapted by these 
strains in host. 
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Introduction 
C. burnetii is the causative agent of Q fever and infects a wide range of hosts. Among these, infections 
are wide-spread in domestic ruminants such as goats, sheep and cattle which are the primary reservoirs 
of the disease  [1–3]. C. burnetii infections in pregnant goats commonly cause abortion [4,5], whereas 
infected cattle usually do not show disease symptoms. Abortions and/or reproductive disorders like 
metritis are rarely manifested in cattle [5–7]. Q fever is a zoonotic disease and infections of humans 
are most often caused by inhalation of contaminated aerosols, which can lead to an acute or chronic 
infection [1,5,8–10]. The zoonotic potential of the bacterium has been underlined in the Q fever 
outbreak during the years 2007-2010 in The Netherlands. During this epidemic, more than 4000 
human cases have been reported and around 40,000 were assumed to be infected based on 
seroprevalence studies [6,11,12]. Genotyping studies showed the predominant presence of a single 
unique genotype in all strains obtained from goats and human patients. This identified goats as the 
major source of the Dutch human Q fever outbreak [6,13] 
Most of the Q fever outbreaks reported so far predominantly involved goats and sheep as a 
source of human infections and only sporadic cases have been attributed to cattle [5,6,14,15]. On the 
contrary, seroprevalence studies in different European countries, including The Netherlands, showed 
higher prevalence of C. burnetii specific antibodies in cattle herds as compared to goats and sheep 
herds [15,16]. Several studies have also shown that cattle strains are associated with specific 
genotypes, which are different from the genotype that is predominantly found in human cases  
[6,17,18]. During the Dutch outbreak, C. burnetii was found in a majority of the dairy cattle herds. 
However, samples from cattle were genotyped as CbNL12 and were clearly distinct from the genotype 
of the Dutch outbreak strains [6,19]. This predominant cattle-associated MLVA genotype was rarely 
detected in goats and humans [6,20]. Therefore, despite being a huge reservoir of C. burnetii, cattle 
herds probably pose only a low risk to humans since human Q fever infections/ outbreaks are 
sporadically related to cattle-associated genotypes. The reduced risk of the C. burnetii reservoir in 
cattle, as compared to goat, could be due to a low susceptibility of cattle to develop clinical Q fever 
and a concomitant reduction of bacterial shedding in the environment [4,21]. During the large Dutch Q 
fever outbreak, C. burnetii was detected in 60% of dairy goat farms with abortive problems [6], 
whereas only few aborted placentas from cow’s were positive for C. burnetii. During abortions in 
goats, large amounts of C. burnetii are shed into the environment and are the main source of infection 
in humans. Besides these factors, goats but not cattle are seasonal breeders which might limit the 
exposure of humans to cattle-derived strains [22,23]. Other factors contributing to the low risk of 
cattle strains to cause Q fever in humans could also be attributed to the genetic potential of cattle-
specific C. burnetii strains. Cattle strains differ genotypically from the majority of strains that could be 
isolated from goat and human and could potentially be less virulent in humans, resulting in no/ mild/ 
sub-clinical forms of the infectious disease. The contribution of these CbNL12 goat strains in the 
Dutch outbreak are not completely understood yet. Although several factors may contribute to 
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different host-ranges and/or disease pathology of the various C. burnetii strains, the exact underlying 
mechanisms are largely unknown. A possible mechanism could be based on C. burnetii strain specific 
differences in antigenic potential and the type of immune responses they induce.  
During the Dutch outbreak period, we were successful in isolating and culturing several C. 
burnetii strains of CbNL01 genotype, isolated from goat and humans, CbNL12 genotype goat strains 
and the cattle related CbNL12 MLVA genotype strains. It is not known yet whether the host-origin of 
the C. burnetii strain or the MLVA genotype is the primary determinant to direct immune responses in 
infected hosts. This is important to know, as it may imply that it is more important to monitor the host-
origin of C. burnetii than to know its genotype, in order to improve the prevention of Q fever.  
Therefore, the objective of the present study was to investigate whether C. burnetii strains originating 
from various hosts (goats, cattle and humans) and having different MLVA genotypes induce different 
immune responses in an established murine model. Based upon the observed low risk of cattle strains 
in Q fever outbreaks and the mild/no clinical symptoms generally noticed in natural cattle hosts, we 
hypothesized that cattle strains are effectively recognized by the host immune system and induce a 
protective immunity, which results in an effective bacterial clearance and the development of no or 
only mild forms of the disease. To this end, we measured phase I and II IgM and IgG antibody levels 
in blood, the number of IFN-γ producing cells upon stimulation of peritoneal cells isolated from 
infected mice, and the mRNA levels of several pro-inflammatory cytokines/chemokines in splenocytes 
as indicators of adaptive and innate immune responses. Both types of responses are known to be 
necessary to limit intracellular bacterial infections and both were demonstrated to be important in 
limiting C. burnetii infections in mice [18,24,25]. Our results demonstrate that the cattle-derived 
strains induced significantly higher innate and adaptive immune responses in mice as compared to 
goat and human-derived strains. This indicates that the origin of C. burnetii strains has a greater 
impact on immune responses in mice, rather than the MLVA genotype of the C. burnetii strains.  
 
Material and methods 
C. burnetii strains 
The C. burnetii strains X09003262–001 (3262), CbCVIC1 and 8014160-001 (601) were primarily 
isolated from aborted goats from different farms during the Dutch Q fever outbreak (2007-2010). The 
human strains 42785537 and 3345937 were isolated from heart valve of two individual chronic Q 
fever patients from Radboud University Medical Center and Canisius Wilhelmina hospital 
respectively from The Netherlands [6,26]. Strains CbG15D6 and 701CbB1 were obtained from goat 
and cattle aborted placentas from France and were kindly provided by A. Rodolakis (INRA, France). 
The cattle strain CbBeB1 was isolated from bulk milk in Belgium and was kindly provided by D. 
Fretin (Coda Cerva, Brussels) [18]. The other human strains Henzerling and Scurry were kindly 
provided by D. Frangoulidis (Bundeswehr Institute of Microbiology, Munich). All strains were typed 
using Multiple Locus Variable number of tandem repeat Analysis (MLVA) and were initially cultured 
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in BGM cells (European Collection of Cell Cultures, Salisbury, UK) [27,28]. The characteristics of the 
strains are indicated in Table 1. The stock cultures of all the strains cultured from BGM cells were 
stored at -80°C. Prior to experimentally infecting mice, the strains were cultured once in BGM cells 
and freeze thawed to obtain bacterial cells. Low passages of these strains (between 4-14 passages) 
were maintained to avoid, as much as possible, the phase variation. The cultured strains were 
quantified by PMA-PCR to obtain live amounts of bacteria as described previously [28]. All strains 
represented phase I protein profiles as analyzed by SDS-PAGE followed by silver staining, using the 
bacterial whole cell lysates as described previously [29–31]. Purified phase I and Phase II NM LPS 
kindly provided by R. Toman (Institute of Virology, Slovakia) were used as controls.  
 
Table 1. C. burnetii strains used in this study 
Strain Genotype Country Host Source Symptom Reference 
3262 CbNL01 Netherlands Goat  Placenta Abortion [19] 
CbCVIC1 CbNL01 Netherlands Goat  Placenta Abortion This study 
601 CbNL12 Netherlands Goat  Placenta Abortion [19] 
CbG15D6 CbNL12 France Goat  Placenta Abortion This study 
701CbB1 CbNL12 France Cattle Placenta Abortion [19] 
CbBEB1 CbNL12 Belgium Cattle Bulk milk - [18] 
3345937 CbNL01 Netherlands Human  heart valve Endocarditis [19] 
42785537 CbNL01 Netherlands Human  heart valve Endocarditis This study 
Henzerling Henzerling Italy Human  Blood Acute [19] 
Scurry  Scurry USA Human  Liver Hepatitis [19] 
 
Murine infection model 
Animal experiments were conducted using 7 week old Specific-Pathogen-Free Swiss female OF1 mice 
(Charles River, l’Arbresle, France). A total of 88 mice were housed under sterile conditions in 
biosafety level 3 facilities and acclimatized for a week before experimental infection. Eight mice per 
experimental group were injected intraperitoneally with 8x104 viable C. burnetii strain (in 200 μl PBS) 
as measured by PMA-PCR. A group of 8 control mice were injected with PBS only. Two mice from 
each experimental group were sacrificed at each time point (7, 14, 21 and 28 days post infection (p.i.)). 
Blood, spleen and peritoneal cells were collected from sacrificed mice for further analysis. Mice were 
weighed and their spleens were aseptically removed, weighed and immediately frozen in liquid 
nitrogen and stored at -80°C in order to preserve RNA. These weights were used for determining 
relative spleen weights (percentage of means of spleen weight/body weight). Bacterial loads of spleens 
were measured as described previously [28].  
Animal experiments were approved by the animal experiment commission of Wageningen 
Bioveterinary Research, and were conducted in accordance with the Dutch regulations on animal 
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experimentation (Registration numbers: 2014013). Humane end points of the experiments were 
defined prior to the actual experiments and all possible measures were taken to minimize animal 
suffering.  
 
Detection and quantification of phase I and II IgM and IgG antibodies 
C. burnetii specific phase I and II IgM and IgG antibody levels were quantified by adaptation of the 
commercially available phase I and II specific ELISA kit from Virion/ Serion (SERION ELISA classic 
Coxiella burnetii Phase 1 and 2, Germany). Optimal serum and anti-mouse IgG and IgM conjugate 
dilutions were assessed in advance based on two-way titrations conducted on both positive and 
negative samples originating from infected and uninfected animals respectively. Maximal absorbance 
within the linear range occurred with a mouse serum dilution of 1:200 and all further analyses were 
performed using this dilution (data not shown). Plates containing specific phase I and II antigens were 
incubated with 100 μl of 1:200 diluted serum in dilution buffer provided in the kit for an hour at 37oC. 
For phase I and II IgM and IgG quantification, alkaline phosphatase conjugated goat anti-mouse IgM 
mu chain antibody and rabbit anti-mouse IgG H&L antibody (Abcam, Cambridge, USA) was found to 
perform best at 1:5000 and 1:1000 dilutions respectively. All other steps were conducted according to 
manufacturer’s instructions. The optical density was measured at 405 nm (EL 808 Ultra microplate 
reader, Bio-tek instruments, USA). Results are presented based on optical density values from serum 
samples of infected mice normalized with values from uninfected control mice [18]. The normalized 
antibody titers were used for comparing humoral immunity generated in mice by C. burnetii strains 
originating from different host-origin or MLVA genotypes. 
 
Interferon-γ Enzyme-linked immunosorbent spot (ELISPOT) assay 
IFN-γ ELISPOT assay was performed using a kit from eBioscience as per the manufacturer’s 
specifications. Briefly, we pre-coated ELISPOT plates (Millipore 96-well MultiScreen HTS) with the 
capture antibody at 4oC overnight. Unbound antibody was removed by washing with PBS. Prior to the 
experiments, plates were blocked with complete media (RPMI 1640, Invitrogen, supplemented with 
10% FCS, 1% L-glutamine, 0.1% BME and 1% penicillin/streptomycin) for 30 min at room 
temperature. At each time point mouse peritoneal cells were isolated from sacrificed infected and 
control mice by washing the peritoneal cavity with 5 ml of cold PBS. The cells obtained were 
centrifuged at 1700 RPM for 5 min at 4oC and washed twice with complete media. The cells were 
counted with a Scepter cell counter (Millipore), supplied with a 40 μm sensor and were subsequently 
plated at a density of 2x105 cells/well from each mouse. The peritoneal cells were stimulated with 
1:2000 dilution of C. burnetii Nine Mile phase I and II antigens (Virion/ Serion, Germany) separately. 
Concanavalin A was used as a positive control and complete media was used as a negative control. 
The cells were incubated overnight at 37°C and 5% CO2. To detect the spots, the plates were washed 
and incubated with biotin-conjugated secondary antibody for 2 hours at room temperature or 4oC 
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overnight. The spots were developed with Avidin–HRP and peroxidase substrate AEC (3-amino-9-
ethyl carbazole, Sigma). Plates were dried in a dry incubator at 37°C. Spots were counted with an 
ImmunoSpot analyzer (CTL, USA). We optimized the counting parameters and the number of specific 
spots was determined as the average of duplicates from each sample after the average number of the 
respective negative controls was subtracted. This corrected number of spots was used for comparing 
cell mediated immunity in response to strains originating from different host-origin or MLVA 
genotypes. 
 
Cytokine and chemokine mRNA measurements 
For determining cytokine and chemokine mRNA levels we used a microarray approach (Mice 
microarray (G4852A), Agilent Technologies) to measure the expression levels of cytokine and 
chemokine producing genes [32]. Total RNA was isolated from mice spleen by using Direct-zol RNA 
Miniprep Kit (Zymo Research, Irvine, USA) as per manufacturer’s instructions. The microarray 
experiments and data analysis were performed as described previously [28,33]. The average gene 
expression of cytokine and chemokine genes of controls and infected mice was normalized with 
expression of the housekeeping gene ACTB [34]. These normalized values were used for comparing 
cytokine and chemokine levels generated in mice exposed to the strains that originated from different 
host-origin or MLVA genotypes.  
 
Statistical analysis 
Data for the parameters antibody assay, ELISPOT assay and cytokine-chemokine levels from mouse 
experiments were calculated by grouping C. burnetii strains based on their host-origin and genotype 
and were expressed as means ± standard error of mean. The bacterial load in spleen was expressed as 
means ± standard deviation. Statistical significant differences in a parameter for different groups were 
assessed by using the Linear Mixed Model to test significant host-origin*genotype interactions at 7, 
14, 21 and 28 days p.i. time points. This was followed by Fisher LSD Post Hoc tests to assess 
differences in groups with a significant interaction. The Linear Mixed Model was also used to assess 
significant differences in the rate of change over time (slope) of a parameter for host-origin*over time 
interaction. Further, t tests were used, for determining differences in a group over time with a 
significant interaction. t tests were also used to determine significant differences in a parameter per 
time point between controls and cattle, goat, human strain inoculated groups of mice. All statistical 
tests were performed using IBM SPSS 20 software and differences were considered significant at a P 
value of <0.05. 
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experimentation (Registration numbers: 2014013). Humane end points of the experiments were 
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overnight. The spots were developed with Avidin–HRP and peroxidase substrate AEC (3-amino-9-
ethyl carbazole, Sigma). Plates were dried in a dry incubator at 37°C. Spots were counted with an 
ImmunoSpot analyzer (CTL, USA). We optimized the counting parameters and the number of specific 
spots was determined as the average of duplicates from each sample after the average number of the 
respective negative controls was subtracted. This corrected number of spots was used for comparing 
cell mediated immunity in response to strains originating from different host-origin or MLVA 
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For determining cytokine and chemokine mRNA levels we used a microarray approach (Mice 
microarray (G4852A), Agilent Technologies) to measure the expression levels of cytokine and 
chemokine producing genes [32]. Total RNA was isolated from mice spleen by using Direct-zol RNA 
Miniprep Kit (Zymo Research, Irvine, USA) as per manufacturer’s instructions. The microarray 
experiments and data analysis were performed as described previously [28,33]. The average gene 
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Data for the parameters antibody assay, ELISPOT assay and cytokine-chemokine levels from mouse 
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and were expressed as means ± standard error of mean. The bacterial load in spleen was expressed as 
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assessed by using the Linear Mixed Model to test significant host-origin*genotype interactions at 7, 
14, 21 and 28 days p.i. time points. This was followed by Fisher LSD Post Hoc tests to assess 
differences in groups with a significant interaction. The Linear Mixed Model was also used to assess 
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tests were performed using IBM SPSS 20 software and differences were considered significant at a P 
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Results 
In the present study, innate and adaptive immune responses generated by mice upon infection of 
various C. burnetii strains were measured. Successful infections of mice by C. burnetii strains were 
detected based on significant levels of splenomegaly in infected animals compared to the respective 
controls (p<0.05, data not shown). All the immune parameters were calculated by grouping strains 
based on their host-origin (goat, cattle and human) or MLVA genotype (CbNL01, CbNL12 and others) 
as given in Table 1. All the various immune parameters were measured as indicated in Material and 
Methods and significant host-origin*genotype interactions were calculated for the various time points 
by multilevel statistics. The results are presented in Table 2 and are explained in detail below.   
 
Table 2. A Significant difference matrix indicating host-origin*genotype interaction of C. burnetii 
strains grouped on their host-origin and genotype at different time points on various immune response 
parameters 
Immune response 
Time-point 
7 14 21 28 
Host 
origin Genotype 
Host 
origin Genotype 
Host 
origin Genotype 
Host 
origin Genotype 
A
nt
ib
od
y 
IgMp2 - - - - - - - - 
IgGp2 - - - - - - - - 
IgMp1 - - - - - - - - 
IgGp1 - - - - - - * - 
C
el
l-
m
ed
ia
te
d 
im
m
un
ity
 
IFNγ 
secreting 
cells 
- - - - - - * - 
cy
to
ki
ne
s-
ch
em
ok
in
es
 
IFN-y - - - - - - * - 
TNF-a - - - - * - * - 
IL-1b - - - - - - * - 
IL-6 - - - - - - * - 
IL-12a - - - - * - - - 
CCL2 - - - - - - * - 
CCL6 - - - - * - * - 
CXCL10 - - - - - - * - 
IL-10 - - - - * - * - 
IL-1RA - - - - - - * - 
Significant differences were indicated as * (p < 0.05) and non-significant differences were indicated as - (p > 
0.05) 
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Similar antibody responses by C. burnetii strains of different origin 
Blood samples from infected and control mice were collected from sacrificed mice and the extracted 
serum was used to measure IgM and IgG phase I and II specific antibodies. From the multilevel 
analysis, an effect of C. burnetii host-origin as well as genotype group was not significant for all time 
points with regard to the IgM and IgG antibody levels against phase II antigens (IgMpII, IgGpII) and 
IgM antibody levels against phase I antigens (IgMpI) (Table 2). This indicates that these antibody 
levels per time point were similar in response to all C. burnetii strains originating from different hosts 
(Fig 1a-1c) or from different MLVA genotypes. However, statistically significant differences in 
kinetics of IgMpII, IgGpII and IgMpI antibody responses could be observed overtime in all strains  
 
 
 
Figure 1. Mice Phase I and II specific IgM and IgG antibodies levels generated in response to C. burnetii strains 
grouped on their origin from cattle, goat and human hosts. The panels are grouped on average IgM and IgG 
antibody levels against C. burnetii strains of various host-origins at 7, 14, 21 and 28 day time points after 
inoculation of mice. a) IgM antibody against phase II (IgMpII) b) IgG antibody against phase II (IgGpII) c) IgM 
antibody against phase I (IgMpI) d)IgG antibody against phase I (IgGpI). Significant higher IgGpI antibody 
levels in response to cattle and goat-derived strains than to human-derived strains at 28 days p.i. are indicated by 
* (p < 0.05). 
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Results 
In the present study, innate and adaptive immune responses generated by mice upon infection of 
various C. burnetii strains were measured. Successful infections of mice by C. burnetii strains were 
detected based on significant levels of splenomegaly in infected animals compared to the respective 
controls (p<0.05, data not shown). All the immune parameters were calculated by grouping strains 
based on their host-origin (goat, cattle and human) or MLVA genotype (CbNL01, CbNL12 and others) 
as given in Table 1. All the various immune parameters were measured as indicated in Material and 
Methods and significant host-origin*genotype interactions were calculated for the various time points 
by multilevel statistics. The results are presented in Table 2 and are explained in detail below.   
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IFN-y - - - - - - * - 
TNF-a - - - - * - * - 
IL-1b - - - - - - * - 
IL-6 - - - - - - * - 
IL-12a - - - - * - - - 
CCL2 - - - - - - * - 
CCL6 - - - - * - * - 
CXCL10 - - - - - - * - 
IL-10 - - - - * - * - 
IL-1RA - - - - - - * - 
Significant differences were indicated as * (p < 0.05) and non-significant differences were indicated as - (p > 
0.05) 
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IgM antibody levels against phase I antigens (IgMpI) (Table 2). This indicates that these antibody 
levels per time point were similar in response to all C. burnetii strains originating from different hosts 
(Fig 1a-1c) or from different MLVA genotypes. However, statistically significant differences in 
kinetics of IgMpII, IgGpII and IgMpI antibody responses could be observed overtime in all strains  
 
 
 
Figure 1. Mice Phase I and II specific IgM and IgG antibodies levels generated in response to C. burnetii strains 
grouped on their origin from cattle, goat and human hosts. The panels are grouped on average IgM and IgG 
antibody levels against C. burnetii strains of various host-origins at 7, 14, 21 and 28 day time points after 
inoculation of mice. a) IgM antibody against phase II (IgMpII) b) IgG antibody against phase II (IgGpII) c) IgM 
antibody against phase I (IgMpI) d)IgG antibody against phase I (IgGpI). Significant higher IgGpI antibody 
levels in response to cattle and goat-derived strains than to human-derived strains at 28 days p.i. are indicated by 
* (p < 0.05). 
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grouped on their host-origin (Fig 1a, b and c). The average IgMpII level overtime peaks significantly 
at 14 days p.i. (data not shown) and then gradually decreases in response to goat, cattle and human 
strains (Fig 1a). The average IgGpII level also significantly increases overtime at 14 days p.i. (data not 
shown) and gradually increases till the end of the experiment (Fig 1b). With respect to antibody levels 
against phase I antigens, the average IgMpI levels significantly increases overtime (data not shown) 
during the whole experimental period (Fig 1c). Significant differences in the IgG antibody levels 
against phase I antigen (IgGpI) overtime were also observed. The IgGpI levels significantly increase at 
28 days p.i. (data not shown) in response to goat and cattle strains, whereas no significant differences 
in IgGpI were observed at all time points (data not shown) in response to human strains (Fig 1d). From 
the multilevel analysis, a significant effect was seen in the host-origin group but not in the genotype 
group at 28 days p.i. on IgGpI antibody response (Table 2). These differences in host-origin strains at 
28 day p.i. were due to significant low antibody responses to human strains compared to goat and 
cattle strains (Fig 1d). Thus, IgMpII, IgGpII and IgMpI kinetics as well as antibody titers were similar 
among the various host-origin groups. However, differences in IgGpI kinetics could be observed later 
in the infection period. Besides, no differences in antibody levels were found between the MLVA 
grouped strains (Table 2). This indicates that the profile of humoral immunity kinetics is determined 
by the host-origin of C. burnetii and not by its MLVA genotype. 
 
 
 
Figure 2. Detection of IFN-γ producing peritoneal cells of mice infected with C. burnetii strains grouped on 
their origin from cattle, goat and human hosts.along with corresponding controls. The results are expressed as the 
mean number of spot forming cells (SFC) per 2x105 peritoneal cells stimulated with phase I and II antigens. 
Significant higher IFN-γ producing peritoneal cells of mice infected with cattle-derived strains than goat and 
human-derived strains at 28 days p.i. were indicated as * (p < 0.05). 
 
141 
 
Cattle-derived strains generate a more profound cell mediated immune response 
IFN-γ ELISPOT assays were performed on peritoneal cells of infected mice and corresponding 
controls to investigate cell mediated immune responses. Commercially obtained C. burnetii phase I 
and II antigens of reference Nine Mile strain were used as stimulus. The stimulants induced a clear 
IFN-γ response in peritoneal cells from all infected mice compared to respective controls (Fig 2). The 
kinetics of the number of IFN-γ producing peritoneal cells obtained from mice infected with goat, 
cattle and human strains, was similar at 7, 14 and 21 days. However, at day 28 the number of IFN-γ  
 
 
 
Figure 3. Normalized gene expression of cytokine and chemokine profiles in spleens of mice exposed to C. 
burnetii strains grouped on their origin and corresponding controls. The results show cytokine and chemokine 
mRNA levels after infection with C. bunetii of goat, cattle and human origin (color coded lines). Indicated are: a) 
pro-inflammatory cytokines and chemokines; and b) anti-inflammatory cytokines. Significant differences 
between infected mice and controls per time-point are indicated as * (P < 0.05).  
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grouped on their host-origin (Fig 1a, b and c). The average IgMpII level overtime peaks significantly 
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producing cells increased significantly only in peritoneal cells of mice infected with cattle origin 
strains compared to goat and human origin strains (Fig 2). From the multilevel analysis, a significant 
effect of C. burnetii host-origin but not of the genotype group was observed at 28 day p.i. in number of 
IFN-γ producing peritoneal cells (Table 2). These results demonstrate that differences in cell mediated 
immunity are based on C. burnetii strains host-origin rather than on MLVA genotype. 
 
Cattle-derived strains induce a profound pro-inflammatory response 
To extend our observations on the immune response differences of C. burnetii strains, weekly 
measurements of mRNA expression of cytokine and chemokine genes were assessed in splenocytes. 
The results of these measurements are shown in Figure 3 and the significance of their relationship with 
host-origin*genotype interactions are shown in Table 2. These involve the pro-inflammatory cytokines 
(IFN-γ, TNF-α, IL-1β, IL-6, IL-12a), inflammatory associated chemokines (CCL2, CCL6, CXCL10) 
(Fig 3a) and anti-inflammatory cytokines (IL-10, IL-1RA) (Fig 3b). The cytokine and chemokine 
mRNA levels in response to the cattle strains were in most cases significantly higher than the response 
to goat and human strains at all time points. In goat strains, the cytokine and chemokine mRNA levels 
were significantly higher than the controls only at early time points (7 day p.i.). The cytokine and 
chemokine mRNA levels in response to the human strains were higher than the controls at early time 
points (7 day p.i.), but they were mostly not significant (Fig 3). The kinetics of mRNA levels were 
similar in response to goat and human strains, with increased cytokine and chemokine levels early in 
 
Table 3. A significant difference matrix of cytokine and chemokine mRNA levels generated by C. 
burnetii strains originating from goat, cattle and human strains at different time points (7, 14, 21 and 
28 days p.i.). Significant differences were indicated as * (p < 0.05) 
Cytokine/ 
chemokines 
mRNA levels comparisons between host-origin strains at 7, 14, 21 and 28 day time points 
Cattle 
vs 
Goat 
Cattle 
vs 
Human 
Goat 
vs 
Human 
Cattle 
vs 
Goat 
Cattle  
vs 
Human  
Goat 
vs 
Human 
Cattle 
vs 
Goat 
Cattle 
vs 
Human 
Goat  
vs 
Human 
Cattle 
vs 
Goat 
Cattle 
vs 
Human 
Goat 
vs 
Human 
7 7 7 14 14 14 21 21 21 28 28 28 
IFN-γ - - - - - - - - - * * - 
TNF-α - - - - - - * * - * * * 
Il-1β - - - - - - - - - * * - 
IL-6 - - - - - - - - - * * - 
IL-12a - - - - - - * - - - - - 
CCL2 - - - - - - - - - * * - 
CCL6 - - - - - - - * - * * - 
CXCL10 - - - - - - - - - * * - 
IL-10 - - - - - - * * - * * - 
IL-1RA - - - - - - - - - * * * 
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the infection period (7 day p.i.) and declining levels later in the infection. In contrast, the cytokine and 
chemokine response to cattle strains did not show large variations in time at 7, 14, and 21 days after 
infection, but increased significantly at 28 days p.i. (Fig 3). From the multilevel analysis, a significant 
effect of C. burnetii host-origin but not of the genotype group was observed at 21 and 28 day p.i. in 
cytokine-chemokine levels (Table 2). These differences in host-origin strains at 21 and 28 day p.i. 
were due to significantly higher cytokine and chemokine mRNA levels in response to cattle strains 
than goat and human strains (Table 3). The mRNA levels in response to goat strains were also 
significant higher for TNF-α and IL-1RA cytokines compared to the response to human strain (Table 
3). Taken together, persistent higher cytokine and chemokine mRNA levels were observed in mice 
splenocytes in response to cattle-derived strains than in response to goat and human derived strains. 
This indicates that only cattle strains generate a profound pro- and anti-inflammatory response upon 
infection. In addition, the cytokine-chemokine responses did not change in mice infected by strains 
grouped on the basis of their MLVA genotype (Table 2). This suggests that innate immune responses 
are mainly driven by the host-origin of C. burnetii strains and not by their MLVA genotype. 
 
Discussion 
Several studies have suggested a genomic group-specific virulence of C. burnetii, based on the 
assumption that genetic differences in bacterial strains could affect its virulence. These studies 
involved strains mostly from human origin and a few from animal origin [35–38]. Our study involves 
the comparison of immune responses of a variety of strains from goat, cattle and human origin 
including those isolated from The Netherlands during the large outbreak period from 2007-2010. We 
compared the innate (cytokines and chemokines) and adaptive (humoral and cell-mediated) immune 
responses generated by these strains in a murine infection model. Our study clearly shows that the 
host-origin of the various C. burnetii strains, rather than the MLVA genotype, determines the outcome 
of the induced immune responses (Table 2). Significant interactions in host-origin strains were mostly 
due to significant differences in immune responses to cattle-derived strains as compared to goat and 
human-derived strains. These results suggest that host immune responses are more dependent on the 
host-origin of C. burnetii strains than on the MLVA genotype.  
In mice, humoral antibody responses were similarly generated by cattle and goat strains at all 
tested time points, except those to the human strains where low IgG antibody response against phase I 
antigens (IgGpI) were observed at 28 day p.i. These low IgGpI antibody titers in response to human 
strains were not expected as whole cell bacterial lysates of all C. burnetii strains showed a protein 
profile typically for the presence of phase I LPS (data not shown). Although, all strains have a phase I 
type LPS, the low IgGpI levels raised by the human-derived strains could be due to a modified outer 
shell (LPS or surface proteins) with a reduced antigenicity.  No significant difference in IgM and IgG 
antibody levels against phase I and II antigens were generated by strains of different genotypes. 
Hence, humoral immune responses seem to be dependent more on host-origin than on MLVA 
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producing cells increased significantly only in peritoneal cells of mice infected with cattle origin 
strains compared to goat and human origin strains (Fig 2). From the multilevel analysis, a significant 
effect of C. burnetii host-origin but not of the genotype group was observed at 28 day p.i. in number of 
IFN-γ producing peritoneal cells (Table 2). These results demonstrate that differences in cell mediated 
immunity are based on C. burnetii strains host-origin rather than on MLVA genotype. 
 
Cattle-derived strains induce a profound pro-inflammatory response 
To extend our observations on the immune response differences of C. burnetii strains, weekly 
measurements of mRNA expression of cytokine and chemokine genes were assessed in splenocytes. 
The results of these measurements are shown in Figure 3 and the significance of their relationship with 
host-origin*genotype interactions are shown in Table 2. These involve the pro-inflammatory cytokines 
(IFN-γ, TNF-α, IL-1β, IL-6, IL-12a), inflammatory associated chemokines (CCL2, CCL6, CXCL10) 
(Fig 3a) and anti-inflammatory cytokines (IL-10, IL-1RA) (Fig 3b). The cytokine and chemokine 
mRNA levels in response to the cattle strains were in most cases significantly higher than the response 
to goat and human strains at all time points. In goat strains, the cytokine and chemokine mRNA levels 
were significantly higher than the controls only at early time points (7 day p.i.). The cytokine and 
chemokine mRNA levels in response to the human strains were higher than the controls at early time 
points (7 day p.i.), but they were mostly not significant (Fig 3). The kinetics of mRNA levels were 
similar in response to goat and human strains, with increased cytokine and chemokine levels early in 
 
Table 3. A significant difference matrix of cytokine and chemokine mRNA levels generated by C. 
burnetii strains originating from goat, cattle and human strains at different time points (7, 14, 21 and 
28 days p.i.). Significant differences were indicated as * (p < 0.05) 
Cytokine/ 
chemokines 
mRNA levels comparisons between host-origin strains at 7, 14, 21 and 28 day time points 
Cattle 
vs 
Goat 
Cattle 
vs 
Human 
Goat 
vs 
Human 
Cattle 
vs 
Goat 
Cattle  
vs 
Human  
Goat 
vs 
Human 
Cattle 
vs 
Goat 
Cattle 
vs 
Human 
Goat  
vs 
Human 
Cattle 
vs 
Goat 
Cattle 
vs 
Human 
Goat 
vs 
Human 
7 7 7 14 14 14 21 21 21 28 28 28 
IFN-γ - - - - - - - - - * * - 
TNF-α - - - - - - * * - * * * 
Il-1β - - - - - - - - - * * - 
IL-6 - - - - - - - - - * * - 
IL-12a - - - - - - * - - - - - 
CCL2 - - - - - - - - - * * - 
CCL6 - - - - - - - * - * * - 
CXCL10 - - - - - - - - - * * - 
IL-10 - - - - - - * * - * * - 
IL-1RA - - - - - - - - - * * * 
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the infection period (7 day p.i.) and declining levels later in the infection. In contrast, the cytokine and 
chemokine response to cattle strains did not show large variations in time at 7, 14, and 21 days after 
infection, but increased significantly at 28 days p.i. (Fig 3). From the multilevel analysis, a significant 
effect of C. burnetii host-origin but not of the genotype group was observed at 21 and 28 day p.i. in 
cytokine-chemokine levels (Table 2). These differences in host-origin strains at 21 and 28 day p.i. 
were due to significantly higher cytokine and chemokine mRNA levels in response to cattle strains 
than goat and human strains (Table 3). The mRNA levels in response to goat strains were also 
significant higher for TNF-α and IL-1RA cytokines compared to the response to human strain (Table 
3). Taken together, persistent higher cytokine and chemokine mRNA levels were observed in mice 
splenocytes in response to cattle-derived strains than in response to goat and human derived strains. 
This indicates that only cattle strains generate a profound pro- and anti-inflammatory response upon 
infection. In addition, the cytokine-chemokine responses did not change in mice infected by strains 
grouped on the basis of their MLVA genotype (Table 2). This suggests that innate immune responses 
are mainly driven by the host-origin of C. burnetii strains and not by their MLVA genotype. 
 
Discussion 
Several studies have suggested a genomic group-specific virulence of C. burnetii, based on the 
assumption that genetic differences in bacterial strains could affect its virulence. These studies 
involved strains mostly from human origin and a few from animal origin [35–38]. Our study involves 
the comparison of immune responses of a variety of strains from goat, cattle and human origin 
including those isolated from The Netherlands during the large outbreak period from 2007-2010. We 
compared the innate (cytokines and chemokines) and adaptive (humoral and cell-mediated) immune 
responses generated by these strains in a murine infection model. Our study clearly shows that the 
host-origin of the various C. burnetii strains, rather than the MLVA genotype, determines the outcome 
of the induced immune responses (Table 2). Significant interactions in host-origin strains were mostly 
due to significant differences in immune responses to cattle-derived strains as compared to goat and 
human-derived strains. These results suggest that host immune responses are more dependent on the 
host-origin of C. burnetii strains than on the MLVA genotype.  
In mice, humoral antibody responses were similarly generated by cattle and goat strains at all 
tested time points, except those to the human strains where low IgG antibody response against phase I 
antigens (IgGpI) were observed at 28 day p.i. These low IgGpI antibody titers in response to human 
strains were not expected as whole cell bacterial lysates of all C. burnetii strains showed a protein 
profile typically for the presence of phase I LPS (data not shown). Although, all strains have a phase I 
type LPS, the low IgGpI levels raised by the human-derived strains could be due to a modified outer 
shell (LPS or surface proteins) with a reduced antigenicity.  No significant difference in IgM and IgG 
antibody levels against phase I and II antigens were generated by strains of different genotypes. 
Hence, humoral immune responses seem to be dependent more on host-origin than on MLVA 
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genotype of C. burnetii strains. Our results also showed early and strong systemic antibody response 
to goat and cattle origin strains of C. burnetii (Fig 1) as seen previously [18]. Also, the observed 
kinetics of IgM and IgG antibody’s in mice against phase I and II antigens are in line with previous 
published work in goats and humans, strengthening mice as a valid experimental model for studying 
immune responses induced by Q fever agents [39,40]. 
A significant effect of C. burnetii host-origin but not the genotype group was observed in cell-
mediated immune response due to augmented pro-inflammatory IFN-γ cytokine production from 
peritoneal cells, especially at the later infection period (28 day p.i). IFN-γ is an important cytokine 
produced by T-lymphocytes which is responsible for cell-mediated immunity [41,42]. During 
microbial infection, T-lymphocytes are found at sites of infection and implement cell-mediated 
immunity in response to bacterial antigens [43]. Isolated peritoneal cells from infected mice showed a 
significant higher IFN-γ response upon stimulation with C. burnetii antigens than corresponding non-
infected control mice.  This could be due to the presence of a different composition of IFN-γ secreting 
immune cells (T-lymphocytes, (natural killer) NK, NK T cells) [42] in the peritoneal cavity of infected 
mice due to intraperitoneal inoculation of bacteria. With respect to infection of C. burnetii strains from 
different origin, a similar kinetics of increase in IFN-γ production was observed from initial to late 
infection period. This is most likely due to an influx of T-lymphocytes and other IFN-γ producing 
cells in the peritoneal cavity as the infection progresses. The observed significant higher IFN-γ 
response from peritoneal cells of mice infected with cattle strains compared to goat and human strains 
at 28 day p.i. period (Fig 2) is probably due to a larger number of pro-inflammatory T-lymphocytes in 
the peritoneal cavity. On the other hand, it is also possible that the low IFN-γ response of peritoneal 
cells of mice infected with goat and human origin could be due to incorrect/ altered antigen 
presentation during T-cell priming resulting in a partial anergy of C. burnetii antigen-specific T cells 
[44]. As IFN-γ cytokine produced by T-lymphocytes controls microbial infection [42], low IFN-γ 
responses of peritoneal cells of mice infected with goat and human origin strains at 28 day p.i., could 
be favorable for C. burnetii survival and/or replication. This low inflammatory response could result in 
reduced protection and prevent/delay elimination of goat and human strains from the murine host 
leading to a persistent infection. In contrast, higher cell-mediated immune response induced by the 
cattle strains at later infection periods could provide improved protection by effectively inhibiting re-
infections and promoting bacterial elimination. For further studies, phenotyping cells from peritoneal 
cavity of mice infected with various strains, will provide information on changes in the composition of 
immune cell populations in relation to IFN-γ response kinetics, presence of poly-functional T cells and 
other cell-immunity related cytokine profiles (such as IL-2, IL-17). This information will improve 
insights into the immune responses that contribute to the protective immunity of various C. burnetii 
strain infections.  
Persistently high cytokines and chemokines mRNA levels were induced in spleens of mice by 
cattle-derived strains throughout the infection period. However, no significant differences were 
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observed between C. burnetii strains of different MLVA genotypes. IFN-γ and inflammatory 
cytokines, such as TNF-α, IL-1β , IL-6, IL-12a secreted by antigen presenting cells (APC) as well as 
several inflammatory chemokines (CCL2, CCL6, CXCL10), were significantly higher in response to 
the cattle strains than to the goat and human strains, especially at later infection period. These high 
cytokine-chemokine levels as well as early stage IFN-γ expression reflect a pro-inflammatory innate 
response of monocyte/ macrophages, NK and NKT cells. These initial splenic macrophage responses 
play a critical role in the expression of innate immune responses and likely drive and direct the 
ensuing adaptive immune response [45]. In addition, anti-inflammatory cytokines (IL-10, IL-1RA) 
were also higher in response to cattle strains than the other strains, showing a co-existence of both pro 
and anti-inflammatory responses. The anti-inflammatory responses are probably involved to balance 
the high pro-inflammatory responses generated by the immune system against antigens of cattle 
strains. Such a response could be critical to prevent uncontrolled inflammation and tissue damage as 
well as appropriate activation of inflammatory processes in the defense against the ongoing cattle 
strain infections [46,47]. IFN-γ cytokine is suggested to be involved in the control of bacterial growth 
by enabling monocytes/macrophages to kill C. burnetii [24,48,49]. Other pro-inflammatory cytokines 
secreted by APC are known to play crucial roles in several aspects of the innate and adaptive 
immunity [42]. Among these, TNF-α is a key cytokine which has important functions in cell-mediated 
defense to intracellular bacteria. Along with IL-12, TNF-α is known to induce IFN- γ production by 
NK cells, thereby enhancing the cytolytic activity of infected cells [24,50]. In mice infected with the 
cattle strains, TNF-α, IL-12a and IFN- γ cytokines were upregulated at 28 days p.i. and may play an 
essential role in controlling the infection. On the contrary, the TNF-α levels are very low in response 
to the goat and human strains at later infection period as compared to the control mice and mice 
infected with cattle strains. This may diminish the ability of the mice immune system to eliminate the 
infection caused by goat and human-derived strains (Fig 3a). Moreover, inflammatory chemokines 
were also at high levels in response to cattle strains and may be associated with directing immune cells 
to the site of infection resulting in a robust local immune response against invading pathogens [42]. As 
innate immunity can become active in the first minutes to hours after exposure to pathogens [51], a 
limitation of our study is that we did not measure cytokine responses at very early time points after the 
infection. Previous study on C. burnetii infection in a macrophage cell line has shown the induction of 
pro-inflammatory cytokines TNF-α, IL-1α within 3 hrs post-exposure [50]. Assessing very early 
cytokine responses in in vivo models will contribute to gain an improved understanding of the initial 
phase of the C. burnetii infection process. 
Higher inflammatory cytokine and chemokine mRNA levels in response to cattle strains 
throughout the whole infection period, compared to the levels induced by goat and human strains, 
could induce a potent immune response. Such a response could result in the effective bacterial 
elimination as observed by decreased bacterial load in spleen as early as 21 day p.i. in response to 
cattle strains, as compared to goat and human strains (Supplementary Fig 1). Based on these 
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genotype of C. burnetii strains. Our results also showed early and strong systemic antibody response 
to goat and cattle origin strains of C. burnetii (Fig 1) as seen previously [18]. Also, the observed 
kinetics of IgM and IgG antibody’s in mice against phase I and II antigens are in line with previous 
published work in goats and humans, strengthening mice as a valid experimental model for studying 
immune responses induced by Q fever agents [39,40]. 
A significant effect of C. burnetii host-origin but not the genotype group was observed in cell-
mediated immune response due to augmented pro-inflammatory IFN-γ cytokine production from 
peritoneal cells, especially at the later infection period (28 day p.i). IFN-γ is an important cytokine 
produced by T-lymphocytes which is responsible for cell-mediated immunity [41,42]. During 
microbial infection, T-lymphocytes are found at sites of infection and implement cell-mediated 
immunity in response to bacterial antigens [43]. Isolated peritoneal cells from infected mice showed a 
significant higher IFN-γ response upon stimulation with C. burnetii antigens than corresponding non-
infected control mice.  This could be due to the presence of a different composition of IFN-γ secreting 
immune cells (T-lymphocytes, (natural killer) NK, NK T cells) [42] in the peritoneal cavity of infected 
mice due to intraperitoneal inoculation of bacteria. With respect to infection of C. burnetii strains from 
different origin, a similar kinetics of increase in IFN-γ production was observed from initial to late 
infection period. This is most likely due to an influx of T-lymphocytes and other IFN-γ producing 
cells in the peritoneal cavity as the infection progresses. The observed significant higher IFN-γ 
response from peritoneal cells of mice infected with cattle strains compared to goat and human strains 
at 28 day p.i. period (Fig 2) is probably due to a larger number of pro-inflammatory T-lymphocytes in 
the peritoneal cavity. On the other hand, it is also possible that the low IFN-γ response of peritoneal 
cells of mice infected with goat and human origin could be due to incorrect/ altered antigen 
presentation during T-cell priming resulting in a partial anergy of C. burnetii antigen-specific T cells 
[44]. As IFN-γ cytokine produced by T-lymphocytes controls microbial infection [42], low IFN-γ 
responses of peritoneal cells of mice infected with goat and human origin strains at 28 day p.i., could 
be favorable for C. burnetii survival and/or replication. This low inflammatory response could result in 
reduced protection and prevent/delay elimination of goat and human strains from the murine host 
leading to a persistent infection. In contrast, higher cell-mediated immune response induced by the 
cattle strains at later infection periods could provide improved protection by effectively inhibiting re-
infections and promoting bacterial elimination. For further studies, phenotyping cells from peritoneal 
cavity of mice infected with various strains, will provide information on changes in the composition of 
immune cell populations in relation to IFN-γ response kinetics, presence of poly-functional T cells and 
other cell-immunity related cytokine profiles (such as IL-2, IL-17). This information will improve 
insights into the immune responses that contribute to the protective immunity of various C. burnetii 
strain infections.  
Persistently high cytokines and chemokines mRNA levels were induced in spleens of mice by 
cattle-derived strains throughout the infection period. However, no significant differences were 
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observed between C. burnetii strains of different MLVA genotypes. IFN-γ and inflammatory 
cytokines, such as TNF-α, IL-1β , IL-6, IL-12a secreted by antigen presenting cells (APC) as well as 
several inflammatory chemokines (CCL2, CCL6, CXCL10), were significantly higher in response to 
the cattle strains than to the goat and human strains, especially at later infection period. These high 
cytokine-chemokine levels as well as early stage IFN-γ expression reflect a pro-inflammatory innate 
response of monocyte/ macrophages, NK and NKT cells. These initial splenic macrophage responses 
play a critical role in the expression of innate immune responses and likely drive and direct the 
ensuing adaptive immune response [45]. In addition, anti-inflammatory cytokines (IL-10, IL-1RA) 
were also higher in response to cattle strains than the other strains, showing a co-existence of both pro 
and anti-inflammatory responses. The anti-inflammatory responses are probably involved to balance 
the high pro-inflammatory responses generated by the immune system against antigens of cattle 
strains. Such a response could be critical to prevent uncontrolled inflammation and tissue damage as 
well as appropriate activation of inflammatory processes in the defense against the ongoing cattle 
strain infections [46,47]. IFN-γ cytokine is suggested to be involved in the control of bacterial growth 
by enabling monocytes/macrophages to kill C. burnetii [24,48,49]. Other pro-inflammatory cytokines 
secreted by APC are known to play crucial roles in several aspects of the innate and adaptive 
immunity [42]. Among these, TNF-α is a key cytokine which has important functions in cell-mediated 
defense to intracellular bacteria. Along with IL-12, TNF-α is known to induce IFN- γ production by 
NK cells, thereby enhancing the cytolytic activity of infected cells [24,50]. In mice infected with the 
cattle strains, TNF-α, IL-12a and IFN- γ cytokines were upregulated at 28 days p.i. and may play an 
essential role in controlling the infection. On the contrary, the TNF-α levels are very low in response 
to the goat and human strains at later infection period as compared to the control mice and mice 
infected with cattle strains. This may diminish the ability of the mice immune system to eliminate the 
infection caused by goat and human-derived strains (Fig 3a). Moreover, inflammatory chemokines 
were also at high levels in response to cattle strains and may be associated with directing immune cells 
to the site of infection resulting in a robust local immune response against invading pathogens [42]. As 
innate immunity can become active in the first minutes to hours after exposure to pathogens [51], a 
limitation of our study is that we did not measure cytokine responses at very early time points after the 
infection. Previous study on C. burnetii infection in a macrophage cell line has shown the induction of 
pro-inflammatory cytokines TNF-α, IL-1α within 3 hrs post-exposure [50]. Assessing very early 
cytokine responses in in vivo models will contribute to gain an improved understanding of the initial 
phase of the C. burnetii infection process. 
Higher inflammatory cytokine and chemokine mRNA levels in response to cattle strains 
throughout the whole infection period, compared to the levels induced by goat and human strains, 
could induce a potent immune response. Such a response could result in the effective bacterial 
elimination as observed by decreased bacterial load in spleen as early as 21 day p.i. in response to 
cattle strains, as compared to goat and human strains (Supplementary Fig 1). Based on these 
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observations, an early and effective bacterial clearance upon infection with cattle-derived strains can 
be speculated, which could lead to minimal or no clinical disease in natural hosts. Increased cytokine 
and chemokine mRNA levels only at early infection periods, as found for goat and human strains, 
could lead to an efficient control of the bacterial infection only during the early stages of the infection 
[24]. It can be speculated that the observed lower levels of cytokine and chemokines in response to 
goat and human strains at later infection periods, may facilitate persistent re-infections resulting in 
severe clinical disease outcomes. Another explanation of the observed high expression of 
inflammatory cytokines generated by cattle strains, could be due to the trained immunity (TI) 
phenomenon. TI has been previously reported for other bacterial species [52,53]. The cattle strain 
antigens could specifically induce epigenetic reprogramming in monocyte/macrophages resulting in 
TI. Such main innate immunity cells (like macrophages) can be trained leading to cell activation and 
enhanced pro-inflammatory cytokine production as host defense mechanisms [53–55]. The observed 
levels of cytokine production in response to the cattle strains (TNF-α, IL-1β, IL-6 and IL-12a) are 
majorly produced by macrophages. The persistent high levels of these cytokines could be due to the 
enhanced potential of macrophages upon bacterial re-infection through TI, leading to profound innate 
immune response against cattle strain antigens at later infection periods. TI is a well-documented 
phenomenon widely studied for the attenuated bacterial vaccine for tuberculosis [53]. In the same 
context, we could argue that cattle strain antigens, in contrast to goat and human strain antigens, might 
induce TI resulting in profound pro-inflammatory responses by host and as a result could qualify as 
potential vaccine candidates. 
Differences in immune responses with respect to different host origins of C. burnetii strains, 
were mainly observed during the late phases of infections with cattle strains. This could implicate that 
high pro-inflammatory responses to cattle strains during late stages of the infection are critical for 
complete bacterial clearance and for inhibiting the development of chronic disease [56]. If true, than 
the chance of chronic disease development increases upon exposure to goat and human strains, 
because low immune responses were observed in mice in response to these strains which might aid in 
bacterial re-infections. Out of the four human strains used in the study, 3 of them originated from 
chronic Q fever patients. The data matches with the observation that persistent infections in humans 
result in chronic disease, while persistent infections of C. burnetii in goats has also been shown 
[1,9,27,57]. From our study we cannot prove whether indeed persistent infections of C. burnetii strains 
occurred in the mice, as our experiments lasted only for 28 days and a complete bacterial clearance 
from mice takes at least 8 weeks [18].  
Apart from analyzing strains based on their host-origin, the strains were also differentiated 
based on their MLVA genotype classification. The strains of the CbNL01 genotype were predominant 
during the Dutch Q fever outbreak, whereas strains of the CbNL12 genotype were much less prevalent 
[6].The present study consistently showed a non-significant effect of genotype-grouped C. burnetii 
strains on the immune responses at all time points (Table 2). Comparative genomics of Dutch CbNL01 
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and CbNL12 genotype strains, showed highly similar genomes of strains representing the same 
genotype (Kuley et al., unpublished). Although, the genome content differs between strains from 
different genotypes, we did not see major differences in immune responses. It could be possible that 
strains from the same host-origin but belonging to different genotypes share the same antigenic profile 
caused by specific point mutations in major antigens and/or by specific modifications of membrane 
proteins [58]. This could affect the bacterial recognition by the host immune system and the observed 
differential immune responses. For example; the cattle strains may encode surface antigens which are 
effectively recognized by the host immune system leading to more efficient defense against the 
pathogen. Besides, the goat and human strains may encode antigens which are not well recognized by 
the host resulting in defective activation or evasion of host immune system. Alternatively, it could also 
be possible that the bacteria undergo genomic re-organizations [35,59,60] and/or alters its gene 
regulation in order to adapt to the host it resides in, resulting in host-origin specific but not genotype-
specific immune responses. Based on our findings, the existence of shared factors in strains originating 
from the same host could be speculated in order to explain the observed host-origin dependent 
immune responses.   
In the present study, temporal changes in immune responses were assessed in 
immunocompetent mice infected with C. burnetii strains. From our study we conclude that C. burnetii 
strains are able to induce both innate and adaptive immune responses, independent of the origin or the 
genotype of the strains. This indicates that both branches of the immune system are important for 
limiting C. burnetii infections [24,61]. The observation that cattle strains elicit higher immune 
response compared to goat and human strains, were also found in experiments using PBMCs of 
healthy humans stimulated with various inactivated C. burnetii strains from different host-origin 
(Ammerdorffer et al., Submitted). In these studies, higher levels of pro-inflammatory cytokines were 
observed in response to cattle strains as compared to others strains originating from goat, sheep and 
chronic human patients. Similar immune responses generated by strains originating from goat and 
human, may indicate similar virulence mechanisms in host. This could be due to the sharing of similar 
surface antigens or other adaptations in host which are not known yet. Based on our findings, we 
suggest that bacteria originating from goat hosts have a greater potential to cause outbreaks in humans 
and needs to be efficiently monitored. In this light, monitoring of cattle strains would be less important 
since these strains can generate stronger immune response in in vivo hosts and thus pose lower risk for 
Q fever outbreaks [10,15,20]. 
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observations, an early and effective bacterial clearance upon infection with cattle-derived strains can 
be speculated, which could lead to minimal or no clinical disease in natural hosts. Increased cytokine 
and chemokine mRNA levels only at early infection periods, as found for goat and human strains, 
could lead to an efficient control of the bacterial infection only during the early stages of the infection 
[24]. It can be speculated that the observed lower levels of cytokine and chemokines in response to 
goat and human strains at later infection periods, may facilitate persistent re-infections resulting in 
severe clinical disease outcomes. Another explanation of the observed high expression of 
inflammatory cytokines generated by cattle strains, could be due to the trained immunity (TI) 
phenomenon. TI has been previously reported for other bacterial species [52,53]. The cattle strain 
antigens could specifically induce epigenetic reprogramming in monocyte/macrophages resulting in 
TI. Such main innate immunity cells (like macrophages) can be trained leading to cell activation and 
enhanced pro-inflammatory cytokine production as host defense mechanisms [53–55]. The observed 
levels of cytokine production in response to the cattle strains (TNF-α, IL-1β, IL-6 and IL-12a) are 
majorly produced by macrophages. The persistent high levels of these cytokines could be due to the 
enhanced potential of macrophages upon bacterial re-infection through TI, leading to profound innate 
immune response against cattle strain antigens at later infection periods. TI is a well-documented 
phenomenon widely studied for the attenuated bacterial vaccine for tuberculosis [53]. In the same 
context, we could argue that cattle strain antigens, in contrast to goat and human strain antigens, might 
induce TI resulting in profound pro-inflammatory responses by host and as a result could qualify as 
potential vaccine candidates. 
Differences in immune responses with respect to different host origins of C. burnetii strains, 
were mainly observed during the late phases of infections with cattle strains. This could implicate that 
high pro-inflammatory responses to cattle strains during late stages of the infection are critical for 
complete bacterial clearance and for inhibiting the development of chronic disease [56]. If true, than 
the chance of chronic disease development increases upon exposure to goat and human strains, 
because low immune responses were observed in mice in response to these strains which might aid in 
bacterial re-infections. Out of the four human strains used in the study, 3 of them originated from 
chronic Q fever patients. The data matches with the observation that persistent infections in humans 
result in chronic disease, while persistent infections of C. burnetii in goats has also been shown 
[1,9,27,57]. From our study we cannot prove whether indeed persistent infections of C. burnetii strains 
occurred in the mice, as our experiments lasted only for 28 days and a complete bacterial clearance 
from mice takes at least 8 weeks [18].  
Apart from analyzing strains based on their host-origin, the strains were also differentiated 
based on their MLVA genotype classification. The strains of the CbNL01 genotype were predominant 
during the Dutch Q fever outbreak, whereas strains of the CbNL12 genotype were much less prevalent 
[6].The present study consistently showed a non-significant effect of genotype-grouped C. burnetii 
strains on the immune responses at all time points (Table 2). Comparative genomics of Dutch CbNL01 
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and CbNL12 genotype strains, showed highly similar genomes of strains representing the same 
genotype (Kuley et al., unpublished). Although, the genome content differs between strains from 
different genotypes, we did not see major differences in immune responses. It could be possible that 
strains from the same host-origin but belonging to different genotypes share the same antigenic profile 
caused by specific point mutations in major antigens and/or by specific modifications of membrane 
proteins [58]. This could affect the bacterial recognition by the host immune system and the observed 
differential immune responses. For example; the cattle strains may encode surface antigens which are 
effectively recognized by the host immune system leading to more efficient defense against the 
pathogen. Besides, the goat and human strains may encode antigens which are not well recognized by 
the host resulting in defective activation or evasion of host immune system. Alternatively, it could also 
be possible that the bacteria undergo genomic re-organizations [35,59,60] and/or alters its gene 
regulation in order to adapt to the host it resides in, resulting in host-origin specific but not genotype-
specific immune responses. Based on our findings, the existence of shared factors in strains originating 
from the same host could be speculated in order to explain the observed host-origin dependent 
immune responses.   
In the present study, temporal changes in immune responses were assessed in 
immunocompetent mice infected with C. burnetii strains. From our study we conclude that C. burnetii 
strains are able to induce both innate and adaptive immune responses, independent of the origin or the 
genotype of the strains. This indicates that both branches of the immune system are important for 
limiting C. burnetii infections [24,61]. The observation that cattle strains elicit higher immune 
response compared to goat and human strains, were also found in experiments using PBMCs of 
healthy humans stimulated with various inactivated C. burnetii strains from different host-origin 
(Ammerdorffer et al., Submitted). In these studies, higher levels of pro-inflammatory cytokines were 
observed in response to cattle strains as compared to others strains originating from goat, sheep and 
chronic human patients. Similar immune responses generated by strains originating from goat and 
human, may indicate similar virulence mechanisms in host. This could be due to the sharing of similar 
surface antigens or other adaptations in host which are not known yet. Based on our findings, we 
suggest that bacteria originating from goat hosts have a greater potential to cause outbreaks in humans 
and needs to be efficiently monitored. In this light, monitoring of cattle strains would be less important 
since these strains can generate stronger immune response in in vivo hosts and thus pose lower risk for 
Q fever outbreaks [10,15,20]. 
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Supplementary figure 
 
 
 
Figure S1. Splenic bacterial loads in mice infected with goat, cattle and human strains at 7, 14, 21 and 28 day 
time points. Significant decrease in bacterial load was observed comparatively early at 21 day p.i. in cattle 
infected group. Significant differences within infected groups were indicated as * (p < 0.05). 
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Abstract 
Coxiella burnetii is the causative agent of Q fever. Although the prevalence of C. burnetii in 
cattle is much higher than in goats and sheep, infected cattle are rarely associated with human 
outbreaks. We investigated whether the immune response of humans differs after contact with C. 
burnetii isolates from different host origins or with different multi-locus variable number of tandem 
repeat analysis (MLVA) genotypes. 
Cytokine responses were measured in human peripheral blood mononuclear cells (PBMCs) 
stimulated with 16 C. burnetii isolates with known MLVA genotype from goats, sheep, cattle, acute 
and chronic Q fever patients. C. burnetii isolates originating from cattle induce significantly more IL-
1β, TNF-α and IL-22 than the isolates from goats, sheep or chronic Q fever patients. Comparing the 
cytokine induction of the isolates based on their MVLA genotype did not reveal differences in 
response between the MLVA genotypes. The pro-inflammatory cytokine response induced in human 
PBMCs by C. burnetii isolates from cattle may explain the low incidence of human Q fever outbreaks 
caused by cattle. The cytokine profile of PBMCs stimulated with C. burnetii isolates from chronic Q 
fever patients resembles isolates from goats. Furthermore, cytokine responses seem to be depending 
on host origin than on MLVA genotype. 
  
157 
 
Introduction 
The zoonotic bacterium Coxiella burnetii caused a large outbreak in the Netherlands between 
2007 and 2010. More than 4.000 acute Q fever cases were reported, but seroprevalence studies 
estimated at least 40.000 individuals infected with C. burnetii [1, 2]. Besides acute Q fever, C. burnetii 
infection can lead to chronic Q fever in 1-5% of the individuals after an initial infection [3]. The main 
sources for Q fever in humans are sheep and goats. In contrast to the observed clinical symptoms in 
humans during C. burnetii infection, infection in ruminants is mostly asymptomatic. However, in 
pregnant sheep and goats infection may cause abortion, premature birth, dead or weak offspring and it 
may cause reproductive disorders in cattle [4, 5]. In  a large review study, overarching the years 1982 
to 2010, was conducted in which, among others, the seroprevalence of C. burnetii-antibodies in goats, 
sheep and cattle was investigated [6]:within-herd prevalence estimates for cattle, goat and sheep were 
respectively 20.8%, 40.0%, 56.9% (Bulgaria), 15.0%, 88.1%, 20.0% (France), 19.3%, 2.5%, 8.7% 
(Germany), and 21.0%, 7.8%, 3.5% (the Netherlands);the herd prevalence (a herd is considered 
positive when at least one animal in the herd was serologically confirmed) in the Netherlands was up 
to 37.0% in cattle, 17.8% in goats and 14.5% in sheep. In France, the herd prevalence for cattle, goats 
and sheep was respectively 73.0%, 40% and 89% [6]. In 2011 and specifically for cattle in the 
Netherlands, Muskens et al [7] identified that 268 of 341 cattle herds (78.6%) tested positive for C. 
burnetii antibodies and at 56.6% of the herds C. burnetii DNA was detected. 
Despite the high percentage of (herd) seroprevalence of C. burnetii in cattle, only a minority 
of the human Q fever outbreaks are attributed to cattle [6]. In addition, while almost all commercial 
milk products from cattle contain C. burnetii DNA, to our knowledge no reports are available 
indicating that these farmers, their family or milk consumers developed Q fever [8]. Several studies 
indicate that specific genotypes of C. burnetii are associated with cattle [8-10]. However, cattle can 
also be infected with other genotypes, when more animal species are present on the same farm [11]. It 
can be hypothesized that humans can become infected by C. burnetii isolates originating from both 
cattle and goat, but infection with cattle isolates might result in fewer, milder or no clinical symptoms 
compared with infections by goat isolates. We hypothesize that the cattle C. burnetii isolates induce a 
more profound immune response in humans, which can eventually result in more effective elimination 
of the bacteria leading to absence of clinical disease. 
To our knowledge, the current literature does not comprise studies focusing on the human 
immune response against different C. burnetii isolates. In order to check our hypothesis, we conducted 
the present study in which we used 16 C. burnetii isolates with either a different origin according to 
the host species and/or different MLVA genotype to investigate their cytokine induction upon 
stimulation of human peripheral blood mononuclear cells (PBMCs). As humans can get infected via 
either goat, sheep or cattle, C. burnetii isolates retrieved from these animals were included in the 
study. In addition, isolates from both acute and chronic Q fever patients were included to examine 
whether they induced a comparable cytokine pattern as the animal isolates. Our findings reveal that the 
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of the human Q fever outbreaks are attributed to cattle [6]. In addition, while almost all commercial 
milk products from cattle contain C. burnetii DNA, to our knowledge no reports are available 
indicating that these farmers, their family or milk consumers developed Q fever [8]. Several studies 
indicate that specific genotypes of C. burnetii are associated with cattle [8-10]. However, cattle can 
also be infected with other genotypes, when more animal species are present on the same farm [11]. It 
can be hypothesized that humans can become infected by C. burnetii isolates originating from both 
cattle and goat, but infection with cattle isolates might result in fewer, milder or no clinical symptoms 
compared with infections by goat isolates. We hypothesize that the cattle C. burnetii isolates induce a 
more profound immune response in humans, which can eventually result in more effective elimination 
of the bacteria leading to absence of clinical disease. 
To our knowledge, the current literature does not comprise studies focusing on the human 
immune response against different C. burnetii isolates. In order to check our hypothesis, we conducted 
the present study in which we used 16 C. burnetii isolates with either a different origin according to 
the host species and/or different MLVA genotype to investigate their cytokine induction upon 
stimulation of human peripheral blood mononuclear cells (PBMCs). As humans can get infected via 
either goat, sheep or cattle, C. burnetii isolates retrieved from these animals were included in the 
study. In addition, isolates from both acute and chronic Q fever patients were included to examine 
whether they induced a comparable cytokine pattern as the animal isolates. Our findings reveal that the 
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origin of the C. burnetii isolates has a greater influence on the cytokine production by human PBMCs, 
compared to the MLVA genotype. Here we provide a possible immunological explanation why C. 
burnetii transmission from infected cattle are less likely to induce infection in humans, which can 
relate to the minimal numbers of human Q fever outbreaks caused by cattle as stated in the current 
literature.  
 
Material and methods 
C. burnetii isolates 
The C. burnetii isolates X09003262-001 (3262), CbCVIC1, 8014160-001 (14160-001), 8014160-002 
(14160-002) and 18430 were isolated from the placenta of goats or sheep that aborted at different 
farms during the Q fever outbreak in the Netherlands. The human C. burnetii isolates from the 
Netherlands, 42785537 and 334937 were isolated from the heart valve from two individual chronic Q 
fever patients from the Radboud University Medical Centre and Canisius Wilhelmina Hospital 
respectively. The other human isolates, Schperling, Henzerling, Herzberg and Scurry were a kind gift 
from Dimitrios Frangoulidis of the Bundeswehr Institute for Microbiology (Munich, Germany). These 
isolates were retrieved from acute Q fever patients, however they were not obtained in the Netherlands 
during the outbreak, and background information about the assumed origin (infection via goat, sheep 
or cattle) is missing. Four isolates were obtained in France from goats (1683CbC2 and CbG15D6), 
sheep (736Cb01) and cattle (701CbB1) and were kindly provided by A. Rodolakis (INRA, France). 
The second cattle isolate (CbBEB1) came from Belgium and was a kind gift from D. Fretin (Coda 
Cerva, Bruxelles). All isolates represent LPS phase I. LPS phase determination was performed by 
SDS-PAGE and silver staining, using purified phase I (RSA493) and phase II (RSA439) C. burnetii 
NM LPS (kindly provided by R. Toman) as controls [12, 13]. More details of the isolates, like origin 
of the host (referred throughout the article as ‘origin’), country and MLVA genotype is described in 
Table 1. All isolates were cultured on Buffalo Green Monkey (BGM) cells as described previously and 
heat inactivated at 99 °C for 30 min [14]. All isolated were quantified by qPCR as described in detail 
by Roest et al. [15]. In short, the qPCR targets a single copy gene encoding a C. burnetii-specific 
hypothetical protein (gene bank number AY502846) using the forward primer 5’-
ATAGCGCCAATCGAAATGGT-3’, the reverse primer 5’- CTTGAATACCCATCCCGAAGTC-3’, 
and the NED-labelled probe 5’-CCCAGTAGGGCAGAAGACGTTCCCC-3’. qPCR was performed 
on a 7500 Fast Real Time PCR system (Applied Biosystems, USA), 
 
MLVA genotyping 
MLVA genotyping was performed by using a selection of 12 loci: ms01, ms03, ms20, ms21, ms22, 
ms24, ms27, ms28, ms30, ms31, ms24 and ms36. The method of MLVA genotyping is described in 
detail by Roest et al. and Arricau-Bouvery et al. [10, 16]. A dendrogram based on the MLVA 
genotype of the isolates was made using BioNumerics 7.5.  
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compared to the MLVA genotype. Here we provide a possible immunological explanation why C. 
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by Roest et al. [15]. In short, the qPCR targets a single copy gene encoding a C. burnetii-specific 
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MLVA genotyping 
MLVA genotyping was performed by using a selection of 12 loci: ms01, ms03, ms20, ms21, ms22, 
ms24, ms27, ms28, ms30, ms31, ms24 and ms36. The method of MLVA genotyping is described in 
detail by Roest et al. and Arricau-Bouvery et al. [10, 16]. A dendrogram based on the MLVA 
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Isolation of human peripheral blood mononuclear cells and stimulation with C. burnetii 
PBMCs from healthy individuals were isolated according to standard protocols (Invitrogen, USA) as 
described previously [17]. 5x105 cells were added to a round-bottom 96-well plate (Corning, The 
Netherlands) and incubated with RPMI medium and the 16 C. burnetii isolates (1x10^7/ml) in the 
presence of 10% human serum. After 24 hours, 48 hours and 7 days supernatants were harvested, 
depending on the cytokine to be measured, and stored at -20°C.  
 
Cytokine measurements  
Cytokine production was measured in the cell supernatants using ELISA according to the 
manufacturer’s protocols. The following kits were used: IL-10 and IFN-γ (Sanquin, the Netherlands), 
TNF-α, IL-1β, IL-1Ra, IL-17 and IL-22 (R&D Systems, USA). Absorption was measured at 450 nm 
using a microplate reader (Bio-Rad Laboratories, the Netherlands). TNF-α and IL-1β were measured 
after 24h, IL-10 and IL-1Ra after 48h and IFN-γ, IL-17 and IL-22 were measured after 7d incubation.  
 
Statistics 
PBMCs of 11 healthy individuals were stimulated with the different C. burnetii isolates. The average 
cytokine production for each isolate was used in a one-way Anova to identify the differences between 
the groups. In case of IL-1β, TNF-α, IL-10, IL-1Ra, IL-17 and IL-22 the homogeneity of variances 
was ≥ 0.05, therefore the Bonferonni Post-Hoc test was used to compare the different groups. For IFN-
γ, difference between the variances in the groups (<0.05) was calculated and the Dunnett T3 Post-Hoc 
test was used. The data are expressed as mean (± standard error of the mean). IBM SPSS 18 software 
was used to perform the statistical analyses and GraphPad Prism 5 software was used generate the 
graphs. Differences with a P value of < 0.05 were considered statistically significant. 
 
Results 
C. burnetii isolates from cattle induce a pro-inflammatory cytokine response 
PBMCs stimulated with cattle isolates produced significantly more of the pro-inflammatory cytokines 
IL-1β and TNF-α, compared to the sheep, goat or isolates from patients with chronic Q fever (Figure 
1A). In contrast, no significant differences were found between the cattle and the isolates from acute 
human cases. In case of IFN-γ, human PBMCs produced similar IFN-γ levels after stimulation with all 
different C. burnetii isolates. The general induction of IFN-γ was much lower than for IL-1β and TNF-
α. The fold induction of IL-1β ranged from 10x in sheep and more than 40x in cattle isolates compared 
with no stimulation, whereas, the fold induction for IFN-γ was only 1.44x and 2.6x in sheep and cattle 
isolates respectively. Besides the high pro-inflammatory cytokine induction of cattle isolates, the  
isolates from acute human cases also produced high amounts of IL-1β and TNF-α. In case of IL-1β 
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Figure 1. Cytokine profiles of the C. burnetii isolates grouped on their origin. PBMCs of 11 healthy individuals 
were stimulated with RPMI medium (striped bar) and 16 different C. burnetii isolates, see Table 1 for the details 
of the isolates. The following cytokines were measured using ELISA: IL-1β, TNF-α, IFN-γ (1A), IL-Ra, IL-10 
(1B), IL-17 and IL-22 (1C). The color of the bars match the following isolates; white (3x chronic human), light 
grey (3x acute human), medium grey (6x goat), dark grey (2x sheep), black (2x cattle). Statistical differences 
were tested using one-way ANOVA. In case of all cytokines, except IFN-γ, the Bonferonni Post-Hoc test was 
used. For IFN-γ, differences were calculates using Fishers Least Significant Difference (LSD). NS: Not 
Significant, *p<0.05, **p<0.01, ***p<0.001. Data is presented as mean ±SEM. 
 
there was a significant difference between isolates from patients with acute Q fever  compared to 
isolates derived from chronic Q fever patients (p=0.038) and sheep isolates (p=0.035) (Figure 1A). In 
addition to the pro-inflammatory cytokines, the anti-inflammatory cytokines IL-1Ra and IL-10 were 
measured. Isolates from acute Q fever patients induced the highest IL-10 and IL-1Ra in human 
PBMCs, followed by the cattle isolates (no significant differences). Comparing the isolates from 
chronic and acute Q fever patients show a trend for a lower IL-10 (p=0.072) and IL-1Ra (p=0.051) in 
the isolates from chronic Q fever patients (Figure 1B). Finally the Th17 cytokines, IL-17 and IL-22 
were measured. For IL-17, no differences were observed between the groups. In contrast, the IL-22 
response was significantly higher in human PBMCs stimulated with cattle isolates compared to the 
other groups, the differences are significant for sheep (p=0.002) goat (p=0.004) and isolates from 
acute and chronic Q fever patients (both p=0.001) (Figure 1C). Comparison of the isolates derived 
from infected cattle and the isolates from individuals with acute Q fever show that except for IL-22, 
there are no significant differences in cytokine responses in human PBMCs. Three of the six goat 
isolates have a low passage number (3-4 times), while the other three isolates have been passed on 
BGM cells 12 to 14 times. Despite these differences in passage number, examination by SDS-PAGE 
and silver staining revealed that all isolates contained phase I LPS. Furthermore, statistical analyses 
between the low and high passage number goat isolates showed no significant difference in IL-1β and 
TNF-α production by human PBMCs upon stimulation (data not shown). 
 
The MLVA genotype of C. burnetii isolates does not influence the cytokine production of human 
PBMCs 
Besides analyzing the isolates based on their origin, the isolates were discriminated based on their 
MLVA genotype. Two main genotypes can be distinguished among our isolates. First the genotype, 
named CbNL01 by Roest et al. [10], was the dominant genotype found during the Dutch Q fever 
outbreak. In total six isolates from our study belong to this genotype, four goats and two isolates from  
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Figure 2. Minimum spanning tree analysis of MLVA genotypes from C. burnetii isolates used in the study. A 
total of 12 micro satellite loci (Table 1) were used to construct a dendrogram of 16 C. burnetii isolates. Numbers 
on the connecting lines refer to the distance between the nodes, e.g. 4 means four different loci. The size of the 
circles is proportional to the number of strains bearing the same genetic profile. Colors indicate the origin from 
which the isolates originate; goat (dark grey), human acute Q fever (black), human chronic Q fever (light grey), 
sheep (dashed) and cattle (white). Branch labels give the. Clustering by minimum spanning tree (MST, 
hypothetical, non-rooted) was performed with Bionumerics 7.5. 
 
chronic Q fever patients. The second main genotype in our study, referred to as CbNL12, contained 
two goat, one sheep and the two cattle isolates. The third group consists of the remaining individual 
genotypes, including the three acute human strains, one chronic human strain and a second sheep 
strain. The differences in MLVA genotype are visualized in Figure 2, which shows the minimal   
spanning tree of all C. burnetii isolates included in this study. Genotype CbNL12 differs with 9 micro 
satellite (ms) loci from CbNL01 and is situated in a separate genotype. From three isolates, 701CbB1, 
CbBEB1 and 18430, one or two ms loci were missing. Based on the 10 known ms loci, these isolates 
belong to the CbNL12 MLVA genotype. 
Comparison of the cytokine induction between the diverse genotypes showed no significant 
differences in the pro-inflammatory cytokines (IL-1β, TNF-α, IFN-γ) (Figure 3A) and other cytokines 
(IL-10, IL-1Ra, IL-17 and IL-22) (Figure 3B and 3C). Among the isolates with the CbNL12 MLVA 
genotype, the isolates originated from infected cattle produced significant more TNF-α, IL-1β, IL-10 
and IL-1Ra (Supplement figure 1).  
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Figure 3. Cytokine profiles of the C. burnetii isolates grouped on their MLVA genotype. PBMCs of 11 healthy 
individuals were stimulated with RPMI medium (striped bar) and 16 different C. burnetii isolates, see Table 1 
for the details of the isolates. The following cytokines were measured using ELISA: IL-1β, TNF-α, IFN-γ (3A), 
IL-Ra, IL-10 (3B), IL-17 and IL-22 (3C). The color of the bars match the following isolates; white (6x 
CbNL01), grey (5x CbNL12), black (5x remaining MLVA genotypes). Statistical differences were tested using 
one-way ANOVA. In case of all cytokines, except IFN-γ, the Bonferonni Post-Hoc test was used. For IFN-γ, 
differences were calculates using Fishers Least Significant Difference (LSD). NS: Not Significant. Data is 
presented as mean ±SEM. 
 
Discussion  
C. burnetii causes Q fever in humans and a broad range of animals throughout the world. In the 
majority of the examined cases, goats and sheep are the most likely source for human Q fever 
outbreaks [6]. Interestingly, in the Netherlands and Germany, the herd prevalence of C. burnetii in 
cattle is much higher than in goat and sheep. This could suggest that infected cattle are a large threat 
for the human population [6]. However, in the Netherlands and other countries with known human Q 
fever outbreaks, cattle are scarcely the source of the outbreak [6]. We hypothesized that these cattle C. 
burnetii isolates induce a more profound immune response in humans, which can eventually result in 
more effective elimination of the bacteria, resulting in less clinical disease. 
Our study revealed that the cytokine patterns induced in human PBMCs depends on the C. 
burnetii isolate host origin. Namely, the two cattle isolates induced higher amounts of IL-1β, TNF-α, 
and IL-22 in human PBMCs than the goat and sheep isolates. In addition, we observed that the MLVA 
genotype of the C. burnetii isolates is not related to the cytokine induction by PBMCs. As the cytokine 
patterns induced in human PBMCs by C. burnetii isolates (grouped on base of their MLVA genotype), 
revealed no significant differences between the groups.  
There are several explanations for the observed differences in cytokine response of human 
PBMCs against C. burnetii isolates originating from different animal hosts, and for the observation 
that the MLVA genotypes used in this study do not effect these cytokine responses.  
We observed that the two cattle isolates with MLVA genotype CbNL12 induced more pro- and anti-
inflammatory cytokines in human PBMCs than the two goats and sheep isolates with the same MLVA 
genotype (Supplement figure 1). However, it is not possible to correlate the cytokine induction by 
human PBMCs against a C. burnetii isolate based on its MLVA genotype. MLVA genotyping depends 
on a selection of loci containing tandem repeats are targeted. These loci do probably not code for 
antigens that are involved in the innate immune response. So, even though the MLVA genotype of the 
C. burnetii isolates is the same, other parts of the genome can differ which might result in variations in 
antigens responsible for diverse responses from host [18].  
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Another explanation for the observed differences in cytokine response upon stimulation by C. 
burnetii isolates coming from different hosts is the expression of diverse virulence factors. Recently, 
D’Amato et al. indicated that C. burnetii Z3055, a clone linked to the Dutch Q fever outbreak isolate 
3262, contains significantly more non synonymous gene mutations for proteins belonging to the 
categories of membrane proteins, ankyrin repeat domain-containing proteins, transcription factors and 
translational proteins [19]. They hypothesized that the epidemic potential of this isolate is based on 
modifications in the in antigenic surface proteins and growth rate, which results in a new serotype 
(classification of micro-organisms based on the cell surface antigens) [19]. Differences in membrane 
proteins or other virulence factors of C. burnetii can make individuals less or more susceptible for 
infection, in addition it could result in fewer or more clinical symptoms depending on the 
responsiveness of the immune system. It can be hypothesized that the C. burnetii isolates from cattle 
possess specific virulence factors, to which the human immune system is more profound to react.  
The responsiveness of the human immune system is another factor which can explain the induced 
cytokine differences between PBMCs stimulation with cattle isolates or goat and sheep isolates. This 
difference in cytokine induction may be explained by the ability of our immune system to mount an 
adequate pro-inflammatory response to these different strains. This was shown for Cryptococcus by 
Schoffelen et al. [20], as they concluded that PBMCs from healthy individuals induced a more 
pronounced inflammatory response against clinical heat-killed C. gattii isolates then to other 
Cryptococcus species and non-clinical C. gattii [20]. From our study we conclude that human PBMCs 
are able to induce a cytokine response against all C. burnetii isolates tested, independent the origin or 
MLVA genotype. There is evidence that insufficient induction of pro-inflammatory cytokines result in 
defective activation of the host immune response on invasion of the organism by pathogenic microbes, 
resulting in increased susceptibility to infections [21]. Of course, the virulence factors of the C. 
burnetii isolates and the responsiveness of the human immune system are linked to each other. The Q 
fever outbreak in the Netherlands can be explained by the fact that, besides possible differences in 
virulence of the isolate, the human immune system is not able to induce an optimal response, probably 
due to different antigens, leading to a higher susceptibility to infection. 
IFN-γ induced by the cattle isolates was not significantly higher than in the isolates from 
either goats or sheep. In contrast, the other pro-inflammatory cytokines IL-1β and TNF-α were 
significant higher in the cattle isolates than in the isolates from either goats or sheep. One explanation 
for the observed difference could be the larger variation of IFN-γ production among the PBMCs of 
healthy individuals, resulting in less mutual differences between isolates of different origin 
(Supplement figure 2). PBMCs of 11 individuals were stimulated with the different isolates and we 
deliberately choose not to exclude the outliers in order to visualize the variance in cytokine responses. 
For example, our data show that there is a reasonable variation in IFN-γ, Il-17 and IL-22 induction per 
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person. Secondly, as mentioned in the results, the general induction of IFN-γ was much lower than for 
IL-1β and TNF-α. Besides the significant differences in IL-1β and TNF-α induction of the cattle 
isolates, IL-22 was significant higher in these isolates than in the goat and sheep isolates. IL-22, in part 
synergistically with other cytokines such as TNF-α, activates the expression of antimicrobial proteins 
like defensins. Furthermore, IL-22 promotes the production of inflammatory mediators, such as 
granulocyte colony-stimulating factor, IL-1β and lipopolysaccharide-binding protein (LBP) [22]. The 
initiation of these immune responses by IL-1β, TNF-α and IL-22 can explain the better clearance of C. 
burnetii originating from cattle by humans.  
The isolates from acute Q fever cases show a similar cytokine profile as the cattle isolates 
except for IL-22, even though these isolates were not retrieved from Dutch patients during the Q fever 
outbreak but from Kyrgyzstan, Italy and Greece. Unfortunately, there is only limited information on 
the background of these isolates, and we do not know whether these individuals were infected via 
cattle, sheep or goat. Although C. burnetii infection of human via cattle is less common, based on the 
cytokine patterns from our study, it is possible that these acute human isolates originated from infected 
cattle. The cytokine pattern of PBMCs stimulated with isolates from chronic Q fever patients was 
similar to that of goat isolates. Based on these findings it is possible to speculate that some C. burnetii 
isolates are inducing acute Q fever, while other C. burnetii isolates are responsible for chronic Q fever 
infections. This hypothesis is strengthened by several studies demonstrating that C. burnetii isolates 
originating from humans with acute Q fever differ in plasmid type [23], lipopolysaccharide profiles 
[24], and chromosomal DNA restriction endonuclease fragment patterns [25] from many isolates 
originating from chronic Q fever. In addition, a 28-kDa membrane-associated protein was identified 
and demonstrated that the acute disease antigen A (adaA) gene is expressed in acute isolates but not 
carried by chronic isolates, suggesting that adaA may be a virulence factor related to acute Q fever 
[26]. In contrast, other studies indicated that no specific gene(s) on plasmids are responsible for a 
specific virulence phenotype [27, 28]. Moreover, during the Dutch Q fever outbreak we assume that 
the majority of the infected individuals, both acute as chronic, are infected with the same C. burnetii 
MLVA genotype originating from goats. Meaning that one C. burnetii MLVA genotype can induce 
either acute or chronic Q fever infections in humans. In our opinion, the disease outcome of C. 
burnetii infections in humans is multi-factorial. Besides the findings presents in this study, we recently 
also described that single nucleotide polymorphisms in specific pattern recognition receptors increase 
the chance to develop chronic Q fever [29]. Taking all this into account, the severity of the infection is 
influenced among others by the origin and virulence of the C. burnetii isolate, as well as the immune 
status and genetic background of the infected individual. This is strengthened by the fact that many 
diverse C. burnetii isolates are found in goats, which are not detected in human samples. It implies that 
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only the origin of the isolate does not correlate to the possibility for human infection and disease 
outcome.  
In conclusion, in the present study we investigated the potential of C. burnetii isolates from 
different species of origin and MLVA genotypes to induce cytokine production in human PBMCs. We 
demonstrated that isolates derived from cattle and from acute Q fever patients induced higher amounts 
of the pro-inflammatory cytokines TNF-α, IL-1β and IL-22 compared to isolates from other sources 
and patients with chronic Q fever. Interestingly, this could not be related to differences in MLVA 
genotype. The observation that cattle isolates elicit higher amounts of pro-inflammatory cytokines 
may explain the epidemiological observation that Q fever in humans is seldom related to cattle as a 
source for human Q fever. Although it must be noted that the all strains from acute patients were not-
related to the present outbreak. The observation that isolates from patient with acute Q fever induce a 
more pronounced pro-inflammatory cytokine response compared to patients with chronic Q fever may 
signify the importance of the inflammatory response to completely eradicates C. burnetii from the host 
after the initial infection in order to prevent chronic infections.  
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Figure S1. Cytokine profiles of the 16 different C. burnetii isolates based on their MLVA genotype. PBMCs of 
11 healthy individuals were stimulated with RPMI medium (striped bar) and 16 different C. burnetii isolates, see 
Table 1 for the details of the isolates. The following cytokines were measured using ELISA: IL-1β, TNF-α, IL-
Ra, IL-10, IL-17, IL-22 and IFN-γ. The color of the bars match the following isolates; white (CbNL01), grey 
(CbNL12), black remaining MLVA genotypes). Data is presented as mean ±SEM. Differences between the 
isolates with MLVA CbNL12 were tested using the Mann–Whitney U test. The significance compared to 
701CbB1 is indicated at the line on top of the graph, the significance compared to CbBEB1 is indicated directly 
on top of the corresponding bar. Only significant results are shown, *p<0.05, **p<0.01, ***p<0.001, **** 
p<0.0001. 
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Figure S2. Cytokine profiles of the 16 different C. burnetii isolates based on their origin. PBMCs of 11 healthy 
individuals were stimulated with RPMI medium (striped bar) and 16 different C. burnetii isolates, see Table 1 
for the details of the isolates. The following cytokines were measured using ELISA: IL-1β, TNF-α, IL-Ra, IL-10, 
IL-17, IL-22and IFN-γ. The color of the bars match the following origin; white (chronic human), light grey 
(acute human), medium grey (goat), dark grey (sheep), black (cattle). Data is presented as mean ±SEM. 
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General Discussion 
Coxiella burnetii is an obligate intracellular bacterium that causes Q fever in animals and humans. Q 
fever can persist in herds of domestic ruminants causing large financial losses and outbreaks pose a 
major threat to public health [1,2]. During 2007-2010, a Q fever outbreak occurred in The 
Netherlands, where more than 40,000 people were estimated to have been infected [3]. The research 
described in this thesis was initiated as a response to the Dutch Q fever outbreak with the goal to 
characterize the C. burnetii strains isolated from clinical materials of infected goat, cattle, sheep and 
human patients [4]. The objectives were to gain a better understanding of C. burnetii virulence, 
diversity, physiology, and strain adaptation to various micro-environments. To this end, bacterial 
genomes were sequenced and comparative genomic approaches were used to identify differences in 
strains and their link with pathogenicity. Furthermore, we studied the diverse immunological host 
responses to C. burnetii strains isolated from different hosts (goat, sheep, cattle and human patients) 
using a mouse infection model and stimulation of healthy human PBMCs. These studies provide an 
overview of pathogen related factors that are potentially involved in successful infection of hosts. The 
studies also highlight the factors underlying the unprecedented Dutch Q fever outbreak. Finally, this 
thesis demonstrates the power of “Omics” approaches to study pathogens like C. burnetii, whose 
fastidious lifestyle makes it challenging to investigate using contemporary molecular-genetic 
techniques. 
 
Molecular characterization and host adaptation of C. burnetii strains along with factors 
underlying the Q fever outbreak 
The comparative analysis of several C. burnetii strains at the genome sequence level showed a high 
similarity of strains within the same genotype. Genome sequences of the Dutch CbNL12 genotype 
strains were most similar to the NM reference strain primarily isolated from ticks, while the genome 
sequences of the outbreak related CbNL01 genotype strains were more divergent. Comparative 
genome analysis also showed that the high virulence of the outbreak strains was not associated with 
acquiring novel virulence-related genes (Chapter 4 and 5). This argues against the idea that the Dutch 
outbreak was due to emergence of hyper-virulent C. burnetii strains though horizontal gene transfer of 
novel virulence factors [3,5,6]. A remarkable finding during our studies was the relatively high 
number of transposase genes present in the CbNL01 genotype strains. Additionally, we observed that 
the genome of the outbreak strains contained a large number of non-synonymous SNPs in genes 
encoding membrane proteins. Thus, the increased virulence/zoonotic potential of the Dutch outbreak 
stains is most likely due to extensive transposon-mediated genome rearrangements and alterations in 
the amino-acid sequence of membrane proteins (Chapter 4 and 5).  
  179 
 
 
 
The presence of a transposase genes (IS elements) is a unique feature of C. burnetii genomes, 
compared to other obligate intracellular pathogens (Rickettsia, Chlamydia, Mycobacterium leprae) and 
are assumed to be associated with adaptation of the pathogen to different intracellular niches 
[7]. These IS elements were present in the outbreak strain genomes in high numbers and were mainly 
associated with genome rearrangements (Chapter 5). These observations provide evidence for the 
notion that the high genome plasticity of the outbreak strains aid in an improved acclimatization of the 
bacteria in its intracellular niche. However, there is no direct evidence that such large-scale genomic 
rearrangements have impact on the functionalities of C. burnetii. On the other hand, genetic 
transposition events have been previously suggested to be involved in the generation of genetic 
variation and adaptation of other bacteria to various environments [8]. Based on the results described 
in this thesis and in the literature, it can be hypothesized that the large number of transposons in the 
outbreak strains might resulted in extensive genome rearrangements in response to environmental 
challenges, including those in the host. Such rearrangements can result in DNA insertions/deletions, 
generation of polymorphisms, pseudo-genes (genes disrupted by IS elements) or differential gene 
regulation favouring growth and survival of the bacteria in different niches [9–12]. Whether such 
genome rearrangements aid in bacterial adaptation can be tested in in vitro evolution models using 
nutritional deprivation conditions, which is a common condition found in the bacterial natural 
environment. It would not be surprising to find that transposition would be enhanced under nutritional 
deprived conditions to generate an array of mutants from which a fitter individual could arise, that are 
then enriched in the population over time due to increased growth and survival. Performing such 
experiments would provide more information on the evolution of virulence of C. burnetii strains.  
Large number of mutations in membrane protein genes could also have contributed to the 
evolutionary success of the Dutch CbNL01 strains, as has been observed for other pathogens [13,14]. 
The altered membrane proteins of the Dutch outbreak strains most probably generated a distinct 
antigenic profile, which could have gone unrecognized by the human immune system leading to more 
efficient bacterial dissemination in the population. In addition, the expression of most of these mutated 
membrane proteins of the outbreak strains was up-regulated in vivo and few of them were among the 
most highly up-regulated ones (Chapter 3). This observation indicates that the altered membrane 
proteins are highly expressed in vivo and that they may contribute significantly to the antigenic make-
up of the bacteria during infections in hosts. Hence, a change in the bacterial antigenic repertoire, 
qualitatively as well as quantitatively, provides a plausible explanation of the increased zoonotic 
potential of the outbreak strains.  
The above conclusion is not in line with the results of the studies presented in Chapters 6 and 
7. Although prominent genetic differences are associated with the CbNL01 genotype Dutch outbreak 
strains and the less prevalent CbNL12 genotype strains (Chapter 5), host immune responses were 
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The above conclusion is not in line with the results of the studies presented in Chapters 6 and 
7. Although prominent genetic differences are associated with the CbNL01 genotype Dutch outbreak 
strains and the less prevalent CbNL12 genotype strains (Chapter 5), host immune responses were 
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observed to be dependent on the origin of the C. burnetii strains, rather than on the MLVA genotype. 
From these findings, we anticipated (Chapter 6 and 7) that strains originating from the same host, but 
belonging to different genotypes, might share genetic factors or mutations in coding regions of the 
genomes. Such altered proteins may affect bacterial recognition by the host immune system and/or aid 
in escape strategies to host responses, resulting in the induction of the observed similar immune 
responses from strains that originate from the same host. However, from our comparative genome 
analysis (Chapter 5), we did not find any additional genes and/or any host-specific SNPs in coding 
sequences, making it less likely that strains originating from the same host (but of different genotype) 
share host-specific signatures. 
As no host-specific genes or SNPs were identified from comparative genome analysis, other 
efficient evolutionary host-adaptation characteristic of C. burnetii strains can be predicted. All C. 
burnetii genome sequences were seen to contain many transposons (Chapter 5). It could be possible 
that C. burnetii strains undergo substantial genome rearrangements via transposition of these mobile 
elements. The high level of genetic diversity associated with these rearrangements could ultimately 
have aided adaptation to the host environment. For instance, genome analysis of the goat and human 
CbNL01 strains showed similar genome rearrangements relative to NM (Chapter 5). Such similarities 
in genome structures of these strains could have resulted in similar strategies for host adaptation and 
the observed similar immune responses, which is different from the immune responses induced by 
cattle strains (Chapter 6). Apart from changes at the genome level, it could also be that under the host 
influence the bacteria modifies its outer proteins/LPS coat or alters its gene regulation for efficient 
adaptation in hosts. For a better understanding of genome-organization and gene-regulation associated 
with host specificity and transmission of C. burnetii strains, further studies are required. Homologous 
and heterologous bacterial transmission studies in natural hosts, such as goats and cattle, may 
determine whether changes at the genome or transcriptome level aid in specialization of the bacteria in 
the host niche. For these experiments bacterial DNA and RNA should be directly isolated from the 
experimentally infected host without any sub-culturing in in vitro culturing systems. Such an approach 
would maintain the bacterial genome rearrangements/ transcripts in response to the residing host. 
These studies will help to further unravel the genetic diversity and uncover new regulatory/adaptive 
mechanisms employed by C. burnetii resulting in host adaptation. 
Phylogenetic analysis based on genotyping [5,15,16] and whole genome sequences (Chapter 
5) indicate that the Dutch CbNL01 genotype strains to most likely originated from Germany and 
spread to the Netherlands via France [5,16]. In France and Germany, only sporadic human cases were 
identified pertaining to the CbNL01 genotype strains and most likely during its transmission it gained 
additional virulence while preserving its MLVA genotype. The high-virulent CbNL01 strains were 
found to be the predominant genotype causing the historically most significant Dutch outbreak of Q 
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fever. Based on these findings, it can be assumed that, apart from the prominent genetic factors of the 
CbNL01 strains, there are other factors that orchestrated the unprecedented Dutch Q fever outbreak. 
One of the putative factors of the emergence of Q fever in Dutch dairy goat farms could be the 
intensive husbandry system and its proximity to the human population. This might have allowed easy 
transmission of the pathogen among the goat population and to humans. Secondly, as goats are 
seasonal breeders, abortions due to C. burnetii infections in dense goat farms cluster in time and could 
have increased the magnitude of environmental C. burnetii contamination resulting in higher risks for 
the emergence of human Q fever [17]. Hence, the introduction of one MLVA genotype of hyper-
virulent C. burnetii into the Dutch dairy goat population diversified over time resulting in a peak of 
goat abortions and leading to an enhanced scale of bacterial spreading over the country and 
transmissions to humans. 
In conclusion, the increase in the number of Q fever cases in the Netherlands among humans 
resulted from infections with hyper-virulent CbNL01 genotype strains present in the Dutch goat 
population. Although, CbNL12 genotype strains (derived from goats) were not identified in humans, 
the ability of the strains to cause human infections should not be under-estimated for several reasons. 
Firstly, both CbNL01 and CbNL12 strain infections caused abortions in goats, indicating that these 
strains are equally virulent in goats. Moreover, the CbNL12 strain is equally virulent to other goat-
origin strains of the CbNL01 genotype as measured by the mice virulence bio-assay (Chapter 2). 
Secondly, inadequate immune responses were generated by all goat-origin strains in mice and human 
PBMCs (Chapter 6 and 7). Finally, there have been reports of a few human Q fever cases in France, 
where the CbNL12 genotype was identified [16]. The studies from this thesis and from literature 
suggest that the virulence potential of C. burnetii strains is not only based on mutations in coding 
genes, but also on other host-adaptation mechanisms such as transposition or differential gene 
regulation and on non-genetic factors such as the risk to exposure (abortion storms in goat and sheep 
contrasting only mild disease in cattle). Additionally, the Dutch outbreak could have been facilitated 
by intensive goat farming in the affected area and its vicinity to the human populations. 
 
Host-specificity and monitoring of goat hosts to control Q fever outbreaks 
Until recently, it was not clear whether the host origin of the C. burnetii strains or the MLVA 
genotype is the bacterial characteristic that is associated with differences in the observed efficiency of 
the host immune response. Studies described in Chapters 6 and 7 emphasize that the immune 
responses depend largely on the host-origin of C. burnetii strains. These findings are important, as it 
implies that for the prevention of human Q fever, the monitoring of C. burnetii hosts is more crucial 
than identifying the specific bacterial genotype. The cattle origin strains induced a protective immune 
response in mice (Chapter 6). Similarly, it could be possible that cattle hosts provoke an efficient 
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origin strains of the CbNL01 genotype as measured by the mice virulence bio-assay (Chapter 2). 
Secondly, inadequate immune responses were generated by all goat-origin strains in mice and human 
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Until recently, it was not clear whether the host origin of the C. burnetii strains or the MLVA 
genotype is the bacterial characteristic that is associated with differences in the observed efficiency of 
the host immune response. Studies described in Chapters 6 and 7 emphasize that the immune 
responses depend largely on the host-origin of C. burnetii strains. These findings are important, as it 
implies that for the prevention of human Q fever, the monitoring of C. burnetii hosts is more crucial 
than identifying the specific bacterial genotype. The cattle origin strains induced a protective immune 
response in mice (Chapter 6). Similarly, it could be possible that cattle hosts provoke an efficient 
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immune response upon C. burnetii infection. Such a strong immune response against cattle origin 
strains, directly reflects the rarely visible clinical disease and low incidence of abortions in natural 
cattle hosts [18]. Additionally, human PBMCs also generated a profound pro-inflammatory response 
upon stimulation with cattle strains (Chapter 7). This finding might explain the epidemiological 
observation that Q fever in humans is seldom associated with the C. burnetii infections in cattle [19]. 
Based on these observations, it can be presumed that C. burnetii strains originating from cattle hosts 
are well recognized by the cattle and human immune system and thereby pose a lower risk for Q fever 
outbreaks in humans as well as within the cattle population itself.  
Host-specificity characteristics are observed in cattle-derived strains which are predominantly 
of the CbNL12 genotype. This genotype has rarely been found in goats [4]. It could be speculated that 
only a minority of bacterial infections transmitted from cattle hosts could successfully adapt in goat 
hosts and the majority is effectively eliminated resulting in a low prevalence of CbNL12 genotype 
strains in goats. The CbNL12 genotype strains has not been identified in Dutch human patients, but 
sporadic human cases with this CbNL12 genotype were identified in France [16]. In this case, it could 
be possible that humans were infected with goat-origin CbNL12 strains, but not with the CbNL12 
cattle strains. This assumption is supported by the fact that human PBMCs provoked relatively high 
pro-inflammatory cytokine responses upon stimulation with cattle strains (CbNL12 genotype strains) 
and relative low responses to goat strains (both CbNL01 and CbNL12 genotype strains) (Chapter 7). 
Based on this finding, it can be speculated that all goat-originating strains can cause infections in 
humans. Additionally, insufficient immune response of humans to goat strains could enable persistent 
re-infections, resulting in chronic disease (Chapters 6 and 7). This indicates that goat strains might be 
more inclined to cause chronic infections in humans as well as in goats, which is also supported by the 
current literature [20,21]. Based on these immunological findings, we (Chapters 6 and 7) suggest that 
C. burnetii bacteria originating from goat hosts have a greater potential to cause Q fever outbreaks in 
humans. Thus, goat herds should be effectively monitored to control transmission of C. burnetii within 
goat population in order to reduce the risk of transmission towards humans. 
An interesting question that arises from the literature is the absence of the high-virulent 
CbNL01 genotypes is cattle populations. It can be postulated that the CbNL01 strains cannot adapt in 
cattle hosts upon heterologous transmission from goats. It could also be possible that the bacteria are 
efficiently cleared due to prominent immune responses by cattle against CbNL01 strains. In  previous 
genotyping studies, only 1 out of 97 genotyped cattle strains was of the CbNL01 genotype [4,22,23]. 
Several reasons could explain this observation. For instance; a low susceptibility of cattle to CbNL01 
genotype strains or low excretion of bacteria, or the above mentioned efficient immune clearance of 
bacteria by host can lead to absence of the CbNL01 genotype strains in the cattle population. On the 
other hand, high prevalence of CbNL12 strains in cattle suggests an adaptation of this genotype in 
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cattle population. Further infection experiments using natural Q fever hosts can broadly expand our 
knowledge of why host-specificity is seen only for a few genotypes and not for others.  
 
Improved understanding of pathogenesis of C burnetii 
Since publication of the first genome sequence of a C. burnetii strain in 2003 [7], genomic approaches 
have emerged in Q fever studies. This has significantly contributed towards an improved knowledge 
of the physiology and the pathogenic abilities of the bacterium. What was lacking in our understanding 
of C. burnetii pathogenesis is a complete picture of the bacterial gene regulatory processes that occur 
during natural infections. Previous whole-genome expression studies of bacterial pathogens such as V. 
cholerae in experimentally infected in vivo models compared with in vitro models, has provided 
insights into virulence properties of the bacteria on entering the host [24]. A similar approach was 
used in Chapter 3, which provided an improved understanding of host-pathogen interactions of C. 
burnetii under in vivo conditions with respect to in vitro conditions. Additionally, combining both 
genome sequencing approaches, in order to find SNPs, and transcriptional regulation studies in mice 
(Chapters 3 and 5) provided further insights into virulence and adaptation mechanisms of the Dutch C. 
burnetii outbreak strains under in vivo conditions.  
Notable observations from genome and transcriptome analyses (Chapters 3 and 5) were the 
presence of point mutations in a majority of the up-regulated membrane protein encoding genes. The 
potential contribution of mutations and in vivo regulation of these membrane proteins to the zoonotic 
potential of the outbreak strains was discussed above. The expression of a large number of DNA repair 
protein encoding genes and transporters (ion/proton and metabolite transporter proteins) was also up-
regulated under in vivo conditions, compared to in vitro culturing conditions. Around 50% of these up-
regulated genes contained point mutations in the outbreak CbNL01strains. This finding is particularly 
interesting because up-regulation of mutated genes under in vivo conditions shows the importance of 
these mutations in bacterial fitness. It could be possible that up-regulation of these altered metabolite 
transporter proteins leads to efficient uptake of host-derived nutrients required for bacterial growth and 
replication in the host hostile environments. Up-regulation of altered ion/proton transporters and DNA 
repair proteins may enhance the capability of the bacterium in maintenance of homeostasis and cell 
integrity in the harsh intracellular environment. Additionally, the expression of predicted virulence 
related genes, encoding signal sequence-containing enzymes (acid phosphatase, phospholipases, sterol 
reductases) and eukaryotic-like domain containing proteins (serine/threonine protein kinases, Type IV 
secretion system effector proteins, ankyrin repeat containing protein), was up-regulated in vivo. This 
indicates that the earlier predicted virulence gene products most probably contribute to the virulence of 
the outbreak strains. The majority of the virulence related proteins that were up-regulated, also carried 
SNPs in the CbNL01 genotype strains. The presence of non-synonymous SNPs in these protein 
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immune response upon C. burnetii infection. Such a strong immune response against cattle origin 
strains, directly reflects the rarely visible clinical disease and low incidence of abortions in natural 
cattle hosts [18]. Additionally, human PBMCs also generated a profound pro-inflammatory response 
upon stimulation with cattle strains (Chapter 7). This finding might explain the epidemiological 
observation that Q fever in humans is seldom associated with the C. burnetii infections in cattle [19]. 
Based on these observations, it can be presumed that C. burnetii strains originating from cattle hosts 
are well recognized by the cattle and human immune system and thereby pose a lower risk for Q fever 
outbreaks in humans as well as within the cattle population itself.  
Host-specificity characteristics are observed in cattle-derived strains which are predominantly 
of the CbNL12 genotype. This genotype has rarely been found in goats [4]. It could be speculated that 
only a minority of bacterial infections transmitted from cattle hosts could successfully adapt in goat 
hosts and the majority is effectively eliminated resulting in a low prevalence of CbNL12 genotype 
strains in goats. The CbNL12 genotype strains has not been identified in Dutch human patients, but 
sporadic human cases with this CbNL12 genotype were identified in France [16]. In this case, it could 
be possible that humans were infected with goat-origin CbNL12 strains, but not with the CbNL12 
cattle strains. This assumption is supported by the fact that human PBMCs provoked relatively high 
pro-inflammatory cytokine responses upon stimulation with cattle strains (CbNL12 genotype strains) 
and relative low responses to goat strains (both CbNL01 and CbNL12 genotype strains) (Chapter 7). 
Based on this finding, it can be speculated that all goat-originating strains can cause infections in 
humans. Additionally, insufficient immune response of humans to goat strains could enable persistent 
re-infections, resulting in chronic disease (Chapters 6 and 7). This indicates that goat strains might be 
more inclined to cause chronic infections in humans as well as in goats, which is also supported by the 
current literature [20,21]. Based on these immunological findings, we (Chapters 6 and 7) suggest that 
C. burnetii bacteria originating from goat hosts have a greater potential to cause Q fever outbreaks in 
humans. Thus, goat herds should be effectively monitored to control transmission of C. burnetii within 
goat population in order to reduce the risk of transmission towards humans. 
An interesting question that arises from the literature is the absence of the high-virulent 
CbNL01 genotypes is cattle populations. It can be postulated that the CbNL01 strains cannot adapt in 
cattle hosts upon heterologous transmission from goats. It could also be possible that the bacteria are 
efficiently cleared due to prominent immune responses by cattle against CbNL01 strains. In  previous 
genotyping studies, only 1 out of 97 genotyped cattle strains was of the CbNL01 genotype [4,22,23]. 
Several reasons could explain this observation. For instance; a low susceptibility of cattle to CbNL01 
genotype strains or low excretion of bacteria, or the above mentioned efficient immune clearance of 
bacteria by host can lead to absence of the CbNL01 genotype strains in the cattle population. On the 
other hand, high prevalence of CbNL12 strains in cattle suggests an adaptation of this genotype in 
  183 
 
 
 
cattle population. Further infection experiments using natural Q fever hosts can broadly expand our 
knowledge of why host-specificity is seen only for a few genotypes and not for others.  
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encoding genes which are orthologs with the NM and CbNL12 strains, indicates that these gene 
variants were under positive selective pressure [10]. The altered proteins in the CbNL01 genotype 
strains might play a role in the manipulation of host components or host intracellular processes 
contributing to successful bacterial infection and persistence in host cells.  
Until now transcriptional studies on C. burnetii were only performed on in vitro cultured cells 
and mostly focused on a few target genes [25,26]. Despite the value of in vitro studies, these models 
cannot easily reproduce the complex and dynamic environment that C. burnetii is exposed to under in 
vivo conditions. Hence, the study as described in Chapter 3 is the first report on C. burnetii genome-
wide gene expression patterns in an in vivo model simulating a natural infection. The study clearly 
revealed up-regulation of a larger number of genes for bacterial survival/growth under in vivo 
conditions, than for in vitro conditions. Further studies involving the generation of knockout mutants 
of the up-regulated genes would be crucial to assess whether absence of these gene products would 
influence bacterial growth and verify their role in virulence of C. burnetii. Additionally, the present 
transcriptome results are based on high-virulent CbNL01 strains. Our previous mouse virulence bio-
assays (Chapter 2 and unpublished data) showed that several strains exhibited low-virulence 
characteristics. A comparison of gene regulation in in vivo hosts of high and low virulent C. burnetii 
strains would contribute to our understanding of pathogenic mechanisms and virulence. 
 
Insights from genomics into the large Dutch Q fever outbreak 
Confirming the source of the Dutch Q fever outbreak 
Molecular epidemiological/genotyping studies strongly suggested that goats were the primary source 
of the Dutch human Q fever outbreak from 2007-2010 [4,16,27]. Although genotyping approaches are 
widely used for outbreak investigations, these methods sometimes lack sufficient discriminatory 
power as it evaluates only a few genome loci. Besides, the development of high-throughput whole 
genome sequencing techniques (WGS) has revolutionized the conduct of outbreak investigation. 
Because of its detailed level of resolution, the WGS techniques could augment the traditional 
approaches leading to more accurate and efficient outbreak investigations. Comparison of the CbNL01 
genotype veterinary and human strain genome sequences showed large genome sequence similarities 
with minimal genetic differences (few point mutations only). Based on these results, the studies in 
Chapters 4 and 5 confirmed the conclusions from previous epidemiological and genotypic studies, 
linking goat and human infections during the large Dutch Q fever outbreak.  
Genome sequencing during outbreaks of infectious diseases is fundamentally useful to 
understand the pathogen evolution and molecular epidemiology. However, such information should 
become available rapidly in order to guide the disease control measures. Recently, with the largest 
Ebola outbreak, real-time WGS samples from Ebola patients provided very detailed information about 
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how cases were related. The determined phylodynamics provided important clues to successfully halt 
the transmission of the virus [28]. Another example is the recent avian influenza H5N8 outbreak in 
The Netherlands where WGS and phylodynamics provided invaluable insights that helped to 
efficiently manage the disease outbreak [29,30].  Real-time outbreak surveillance at the genome 
sequence level is now possible and has been used in several other outbreak cases in recent years 
[31,32] and has proved to have a broad impact on public health. The development of a fully automated 
bioinformatics pipeline for WGS data analysis of C. burnetii is much needed to make this powerful 
tool more widely accessible for future real-time investigations of Q fever outbreaks.  
 
Phylogenetic diversity of Dutch C. burnetii strains  
The phylogenome analysis of a large number of strains from different geographical areas has helped to 
reconstitute the epidemiology of C. burnetii strains from one region to another as described above for 
Dutch outbreak CbNL01 genotype strains [5,16]. Furthermore, Chapter 5 also showed a predominant 
clustering of genome sequences of the CbNL12 genotype strains isolated from cattle in The 
Netherlands and France. Similar observations were seen in C. burnetii genotyping studies, which 
showed the presence of CbNL12 genotypes in consumer cow milk products obtained from various 
European countries [23]. Thus, phylogenetics implies a clonal spread and host-specificity of CbNL12 
strains among the European cattle population.  
Although WGS and genotyping approaches showed similar results with respect to Dutch Q 
fever outbreak, analytically WGS offers superior resolution of strain types and is less prone to false-
positive/ negatives. Further, genomic differences distinguishing strains can be precisely measured, 
allowing high-resolution inference of phylogenomic relationships and of the sequence of transmission 
events. Given these results, the WGS should replace traditional methods as the gold standard method 
for bacterial strain typing in molecular epidemiology applications and outbreak investigations.  
 
Culturing and infection models of C. burnetii 
In vitro model for cell-free culture of C. burnetii 
For long time, in vitro growth of C. burnetii was limited to the use of mammalian cell cultures or 
embryonated eggs [33,34]. This changed when the host cell-free medium became available for in vitro 
growth of C. bunetii. This advanced medium is designed such that the metabolic requirements of C. 
burnetii are fully met, allowing its growth in liquid medium and as “colonies” in top-agar plates 
[35,36]. In Chapters 2, 4 and 5 the successful growth of C. burnetii was demonstrated for several 
strains. The reference NM strain grew rapidly in this new medium with optimal bacterial yields, while 
the Dutch field strains were more difficult to grow. The initial cultures of the Dutch field strains had 
longer lag phases than the reference strain, although this improved with repeated culture. From these 
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how cases were related. The determined phylodynamics provided important clues to successfully halt 
the transmission of the virus [28]. Another example is the recent avian influenza H5N8 outbreak in 
The Netherlands where WGS and phylodynamics provided invaluable insights that helped to 
efficiently manage the disease outbreak [29,30].  Real-time outbreak surveillance at the genome 
sequence level is now possible and has been used in several other outbreak cases in recent years 
[31,32] and has proved to have a broad impact on public health. The development of a fully automated 
bioinformatics pipeline for WGS data analysis of C. burnetii is much needed to make this powerful 
tool more widely accessible for future real-time investigations of Q fever outbreaks.  
 
Phylogenetic diversity of Dutch C. burnetii strains  
The phylogenome analysis of a large number of strains from different geographical areas has helped to 
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European countries [23]. Thus, phylogenetics implies a clonal spread and host-specificity of CbNL12 
strains among the European cattle population.  
Although WGS and genotyping approaches showed similar results with respect to Dutch Q 
fever outbreak, analytically WGS offers superior resolution of strain types and is less prone to false-
positive/ negatives. Further, genomic differences distinguishing strains can be precisely measured, 
allowing high-resolution inference of phylogenomic relationships and of the sequence of transmission 
events. Given these results, the WGS should replace traditional methods as the gold standard method 
for bacterial strain typing in molecular epidemiology applications and outbreak investigations.  
 
Culturing and infection models of C. burnetii 
In vitro model for cell-free culture of C. burnetii 
For long time, in vitro growth of C. burnetii was limited to the use of mammalian cell cultures or 
embryonated eggs [33,34]. This changed when the host cell-free medium became available for in vitro 
growth of C. bunetii. This advanced medium is designed such that the metabolic requirements of C. 
burnetii are fully met, allowing its growth in liquid medium and as “colonies” in top-agar plates 
[35,36]. In Chapters 2, 4 and 5 the successful growth of C. burnetii was demonstrated for several 
strains. The reference NM strain grew rapidly in this new medium with optimal bacterial yields, while 
the Dutch field strains were more difficult to grow. The initial cultures of the Dutch field strains had 
longer lag phases than the reference strain, although this improved with repeated culture. From these 
Chapter 8
186
  186 
 
 
 
observations, it can be assessed that different C. burnetii strains differ in their adaptation capabilities 
to new environmental conditions but eventually adapt to the prevailing conditions and thrive in the 
environment it resides in. Once adapted, the virulence characteristics of these strains are similar to 
cell-based cultured strains of similar passage number (Chapter 2). Moreover, at the transcriptome level 
we observed that the gene expression profiles of bacteria from the first two serial passages from cell-
cultures to cell-free cultures were very similar to completely adapted cell-free cultured strains (Chapter 
3). This suggested rapid adaptation capabilities of C. burnetii when moved from one environment to 
another. Overall, robust growth of several C. burnetii strains was observed in the liquid cell-free 
medium. However, colony formation in agarose plates was successful only for the reference NM strain 
which is also widely shown by other research groups [36,37], but not for other field strain. For the 
field strains no correlations of colony forming units (CFU) with focus forming units (FFU) was 
observed. This demonstrates that more research is needed to generate a reliable plating method for 
laboratory and field strains. Further improvement of the plating method for C. burnetii is necessary for 
development of a fully axenic system for genetic transformation and clone selection.  
In Chapter 2, similar virulence parameters of C. burnetii strains propagated from cell-free 
cultures and in vivo mimicking cell-based culture systems were observed. This suggests that C. 
burnetii propagated in the advanced cell-free system maintain their virulence associated 
characteristics. Thereby, the cell-free culture system is a valuable tool to study the pathogen by using 
molecular-techniques. Such techniques are much more difficult to apply when cell-based growth 
systems are used. Additionally, the axenic system will aid in development of Q fever preventatives, 
such as subunit vaccines as well as production of recombinant antigens. In Chapters 4 and 5, we have 
also used this cell free system to obtain pure bacterial DNA for WGS studies. Finally, a similar 
strategy used to establish cell-free culture conditions for C. burnetii was applicable for the 
development of a axenic culture system for Chlamydia [38]. Therefore such an approach could also be 
applicable to support the growth of other medically important obligate intracellular pathogens.  
 
Infection model for C. burnetii 
All our animal experiments were conducted with a newly developed mice model using “Swiss OF1 
mice”. This model is currently being used by several other research groups for evaluating 
pathogenicity of C. burnetii with consistent outcomes [39]. In Chapter 2 we observed similar relative 
virulence of several cell-cultured strains from two independent animal experiments. This observation 
further underlines the reproducibility of these virulence associated measurements of C. burnetii in the 
developed mice model. Consistent with previous studies [34], the Swiss OF1 mice likewise showed 
early and strong systemic antibody responses to several C. burnetii strains. The observed kinetics of 
IgM and IgG antibody’s in mice against phase I and II antigens were also in line with previous 
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published work in goats [40] and humans [41], strengthening the Swiss OF1 mice as a valid 
experimental model for immunological studies on Q fever agents (Chapter 6). Additionally, gene 
expression profiles of C. burnetii outbreak strains isolated from mice spleen and from goat aborted 
placenta were similar to each other (unpublished data). Such similar gene expression profiles of 
bacteria obtained from natural hosts and the experimental infection mice model further emphasizes the 
relevance of mice infection models in the study of Q fever. 
 
Tools and approaches to study C. burnetii pathogen 
Enumeration of live bacteria 
As colony counting in top-agar plates was not suitable for all C. burnetii strains, we searched for 
alternative methods to assess bacterial viability. One way to achieve this is by quantification of mRNA 
transcripts. However, the correlation between the occurrence of mRNA and viability is not necessarily 
always well-defined. This is because, mRNA synthesis might indicate the metabolic activity of cells 
rather than viability, which diminishes the power of this method [42]. Alternately, cell viability can be 
evaluated by indirect measurements of the state of the cells, such as membrane integrity. Often dual 
fluorescence staining kits are used for this purpose requiring use of a flow cytometer or fluorescent 
microscope [43]. The high cost of these instruments means they are not always available in level 3 
bio-safety laboratories. To circumvent these constraints, a simple method was designed which 
distinguished live and dead bacterial cells, based on the same principle of cell membrane integrity, by 
using a propidium monoazide (PMA) dye. The PMA dye selectively penetrates only into dead 
bacterial cells with compromised membranes and intercalates with DNA, inhibiting its amplification 
in a subsequent qPCR step [44]. Such a system is for instance used in the detection of Legionella in 
drinking and sanitary water systems, where detection of live/dead bacteria is crucial [44,45]. The PMA 
technique was applicable to C. burnetii obtained from both cell-based and cell-free systems. The live 
bacterial copies assessed by PMA-PCR were similar to bacterial counts obtained from laborious 
traditional methods such as FFU [46] and CFU [36], validating the efficiency of PMA-PCR technique. 
This safe and feasible PMA-PCR method allowed the number of living organisms to be calculated in 
the inocula used for in vitro and in vivo infections, with reproducible outcomes (Chapters 2 and 6). 
 
Mechanism of phase variation and its immunological outcomes 
Phase variation is a well-recognized phenomenon in C. burnetii. Although, bacterial culture in in vitro 
systems is the only well-defined factor known to influence phase variation. The precise mechanism of 
phase variation, resulting in truncation of LPS, is still unknown. Deletion of (part of) cluster of O-
antigen genes (CBU0676 to CBU706) which are implicated in the synthesis of the terminal part of 
LPS, is generally thought to be associated with phase variation [47]. Transcriptome and genome 
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early and strong systemic antibody responses to several C. burnetii strains. The observed kinetics of 
IgM and IgG antibody’s in mice against phase I and II antigens were also in line with previous 
  187 
 
 
 
published work in goats [40] and humans [41], strengthening the Swiss OF1 mice as a valid 
experimental model for immunological studies on Q fever agents (Chapter 6). Additionally, gene 
expression profiles of C. burnetii outbreak strains isolated from mice spleen and from goat aborted 
placenta were similar to each other (unpublished data). Such similar gene expression profiles of 
bacteria obtained from natural hosts and the experimental infection mice model further emphasizes the 
relevance of mice infection models in the study of Q fever. 
 
Tools and approaches to study C. burnetii pathogen 
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transcripts. However, the correlation between the occurrence of mRNA and viability is not necessarily 
always well-defined. This is because, mRNA synthesis might indicate the metabolic activity of cells 
rather than viability, which diminishes the power of this method [42]. Alternately, cell viability can be 
evaluated by indirect measurements of the state of the cells, such as membrane integrity. Often dual 
fluorescence staining kits are used for this purpose requiring use of a flow cytometer or fluorescent 
microscope [43]. The high cost of these instruments means they are not always available in level 3 
bio-safety laboratories. To circumvent these constraints, a simple method was designed which 
distinguished live and dead bacterial cells, based on the same principle of cell membrane integrity, by 
using a propidium monoazide (PMA) dye. The PMA dye selectively penetrates only into dead 
bacterial cells with compromised membranes and intercalates with DNA, inhibiting its amplification 
in a subsequent qPCR step [44]. Such a system is for instance used in the detection of Legionella in 
drinking and sanitary water systems, where detection of live/dead bacteria is crucial [44,45]. The PMA 
technique was applicable to C. burnetii obtained from both cell-based and cell-free systems. The live 
bacterial copies assessed by PMA-PCR were similar to bacterial counts obtained from laborious 
traditional methods such as FFU [46] and CFU [36], validating the efficiency of PMA-PCR technique. 
This safe and feasible PMA-PCR method allowed the number of living organisms to be calculated in 
the inocula used for in vitro and in vivo infections, with reproducible outcomes (Chapters 2 and 6). 
 
Mechanism of phase variation and its immunological outcomes 
Phase variation is a well-recognized phenomenon in C. burnetii. Although, bacterial culture in in vitro 
systems is the only well-defined factor known to influence phase variation. The precise mechanism of 
phase variation, resulting in truncation of LPS, is still unknown. Deletion of (part of) cluster of O-
antigen genes (CBU0676 to CBU706) which are implicated in the synthesis of the terminal part of 
LPS, is generally thought to be associated with phase variation [47]. Transcriptome and genome 
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sequencing studies conducted in Chapters 2 and 5 significantly contributed to the knowledge of the 
mechanism of phase variation. The general observations from these studies were that deletion of 
genome region encoding the O-antigen genes (38 kb size) occurs with increasing passages in in vitro 
culture models. All CbNL01 sequenced strains showed a deletion of a portion of the CBU0691 gene. 
The expression of this truncated gene was also downregulated in a highly-passaged CbNL01 genotype 
strain (602). This deletion could have a significant effect on LPS synthesis as it is implicated in 
virenose synthesis, a unique component of the C. burnetii phase I structure. Such a deletion event in 
the CBU0691 gene of all CbNL01 strains could be the starting point for phase variation. Moreover, in 
low passaged NLhu3345937 strain of CbNL01 genotype, a deletion of several genes at the beginning 
of the O-antigen gene cluster (CBU0676 to CBU0682) was also observed. These genes were also 
deleted in a high passaged 602 strain (Chapter 2), but not in low passaged 602 strain (Chapter 5). 
Combining these results, it can be speculated that the possible mechanism of excision of O-antigen 
genes in CbNL01 strains is as follows:  the process is initiated by the deletion of a portion of the 
CBU0691 gene followed by deletions of O-antigen genes in the beginning of the LPS gene cluster 
(CBU0676 to CBU0682), deletion further progresses till the gene CBU0697 at the end of the O-
antigen cluster as seen in high passaged 602 strain (Chapter 2). Additionally, genome sequences of all 
CbNL12 strains showed only one deletion of 201 bp within gene CBU0686. These consistent partial 
gene deletions in CbNL01 and CbNL12 strains suggest a genotype-specific phase shifting of C. 
burnetii strains. Moreover, deletions were not observed in the other genotypes strains, but only in 
CbNL01 and CbNL12 genotype strains, although a low passage numbers were used for analyses of C. 
burnetii strains. Based on these findings, it can be speculated that CbNL01 and CbNL12 show a higher 
rate of phase variation compared to the other genotype strains.  
Immunological studies upon C. burnetii infection in mice, guinea pigs and the natural hosts 
goats and humans showed an early antibody response against phase II antigens rather than phase I 
antigens, though the infecting strains contained a phase I LPS (Chapter 6) [40,41,48,49]. There is no 
good explanation for such a typical phase II response prior to phase I responses. It could be possible 
that the primary phase II response, demonstrated to be a non-protective response [50], could act as an 
immunological decoy tactic to avoid/ delay responses against phase I antigens that efficiently 
neutralize the pathogen. Previous studies have provided clues that the delayed phase I antibody 
response are due to shielding of toll-like receptor ligands by LPS [50]. Whereas, the early phase II 
antibody responses are generated against easily accessible surface proteins that are shared in both 
phase I and II bacteria [51]. To this end, the existing literature does not comprise studies focusing on 
the advantages of an early phase II antibody response for a phase I bacteria. Further studies on 
identification of components resulting in the generation of phase II antibodies in a phase I LPS 
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containing bacteria and the role of phase II antibody in overall bacterial protection, will be crucial to 
gain a better understanding of C. burnetii infection process and survival in hosts.  
 
Recommendations and future scientific perspectives 
The studies presented in this thesis provide the results of genomic and transcriptomic studies to 
investigate the genetic potential of C. burnetii and provides more information on virulence, diversity 
and differential immune responses against various C. burnetii infections. The results described in this 
thesis contribute to a better explanation of the large Dutch Q fever outbreak and improve our 
understanding of bacterial adaptations, pathogenesis as well as genotype-phenotype relationships of C. 
burnetii strains. Furthermore, these results provide a framework for future studies and 
recommendations for the development of vaccines and diagnostic tools for Q fever. 
The problem with the current C. burnetii vaccines used in goats, is that after vaccination the 
bacteria are not completely eliminated from the host, although the clinical symptoms such as abortions 
and bacterial shedding are significantly decreased [52]. Since the current vaccines are prepared from 
the NM phase I strain, it might not represent the optimal antigenic repertoire of goat strains. The 
mutations in several membrane proteins of goat strains relative to the NM strain strengthen this 
(Chapter 5). The transcriptome study of a goat strain has shown up-regulation of several membrane 
associated proteins, including the mutated ones, under in vivo conditions (Chapter 3). Based on these 
findings, membrane proteins could potentially qualify as vaccine candidates and should be further 
tested for antigenicity and their potential for protection. Subunit vaccines prepared from these 
(mutated) surface proteins might confer improved protection to goats. Antigenicity of these surface 
associated proteins can be assessed by a protein array approach using convalescent sera generated 
from infected goats. Such an approach would be a robust way to assess large-scale identification of C. 
burnetii specific antibodies in sera. Proteins which are recognized by antibodies should be further 
checked to see if these purified proteins can elicit strong antibody response and confer protection in 
mice and ultimately in natural goat hosts against C. burnetii infection. Additionally, differentiation of 
infected and vaccinated animals is not possible based on the current phase I Q fever vaccines. This is a 
major drawback because the immune response generated by the current vaccines cannot be 
discriminated from the immune response from animals that have been exposed to a natural infection. 
Thus, development of specific vaccines such as DIVA (Differentiating Infected from Vaccinated 
Animals) vaccines that can distinguish infected and vaccinated animals could be a possible solution. 
Such vaccines will successfully allow treatment of infected animals differently from vaccinated 
animals.  
The studies in this thesis demonstrated that human PBMCs respond differently to strains 
obtained from acute and chronic infected patients. A low inflammatory cytokine response is generated 
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by human PBMCs upon stimulation with strains isolated from chronic patients and significantly higher 
response is generated against strains isolated from acute patients (Chapter 7). This indicates that the 
human acute and chronic origin strains might express different antigens or confer a differential 
transcriptional response in the host during acute and chronic infections. Such information can be used 
for vaccine development and/ or therapeutic treatments directed towards prevention of bacterial 
resistance to host response and its persistent re-infections. 
A final recommendation concerns the presence of around 33% of hypothetical genes in the 
genome of C. burnetii emphasizing a large gap in our knowledge on the functional properties of this 
pathogen. Additionally, we observed that these genes contained a large number of mutations in the 
outbreak strains and that they are differentially regulated under in vivo conditions, compared to in vitro 
conditions (Chapters 5 and 3). This highlights the potential contribution of these hypothetical genes in 
unique lifestyle and/or pathogenic potential of C. burnetii. Improved functional annotation of these 
genes is crucial for further a better understanding of how this pathogen hides/resides in its natural host. 
Elucidating the function of unknown genes is one the biggest challenges of the post-genomic era 
especially for bacteria that cannot be easily cultured in vitro. 
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Summary 
The largest reported Q fever outbreak in The Netherlands has resulted in a serious burden of disease in 
humans and mass culling of infected goats. In order to minimize such complications in the future, it is 
imperative to have a thorough understanding of the disease causing pathogen and development of 
effective Q fever vaccines. The research described in this thesis focuses on the molecular 
characterization of C. burnetii outbreak strains from infected goats, cattle, sheep and humans using 
pathogen-omics approaches. Our studies were initialized to better understand the bacterial 
pathogenesis and identify pathogen related factors that has modulated the disease outbreak. We also 
examined the differential immune responses generated against various C. burnetii strains derived from 
a variety of hosts in different model-systems. These experiments were conducted to provide an 
immunological explanation, why C. burnetii strains from goats are associated with high virulence and 
large disease outbreaks, contrasting the strains found in cattle. The results in this thesis expand our 
knowledge regarding pathogen associated molecular and immunological factors involved in host 
infections. 
Chapter 1, as an introduction provides the necessary background information of the Q fever 
disease and its causative agent C. burnetii, to offer a better understanding of the studies presented in 
this thesis. The Q fever outbreak in the Netherlands, tools used for outbreak investigation and control 
measures taken to limit the disease in humans are explained in detail, which provides the basis of the 
conducted research. In addition, this chapter also briefly introduces the fast advancements in molecular 
Q fever research in the recent years, while pinpointing some of the missing gaps that needs to be 
addressed. This is vital in order to obtain a further improved knowledge of the pathogen, which can 
aid in prevention of future Q fever outbreaks using better diagnostics or vaccines designed at the 
molecular level. 
The first publication of C. burnetii complete genome in 2003 has significantly improved the 
knowledge on the metabolic requirements of the pathogen. This has led to the development of an 
axenic medium, which allowed propagation of C. burnetii outside host cells. As studies of 
pathogenicity and molecular engineering can benefit from this system, in Chapter 2 we checked if C. 
burnetii strains virulence phenotype is consistently maintained in the cell-free system compared to the 
gold standard cell-based culturing system. These experiments were conducted in order to confirm that 
this advanced culture system maintains the virulence characteristics of the bacteria and not lead to 
additional culture-specific adaptations. We assessed the viability of C. burnetii by a propidium 
monoazide (PMA) treatment based real time PCR and determined expression of LPS encoding genes 
of bacteria in both culture systems as key parameters of its infection potential. We also used a mice 
infection model to directly assess the virulence potential of the strains propagated from both these 
systems using the degree of splenomegaly and bacterial load in spleen (accepted virulence associated 
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measurements). Our studies showed similar virulence phenotype of strains propagated from both 
culture systems confirming that the cell-free culture system itself does not have a significant influence 
on virulence phenotype of C. burnetii strains compared to cell-cultures. Additionally, a high passaged 
cell-free cultured strain showed LPS modification from phase I to phase II forms, which is also 
characteristically seen upon serial passage of C. burnetii in other in vitro models (embryonated eggs 
and cell cultures). 
As an obligate intracellular pathogen, C. burnetii requires metabolic regulation such that it can 
adapt to the intracellular environment of the host cell. In Chapter 3 we assessed the complete 
transcriptional profile of C. burnetii in vivo during infection (mice spleen) and in in vitro models (cell 
and cell-free cultures) to assess differential gene regulation of the bacterium in different micro-
environments. Between different models we observed major differential regulation of the bacteria in 
metabolic pathways and virulence associated genes. Under in vivo conditions, the prominent findings 
from our study include the enhanced expression of anionic cardiolipins and ion/proton exchangers for 
pH homeostasis and survival of the pathogen within the highly acidic vacuoles of host cells; enhanced 
organic molecule transportation indicating bacterial dependence on host products; anaerobic energy 
metabolism and enhanced ROS scavenging enzymes/ DNA repair mechanisms to combat against 
oxidative stress in host cells.  The in vivo environment also significantly induced expression of several 
known virulence genes in C. burnetii, including those implicated in LPS synthesis, colonization and 
factors predicted to be associated with host-cell modulations (inhibition of apoptosis, mimicking host 
proteins). This indicates that the virulence gene products most probably contribute to the bacterial 
adaptation and survival under in vivo conditions. The present study improved our knowledge on 
bacterial adaptation in host-specific environments and provided a framework for identification of 
virulence factors important for the design of vaccines. 
In Chapter 4 and 5 we determined and fully reconstructed the genome sequences of C. 
burnetii strains collected from goats, sheep and cattle during Dutch Q fever outbreak period. 
Additional strains obtained from Dutch chronic Q fever patients were also included. In these studies 
we used comparative bioinformatics approaches and identified highly similar genome sequences of 
outbreak CbNL01 genotype goat and human strains. These findings confirmed the previous 
epidemiological and genotypic studies linking goats as source of human infections during the Dutch Q 
fever outbreak. Furthermore, our phylogenetic analysis of sequenced strains along with all published 
genome sequences of C. burnetii showed a genotype-specific clustering of genomes indicating similar 
genome sequences of strains within one MLVA genotypic group. Hence, our studies additionally 
validated genotyping tools (MLVA and MST) as good representations of full genome diversity. Even 
though Whole Genome Sequencing might be preferred in the future, MLVA and MST provided 
invaluable insights for outbreak investigations and molecular epidemiology of C. burnetii during the 
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fever outbreak. Furthermore, our phylogenetic analysis of sequenced strains along with all published 
genome sequences of C. burnetii showed a genotype-specific clustering of genomes indicating similar 
genome sequences of strains within one MLVA genotypic group. Hence, our studies additionally 
validated genotyping tools (MLVA and MST) as good representations of full genome diversity. Even 
though Whole Genome Sequencing might be preferred in the future, MLVA and MST provided 
invaluable insights for outbreak investigations and molecular epidemiology of C. burnetii during the 
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Dutch Q fever outbreak. We further assessed genetic differences in outbreak CbNL01 strains 
compared to the reference Nine Mile (NM) and CbNL12 genome sequences. We found major 
differences predominantly as point mutations and increase in number of transposase genes in outbreak 
strain. Non-synonymous point mutations were found in several membrane proteins, DNA repair genes, 
genes involved in translation, transporters, Type IV secretion system and potential virulence factors. 
Mutations in genes encoding membrane proteins which were orthologs with the NM and CbNL12 
strains, indicates that these genes are under selective pressure to vary antigenically. While mutations in 
other genes could be possibly involved in alter of protein synthesis, protein export abilities as well as 
increase in virulence potential. Moreover, the large number of transposons resulted in increased 
genome plasticity of outbreak strains compared to other strains. Such movement of mobile elements 
could have a major influence on C. burnetii's genome evolution and function by aiding in improved 
acclimatization of the bacteria in its intracellular niche. These variations in critical genes of C. burnetii 
and extensive transposon-mediated genome rearrangements could have led to the increased epidemic 
potential of CbNL01 strains. 
 In Chapter 6 and 7 we used the strains described in Chapter 5 to identify if differences in 
host immune responses are dependent on host-origin or the MLVA genotype of C. burnetii strains. We 
assessed the immune responses in an in vivo mice infection model (Chapter 6) and by using an in 
vitro model of healthy human PBMCs (Chapter 7). From both the studies we saw a clear effect of 
host-origin grouping of C. burnetii strains rather than the MLVA genotype. Among different host-
origin strains, strains derived from cattle generated high pro-inflammatory cytokine-chemokines (IFN-
γ, TNF-α, IL-1β, IL-6, IL-12a, CCL2, CCL6, CXCL10), cell-mediated and antibody responses (IgG 
against phase I antigens) in mice compared to goat and human strains. Similarly, stimulation of human 
PBMCs with inactivated cattle strains also induced significantly more pro-inflammatory cytokines 
(TNF-α, IL-1β, IL-22) than goat, sheep and chronic human strains. Corresponding results from both 
studies showing protective immune responses to cattle strains could indicate that the mice and human 
immune system provoke an efficient defense against the pathogen, which could result in bacterial 
clearance and mild/ no disease symptoms. Whereas low immune responses to goat and human strains 
could result in less protection and prevent/delay elimination of these strains from the host leading to 
persistent infections and severe/chronic disease development. The differential immune responses 
generated by cattle, goat and human-derived strains reflect the observed differences in phenotypic 
expression of Q fever in natural hosts; where infected cattle rarely show clinical disease, contrasting 
the severe disease outcomes like abortions and chronic disease development in goats and humans 
respectively. Moreover, it might be possible that humans are less susceptible to cattle strains, as the 
human PBMCs elicits high pro-inflammatory response to cattle strains, which supports the molecular 
epidemiological observation (using MLVA) that cattle are rarely identified as the source of human Q 
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fever outbreaks. Based on our findings, we suggest that bacteria originating from goat hosts have a 
greater potential to cause outbreaks in humans and needs to be efficiently monitored. Additionally, the 
cattle strains seem to be low-virulent strains as strong pro-inflammatory and protective immune 
response of the host upon infection indicate its reduced pathogenic potential. 
In the general discussion (Chapter 8), the results of the thesis are presented and discussed in 
relation to the Dutch Q fever outbreak and the available international literature. Major outcomes of the 
thesis include the prominent genetic differences (several point mutations) and increased plasticity of 
the CbNL01 outbreak strains genomes, which might have resulted in its increased epidemic potential. 
Additionally, transcriptome analysis has contributed to an improved understanding of the pathogenesis 
of outbreak strains. The genome and transcriptome studies collectively showed up-regulation of most 
of the mutated genes of the outbreak strains under in vivo conditions, emphasizing the role of these 
genetic changes in evolutionary success of C. burnetii. The comparative analysis of several C. burnetii 
strains at the genome sequence level also showed a high similarity of strains within the same 
genotype. On the contrary, our results based on immune responses to various C. burnetii strains did 
not show any differences associated with the strain genotype, but only a strong association with its 
host-origin. This suggests that the virulence potential of C. burnetii strains is not only based on genetic 
differences, but also on other host-adaptation mechanisms such as transposition or differential gene 
regulation, which needs to be further investigated. Additionally, other non-genetic factors such as the 
risk to exposure (abortion storms in goat and sheep contrasting only mild disease in cattle), intensive 
goat farming and its proximity to the human populations could have facilitated the Dutch Q fever 
outbreak. One of the important outcomes highlighted in the discussion is the use of ultimate high-
resolution approaches like whole genome sequencing for molecular epidemiology and outbreak 
investigations of infectious diseases. This thesis also introduced and validated several basic and 
molecular tools to efficiently study virulence characteristics of intracellular bacterial pathogens. In 
addition, the present work provides a basis for future studies towards the development/design of 
vaccines and high-resolution diagnostic tools for Q fever, which could offer great potential in the 
control of Q fever outbreaks as well as limiting its transmission to humans. 
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Samenvatting 
De grootste Q koorts uitbraak gerapporteerd in Nederland heeft geleid tot ernstige ziekte bij de mens 
en tot massale ruiming van besmette geiten. Om dergelijke ziekte uitbraken in de toekomst te kunnen 
voorkomen, is het nodig om meer inzicht te verkrijgen in de ziekte veroorzakende bacterie. Dit inzicht 
zou kunnen leiden tot de ontwikkeling van vaccins gericht tegen Q koorts infecties. Het in dit 
proefschrift beschreven onderzoek richt zich op de karakterisering van C. burnetii stammen die bij de 
uitbraak hebben geleid tot een infectie in geiten, runderen, schapen en mensen. Hiervoor hebben we 
“pathogeen-omics” benaderingen gebruikt. Onze studies werden gestart om een beter inzicht te krijgen 
in de bacteriële pathogenese en om pathogeen gerelateerde factoren, die een rol hebben gespeeld bij de 
uitbraak, te kunnen identificeren. We onderzochten ook de immuun responsen die opgewekt werden 
tegen de verschillende C. burnetii stammen afkomstig van verschillende gastheren, in verschillende 
modelsystemen. Deze experimenten werden uitgevoerd om een immunologische verklaring te kunnen 
geven voor de waarneming dat C. burnetii stammen afkomstig van geiten hoog virulent zijn en leiden 
tot ziekte uitbraken, in tegenstelling tot stammen afkomstig van runderen. De resultaten beschreven in 
dit proefschrift hebben geleid tot meer kennis van de pathogeen geassocieerde moleculaire en 
immunologische factoren, die betrokken zijn bij gastheer-pathogeen interacties. 
Om de verschillende studies die beschreven zijn in dit proefschrift beter te kunnen begrijpen, 
zorgt hoofdstuk 1 voor de benodigde achtergrond informatie over Q koorts en over de ziekte 
verwekker C. burnetii. Hieronder valt de algemene beschrijving van de Q koorts uitbraak in 
Nederland, de verschillende methodes die gebruikt werden om het onderzoek naar de uitbraken uit te 
voeren en de controlemaatregelen die genomen zijn om de ziekte bij de mens te beperken. Bovendien 
geeft dit hoofdstuk inzicht in de ontwikkelingen van het Q koorts onderzoek gedurende de afgelopen 
jaren en is er aandacht voor nog ontbrekende kennis rondom intracellulaire bacteriën. Dit alles is van 
belang om een meer kennis te verkrijgen over de ziekteverwekker, kan helpen bij het voorkomen van 
toekomstige Q koorts uitbraken en kan bijdragen aan de ontwikkeling van verbeterde diagnostiek of 
van effectieve vaccins. 
De kennis over het metabole vermogen van C. burnetii is in 2003 sterk verbeterd door de 
publicatie van de eerste complete genoom sequentie. Dit heeft geleid tot de ontwikkeling van een 
axenisch medium waardoor vermeerdering van C. burnetii buiten eukaryote gastheercellen mogelijk 
werd. In hoofdstuk 2 beschrijven we onderzoek waarin we hebben gekeken of het  virulente fenotype 
van C. burnetii-stammen stabiel wordt gehandhaafd na groei van de bacteriën in het cel vrije systeem 
vergeleken met groei van de bacteriën in gastheercellen (de gouden standaard). Deze experimenten 
werden uitgevoerd om te bevestigen dat groei in een cel vrij systeem niet leidt tot verlies van 
virulentie kenmerken. Ook hebben we de levensvatbaarheid van C. burnetii na een propidium 
monoazide (PMA) behandeling getest in een real-time PCR. Tevens werd de expressie van LPS 
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coderende genen van de bacteriën in beide kweeksystemen bepaald. Expressie van LPS wordt 
beschouwd als een belangrijke parameter voor het vermogen van de bacterie om gastheercellen te 
kunnen infecteren. Als laatste hebben we een muis infectie model gebruikt om de virulentie van C. 
burnetii stammen gekweekt m.b.v. de beide kweeksystemen te beoordelen door de mate van 
splenomegalie en bacteriële verontreiniging in de milt te meten (geaccepteerde virulentie 
geassocieerde bepalingen). Onze studies toonden aan dat het virulente fenotype van de stammen in 
beide kweeksystemen werd gehandhaafd. Daarnaast werd in een C. burnetii stam, die zeer frequent 
werd gepasseerd in het cel vrije medium, een LPS modificatie van fase I naar II aangetoond. Een 
degelijke modificatie is kenmerkend voor een herhaaldelijke passage van C. burnetii stammen in 
andere in vitro modellen (zoals b.v. in bevruchte eieren en celculturen).  
Omdat C. burnetii een obligaat intracellulaire pathogeen is, zal de bacterie zich snel metabool 
moeten kunnen aanpassen aan de extra- en intracellulaire omgeving van de gastheer cel. Om de 
differentiële genregulatie van de bacterie onder de  verschillende groei omstandigheden te bestuderen, 
beschrijven we in hoofdstuk 3 het volledige expressie profiel van alle C. burnetii genen na in vivo 
infectie van muizen (milt) en na groei in verschillende in vitro modellen (cel en cel-vrij culturen). 
Tussen de bacteriën, gegroeid onder de verschillende condities, werden grote verschillen 
waargenomen in de expressieprofielen van metabole genen, maar ook van enkele met virulentie 
geassocieerde genen. Onder in vivo omstandigheden waren de meest opvallende waarnemingen de 
verhoogde expressie van genen coderend voor anionische cardiolipines en ion/proton wisselaars, die 
de bacterie gebruikt om de pH homeostase in stand te houden en te overleven binnen de sterk zure 
vacuolen van de gastheercellen; genen betrokken bij transport van organische moleculen, die duiden 
op de bacteriële afhankelijkheid van gastheer producten; genen die leiden tot een verhoogd anaeroob 
energiemetabolisme en verhoogde expressie van ROS enzymen en DNA herstelmechanismen die het 
de bacterie mogelijk maken om de oxidatieve stress in de gastheercellen te bestrijden. De in vivo 
omgeving leidt ook tot geïnduceerde expressie van een aantal bekende virulentiegenen van C. burnetii, 
waaronder genen die betrokken zijn bij de synthese van LPS en bij kolonisatie, maar ook van factoren 
geassocieerd met gastheercel modulaties (remming van apoptose of het nabootsen van 
gastheereiwitten). Dit betekent dat deze genproducten waarschijnlijk bijdragen aan de aanpassing van 
de bacterie aan de gastheer en de overleving van de bacterie onder in vivo omstandigheden. Deze 
studie geeft daarmee meer inzicht in de strategieën die de bacterie inzet om zich snel aan te kunnen 
passen aan de gastheer-specifieke omgeving en kan de basis vormen voor de identificatie van 
virulentiefactoren die van belang zijn voor het ontwerpen van vaccins.  
In de hoofdstukken 4 en 5 beschrijven we de volledig gereconstrueerde genoomsequenties 
van C. burnetii-stammen verzameld van geiten, schapen en runderen tijdens de Nederlandse Q koorts 
uitbraak periode. Extra stammen verkregen uit Nederlandse chronische Q koorts patiënten werden ook 
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meegenomen. In deze studies gebruikten we vergelijkende bioinformatica benaderingen en 
bevestigden dat de genoomsequenties van zowel geit en humane oorsprong beide behoorden tot het 
CbNL01 genotype, zoals vastgesteld in eerdere epidemiologische en genotypische studies. Die studies 
wezen er op dat geiten de bron waren voor de menselijke infecties tijdens de Nederlandse Q koorts 
uitbraak. Verder wezen fylogenetische analyses van de gesequencete stammen, samen met alle al 
gepubliceerde genoomsequenties van C. burnetii, op een genotype-specifieke clustering van de 
genomen. Dit duidt erop dat stammen die behoren tot één genotypische MLVA groep vergelijkbare 
genoomsequenties hebben. Hiermee toonden onze studies aan dat de meer routinematig toepasbare 
methodes, die nu frequent worden gebruikt om stammen te genotyperen (MLVA en MST), de genoom 
diversiteit goed weergeven. Hoewel “Whole Genome Sequencing” in de toekomst de voorkeur zal 
hebben, hebben MLVA en MST zeer waardevolle inzichten gegeven in de moleculaire epidemiologie 
van C. burnetii tijdens de Nederlandse Q koorts uitbraak. De gedetailleerde genetische verschillen 
tussen de CbNL01 uitbraak stammen, de referentie stam Nine Mile (NM) en stammen behorend tot het 
CbNL12 genotype werden ook in kaart gebracht. De genoom sequenties van deze stammen 
verschilden aanzienlijk. Er werden vooral veel puntmutaties gevonden en in de uitbraakstam was er 
een significante toename van het aantal transposase genen. Coderende puntmutaties werden gevonden 
in verschillende membraaneiwitten, DNA herstel genen, genen betrokken bij translatie, transport 
eiwitten, een Type IV secretie systeem en in potentiële virulentiefactoren. Het voorkomen van 
mutaties in genen die coderen voor membraaneiwitten met orthologen in NM en in CbNL12 stammen 
duidt er op dat deze genen onder selectiedruk antigene variatie hebben ondergaan. Daarnaast zijn er 
ook mutaties gevonden in genen die mogelijk betrokken zijn bij het veranderen van eiwitsynthese, bij 
eiwitexport en die leiden tot een toename van virulentie. Het toegenomen aantal transposons in de 
uitbraak stam vergeleken met andere stammen duidt op een toename in genoom plasticiteit. Een 
dergelijke plasticiteit kan van invloed zijn op de evolutie van het genoom van C. burnetii en is bekend 
te kunnen bijdragen aan een snelle aanpassing van de bacteriën aan een wisselende omgeving 
(bijvoorbeeld van extra- naar intracellulair). Al deze wijzigingen in C. burnetii genen en de 
uitgebreide transposon gemedieerde genoom re-arrangements kunnen hebben bijgedragen aan het 
toegenomen epidemische vermogen van de CbNL01 stammen. 
In de hoofdstukken 6 en 7 hebben we de in hoofdstuk 5 beschreven stammen gebruikt om te 
identificeren of verschillen in de gastheer immuunreacties afhankelijk zijn van de gastheer waaruit de 
bacterie is geïsoleerd of van het MLVA genotype waartoe de stam behoort. We hebben de 
immuunrespons bestudeerd in een in vivo muis infectie model (hoofdstuk 6) en met behulp van een in 
vitro model van gezonde menselijke PBMCs (hoofdstuk 7). In beide studies zagen we dat immuun 
responsen opgewekt tegen C. burnetii stammen afkomstig van eenzelfde gastheer vergelijkbaar waren, 
terwijl de reactie tegen stammen met eenzelfde MLVA genotype dat niet waren. Ook genereerden de 
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stammen afkomstig van runderen hogere pro-inflammatoire cytokine-chemokinen (IFN-γ, TNF-α, IL-
1β, IL-6, IL-12a, CCL2, CCL6, CXCL10), cel gemedieerde en antilichaam- responsen (IgG tegen fase 
I antigenen) in muizen dan stammen afkomstig van geiten en mensen. Bovendien leidde stimulatie van 
menselijke PBMCs met geïnactiveerde runder stammen tot aanzienlijk hogere pro-inflammatoire 
cytokine (TNF-α, IL-1β, IL-22) responsen dan stammen afkomstig van geiten, schapen en chronisch 
zieke mensen. Deze resultaten zouden er op kunnen wijzen dat muizen en mensen in staat zijn om een 
beschermende immuunrespons op te wekken tegen runder stammen waardoor er een efficiënte 
bescherming tegen de bacterie ontstaat. Dit kan resulteren in een efficiëntere verwijdering van de 
bacterie waardoor er mildere / geen ziektesymptomen ontstaan. Aan de andere kant zal de lage 
immuunrespons opgewekt tegen geiten en humane stammen leiden tot een laag niveau van 
bescherming waardoor de eliminatie van deze stammen wordt vertraagd en er ernstige infecties of 
chronische ziektes kunnen ontstaan. De differentiële immuunresponsen gegenereerd door stammen 
afkomstig van runderen, geiten en mensen weerspiegelen het verschil in het epidemiologisch succes 
van C. burnetii stammen waargenomen in de natuurlijke gastheren. Terwijl besmette runderen zelden 
klinische ziekte vertonen, ontwikkelen geiten en mensen ernstige ziekte, waaronder abortus en 
chronische infecties. Daarnaast zou het ook mogelijk kunnen zijn dat mensen minder gevoelig zijn 
voor runder stammen dan voor geiten stammen; omdat in humane PBMCs hoge pro-inflammatoire 
responsen worden opgewekt tegen runder stammen. Deze hypothese wordt ondersteund door 
moleculaire epidemiologische gegevens (MLVA) die laten zien dat runderen zelden worden 
geïdentificeerd als de bron van menselijke Q koorts uitbraken. Op basis van onze bevindingen lijkt het 
aannemelijk dat bacteriën afkomstig van geiten een hoog risico vormen voor het veroorzaken van 
uitbraken bij de mens. Deze geiten stammen moeten daarom efficiënt worden gemonitord. Runder 
stammen lijken daarentegen, op basis van de sterk pro-inflammatoire en beschermende 
immuunrespons die in de gastheer wordt opgewekt, laag-virulent. 
In de algemene discussie (hoofdstuk 8) worden de resultaten van het proefschrift 
gepresenteerd en besproken in relatie tot de Nederlandse Q koorts uitbraak en de beschikbare 
internationale literatuur. De belangrijkste resultaten van het proefschrift zijn onder meer de opvallende 
genetische verschillen (meerdere puntmutaties) en verhoogde plasticiteit van de genomen van de 
Nederlandse CbNL01 uitbraak stammen. Deze verschillen kunnen hebben geleid tot het toegenomen 
epidemische vermogen van deze stammen. De transcriptoom analyse heeft bijgedragen aan een beter 
begrip van de pathogenese van de uitbraak stammen. De genoom en transcriptoom studies hebben 
beide laten zien dat de meeste van de gemuteerde genen van de uitbraak stammen onder in vivo 
omstandigheden sterker worden aangeschakeld. Dit onderstreept de rol van deze genetische 
veranderingen bij het evolutionaire succes van C. burnetii. De vergelijkende analyse van de 
genoomsequenties van een aantal C. burnetii-stammen liet een hoge mate van gelijkenis zien tussen 
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stammen behorend tot eenzelfde genotype. C. burnetii stammen behorend tot hetzelfde genotype 
vertoonden op basis van de immuunresponsen echter geen overeenkomsten. Er  was echter wel een 
sterke associatie tussen deze stammen op basis van gastheer-oorsprong. Dit suggereert dat de 
virulentie van C. burnetii-stammen niet alleen gebaseerd is op de genetische verschillen, maar ook op 
gastheer-adaptatie mechanismen zoals het optreden van transposon gemedieerde veranderingen  of 
differentiële genregulatie. Dergelijke mechanismen zullen in de toekomst nog verder moeten worden 
onderzocht en zullen een belangrijke bijdrage kunnen leveren aan het bestuderen van intracellulaire 
bacteriële infecties. Bovendien kunnen andere niet-genetische factoren zoals het risico op blootstelling 
(contrast tussen de abortus storm in geiten en schapen en de milde ziekte verschijnselen bij runderen), 
intensieve geiten houderij en de nabijheid van de menselijke bevolking een rol hebben gespeeld bij het 
ontstaan en de efficiënte verspreiding van Q koorts in Nederland. Dit proefschrift onderschrijft het 
belang van het gebruik van hoge resolutie benaderingen zoals, whole genome sequencing technieken 
voor moleculair epidemiologische studies en onderzoek naar infectieziekte uitbraken. In dit 
proefschrift worden een aantal C. burnetii-specifieke moleculaire tools geïntroduceerd en gevalideerd, 
waarmee ook virulentie kenmerken van intracellulaire bacteriële pathogenen in het algemeen 
efficiënter kunnen worden bestudeerd. Bovendien, biedt het huidige werk een basis voor nieuwe 
studies naar de ontwikkeling van vaccins en diagnostische tools voor Q koorts. Dergelijke tools die 
mogelijk snel een virulenter type zouden kunnen aantonen zouden van grote meerwaarde kunnen zijn 
bij de bestrijding van Q koorts uitbraken evenals bij het voorkomen van de overdracht van C. burnetii 
van dier naar mens. 
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Statistics for the Life Sciences, 2014 
 
General 
Information Literacy including EndNote, 2011 
WIAS Introduction Course, 2012 
WIAS Course Ethics and Philosophy in Life Sciences, 2012 
High Impact writing for academic publications, 2013 
Writing for academic publications, 2014 
 
Research Skills Training 
Preparation of PhD proposal, 2011
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